data_2jug_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jug _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.183 0 N-CA-C 111.953 0.353 . . . . 2.87 111.953 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.01 97.17 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.074 -0.584 . . . . 2.3 112.181 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.78 95.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.787 0.327 . . . . 2.64 110.713 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.644 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 49.7 tp -63.07 -47.5 82.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 2.19 110.788 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.08 -47.78 84.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 2.17 110.155 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -50.57 73.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 2.28 112.005 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.644 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.8 p80 -72.78 -29.07 62.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 2.24 110.866 -173.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.15 65.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 1.33 110.528 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.65 -40.68 69.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.985 -0.552 . . . . 1.75 110.919 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.2 t -65.24 -42.58 93.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 2.66 111.077 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.79 -25.09 59.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.05 0.452 . . . . 2.04 110.317 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.63 6.66 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.565 -0.743 . . . . 1.44 112.587 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.59 ' O ' HD12 ' A' ' 55' ' ' LEU . 17.9 t -90.63 102.37 13.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 109.505 -0.554 . . . . 1.4 109.505 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HE ' ' NE2' ' A' ' 58' ' ' GLN . 3.8 mpt_? -115.03 128.74 56.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.771 -0.455 . . . . 3.03 109.771 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.639 ' O ' HD22 ' A' ' 56' ' ' LEU . 5.4 mp -126.11 120.7 30.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.98 -0.378 . . . . 1.67 109.98 175.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 56' ' ' LEU . 28.8 p90 -136.22 145.77 46.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 2.43 110.49 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.0 p -91.22 124.16 43.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.23 0.538 . . . . 3.4 110.193 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.07 101.17 7.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.162 -0.472 . . . . 4.2 110.076 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.29 -102.58 0.96 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.768 -0.73 . . . . 4.37 111.67 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.622 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 4.8 pt-20 -101.27 -21.97 14.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.3 111.274 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 10.6 tpp180 -121.33 136.51 54.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.174 -0.611 . . . . 6.12 112.349 -170.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.5 tt -80.01 129.15 34.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.079 -0.964 . . . . 2.68 109.453 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.474 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 8.0 mpt_? -99.69 136.95 38.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.255 -0.43 . . . . 4.59 109.865 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.98 130.68 56.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.905 -0.589 . . . . 2.52 109.673 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 51.8 tp60 -111.75 109.61 19.54 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.029 -0.73 . . . . 2.89 109.029 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 113.56 4.92 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.179 -0.464 . . . . 1.69 111.347 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.564 ' O ' HG23 ' A' ' 36' ' ' VAL . 39.8 Cg_exo -58.22 149.56 71.89 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.93 2.42 . . . . 2.21 111.971 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.47 123.64 12.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.503 2.135 . . . . 2.47 112.052 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.15 -34.37 5.66 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.546 -0.835 . . . . 1.81 112.945 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 33' ' ' PRO . 23.1 m -81.69 -21.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.321 . . . . 1.86 111.559 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.408 ' HA ' ' HE3' ' A' ' 37' ' ' MET . 8.7 tpp -82.8 22.58 0.9 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.242 0.544 . . . . 1.42 111.402 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -52.53 141.49 34.08 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 1.78 110.42 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.5 -33.19 29.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.14 2.56 . . . . 1.87 113.856 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 32.5 tt0 -72.21 -33.61 67.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.645 -0.422 . . . . 2.76 110.708 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 36' ' ' VAL . 2.3 tt -65.96 -40.79 91.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.21 0.529 . . . . 1.65 109.812 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.48 ' HA ' HD13 ' A' ' 45' ' ' LEU . 63.7 tp60 -59.65 -35.53 74.59 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.269 -0.878 . . . . 2.06 110.069 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.4 t -69.2 -29.65 67.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.651 -0.704 . . . . 2.01 110.107 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.9 mmt180 -70.89 -39.83 72.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.779 -0.452 . . . . 3.9 109.779 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 42' ' ' GLN . 69.4 mt -58.77 -39.44 81.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.064 -0.517 . . . . 1.42 109.796 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.0 -22.39 9.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.743 -0.662 . . . . 2.3 112.658 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 33.61 81.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.108 -0.568 . . . . 2.57 111.96 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' ' CD ' ' A' ' 51' ' ' GLU . . . -100.8 153.43 19.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.051 0.453 . . . . 2.42 110.745 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.5 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.6 ptm180 -68.8 -50.03 53.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.609 0.966 . . . . 5.86 113.609 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -57.37 -47.8 80.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.6 0.592 . . . . 3.23 112.6 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HG2' ' N ' ' A' ' 52' ' ' LEU . 3.1 pm0 -72.59 -36.99 68.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.935 -0.306 . . . . 2.75 110.205 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 56' ' ' LEU . 43.3 mt -64.86 -38.76 92.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.695 -0.402 . . . . 2.4 110.038 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 49' ' ' ARG . 82.5 mt -55.61 -41.62 65.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.186 0.517 . . . . 3.13 109.895 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -26.14 65.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 2.03 111.078 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 19' ' ' VAL . 2.7 mm? -70.85 -31.89 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.946 -0.302 . . . . 1.89 111.237 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -75.71 -38.27 58.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.127 0.489 . . . . 2.2 110.339 171.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -51.87 -28.62 16.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.597 -1.183 . . . . 4.58 111.202 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 3.4 pt20 -65.96 -40.48 91.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.369 -0.378 . . . . 1.75 110.713 175.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.444 ' CD1' ' HG2' ' A' ' 20' ' ' ARG . 19.7 mt -86.81 -13.56 44.72 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.798 1.407 . . . . 2.94 114.798 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.466 ' HA ' HE21 ' A' ' 60' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 113.076 0.769 . . . . 2.58 113.076 -168.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 N-CA-C 112.214 -0.354 . . . . 5.13 112.214 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.37 95.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.922 0.391 . . . . 6.14 110.649 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.552 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 49.6 tp -63.52 -46.84 84.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.015 -0.538 . . . . 4.74 110.436 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.61 -49.95 75.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 3.19 110.079 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.6 -53.32 59.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 4.03 112.125 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.552 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 3.5 p80 -69.86 -31.6 69.52 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.445 -0.502 . . . . 5.58 111.068 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.19 -40.23 74.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.137 0.494 . . . . 3.33 110.343 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.67 74.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 4.37 110.761 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -62.04 -45.87 91.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 6.1 111.282 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.97 -24.96 61.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.729 0.3 . . . . 6.81 111.087 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.04 39.72 6.86 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.646 -0.788 . . . . 5.35 112.263 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.421 ' O ' HD12 ' B' ' 55' ' ' LEU . 39.6 t -90.95 110.23 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.708 -0.479 . . . . 3.76 109.708 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.591 ' HE ' ' NE2' ' B' ' 58' ' ' GLN . 3.7 mpt_? -127.65 136.71 51.99 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.885 -0.326 . . . . 7.44 110.782 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.51 ' O ' HD22 ' B' ' 56' ' ' LEU . 5.3 mp -130.02 122.4 28.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.247 -0.649 . . . . 3.8 109.247 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.588 ' HB3' HD13 ' B' ' 56' ' ' LEU . 34.5 p90 -138.35 139.29 38.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 7.27 110.913 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.8 p -84.34 117.38 29.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 7.74 110.002 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.497 ' HB3' HH11 ' B' ' 29' ' ' ARG . 8.9 tp10 -112.13 101.18 9.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.864 -0.607 . . . . 9.44 109.544 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.8 -95.47 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.109 -0.567 . . . . 10.31 112.526 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.2 -25.6 12.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.999 0.428 . . . . 9.56 111.18 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -122.56 130.09 52.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 7.94 111.342 -166.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.3 tt -77.0 126.71 31.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.662 -0.699 . . . . 5.2 109.57 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.497 HH11 ' HB3' ' B' ' 24' ' ' GLU . 7.5 mpt_? -96.76 137.82 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.174 -0.467 . . . . 8.44 110.045 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.449 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -117.29 130.63 56.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.767 -0.651 . . . . 4.16 109.838 -176.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -110.47 109.73 20.2 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.095 -0.705 . . . . 7.26 109.095 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.5 112.5 5.99 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 5.75 111.255 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.507 ' O ' HG23 ' B' ' 36' ' ' VAL . 33.0 Cg_exo -59.37 146.17 95.67 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.616 2.211 . . . . 7.34 111.673 174.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.13 123.32 12.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.285 1.99 . . . . 9.22 112.129 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.09 -34.25 5.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.657 -0.783 . . . . 8.58 112.831 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 33' ' ' PRO . 13.9 m -83.03 -18.46 10.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.082 0.441 . . . . 7.19 111.316 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.416 ' HA ' ' HE3' ' B' ' 37' ' ' MET . 10.5 tpp -84.55 20.75 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.212 0.53 . . . . 6.01 111.501 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.7 p -50.62 136.34 25.2 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 8.28 110.475 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.58 -38.49 21.83 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.78 2.987 . . . . 7.89 114.499 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 31.3 tt0 -66.86 -29.45 69.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.643 -0.423 . . . . 9.22 110.94 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.411 HD12 ' O ' ' B' ' 36' ' ' VAL . 7.0 tt -73.1 -35.1 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.866 -0.42 . . . . 6.37 109.866 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -60.97 -36.33 79.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.477 0.656 . . . . 5.19 109.348 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -67.2 -31.92 72.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.378 -0.828 . . . . 7.5 110.313 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 38.0 mmt180 -68.54 -40.25 80.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.293 -0.412 . . . . 8.73 109.936 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.481 ' HA ' HD13 ' B' ' 10' ' ' LEU . 83.2 mt -61.19 -37.73 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 4.2 110.284 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.91 -22.53 11.5 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.628 -0.715 . . . . 5.65 112.714 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.47 30.17 74.83 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.006 -0.616 . . . . 4.5 112.517 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.35 158.74 15.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.044 0.449 . . . . 5.81 110.658 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.622 ' HD2' ' OE1' ' A' ' 26' ' ' GLU . 8.4 ptm180 -68.47 -50.25 53.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.589 0.959 . . . . 8.59 113.589 -172.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -58.33 -50.09 74.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.818 0.673 . . . . 7.48 112.818 -167.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -68.43 -40.81 81.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.309 -0.256 . . . . 5.72 110.309 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.598 ' O ' HD23 ' B' ' 56' ' ' LEU . 53.4 mt -63.72 -36.31 83.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.557 -0.292 . . . . 3.39 111.082 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.8 mt -57.43 -42.39 80.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.13 0.49 . . . . 6.75 110.073 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.09 72.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.88 -0.6 . . . . 3.81 110.981 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.578 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.4 mm? -66.37 -28.83 68.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.17 -0.468 . . . . 2.46 111.422 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.598 HD23 ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER -79.65 -33.85 40.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 5.83 110.192 172.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -57.11 -32.03 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 7.69 111.443 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.591 ' NE2' ' HE ' ' B' ' 20' ' ' ARG . 28.6 pt20 -67.45 -26.69 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.591 -0.277 . . . . 4.23 111.574 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.33 -0.252 0 N-CA-C 112.382 0.512 . . . . 6.46 112.382 -175.176 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.585 0.587 . . . . 2.87 112.585 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.43 -42.08 88.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.562 -0.351 . . . . 2.3 112.697 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.28 90.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.942 0.401 . . . . 2.64 110.802 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.99 -46.58 74.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 2.19 110.235 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.317 -0.856 . . . . 2.17 110.221 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.26 79.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.983 0.421 . . . . 2.28 110.992 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.59 -28.95 61.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.95 -0.568 . . . . 2.24 110.956 -174.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.4 -41.08 49.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 1.33 110.317 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.99 82.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.475 . . . . 1.75 111.058 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -66.71 -30.38 70.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.871 -0.604 . . . . 2.66 110.661 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.19 -26.1 26.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.166 -0.47 . . . . 2.04 110.841 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.23 30.81 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.794 -0.717 . . . . 1.44 113.123 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.44 HG23 HD21 ' A' ' 41' ' ' LEU . 44.1 t -74.39 113.23 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.275 -0.639 . . . . 1.4 109.275 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.644 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 98.6 mtt180 -124.56 135.91 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.448 -0.342 . . . . 3.03 110.944 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.94 131.71 42.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 1.67 110.167 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.469 ' HB3' HD12 ' A' ' 56' ' ' LEU . 30.5 p90 -151.63 152.65 33.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.717 -0.475 . . . . 2.43 109.717 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.9 p -99.49 126.78 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.335 0.588 . . . . 3.4 110.54 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.67 105.86 10.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.79 -0.641 . . . . 4.2 109.77 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.16 -107.8 2.42 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.829 -0.7 . . . . 4.37 111.397 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.08 -8.35 15.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.811 0.339 . . . . 5.3 110.243 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 10.2 tpp180 -116.31 134.28 55.07 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.635 0.605 . . . . 6.12 112.635 -170.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 8.3 tt -76.96 124.98 28.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.102 -0.954 . . . . 2.68 108.939 171.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 11.7 mmm180 -97.94 135.32 39.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.592 -0.522 . . . . 4.59 109.592 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.35 132.08 55.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.993 0.425 . . . . 2.52 110.533 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.752 ' HA ' HE21 ' A' ' 31' ' ' GLN . 0.0 OUTLIER -123.13 114.27 20.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.194 -0.457 . . . . 2.89 109.951 174.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.03 126.43 4.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.277 -0.42 . . . . 1.69 110.736 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 36' ' ' VAL . 30.2 Cg_exo -63.89 157.13 54.2 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.914 2.41 . . . . 2.21 111.904 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.61 123.14 12.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.361 2.041 . . . . 2.47 112.342 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 38' ' ' THR . . . 111.36 -37.32 3.76 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.671 -0.695 . . . . 1.81 113.413 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.548 HG23 ' HD2' ' A' ' 33' ' ' PRO . 18.6 m -77.1 -15.73 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.385 0.513 . . . . 1.86 112.385 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.41 20.98 0.81 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.822 0.344 . . . . 1.42 111.232 -173.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 35' ' ' GLY . 16.9 p -50.86 142.02 17.44 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.372 -0.376 . . . . 1.78 110.944 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -52.06 -34.41 57.46 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.925 2.417 . . . . 1.87 112.961 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -71.29 -29.81 65.49 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 2.76 110.372 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 36' ' ' VAL . 3.0 tt -71.76 -37.13 70.56 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.748 0.785 . . . . 1.65 109.69 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -58.69 -36.5 74.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.788 -1.097 . . . . 2.06 109.664 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.4 t -71.84 -30.09 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.427 -0.806 . . . . 2.01 110.618 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.2 mmt180 -63.71 -44.94 92.15 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.865 -0.42 . . . . 3.9 109.865 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.347 -0.842 . . . . 1.42 109.467 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.64 -22.57 8.79 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.456 -0.793 . . . . 2.3 113.064 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' B' ' 27' ' ' ARG . . . 71.73 20.14 78.44 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.768 -0.729 . . . . 2.57 112.007 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -81.56 147.47 29.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.854 -0.338 . . . . 2.42 110.285 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.551 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.3 ptm180 -70.73 -51.91 24.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.371 -0.377 . . . . 5.86 111.863 -174.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -61.84 -32.32 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.506 0.669 . . . . 3.23 110.581 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.8 tp10 -72.46 -43.34 63.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.03 -0.987 . . . . 2.75 109.974 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.66 -24.85 61.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.714 -0.676 . . . . 2.4 111.152 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 49' ' ' ARG . 73.9 mt -61.23 -49.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.926 -0.398 . . . . 3.13 109.926 173.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.63 67.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.203 0.525 . . . . 2.03 110.614 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -70.01 -39.43 75.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 1.89 109.317 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 3.8 tp -79.17 -31.27 43.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.763 -0.653 . . . . 2.2 109.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -64.38 -24.0 67.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 4.58 110.535 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -60.18 -31.38 70.07 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.528 ' HG ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -105.81 4.96 30.37 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.968 -0.693 . . . . 2.94 111.461 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 99.1 mt-30 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.535 . . . . 2.58 110.054 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 CA-C-O 120.155 -0.247 . . . . 5.13 112.924 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.79 90.62 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.82 0.343 . . . . 6.14 110.709 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 64.5 tp -72.68 -46.06 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.12 -0.491 . . . . 4.74 110.188 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.26 -51.4 70.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.719 -0.673 . . . . 3.19 110.27 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.17 85.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 4.03 111.156 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.46 -40.28 89.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.937 -0.574 . . . . 5.58 111.004 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.15 63.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 3.33 110.823 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.29 -46.62 87.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 4.37 111.676 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 30.1 m -64.6 -28.35 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 6.1 111.363 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.414 ' O ' ' HG2' ' B' ' 33' ' ' PRO . 70.3 mt -86.33 -25.27 25.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 6.81 110.599 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.64 26.32 27.66 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.79 -0.719 . . . . 5.35 112.606 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.84 111.25 12.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.552 -0.536 . . . . 3.76 109.552 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 98.5 mtt180 -125.01 139.36 53.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.359 -0.382 . . . . 7.44 111.055 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.459 HD23 ' CE2' ' B' ' 30' ' ' PHE . 5.9 mp -135.29 134.38 39.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 3.8 109.964 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.515 ' HB3' HD12 ' B' ' 56' ' ' LEU . 36.5 p90 -153.07 154.82 35.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.944 -0.391 . . . . 7.27 109.944 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.9 p -99.34 123.39 52.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.531 . . . . 7.74 110.566 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -119.39 102.85 8.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.5 -0.555 . . . . 9.44 109.5 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.09 -109.32 2.76 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.382 -0.687 . . . . 10.31 111.382 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.68 -6.82 15.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.908 0.385 . . . . 9.56 110.506 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 9.4 tpp180 -118.22 127.46 53.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.206 0.526 . . . . 7.94 111.823 -169.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 8.7 tt -73.8 126.75 31.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 5.2 108.97 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.454 ' HB2' ' CE2' ' B' ' 22' ' ' TRP . 9.1 mmm180 -99.85 135.05 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.557 -0.535 . . . . 8.44 109.557 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.459 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.7 OUTLIER -112.23 134.29 53.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.309 -0.405 . . . . 4.16 110.194 -176.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.754 ' HA ' HE21 ' B' ' 31' ' ' GLN . 0.0 OUTLIER -124.2 112.63 17.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.145 -0.479 . . . . 7.26 109.89 175.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.89 122.06 4.2 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.342 -0.39 . . . . 5.75 110.491 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.508 ' O ' HG21 ' B' ' 36' ' ' VAL . 32.5 Cg_exo -59.94 154.09 52.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.882 2.388 . . . . 7.34 112.12 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.8 122.97 12.66 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.534 2.156 . . . . 9.22 112.347 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.74 -37.15 3.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.655 -0.783 . . . . 8.58 113.091 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.508 HG21 ' O ' ' B' ' 33' ' ' PRO . 11.0 m -80.17 -7.38 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.0 0.4 . . . . 7.19 111.587 -175.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.888 ' HA ' ' HE3' ' B' ' 37' ' ' MET . 0.2 OUTLIER -84.18 18.82 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.81 0.338 . . . . 6.01 111.174 -175.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 19.5 p -49.94 141.44 14.5 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 8.28 111.471 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -52.69 -34.89 66.11 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.23 2.62 . . . . 7.89 113.175 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 0.0 OUTLIER -72.11 -30.08 64.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.768 -0.373 . . . . 9.22 110.344 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.592 ' HA ' ' HG2' ' B' ' 44' ' ' ARG . 8.9 tt -74.11 -32.5 63.23 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.735 -0.469 . . . . 6.37 109.735 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -60.39 -36.62 78.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.773 -0.649 . . . . 5.19 109.341 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -72.28 -29.86 64.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.353 -0.84 . . . . 7.5 110.497 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' B' ' 41' ' ' LEU . 35.9 mmt180 -63.32 -48.0 79.87 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 8.73 109.83 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -58.61 -43.03 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.435 -0.802 . . . . 4.2 109.916 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.49 -24.01 6.84 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.188 -0.915 . . . . 5.65 112.742 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.24 12.71 83.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.945 -0.645 . . . . 4.5 112.546 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -73.37 148.42 43.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.244 -0.28 . . . . 5.81 110.244 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 53' ' ' ILE . 12.0 ptm180 -69.4 -51.09 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.34 -0.391 . . . . 8.59 111.987 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.8 -31.18 72.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.935 0.398 . . . . 7.48 111.263 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.2 OUTLIER -71.44 -40.47 70.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.38 . . . . 5.72 110.302 -178.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 82.1 mt -76.04 -23.94 55.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 3.39 111.211 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 49' ' ' ARG . 76.8 mt -61.28 -48.38 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.732 -0.47 . . . . 6.75 109.732 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.48 -36.89 82.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 3.81 110.343 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' B' ' 52' ' ' LEU . 3.1 tm? -59.81 -45.51 92.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 2.46 110.013 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' B' ' 22' ' ' TRP . 43.0 tp -68.41 -35.59 77.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.035 0.445 . . . . 5.83 110.575 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.15 -22.58 66.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 7.69 111.271 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -62.55 -31.14 71.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.634 -0.257 . . . . 4.23 111.439 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.63 ' H ' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 6.46 111.618 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 110.421 -0.215 . . . . 2.87 110.421 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.39 -40.45 85.79 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 123.442 0.464 . . . . 2.3 112.404 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.1 76.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.976 0.417 . . . . 2.64 111.116 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.705 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 59.2 tp -66.28 -46.55 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 2.19 110.506 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.23 -48.72 80.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.678 -0.692 . . . . 2.17 110.277 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.76 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.454 -0.339 . . . . 2.28 111.663 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.705 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.1 p80 -76.5 -26.92 55.8 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.829 0.347 . . . . 2.24 110.794 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.71 -35.63 51.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.122 -0.231 . . . . 1.33 110.538 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.6 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 1.75 111.384 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.8 p -65.78 -41.78 91.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 2.66 110.449 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.491 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 50.0 mt -77.87 -26.38 49.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 2.04 110.022 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.2 18.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.724 -0.671 . . . . 1.44 113.348 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.39 135.48 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.86 -0.793 . . . . 1.4 108.86 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 71.4 mtt180 -130.81 126.63 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.693 -0.194 . . . . 3.03 110.653 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 52' ' ' LEU . 6.1 mp -133.52 117.15 16.8 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 1.67 111.815 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 56' ' ' LEU . 26.7 p90 -129.75 149.08 51.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 2.43 109.315 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.09 128.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.347 0.594 . . . . 3.4 111.349 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.436 ' HB3' ' NE ' ' A' ' 29' ' ' ARG . 38.1 tt0 -120.75 116.5 25.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.747 -0.834 . . . . 4.2 108.747 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.42 -109.46 2.9 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.092 -1.203 . . . . 4.37 110.092 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.69 -15.0 10.8 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.808 0.337 . . . . 5.3 110.291 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -92.43 144.46 25.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.563 0.697 . . . . 6.12 111.445 -172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.4 tm? -85.96 129.28 34.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.969 -1.014 . . . . 2.68 109.903 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.436 ' NE ' ' HB3' ' A' ' 24' ' ' GLU . 4.2 mpt_? -97.25 130.07 44.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.136 -0.691 . . . . 4.59 109.136 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CE2' HD23 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -114.26 131.32 56.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.508 -0.314 . . . . 2.52 110.882 -171.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 6.1 tp-100 -130.15 123.87 31.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.196 -0.456 . . . . 2.89 109.919 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.47 138.06 11.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.397 -0.365 . . . . 1.69 110.816 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' HG21 ' A' ' 36' ' ' VAL . 27.5 Cg_endo -68.03 155.31 70.09 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.6 2.2 . . . . 2.21 111.25 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.04 122.47 10.97 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 122.38 2.053 . . . . 2.47 112.464 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.5 -28.78 9.21 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.712 -0.676 . . . . 1.81 113.31 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.59 HG21 ' O ' ' A' ' 33' ' ' PRO . 22.9 m -83.74 -11.75 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.878 0.696 . . . . 1.86 112.878 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.503 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -83.55 20.42 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.696 0.284 . . . . 1.42 111.747 -173.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 p -53.1 147.09 18.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 1.78 111.444 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.7 -33.84 51.2 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 1.87 113.508 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.1 tt0 -70.78 -35.14 72.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.515 -0.474 . . . . 2.76 110.499 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -64.36 -41.15 96.88 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 121.032 0.444 . . . . 1.65 109.827 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -59.86 -37.36 79.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.06 109.946 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -67.68 -28.84 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 2.01 110.35 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 35.2 mmt180 -73.18 -43.98 60.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.311 -0.404 . . . . 3.9 110.17 176.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 53.9 mt -62.51 -42.93 99.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.364 0.602 . . . . 1.42 109.431 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.21 -23.06 7.44 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.607 -0.724 . . . . 2.3 112.778 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.18 16.31 76.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.917 -0.659 . . . . 2.57 111.761 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.588 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -76.63 148.77 36.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.944 0.402 . . . . 2.42 110.357 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.0 ptp180 -69.11 -51.04 42.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 5.86 111.943 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -61.87 -33.67 74.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 3.23 110.226 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.455 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -67.99 -46.5 71.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.253 -0.885 . . . . 2.75 110.476 -177.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 21' ' ' LEU . 72.9 mt -66.23 -30.27 70.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.383 -0.826 . . . . 2.4 111.175 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 49' ' ' ARG . 89.2 mt -60.97 -43.55 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.713 0.768 . . . . 3.13 110.017 174.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.166 -0.925 . . . . 2.03 110.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 55' ' ' LEU . 2.7 tm? -64.55 -38.14 89.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.832 -1.173 . . . . 1.89 107.832 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -69.68 -39.66 76.84 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.267 -1.333 . . . . 2.2 112.214 174.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -50.97 -29.7 12.99 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.157 -0.474 . . . . 4.58 111.42 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -54.09 -47.85 71.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.323 0.582 . . . . 1.75 110.784 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' O ' ' A' ' 59' ' ' LEU . 7.9 tt -84.74 -32.42 23.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 2.94 110.394 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.636 -0.711 . . . . 2.58 110.9 -173.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.251 0 N-CA-C 114.296 0.478 . . . . 5.13 114.296 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -48.14 78.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.092 0.446 . . . . 6.14 111.278 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.564 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 64.8 tp -63.47 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 4.74 110.688 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.48 -47.95 81.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 3.19 110.291 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.78 84.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 4.03 111.845 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.564 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 2.4 p80 -75.39 -27.33 59.03 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.342 -0.543 . . . . 5.58 111.169 -175.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.89 -38.78 52.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.871 -0.332 . . . . 3.33 110.848 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.65 76.99 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.288 -0.414 . . . . 4.37 111.311 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 23.3 p -64.22 -40.35 95.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 6.1 110.686 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.598 HD11 ' HB ' ' B' ' 36' ' ' VAL . 90.6 mt -75.22 -25.29 58.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 6.81 110.296 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.33 19.77 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.679 -0.772 . . . . 5.35 112.716 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.6 133.12 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.293 -0.632 . . . . 3.76 109.293 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.768 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 69.4 mtt180 -130.86 128.91 41.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.678 -0.237 . . . . 7.44 110.981 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.681 HD21 HD21 ' B' ' 52' ' ' LEU . 6.2 mp -134.29 122.74 23.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.995 -0.372 . . . . 3.8 109.995 173.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.412 ' HB3' HD22 ' B' ' 56' ' ' LEU . 30.4 p90 -137.2 148.15 46.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.78 -0.452 . . . . 7.27 109.78 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.12 128.17 49.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.422 0.63 . . . . 7.74 111.345 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.475 ' HB3' ' NE ' ' B' ' 29' ' ' ARG . 37.4 tt0 -118.83 117.14 28.07 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.154 -1.054 . . . . 9.44 108.154 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.25 -108.9 2.64 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.453 -1.059 . . . . 10.31 110.453 -168.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -15.15 10.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.232 0.539 . . . . 9.56 110.132 173.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.15 142.02 27.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.407 0.623 . . . . 7.94 111.167 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.6 HD12 HD22 ' B' ' 21' ' ' LEU . 3.2 tm? -86.19 132.28 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.097 -0.956 . . . . 5.2 110.224 -174.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.475 ' NE ' ' HB3' ' B' ' 24' ' ' GLU . 3.8 mpt_? -100.82 130.96 46.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.203 -0.666 . . . . 8.44 109.203 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.528 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -113.9 131.75 56.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.748 0.309 . . . . 4.16 110.828 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.768 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 6.3 tp-100 -130.55 121.26 25.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.78 -0.452 . . . . 7.26 109.78 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.61 134.49 8.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.484 -0.325 . . . . 5.75 110.939 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.49 ' O ' HG21 ' B' ' 36' ' ' VAL . 29.8 Cg_endo -63.97 154.73 68.43 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.491 2.127 . . . . 7.34 111.865 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.38 122.96 12.56 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.424 2.083 . . . . 9.22 112.779 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.22 -32.13 6.7 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.81 -0.709 . . . . 8.58 113.402 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.598 ' HB ' HD11 ' B' ' 17' ' ' LEU . 10.7 m -85.29 2.99 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.183 0.438 . . . . 7.19 112.183 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.857 ' HE2' ' HA ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -93.46 19.35 8.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.894 0.378 . . . . 6.01 111.03 -176.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -53.46 145.51 27.58 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.547 . . . . 8.28 111.966 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.86 -39.51 39.42 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.356 2.704 . . . . 7.89 113.536 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 32.4 tt0 -65.62 -36.65 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.866 -0.334 . . . . 9.22 110.59 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 5.6 tt -68.26 -34.12 75.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.059 -0.348 . . . . 6.37 110.059 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -62.89 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 5.19 109.991 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 31.7 t -68.74 -34.11 75.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 7.5 110.183 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 28.2 mmt180 -63.84 -43.68 95.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.114 -0.494 . . . . 8.73 109.946 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 69.8 mt -65.97 -43.71 87.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 4.2 109.933 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 -22.16 9.57 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.572 -0.74 . . . . 5.65 112.408 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.14 19.74 78.69 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.877 -0.678 . . . . 4.5 111.42 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.85 149.41 36.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.826 0.346 . . . . 5.81 110.7 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' B' ' 53' ' ' ILE . 3.4 ptp180 -69.49 -50.32 46.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.206 -0.452 . . . . 8.59 111.735 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -64.73 -30.43 71.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.748 0.309 . . . . 7.48 111.456 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.542 ' HB2' ' HB1' ' B' ' 48' ' ' ALA . 0.3 OUTLIER -69.61 -45.35 68.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 5.72 110.814 -179.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.681 HD21 HD21 ' B' ' 21' ' ' LEU . 61.2 mt -67.32 -28.08 67.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 3.39 110.911 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.505 HG13 ' O ' ' B' ' 49' ' ' ARG . 90.9 mt -63.41 -48.67 86.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.114 0.483 . . . . 6.75 110.017 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . 0.511 ' HA ' ' HD2' ' B' ' 57' ' ' ARG . . . -68.4 -36.08 78.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 3.81 110.734 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.425 ' O ' HD11 ' B' ' 55' ' ' LEU . 2.1 tm? -55.93 -39.95 72.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.509 -0.768 . . . . 2.46 109.399 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.486 HD21 ' O ' ' B' ' 21' ' ' LEU . 0.8 OUTLIER -74.69 -27.65 60.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 5.83 110.234 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' B' ' 54' ' ' ALA . 80.1 mtt180 -62.58 -26.33 68.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.494 -0.321 . . . . 7.69 111.114 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -57.31 -39.71 76.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.349 0.595 . . . . 4.23 110.872 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.48 -0.782 . . . . 6.46 110.332 -176.491 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 -0.027 0 CA-C-O 120.597 0.237 . . . . 2.87 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.13 -39.14 95.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.137 -0.554 . . . . 2.3 112.24 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.75 -42.86 85.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.06 0.457 . . . . 2.64 110.682 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.677 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 45.9 tp -64.65 -47.13 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.813 -0.63 . . . . 2.19 110.268 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.21 -46.5 88.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.628 -0.715 . . . . 2.17 110.062 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -50.98 71.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 2.28 111.673 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.677 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 3.8 p80 -76.83 -27.96 55.35 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.657 -0.417 . . . . 2.24 110.954 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.11 66.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.068 -0.253 . . . . 1.33 110.496 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.75 92.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.131 0.491 . . . . 1.75 110.764 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -65.08 -33.39 75.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.498 -0.774 . . . . 2.66 110.845 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.497 HD12 ' HB ' ' A' ' 36' ' ' VAL . 83.8 mt -85.73 -26.32 25.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.108 0.48 . . . . 2.04 109.949 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.72 35.73 35.13 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.442 -0.799 . . . . 1.44 112.476 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.474 ' O ' HD11 ' A' ' 55' ' ' LEU . 97.4 t -69.38 108.67 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.335 -0.987 . . . . 1.4 108.335 170.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 51.7 mtt180 -112.18 133.64 54.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.155 0.502 . . . . 3.03 111.625 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.715 HD22 HD23 ' A' ' 52' ' ' LEU . 5.9 mp -130.41 136.69 49.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.892 -1.049 . . . . 1.67 109.728 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.51 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 22.9 p90 -158.2 137.92 12.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.49 -0.777 . . . . 2.43 109.257 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -85.33 121.63 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.665 -0.494 . . . . 3.4 109.665 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 33.1 tt0 -115.77 102.38 9.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.777 -0.647 . . . . 4.2 109.843 -175.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.67 -90.39 0.39 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.485 -0.779 . . . . 4.37 111.938 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -111.43 -28.71 8.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.546 0.212 . . . . 5.3 111.338 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -117.07 142.48 46.93 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.946 -0.701 . . . . 6.12 112.252 -169.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.615 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -69.3 124.34 23.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.867 -1.061 . . . . 2.68 108.565 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 15.5 mmm180 -101.45 136.36 41.42 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.601 -0.518 . . . . 4.59 109.601 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.8 135.67 55.1 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.539 -0.541 . . . . 2.52 109.539 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 25.2 tp60 -131.56 106.56 8.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.859 -0.422 . . . . 2.89 109.859 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.43 123.67 28.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 1.69 111.196 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD2' HG21 ' A' ' 36' ' ' VAL . 31.5 Cg_exo -61.51 160.01 29.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.649 2.233 . . . . 2.21 111.581 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.704 ' HB3' HG21 ' B' ' 38' ' ' THR . 28.4 Cg_endo -63.97 122.73 10.86 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.35 2.033 . . . . 2.47 112.753 -176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 38' ' ' THR . . . 97.55 -37.66 3.38 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.875 -0.679 . . . . 1.81 114.06 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' HB ' HD12 ' A' ' 17' ' ' LEU . 26.7 m -68.63 -14.01 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.285 0.846 . . . . 1.86 113.285 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.8 tpp -86.01 23.51 1.48 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.892 0.377 . . . . 1.42 111.41 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.621 HG21 ' HB3' ' B' ' 34' ' ' PRO . 43.7 p -50.74 145.77 10.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.44 -0.346 . . . . 1.78 110.764 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.532 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 52.1 Cg_exo -53.18 -28.97 44.09 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.915 2.41 . . . . 1.87 113.435 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 38.7 tt0 -67.97 -48.33 66.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.886 -0.413 . . . . 2.76 109.886 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.26 -37.23 86.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.428 0.633 . . . . 1.65 109.883 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -56.42 -41.15 75.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.92 -1.036 . . . . 2.06 109.85 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 2.01 110.663 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 3.4 mmp_? -67.61 -38.04 83.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.487 -0.324 . . . . 3.9 110.432 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.7 mt -64.6 -43.26 94.36 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.152 -0.684 . . . . 1.42 109.152 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.65 -23.78 6.31 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 2.3 113.448 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.92 14.38 75.88 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 2.57 111.825 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.536 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -84.0 150.15 25.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.991 -0.374 . . . . 2.42 109.991 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' A' ' 53' ' ' ILE . 19.1 ptp180 -69.35 -50.56 45.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 111.773 0.286 . . . . 5.86 111.773 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.493 ' HA ' HD13 ' A' ' 53' ' ' ILE . 8.9 p80 -56.96 -35.73 69.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.052 0.454 . . . . 3.23 110.529 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.09 -51.12 67.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.368 -0.833 . . . . 2.75 109.852 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.715 HD23 HD22 ' A' ' 21' ' ' LEU . 80.8 mt -69.18 -25.65 64.45 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.672 -1.149 . . . . 2.4 111.016 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.5 mt -59.74 -47.7 90.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.789 0.328 . . . . 3.13 110.304 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -31.49 71.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.342 0.591 . . . . 2.03 110.494 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 2.1 tm? -71.54 -41.34 69.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.201 1.001 . . . . 1.89 108.461 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.592 HD21 ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.93 -43.14 99.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.808 -1.542 . . . . 2.2 110.135 178.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.38 -29.26 70.59 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.576 -1.193 . . . . 4.58 111.616 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.6 pt20 -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.659 -0.417 . . . . 1.75 110.847 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 21.52 17.15 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.805 0.336 . . . . 2.94 110.552 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.485 -0.561 . . . . 2.58 109.485 177.269 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.224 0 N-CA-C 112.812 -0.115 . . . . 5.13 112.812 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.72 -43.46 62.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.815 0.34 . . . . 6.14 110.747 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.507 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 69.1 tp -59.05 -47.54 84.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 4.74 110.76 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.92 -45.58 94.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.545 . . . . 3.19 110.048 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.9 63.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 4.03 112.323 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.507 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 8.9 p80 -76.81 -28.42 55.56 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 5.58 111.299 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -45.32 69.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.711 0.291 . . . . 3.33 110.583 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.25 95.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 4.37 111.182 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -61.83 -39.33 91.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 6.1 111.096 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.561 HD12 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -79.47 -26.63 41.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.796 -0.361 . . . . 6.81 110.594 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.76 33.03 19.99 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.849 -0.691 . . . . 5.35 112.495 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.407 ' O ' HD11 ' B' ' 55' ' ' LEU . 77.4 t -75.86 104.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.124 -0.695 . . . . 3.76 109.124 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 50.3 mtt180 -110.81 135.05 51.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.083 0.468 . . . . 7.44 111.9 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.606 HD22 HD23 ' B' ' 52' ' ' LEU . 6.2 mp -131.0 140.86 50.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.437 -0.801 . . . . 3.8 108.961 171.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.576 ' HA ' HD23 ' B' ' 56' ' ' LEU . 30.0 p90 -159.44 141.67 13.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.745 -0.465 . . . . 7.27 109.745 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.05 115.89 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.328 0.585 . . . . 7.74 109.793 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.454 ' HB2' ' HG3' ' B' ' 29' ' ' ARG . 27.4 tt0 -112.25 103.97 12.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 9.44 109.909 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.1 -90.7 0.51 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.752 -0.658 . . . . 10.31 112.342 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -115.7 -29.53 6.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.953 0.406 . . . . 9.56 110.871 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' B' ' 27' ' ' ARG . 5.9 tpp180 -115.08 138.83 50.44 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.291 -0.563 . . . . 7.94 111.651 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.549 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -68.48 126.34 29.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.405 -0.816 . . . . 5.2 108.984 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' B' ' 24' ' ' GLU . 14.1 mmm180 -102.97 135.24 45.02 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.799 -0.445 . . . . 8.44 109.799 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.507 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.1 t80 -119.76 132.44 55.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 4.16 109.54 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 24.9 tp60 -128.23 102.78 6.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.451 . . . . 7.26 109.781 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.45 122.59 31.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.957 -0.565 . . . . 5.75 111.335 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 31.4 Cg_exo -61.82 158.54 37.41 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.752 2.301 . . . . 7.34 111.748 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.621 ' HB3' HG21 ' A' ' 38' ' ' THR . 33.8 Cg_endo -64.86 123.4 11.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.404 2.069 . . . . 9.22 112.771 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.483 ' O ' HG23 ' B' ' 38' ' ' THR . . . 98.27 -36.92 3.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.968 -0.634 . . . . 8.58 113.777 172.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.561 ' HB ' HD12 ' B' ' 17' ' ' LEU . 24.8 m -72.09 -12.74 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.658 0.614 . . . . 7.19 112.658 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 19.3 tpp -86.2 22.58 1.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.923 0.392 . . . . 6.01 111.419 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.704 HG21 ' HB3' ' A' ' 34' ' ' PRO . 22.9 p -48.73 143.55 7.91 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.273 -0.421 . . . . 8.28 111.049 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.39 -27.5 39.83 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.236 2.624 . . . . 7.89 113.443 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.82 -50.68 61.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 9.22 109.949 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 tt -66.89 -33.45 75.62 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 6.37 109.817 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -56.83 -42.68 80.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.842 -0.617 . . . . 5.19 109.731 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.52 -29.65 63.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.499 -0.773 . . . . 7.5 110.702 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.633 ' CZ ' ' HA ' ' B' ' 44' ' ' ARG . 3.1 mmp_? -67.17 -38.79 86.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 8.73 110.482 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.99 -43.33 96.04 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.25 -0.648 . . . . 4.2 109.25 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.17 -23.85 6.72 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.436 -0.802 . . . . 5.65 113.354 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.16 12.25 79.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.71 -0.757 . . . . 4.5 112.007 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -80.46 151.36 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.265 -0.272 . . . . 5.81 110.265 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 18.0 ptp180 -68.31 -45.2 73.65 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.869 -0.332 . . . . 8.59 111.493 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -63.22 -35.61 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.227 -0.189 . . . . 7.48 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -46.47 82.52 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.071 0.462 . . . . 5.72 110.422 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.606 HD23 HD22 ' B' ' 21' ' ' LEU . 68.8 mt -69.97 -24.56 63.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 3.39 111.391 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 77.8 mt -65.07 -48.74 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.765 0.317 . . . . 6.75 110.264 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.56 95.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.316 0.579 . . . . 3.81 110.022 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.407 HD11 ' O ' ' B' ' 19' ' ' VAL . 1.1 tm? -58.88 -47.06 86.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.211 -0.904 . . . . 2.46 109.751 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' B' ' 22' ' ' TRP . 0.1 OUTLIER -55.39 -45.29 76.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.469 0.652 . . . . 5.83 110.604 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -64.72 -28.92 69.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 7.69 112.022 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -63.69 -30.01 71.17 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.769 0.318 . . . . 4.23 111.266 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.722 0.296 . . . . 6.46 110.771 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 11' ' ' LEU . . . . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.966 0.413 . . . . 2.87 110.121 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.53 -44.23 96.92 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.698 -0.683 . . . . 2.3 112.482 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.16 98.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.033 0.444 . . . . 2.64 111.055 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.633 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 39.9 tp -64.83 -46.67 80.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.829 -0.623 . . . . 2.19 110.755 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 7' ' ' ALA . 87.7 mt -58.73 -51.04 71.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.119 -0.491 . . . . 2.17 109.941 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.451 -0.795 . . . . 2.28 112.175 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.633 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 5.6 p80 -71.7 -28.09 63.47 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.625 -0.43 . . . . 2.24 110.841 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.85 39.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.035 0.445 . . . . 1.33 110.504 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.7 85.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 1.75 110.927 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -69.21 -22.95 63.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 2.66 110.776 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 98.9 mt -84.23 -25.52 29.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.232 0.539 . . . . 2.04 109.776 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.29 16.12 25.94 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.831 -0.7 . . . . 1.44 112.899 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.98 115.11 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.582 -0.525 . . . . 1.4 109.582 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.736 ' HD3' HD13 ' A' ' 59' ' ' LEU . 95.5 mtt180 -131.11 134.14 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.25 -0.432 . . . . 3.03 111.544 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.5 mp -128.82 133.46 48.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.123 -0.489 . . . . 1.67 109.856 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' HB3' HD13 ' A' ' 56' ' ' LEU . 22.8 p90 -151.92 149.1 28.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.179 -0.304 . . . . 2.43 110.179 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.6 p -87.86 128.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 3.4 109.818 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 32.8 tt0 -132.73 110.97 10.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.116 -0.493 . . . . 4.2 110.152 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.58 -101.46 1.0 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.766 -0.731 . . . . 4.37 111.712 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' OE1' ' HD3' ' B' ' 49' ' ' ARG . 0.3 OUTLIER -116.78 -3.79 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.575 0.213 . . . . 5.3 111.575 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.501 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 11.9 tpp180 -134.58 152.12 51.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.391 0.615 . . . . 6.12 111.912 -174.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.4 tt -80.81 132.66 35.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.302 -0.863 . . . . 2.68 109.751 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.501 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.3 mpt_? -99.71 140.57 33.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 4.59 109.836 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.08 130.95 53.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.071 -0.715 . . . . 2.52 109.071 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 62.7 tp60 -122.77 119.66 31.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.624 -0.51 . . . . 2.89 109.624 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.11 129.13 5.24 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.798 0.332 . . . . 1.69 110.851 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HD2' HG23 ' A' ' 36' ' ' VAL . 31.5 Cg_exo -61.48 154.47 59.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.681 2.254 . . . . 2.21 112.166 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.51 122.51 9.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.113 1.876 . . . . 2.47 112.115 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.88 -33.98 5.47 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.7 -0.762 . . . . 1.81 113.101 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' O ' HD21 ' A' ' 41' ' ' LEU . 34.1 m -79.69 -12.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.245 0.522 . . . . 1.86 112.1 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.61 21.71 0.79 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.086 -0.506 . . . . 1.42 111.243 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.7 p -50.4 139.5 19.66 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.329 -0.396 . . . . 1.78 110.971 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.507 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 83.3 Cg_exo -47.22 -39.36 26.75 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.314 2.676 . . . . 1.87 113.282 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 39.3 tt0 -63.08 -40.68 98.38 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.207 -0.197 . . . . 2.76 110.517 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -62.95 -40.04 96.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.793 0.33 . . . . 1.65 110.362 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.47 ' HA ' HD13 ' A' ' 45' ' ' LEU . 5.8 mt-30 -64.8 -39.48 93.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.249 0.547 . . . . 2.06 110.129 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -66.79 -29.63 69.62 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.094 -0.957 . . . . 2.01 109.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 51.0 mtt-85 -75.19 -38.61 60.72 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 115.882 -0.599 . . . . 3.9 110.079 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 42' ' ' GLN . 97.4 mt -55.69 -44.32 77.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.189 -0.671 . . . . 1.42 109.189 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.28 -23.24 5.52 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.579 -0.737 . . . . 2.3 113.134 168.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.71 74.18 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.737 -0.744 . . . . 2.57 111.484 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -85.08 149.52 25.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.652 0.263 . . . . 2.42 110.57 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.625 ' HD3' ' OE1' ' B' ' 26' ' ' GLU . 7.6 ptt180 -67.47 -51.65 48.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.375 . . . . 5.86 111.984 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -57.23 -39.34 75.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.384 0.611 . . . . 3.23 110.036 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.77 -55.83 22.98 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.853 -1.067 . . . . 2.75 110.351 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 93.3 mt -70.33 -26.65 63.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.091 -0.959 . . . . 2.4 111.854 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 49' ' ' ARG . 70.7 mt -62.02 -52.29 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 3.13 110.227 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.29 70.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.401 0.62 . . . . 2.03 110.23 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 55' ' ' LEU . 3.5 tm? -68.46 -29.46 68.1 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.196 -0.911 . . . . 1.89 109.929 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -82.72 -32.85 27.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.058 0.456 . . . . 2.2 110.602 174.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.76 -21.9 63.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 4.58 111.67 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -69.15 -22.63 63.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.916 0.389 . . . . 1.75 111.03 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.736 HD13 ' HD3' ' A' ' 20' ' ' ARG . 10.4 tt -73.98 -27.59 61.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.244 -0.651 . . . . 2.94 109.244 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.58 110.357 178.671 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 CA-C-O 120.008 -0.329 . . . . 5.13 113.369 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.72 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.0 0.4 . . . . 6.14 110.96 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.45 -46.6 89.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 4.74 110.354 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.89 -49.94 74.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.001 -0.545 . . . . 3.19 110.792 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.06 -53.04 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.551 . . . . 4.03 112.337 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.535 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 5.0 p80 -70.73 -28.42 64.7 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.283 -0.567 . . . . 5.58 110.903 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.95 59.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.066 0.46 . . . . 3.33 110.406 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.11 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.691 -0.686 . . . . 4.37 110.85 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -67.69 -26.74 66.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 6.1 110.547 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' B' ' 13' ' ' HIS . 92.5 mt -81.27 -24.88 36.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 6.81 110.42 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.28 15.47 25.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 5.35 112.809 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -73.95 114.92 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.939 -0.393 . . . . 3.76 109.939 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.749 ' HD3' HD13 ' B' ' 59' ' ' LEU . 94.6 mtt180 -131.05 136.99 48.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.315 -0.402 . . . . 7.44 111.491 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.487 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.7 mp -129.91 136.42 49.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 3.8 109.751 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.712 ' HB3' HD13 ' B' ' 56' ' ' LEU . 28.8 p90 -153.9 150.07 27.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.792 0.329 . . . . 7.27 110.381 175.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.2 p -88.03 130.69 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.482 -0.562 . . . . 7.74 109.482 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.664 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 35.0 tt0 -134.89 114.37 12.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.236 -0.438 . . . . 9.44 110.272 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -102.86 0.85 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.984 -0.627 . . . . 10.31 111.912 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.625 ' OE1' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -0.08 12.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.572 0.225 . . . . 9.56 111.266 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.513 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 10.7 tpp180 -140.14 146.77 39.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.106 -0.638 . . . . 7.94 111.395 -171.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.2 tt -79.13 135.71 36.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.515 . . . . 5.2 110.332 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.664 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 4.8 mpt_? -101.09 137.86 38.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 8.44 110.134 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.487 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.6 t80 -119.01 131.49 56.0 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.355 -0.609 . . . . 4.16 109.355 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -126.18 114.02 17.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.833 -0.432 . . . . 7.26 109.833 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.39 130.49 7.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 5.75 111.265 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.49 ' O ' HG21 ' B' ' 36' ' ' VAL . 32.1 Cg_exo -61.98 151.71 79.74 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.806 2.337 . . . . 7.34 112.302 175.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.507 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 34.9 Cg_endo -65.86 123.26 11.08 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.158 1.905 . . . . 9.22 112.326 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.42 -33.07 5.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.758 -0.734 . . . . 8.58 112.945 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.571 ' O ' HD21 ' B' ' 41' ' ' LEU . 22.5 m -83.99 -7.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.181 0.49 . . . . 7.19 111.53 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.803 ' HA ' ' HE3' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.43 20.22 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.399 . . . . 6.01 111.289 -175.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 14.9 p -50.67 138.91 22.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 8.28 111.338 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.01 -41.4 33.18 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.486 2.791 . . . . 7.89 113.473 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.581 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 42.5 tt0 -57.74 -40.74 80.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.506 0.194 . . . . 9.22 111.043 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.571 HD21 ' O ' ' B' ' 36' ' ' VAL . 2.5 tp -64.37 -42.39 96.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.86 0.362 . . . . 6.37 110.081 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.489 ' HA ' HD13 ' B' ' 45' ' ' LEU . 22.8 mt-30 -63.66 -36.99 85.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 5.19 109.97 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 17.2 t -68.02 -37.02 80.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.666 -0.697 . . . . 7.5 109.955 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 56.5 mtt-85 -66.56 -40.36 88.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.418 -0.355 . . . . 8.73 110.422 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' B' ' 42' ' ' GLN . 91.7 mt -56.92 -43.76 81.74 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-O 121.285 0.564 . . . . 4.2 109.732 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.19 -23.42 6.15 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.474 -0.784 . . . . 5.65 112.95 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.99 28.14 73.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.994 -0.622 . . . . 4.5 111.664 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.44 150.26 24.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.528 0.204 . . . . 5.81 110.467 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.501 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 11.0 ptt-85 -65.89 -50.21 65.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.338 -0.392 . . . . 8.59 111.403 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -57.48 -42.11 82.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.752 -0.204 . . . . 7.48 111.398 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -54.22 40.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.448 -0.342 . . . . 5.72 110.809 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.434 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 75.8 mt -67.91 -27.67 66.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.286 0.476 . . . . 3.39 112.286 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 49' ' ' ARG . 72.0 mt -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.808 -0.357 . . . . 6.75 110.09 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.75 -36.08 77.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.413 0.625 . . . . 3.81 110.486 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.486 ' O ' ' HG3' ' B' ' 58' ' ' GLN . 2.9 tm? -63.39 -29.21 70.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 2.46 110.134 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.712 HD13 ' HB3' ' B' ' 22' ' ' TRP . 22.9 tp -79.25 -32.38 43.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 5.83 110.694 173.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.59 -20.23 65.34 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.013 0.375 . . . . 7.69 112.013 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' B' ' 55' ' ' LEU . 1.5 pp0? -73.36 -17.93 61.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.768 -0.373 . . . . 4.23 110.893 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.749 HD13 ' HD3' ' B' ' 20' ' ' ARG . 10.1 tt . . . . . 0 C--N 1.329 -0.285 0 N-CA-C 109.398 -0.593 . . . . 6.46 109.398 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 110.379 -0.23 . . . . 2.87 110.379 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.1 92.87 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.579 -0.609 . . . . 2.3 111.579 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.22 85.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 2.64 110.306 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.691 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 36.6 tp -61.76 -46.84 87.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.918 -0.583 . . . . 2.19 110.042 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.4 -47.57 85.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.493 -0.776 . . . . 2.17 109.933 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.42 73.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.449 . . . . 2.28 112.043 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.691 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 4.5 p80 -74.75 -27.76 60.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.649 -0.421 . . . . 2.24 110.625 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 -45.36 71.69 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.203 -0.295 . . . . 1.33 110.203 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 1.75 110.935 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -65.34 -31.98 73.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 2.66 111.235 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.626 HD13 ' HB ' ' A' ' 36' ' ' VAL . 74.6 mt -85.35 -26.43 26.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 2.04 110.166 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.35 33.23 26.22 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.51 -0.768 . . . . 1.44 112.804 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.693 HG22 HD23 ' A' ' 41' ' ' LEU . 54.0 t -71.71 121.06 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.81 -0.811 . . . . 1.4 108.81 173.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.776 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 74.7 mtt180 -126.5 131.71 51.56 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.378 -0.23 . . . . 3.03 110.378 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 HD12 ' A' ' 28' ' ' LEU . 6.1 mp -132.33 125.52 31.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.729 -0.471 . . . . 1.67 109.729 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -143.11 134.45 26.07 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.917 0.389 . . . . 2.43 109.984 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -92.77 125.41 45.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 3.4 109.959 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.25 118.16 28.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.907 -0.588 . . . . 4.2 109.661 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.05 -97.04 0.56 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.688 -0.687 . . . . 4.37 111.664 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -116.63 -16.29 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.734 0.302 . . . . 5.3 111.444 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 11.9 tpp180 -114.76 135.2 54.43 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.836 -0.746 . . . . 6.12 112.643 -167.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.577 HD12 HD22 ' A' ' 21' ' ' LEU . 3.4 tm? -78.24 124.76 28.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.505 -1.225 . . . . 2.68 108.84 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.96 143.97 30.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.001 -0.37 . . . . 4.59 110.001 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.66 131.89 55.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 2.52 110.702 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.776 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 5.2 tp-100 -126.36 114.33 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.872 -0.603 . . . . 2.89 109.692 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.83 126.85 4.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.864 0.364 . . . . 1.69 111.343 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.572 ' O ' HG21 ' A' ' 36' ' ' VAL . 24.0 Cg_exo -65.38 155.83 66.61 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.904 2.402 . . . . 2.21 112.053 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.09 123.79 13.91 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.728 2.285 . . . . 2.47 112.563 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.15 -31.88 6.68 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 1.81 113.2 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.626 ' HB ' HD13 ' A' ' 17' ' ' LEU . 15.4 m -85.11 -19.87 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.091 0.446 . . . . 1.86 112.157 -174.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.502 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.39 20.29 0.89 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.42 111.43 -171.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.3 p -51.75 142.16 24.77 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 1.78 110.894 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.68 -38.29 28.88 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.207 2.605 . . . . 1.87 113.244 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 55.4 tt0 -61.54 -39.98 93.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 2.76 111.056 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.693 HD23 HG22 ' A' ' 19' ' ' VAL . 1.9 tp -60.35 -44.55 95.44 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.882 0.372 . . . . 1.65 110.134 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.655 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.36 -39.01 75.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 2.06 110.125 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -68.84 -29.84 68.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.578 . . . . 2.01 110.504 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 27.4 mmt180 -73.1 -40.9 64.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.99 -0.374 . . . . 3.9 109.99 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 50.8 mt -60.19 -38.46 83.34 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.544 0.688 . . . . 1.42 109.161 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.3 -23.23 8.57 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.183 -0.917 . . . . 2.3 113.062 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.14 19.32 71.96 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.934 -0.651 . . . . 2.57 112.064 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . . . -82.87 149.66 26.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.899 -0.408 . . . . 2.42 109.899 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.4 ptp85 -69.06 -50.62 46.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.487 -0.324 . . . . 5.86 111.521 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.447 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 8.6 p80 -61.59 -32.97 73.1 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.095 0.474 . . . . 3.23 110.836 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -66.25 -51.24 59.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.326 -0.852 . . . . 2.75 110.309 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.452 HD21 HD21 ' A' ' 21' ' ' LEU . 91.2 mt -69.08 -26.52 64.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.925 -1.034 . . . . 2.4 111.124 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.4 mt -61.0 -48.16 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 3.13 109.998 174.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.63 66.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 2.03 110.609 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.7 tm? -69.39 -38.13 77.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 1.89 109.398 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.5 tp -79.46 -26.8 41.65 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.452 0.644 . . . . 2.2 109.633 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -65.29 -26.77 68.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 4.58 110.437 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.57 -27.89 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 1.75 110.274 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 20' ' ' ARG . 51.0 mt -74.24 -19.19 60.59 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.581 -0.736 . . . . 2.94 110.911 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.798 -0.637 . . . . 2.58 109.875 178.552 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 111.693 -0.563 . . . . 5.13 111.693 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.0 83.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.892 0.377 . . . . 6.14 110.173 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.517 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 58.5 tp -61.51 -46.59 89.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.867 -0.606 . . . . 4.74 109.89 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.31 -49.15 76.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.728 -0.669 . . . . 3.19 109.66 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.78 -53.26 58.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 4.03 112.307 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.517 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 4.0 p80 -73.52 -27.92 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.19 -0.604 . . . . 5.58 110.952 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.17 78.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 3.33 110.445 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.15 94.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 4.37 110.8 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -61.99 -36.7 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.749 -0.66 . . . . 6.1 111.141 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.534 HD13 ' HB ' ' B' ' 36' ' ' VAL . 82.5 mt -82.03 -24.92 35.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 6.81 110.632 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.52 31.65 18.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.045 -0.598 . . . . 5.35 112.673 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.635 HG22 HD23 ' B' ' 41' ' ' LEU . 45.8 t -75.38 123.08 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.689 -0.486 . . . . 3.76 109.689 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.878 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 77.6 mtt180 -129.33 131.11 46.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.531 -0.304 . . . . 7.44 111.107 -173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.65 HD22 HD12 ' B' ' 28' ' ' LEU . 5.7 mp -134.64 125.74 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.328 -0.396 . . . . 3.8 110.135 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.463 ' HB3' HD11 ' B' ' 56' ' ' LEU . 20.4 p90 -143.5 137.05 28.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 7.27 110.21 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 5.7 p -96.48 118.37 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.183 0.515 . . . . 7.74 110.172 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.3 114.43 26.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.85 -0.614 . . . . 9.44 109.664 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.36 -98.89 1.05 Allowed Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 111.327 -0.709 . . . . 10.31 111.327 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -116.99 -16.53 10.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.852 0.358 . . . . 9.56 111.598 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 7.5 tpp180 -115.53 128.44 55.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.409 0.623 . . . . 7.94 111.962 -166.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.65 HD12 HD22 ' B' ' 21' ' ' LEU . 3.3 tm? -74.62 124.39 26.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.801 -1.09 . . . . 5.2 109.551 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -100.38 145.31 28.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.295 -0.261 . . . . 8.44 110.295 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.457 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -120.14 131.67 55.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 4.16 110.57 -174.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.878 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 5.6 tp-100 -125.32 114.39 18.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.433 -0.58 . . . . 7.26 109.433 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -151.58 122.17 3.67 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 5.75 111.031 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.531 ' O ' HG21 ' B' ' 36' ' ' VAL . 31.4 Cg_exo -60.27 152.92 63.14 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.917 2.411 . . . . 7.34 112.181 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.07 124.05 15.05 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.512 2.141 . . . . 9.22 112.409 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.75 -29.03 8.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.705 -0.76 . . . . 8.58 112.926 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.551 ' O ' HD21 ' B' ' 41' ' ' LEU . 6.4 m -89.0 -14.61 9.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.533 -0.393 . . . . 7.19 111.293 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.871 ' HE1' ' HA ' ' B' ' 37' ' ' MET . 0.4 OUTLIER -82.25 18.45 1.41 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.89 0.376 . . . . 6.01 111.239 -174.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.8 p -52.08 142.91 25.94 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 8.28 111.114 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . 0.422 ' HG3' ' OE1' ' A' ' 31' ' ' GLN . 71.4 Cg_exo -49.33 -37.16 39.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.263 2.642 . . . . 7.89 113.302 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 38.0 tt0 -61.43 -38.26 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.077 -0.249 . . . . 9.22 111.13 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.635 HD23 HG22 ' B' ' 19' ' ' VAL . 2.9 tp -62.79 -40.36 97.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.869 0.366 . . . . 6.37 110.115 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.714 ' HA ' HE21 ' B' ' 42' ' ' GLN . 0.0 OUTLIER -59.62 -39.64 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 5.19 109.857 176.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 24.5 t -68.29 -32.35 72.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.773 . . . . 7.5 110.703 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 23.7 mmt180 -71.71 -41.67 68.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 8.73 110.093 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 78.3 mt -61.28 -39.6 91.01 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.858 -0.61 . . . . 4.2 109.779 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.06 -23.16 8.26 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.532 -0.758 . . . . 5.65 112.807 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.89 72.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.077 -0.582 . . . . 4.5 112.381 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' B' ' 51' ' ' GLU . . . -76.1 150.43 37.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.047 -0.353 . . . . 5.81 110.047 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.512 ' O ' HG13 ' B' ' 53' ' ' ILE . 8.8 ptp85 -65.27 -48.99 71.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.579 -0.282 . . . . 8.59 111.034 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -66.66 -32.07 73.15 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.299 . . . . 7.48 111.806 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' B' ' 48' ' ' ALA . 0.4 OUTLIER -64.97 -44.27 89.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 5.72 110.534 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.85 -25.0 55.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.047 -0.524 . . . . 3.39 111.506 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.512 HG13 ' O ' ' B' ' 49' ' ' ARG . 80.0 mt -63.54 -47.46 91.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.672 -0.492 . . . . 6.75 109.672 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.21 74.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 3.81 110.233 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.491 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.8 tm? -62.53 -44.57 96.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.761 -0.654 . . . . 2.46 109.778 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' B' ' 22' ' ' TRP . 28.2 tp -68.58 -30.95 69.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.3 0.571 . . . . 5.83 110.763 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -66.55 -29.66 69.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.074 -0.512 . . . . 7.69 110.911 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 8.2 pt20 -68.03 -24.59 65.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 4.23 110.381 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.434 HD23 ' HG2' ' B' ' 20' ' ' ARG . 55.7 mt . . . . . 0 CA--C 1.516 -0.349 0 CA-C-N 115.805 -0.634 . . . . 6.46 110.453 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.833 0.349 . . . . 2.87 110.449 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.37 -37.58 94.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.943 -0.571 . . . . 2.3 111.947 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.55 89.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 2.64 110.748 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.747 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 32.6 tp -64.22 -47.33 80.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 2.19 110.152 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.81 -49.09 77.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.443 -0.798 . . . . 2.17 109.999 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -50.48 71.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.813 -0.63 . . . . 2.28 112.238 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.747 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 4.2 p80 -73.13 -27.49 61.71 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.454 -0.498 . . . . 2.24 110.55 -174.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.68 68.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.818 0.342 . . . . 1.33 110.392 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -31.82 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 1.75 110.696 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.977 -0.556 . . . . 2.66 110.762 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.583 HD13 ' HB ' ' A' ' 36' ' ' VAL . 97.6 mt -79.96 -25.89 40.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.094 0.474 . . . . 2.04 110.257 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.15 42.63 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.984 -0.627 . . . . 1.44 112.276 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.67 121.28 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 109.353 -0.61 . . . . 1.4 109.353 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 76.8 mtt180 -122.25 135.23 54.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.77 -0.456 . . . . 3.03 109.77 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.794 HD21 HD21 ' A' ' 52' ' ' LEU . 6.0 mp -135.85 124.36 23.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 1.67 110.183 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HB3' HD13 ' A' ' 56' ' ' LEU . 23.8 p90 -140.84 140.6 34.66 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.894 -0.41 . . . . 2.43 109.894 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.51 123.0 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.943 0.401 . . . . 3.4 110.147 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -110.34 101.84 10.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.025 -0.731 . . . . 4.2 109.025 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.01 -86.15 0.22 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.766 -0.652 . . . . 4.37 112.1 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.63 -32.03 5.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.207 0.527 . . . . 5.3 110.78 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.31 133.37 50.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 6.12 112.029 -167.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.594 HD13 HD22 ' A' ' 21' ' ' LEU . 3.2 tm? -69.6 126.15 28.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.882 -1.054 . . . . 2.68 109.445 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.635 ' NH1' ' HB3' ' A' ' 24' ' ' GLU . 7.3 mpt_? -98.58 131.11 45.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.628 -0.508 . . . . 4.59 109.628 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CE2' HD23 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -108.45 145.99 33.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.063 -0.517 . . . . 2.52 110.201 -175.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 8.6 tp-100 -145.41 110.49 5.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.981 -0.378 . . . . 2.89 109.981 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.03 135.68 11.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.565 -0.289 . . . . 1.69 110.848 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.564 ' O ' HG21 ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.26 156.98 37.42 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.89 2.394 . . . . 2.21 112.179 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' B' ' 38' ' ' THR . 20.0 Cg_endo -63.1 123.95 13.08 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.437 2.092 . . . . 2.47 112.35 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.64 -37.23 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.81 113.275 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.583 ' HB ' HD13 ' A' ' 17' ' ' LEU . 33.3 m -75.06 -11.92 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.609 0.596 . . . . 1.86 112.609 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -82.16 21.51 0.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.187 -0.46 . . . . 1.42 111.711 -173.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.595 HG22 ' HB3' ' B' ' 34' ' ' PRO . 35.2 p -50.64 143.91 13.58 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 116.608 -0.269 . . . . 1.78 110.954 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.51 -32.91 65.48 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.54 2.16 . . . . 1.87 111.954 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 18.4 tp10 -57.93 -50.21 74.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.856 -0.611 . . . . 2.76 110.2 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 36' ' ' VAL . 2.4 tp -61.79 -47.53 84.73 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.65 110.293 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.414 ' HA ' HD11 ' A' ' 45' ' ' LEU . 25.3 tp60 -57.13 -39.25 74.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 2.06 111.204 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.9 t -71.44 -29.55 65.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.381 -0.372 . . . . 2.01 110.391 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 96.3 mtt180 -77.76 -28.73 50.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 3.9 110.94 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 42' ' ' GLN . 87.2 mt -64.86 -33.85 76.99 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.784 -0.821 . . . . 1.42 108.784 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 -24.03 6.79 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.078 -0.965 . . . . 2.3 113.044 171.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.87 11.6 60.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.967 -0.635 . . . . 2.57 112.12 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -78.42 150.47 33.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.137 -0.32 . . . . 2.42 110.137 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.553 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -67.46 -50.15 60.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.298 -0.41 . . . . 5.86 111.16 -173.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.62 -34.54 78.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 3.23 110.808 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -66.1 -48.67 70.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.699 -0.682 . . . . 2.75 109.844 -178.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.794 HD21 HD21 ' A' ' 21' ' ' LEU . 76.8 mt -72.07 -24.2 61.47 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.05 -0.977 . . . . 2.4 111.238 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 49' ' ' ARG . 74.7 mt -62.37 -43.92 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.769 -0.456 . . . . 3.13 109.769 172.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.06 -25.76 65.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 2.03 110.319 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB2' ' HA ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -71.56 -29.76 65.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 1.89 110.202 -178.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 5.5 tp -84.27 -40.15 18.36 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.444 -0.798 . . . . 2.2 110.619 172.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -56.89 -28.97 62.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.276 -0.875 . . . . 4.58 111.156 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 11.8 pt20 -68.21 -20.36 64.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.357 -0.838 . . . . 1.75 111.594 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.8 tp -89.23 -6.44 56.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.352 -0.385 . . . . 2.94 110.718 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 116.235 -0.439 . . . . 2.58 110.605 -179.86 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 112.096 -0.402 . . . . 5.13 112.096 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.22 88.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.886 0.374 . . . . 6.14 110.705 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.539 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 63.3 tp -64.22 -46.94 81.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.006 -0.543 . . . . 4.74 110.141 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' B' ' 58' ' ' GLN . 3.2 tm? -59.57 -49.2 78.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 3.19 110.544 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.11 -53.28 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 4.03 111.979 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.539 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 3.3 p80 -71.79 -27.03 62.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.605 -0.438 . . . . 5.58 111.068 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.5 73.2 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.199 -0.297 . . . . 3.33 110.199 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -36.54 83.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.03 -0.532 . . . . 4.37 110.473 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -58.64 -39.45 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.695 -0.684 . . . . 6.1 110.701 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -82.61 -25.22 33.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 6.81 110.871 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.0 27.91 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.781 -0.723 . . . . 5.35 111.939 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -77.71 121.84 31.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.687 -0.486 . . . . 3.76 109.687 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.587 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 78.1 mtt180 -122.59 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.317 -0.401 . . . . 7.44 110.427 -175.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.714 HD21 HD21 ' B' ' 52' ' ' LEU . 5.9 mp -136.27 124.7 23.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 3.8 110.219 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.696 ' HB3' HD13 ' B' ' 56' ' ' LEU . 30.0 p90 -142.23 140.81 32.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 7.27 110.329 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.39 123.16 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.227 0.537 . . . . 7.74 110.337 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.601 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 2.8 tm-20 -111.91 100.66 9.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.884 -0.784 . . . . 9.44 108.884 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.55 -87.42 0.27 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.801 -0.636 . . . . 10.31 112.137 -177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -116.25 -31.82 5.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.308 0.575 . . . . 9.56 110.725 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -106.26 128.42 53.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 7.94 111.659 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.576 HD13 HD22 ' B' ' 21' ' ' LEU . 3.2 tm? -64.97 123.5 19.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.874 -1.057 . . . . 5.2 109.648 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.601 ' NH1' ' HB3' ' B' ' 24' ' ' GLU . 8.1 mpt_? -95.75 130.5 42.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.749 -0.463 . . . . 8.44 109.749 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.552 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -106.49 150.13 26.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.059 -0.519 . . . . 4.16 110.134 -176.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 8.4 tp-100 -149.16 112.06 4.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.742 -0.466 . . . . 7.26 109.742 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.67 135.04 10.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.628 -0.26 . . . . 5.75 110.78 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.505 ' O ' HG21 ' B' ' 36' ' ' VAL . 32.0 Cg_exo -60.54 153.62 59.82 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.752 2.301 . . . . 7.34 112.458 176.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.595 ' HB3' HG22 ' A' ' 38' ' ' THR . 19.3 Cg_endo -60.83 123.19 12.47 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.557 2.172 . . . . 9.22 112.52 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.71 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.674 -0.774 . . . . 8.58 113.281 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' B' ' 17' ' ' LEU . 18.9 m -80.62 -7.53 10.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 117.03 0.415 . . . . 7.19 111.935 -173.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.825 ' HA ' ' HE3' ' B' ' 37' ' ' MET . 0.6 OUTLIER -82.84 20.14 1.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.344 -0.389 . . . . 6.01 111.692 -173.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 34' ' ' PRO . 38.0 p -51.28 144.75 15.06 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.719 0.295 . . . . 8.28 111.603 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.96 -30.59 59.51 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.805 2.336 . . . . 7.89 112.188 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 17.6 tp10 -59.56 -50.0 75.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.932 -0.576 . . . . 9.22 109.789 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.567 HD23 ' O ' ' B' ' 36' ' ' VAL . 3.1 tp -63.5 -45.8 89.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 6.37 110.14 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -56.97 -41.03 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 5.19 111.036 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -70.0 -31.75 69.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.301 -0.408 . . . . 7.5 110.622 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 99.4 mtt180 -76.9 -28.84 55.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.523 -0.308 . . . . 8.73 110.883 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 94.5 mt -64.62 -33.56 76.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.114 -0.699 . . . . 4.2 109.114 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.93 -23.09 8.17 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.127 -0.942 . . . . 5.65 112.824 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.1 8.64 54.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.983 -0.627 . . . . 4.5 112.208 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.47 149.82 36.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.975 0.417 . . . . 5.81 110.429 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.554 ' O ' HG13 ' B' ' 53' ' ' ILE . 0.3 OUTLIER -62.72 -49.96 72.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.838 -0.619 . . . . 8.59 111.665 -175.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -66.18 -33.48 75.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.644 0.239 . . . . 7.48 111.644 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.95 -45.01 75.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 5.72 110.51 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.714 HD21 HD21 ' B' ' 21' ' ' LEU . 53.2 mt -73.97 -23.74 59.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.483 . . . . 3.39 111.34 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.554 HG13 ' O ' ' B' ' 49' ' ' ARG . 71.3 mt -64.16 -41.9 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.615 -0.513 . . . . 6.75 109.615 171.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.18 -31.44 70.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 3.81 110.534 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' B' ' 52' ' ' LEU . 1.1 mm? -63.32 -34.52 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.838 -0.619 . . . . 2.46 110.82 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' B' ' 22' ' ' TRP . 34.5 tp -79.46 -41.8 26.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 5.83 110.506 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -61.45 -20.84 63.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.482 -0.781 . . . . 7.69 111.638 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 24.7 pt20 -77.72 -20.85 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.788 0.328 . . . . 4.23 110.613 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.2 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 6.46 110.362 -176.386 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.482 0.182 . . . . 2.87 111.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.62 -46.93 92.6 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.127 -0.559 . . . . 2.3 112.37 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.0 -41.31 77.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 2.64 110.995 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.662 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 28.2 tp -62.9 -47.3 83.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 2.19 110.667 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.14 -44.46 95.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.843 -0.617 . . . . 2.17 109.584 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.17 80.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.008 -0.542 . . . . 2.28 112.148 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.662 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 7.0 p80 -71.67 -28.4 63.71 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.415 -0.514 . . . . 2.24 110.617 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.29 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 1.33 109.927 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.0 75.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.75 110.762 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 t -65.54 -38.14 88.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.081 -0.509 . . . . 2.66 110.224 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 92.2 mt -73.99 -24.77 59.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 2.04 109.941 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.56 31.93 17.36 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.618 -0.719 . . . . 1.44 112.461 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -71.2 132.89 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.965 -0.754 . . . . 1.4 108.965 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 44.6 mtt180 -129.99 134.15 47.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.914 -0.402 . . . . 3.03 109.914 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 52' ' ' LEU . 6.0 mp -137.14 127.36 26.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.67 109.563 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.508 ' HB3' HD11 ' A' ' 56' ' ' LEU . 24.2 p90 -146.61 137.01 23.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.013 0.435 . . . . 2.43 110.325 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -79.56 124.0 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.149 0.499 . . . . 3.4 110.402 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.24 105.25 8.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 4.2 109.568 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.66 -112.22 4.33 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.395 -0.907 . . . . 4.37 111.403 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -104.19 -18.8 14.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.3 110.8 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -107.05 127.05 53.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.495 0.664 . . . . 6.12 111.35 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.481 HD21 HD23 ' A' ' 21' ' ' LEU . 9.7 tt -74.68 114.42 13.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.479 -0.782 . . . . 2.68 109.269 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 9.1 mmm180 -80.47 139.53 36.37 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.752 -0.462 . . . . 4.59 109.752 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.428 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -124.25 132.72 53.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 2.52 109.73 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.728 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 56.7 tp60 -127.47 114.75 17.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.574 -0.528 . . . . 2.89 109.574 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -142.53 127.71 10.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.342 -0.39 . . . . 1.69 110.893 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.501 ' O ' HG21 ' A' ' 36' ' ' VAL . 32.1 Cg_exo -60.42 156.49 40.97 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.934 2.422 . . . . 2.21 111.705 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HB3' HG23 ' B' ' 38' ' ' THR . 30.0 Cg_endo -65.76 123.36 11.25 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.268 1.979 . . . . 2.47 112.39 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' THR . . . 106.89 -37.13 3.98 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.777 -0.725 . . . . 1.81 113.406 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.501 HG21 ' O ' ' A' ' 33' ' ' PRO . 35.8 m -75.82 -15.69 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.682 0.623 . . . . 1.86 112.682 -173.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.422 ' HA ' ' HE1' ' A' ' 37' ' ' MET . 9.1 tpp -84.57 23.27 1.16 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.294 0.569 . . . . 1.42 111.311 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.672 HG23 ' HB3' ' B' ' 34' ' ' PRO . 17.8 p -50.7 143.73 14.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.78 110.39 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.79 -30.17 45.82 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.801 2.334 . . . . 1.87 112.435 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 8.4 tp10 -60.54 -47.4 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 2.76 110.106 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 36' ' ' VAL . 4.0 tp -58.08 -49.55 76.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.793 0.33 . . . . 1.65 110.572 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.531 ' HA ' HD12 ' A' ' 45' ' ' LEU . 18.3 tp60 -60.45 -36.11 77.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.939 -0.573 . . . . 2.06 110.754 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.5 t -64.18 -32.61 74.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.012 0.434 . . . . 2.01 110.039 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 19.9 mmt180 -78.92 -40.38 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 3.9 110.873 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 42' ' ' GLN . 84.6 mt -52.82 -37.24 59.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.979 -0.748 . . . . 1.42 108.979 171.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.69 -22.84 8.32 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.231 -0.895 . . . . 2.3 112.048 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.71 14.21 72.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.978 -0.63 . . . . 2.57 112.229 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 51' ' ' GLU . . . -79.38 148.42 32.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.935 -0.394 . . . . 2.42 109.935 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 1.6 ptm180 -69.76 -51.2 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.459 -0.337 . . . . 5.86 111.745 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -56.99 -34.86 68.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.148 0.499 . . . . 3.23 110.564 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.41 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -65.82 -49.96 66.37 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.639 -0.709 . . . . 2.75 110.316 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.667 HD11 HD22 ' A' ' 21' ' ' LEU . 87.4 mt -75.21 -24.54 57.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.965 -1.016 . . . . 2.4 111.284 -174.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.9 mt -63.68 -42.91 97.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.852 -0.425 . . . . 3.13 109.852 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.57 76.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.316 0.579 . . . . 2.03 110.133 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.652 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.4 tm? -70.74 -31.67 68.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 1.89 109.508 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.7 tp -79.2 -36.72 39.7 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.993 -0.549 . . . . 2.2 109.737 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -55.5 -29.62 59.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 4.58 111.251 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.3 pt20 -56.1 -34.3 65.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.5 -0.318 . . . . 1.75 111.183 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.674 HD11 ' HB3' ' A' ' 20' ' ' ARG . 79.2 mt -83.72 -5.46 59.2 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.887 0.328 . . . . 2.94 111.887 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 110.337 -0.246 . . . . 2.58 110.337 -177.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 120.438 -0.09 . . . . 5.13 112.945 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.2 93.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 6.14 110.81 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 56.0 tp -60.85 -47.52 86.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.056 -0.52 . . . . 4.74 110.47 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.97 -43.44 92.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.732 -0.667 . . . . 3.19 109.653 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.33 -51.43 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.639 . . . . 4.03 112.315 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 14.2 p80 -72.52 -28.22 62.73 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.334 -0.546 . . . . 5.58 110.934 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.85 -43.43 75.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.189 0.519 . . . . 3.33 110.054 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.71 76.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.477 -0.783 . . . . 4.37 110.806 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -67.57 -34.33 76.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.053 -0.521 . . . . 6.1 110.308 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.548 HD11 ' HB ' ' B' ' 36' ' ' VAL . 86.7 mt -75.85 -24.34 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 6.81 110.426 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.86 28.43 21.2 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.785 -0.722 . . . . 5.35 112.389 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.11 132.74 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.471 -0.566 . . . . 3.76 109.471 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.835 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 76.6 mtt180 -130.48 132.9 45.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.592 0.234 . . . . 7.44 110.971 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.62 HD22 HD11 ' B' ' 52' ' ' LEU . 5.7 mp -137.98 127.45 24.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.843 -0.429 . . . . 3.8 109.843 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.648 ' HB3' HD11 ' B' ' 56' ' ' LEU . 29.3 p90 -147.78 139.97 24.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.932 0.396 . . . . 7.27 110.361 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.3 p -78.65 130.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.155 0.502 . . . . 7.74 110.405 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -132.16 101.0 5.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 9.44 109.668 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.74 -110.3 3.27 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.691 -0.766 . . . . 10.31 111.364 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.76 -11.69 16.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.701 0.286 . . . . 9.56 111.077 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.12 123.31 48.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 7.94 111.054 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 9.1 tt -74.64 115.07 13.78 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.329 -0.619 . . . . 5.2 109.329 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -79.89 139.31 37.17 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.006 -0.368 . . . . 8.44 110.006 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.488 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -122.14 133.2 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.457 -0.571 . . . . 4.16 109.457 -177.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.835 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 55.3 tp60 -129.81 112.52 13.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.63 -0.508 . . . . 7.26 109.63 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.05 133.1 16.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 5.75 111.136 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.445 ' O ' HG21 ' B' ' 36' ' ' VAL . 37.2 Cg_exo -62.98 153.58 72.58 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.056 2.504 . . . . 7.34 112.007 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.672 ' HB3' HG23 ' A' ' 38' ' ' THR . 30.3 Cg_endo -63.77 123.95 12.82 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.421 2.081 . . . . 9.22 112.725 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 -36.85 4.13 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.597 -0.811 . . . . 8.58 113.455 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' B' ' 17' ' ' LEU . 23.3 m -78.96 -9.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.017 0.377 . . . . 7.19 112.017 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.778 ' HE1' ' HA ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.85 19.98 1.26 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 6.01 111.35 -176.009 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 34' ' ' PRO . 10.6 p -51.04 144.7 13.62 Favored Pre-proline 0 C--O 1.236 0.387 0 CA-C-N 116.442 -0.344 . . . . 8.28 111.094 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.99 -30.71 49.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.819 2.346 . . . . 7.89 112.304 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.547 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 11.7 tp10 -60.42 -43.64 96.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 9.22 110.556 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.543 HD22 ' O ' ' B' ' 36' ' ' VAL . 11.1 tp -62.43 -46.19 89.7 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 110.234 -0.284 . . . . 6.37 110.234 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.421 ' HA ' HD12 ' B' ' 45' ' ' LEU . 18.9 tp60 -61.73 -37.55 84.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.169 -0.469 . . . . 5.19 110.378 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -63.06 -35.17 79.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.38 -0.373 . . . . 7.5 110.343 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 16.7 mmt180 -77.54 -39.95 44.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 8.73 110.868 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 42' ' ' GLN . 86.3 mt -56.81 -36.01 69.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 4.2 109.625 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.67 -22.95 8.09 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.162 -0.926 . . . . 5.65 112.219 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.44 75.73 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.083 -0.58 . . . . 4.5 111.863 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.69 149.93 29.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.217 -0.29 . . . . 5.81 110.217 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.518 ' O ' HG13 ' B' ' 53' ' ' ILE . 2.0 ptm180 -68.67 -48.86 62.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 8.59 111.182 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -60.07 -36.52 77.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.846 0.313 . . . . 7.48 111.846 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -47.11 80.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.114 0.483 . . . . 5.72 110.718 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.62 HD11 HD22 ' B' ' 21' ' ' LEU . 86.0 mt -75.33 -24.77 57.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 3.39 111.616 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 49' ' ' ARG . 83.1 mt -66.67 -39.57 84.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.946 -0.39 . . . . 6.75 109.946 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.89 83.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.201 0.524 . . . . 3.81 110.207 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.701 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.1 tm? -63.38 -34.93 78.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.247 -0.888 . . . . 2.46 110.02 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' B' ' 22' ' ' TRP . 17.8 tp -73.24 -38.67 65.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 5.83 110.473 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -57.18 -28.63 62.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 7.69 111.985 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 17.5 pt20 -60.92 -26.37 67.43 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.887 -0.325 . . . . 4.23 110.905 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.331 -0.395 . . . . 6.46 111.052 -177.119 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.878 0.37 . . . . 2.87 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.38 92.36 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.049 -0.523 . . . . 2.3 111.909 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.06 -41.7 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 2.64 110.728 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.682 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 51.0 tp -62.12 -46.4 89.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 2.19 110.317 176.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.16 -47.36 86.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.391 -0.822 . . . . 2.17 110.115 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.33 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 2.28 112.116 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.682 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.9 p80 -69.94 -27.07 64.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.884 0.373 . . . . 2.24 110.216 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.12 -36.88 66.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 1.33 110.284 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.52 83.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.948 -0.569 . . . . 1.75 111.146 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 p -67.0 -21.93 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 2.66 111.515 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.15 -25.07 15.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.189 0.518 . . . . 2.04 110.447 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.76 37.38 13.64 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 1.44 112.636 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.25 120.15 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.992 -0.744 . . . . 1.4 108.992 174.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HB3' HD23 ' A' ' 59' ' ' LEU . 20.7 mtt180 -120.07 128.89 53.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.57 -0.286 . . . . 3.03 110.69 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -133.03 124.11 27.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.484 -0.562 . . . . 1.67 109.484 173.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -141.48 143.15 33.68 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.937 -0.394 . . . . 2.43 109.937 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.27 129.81 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.689 -0.486 . . . . 3.4 109.689 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 14.2 tp10 -136.91 120.2 16.82 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.375 -0.602 . . . . 4.2 109.375 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.9 -105.04 1.36 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.824 -0.703 . . . . 4.37 111.82 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE1' ' HB3' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.86 -3.06 11.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.69 0.255 . . . . 5.3 111.69 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.446 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 9.4 tpp180 -129.19 152.18 49.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 6.12 112.116 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.433 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -75.7 122.34 23.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.046 -0.979 . . . . 2.68 108.618 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.446 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.2 mpt_? -99.03 131.08 45.34 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.366 -0.605 . . . . 4.59 109.366 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.446 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -108.21 154.07 22.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 2.52 110.245 -172.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 23.9 tp60 -153.25 110.43 3.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.805 -0.442 . . . . 2.89 109.805 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.74 134.98 26.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.122 -0.49 . . . . 1.69 110.66 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 36' ' ' VAL . 37.0 Cg_exo -61.91 156.09 51.05 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.612 2.208 . . . . 2.21 111.555 172.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' B' ' 38' ' ' THR . 22.9 Cg_endo -63.79 123.3 11.75 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.267 1.978 . . . . 2.47 112.305 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 38' ' ' THR . . . 106.88 -37.68 3.7 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.936 -0.649 . . . . 1.81 113.448 173.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.559 HG23 ' HD2' ' A' ' 33' ' ' PRO . 33.8 m -70.65 -20.3 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.518 0.562 . . . . 1.86 112.518 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.4 tpp -82.61 24.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.022 0.439 . . . . 1.42 111.446 -173.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.474 HG22 ' HB3' ' B' ' 34' ' ' PRO . 8.3 p -49.69 143.08 11.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 1.78 110.872 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.614 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 82.6 Cg_exo -45.76 -40.76 19.51 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.299 2.666 . . . . 1.87 113.773 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 8.9 pt-20 -61.89 -44.61 96.45 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 120.736 0.303 . . . . 2.76 110.525 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.409 ' N ' ' HG3' ' A' ' 40' ' ' GLU . 3.0 tt -67.69 -44.82 76.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.334 0.588 . . . . 1.65 109.908 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -56.17 -41.7 75.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.578 -1.192 . . . . 2.06 110.548 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -72.8 -29.24 63.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.927 -0.579 . . . . 2.01 111.042 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.8 mtp180 -75.84 -28.08 58.11 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.956 -0.298 . . . . 3.9 111.017 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.69 -43.77 98.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.536 -0.542 . . . . 1.42 109.536 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.9 -23.61 5.77 Favored Glycine 0 C--N 1.329 0.158 0 CA-C-N 115.644 -0.707 . . . . 2.3 112.97 171.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.41 18.11 69.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.907 -0.663 . . . . 2.57 112.47 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.606 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -72.72 147.8 45.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.121 -0.325 . . . . 2.42 110.121 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.571 ' O ' HG13 ' A' ' 53' ' ' ILE . 22.9 ptt180 -68.34 -50.67 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.334 -0.393 . . . . 5.86 111.644 -172.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.422 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 11.9 p80 -60.23 -36.06 76.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.739 0.781 . . . . 3.23 110.048 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.63 -42.75 70.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.608 -1.178 . . . . 2.75 110.214 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 63.3 mt -70.4 -25.41 63.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.598 -0.728 . . . . 2.4 110.822 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.1 mt -60.5 -50.03 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.792 -0.447 . . . . 3.13 109.792 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.15 70.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.199 0.523 . . . . 2.03 110.758 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 55' ' ' LEU . 2.6 tm? -71.09 -40.6 71.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.801 . . . . 1.89 109.959 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.2 tp -77.23 -31.31 55.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.952 -0.567 . . . . 2.2 109.756 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -61.81 -31.22 71.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 4.58 110.506 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.61 -29.62 70.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.522 . . . . 1.75 110.613 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 20' ' ' ARG . 29.7 tp -90.02 -2.87 58.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 2.94 110.553 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.108 -0.496 . . . . 2.58 110.617 -179.292 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.012 -0.435 . . . . 5.13 112.012 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.38 92.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 6.14 110.906 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.628 HD13 ' HE2' ' B' ' 13' ' ' HIS . 57.1 tp -64.29 -45.91 85.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.567 . . . . 4.74 109.844 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.78 -47.08 87.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 3.19 110.114 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -52.85 63.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 4.03 112.291 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.628 ' HE2' HD13 ' B' ' 10' ' ' LEU . 5.0 p80 -72.45 -26.34 61.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.566 -0.453 . . . . 5.58 110.963 -176.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.33 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 3.33 110.093 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -37.39 82.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.79 -0.641 . . . . 4.37 111.292 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 12.3 p -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 6.1 111.282 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.552 HD12 ' HB ' ' B' ' 36' ' ' VAL . 93.4 mt -91.7 -25.17 19.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 6.81 110.548 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 84.7 35.65 13.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.843 -0.694 . . . . 5.35 112.51 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.4 124.62 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.396 -0.594 . . . . 3.76 109.396 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.62 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 30.4 mtt180 -124.01 127.85 48.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.776 0.322 . . . . 7.44 111.194 -171.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.478 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.1 mp -135.15 124.74 25.08 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.476 -0.564 . . . . 3.8 109.476 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.534 ' HB3' HD12 ' B' ' 56' ' ' LEU . 26.5 p90 -143.63 143.6 31.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.881 0.372 . . . . 7.27 110.712 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.15 124.73 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.123 0.487 . . . . 7.74 110.076 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.584 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 10.8 tp10 -130.98 118.28 20.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.614 -0.513 . . . . 9.44 109.614 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 -104.26 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.76 -0.733 . . . . 10.31 111.803 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -4.86 11.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.79 0.329 . . . . 9.56 111.763 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . 0.441 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 8.5 tpp180 -130.33 148.69 52.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.343 0.592 . . . . 7.94 111.872 -170.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.477 HD11 HD23 ' B' ' 21' ' ' LEU . 3.0 tm? -73.48 115.96 13.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.154 -0.93 . . . . 5.2 108.735 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 6.2 mpt_? -90.81 132.59 35.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.895 -0.409 . . . . 8.44 109.895 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.478 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.0 OUTLIER -109.78 152.23 25.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.922 -0.581 . . . . 4.16 110.263 -173.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 25.4 tp60 -152.65 110.02 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.836 -0.431 . . . . 7.26 109.836 172.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.09 137.04 29.23 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.288 -0.415 . . . . 5.75 111.115 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.42 ' O ' HG21 ' B' ' 36' ' ' VAL . 38.6 Cg_exo -62.75 154.6 64.7 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.675 2.25 . . . . 7.34 111.796 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.614 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 27.9 Cg_endo -63.22 123.52 12.31 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.306 2.004 . . . . 9.22 112.629 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.461 ' O ' HG21 ' B' ' 38' ' ' THR . . . 105.5 -37.46 3.8 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.661 -0.78 . . . . 8.58 113.499 173.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.552 ' HB ' HD12 ' B' ' 17' ' ' LEU . 19.8 m -73.28 -12.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.108 0.454 . . . . 7.19 111.948 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.5 tpp -89.11 22.43 2.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.958 0.409 . . . . 6.01 111.505 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 34' ' ' PRO . 18.7 p -49.06 142.93 9.32 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.433 -0.349 . . . . 8.28 111.149 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -43.76 -42.33 11.75 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.964 3.109 . . . . 7.89 114.187 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.658 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 8.5 pt-20 -59.91 -45.65 91.86 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 121.133 -0.227 . . . . 9.22 110.921 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.497 ' N ' ' HG3' ' B' ' 40' ' ' GLU . 9.2 tt -70.34 -39.7 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.908 -0.404 . . . . 6.37 109.908 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp60 -56.76 -43.51 80.87 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.668 -0.697 . . . . 5.19 110.515 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.3 t -72.14 -31.25 65.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.911 -0.586 . . . . 7.5 110.842 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 65.3 mtp180 -71.51 -28.87 64.2 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.225 -0.19 . . . . 8.73 111.292 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.34 -44.74 86.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.529 0.68 . . . . 4.2 109.328 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.68 -23.75 5.51 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.278 -0.873 . . . . 5.65 112.982 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 18.74 74.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.266 -0.492 . . . . 4.5 112.39 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . 0.614 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -71.55 148.75 46.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.835 0.317 . . . . 5.81 110.425 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.573 ' O ' HG13 ' B' ' 53' ' ' ILE . 17.6 ptt180 -68.15 -46.93 69.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.331 -0.395 . . . . 8.59 111.448 -172.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -63.62 -35.64 81.19 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.702 0.287 . . . . 7.48 111.238 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.9 -38.96 69.85 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.658 -0.417 . . . . 5.72 110.302 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' B' ' 48' ' ' ALA . 46.4 mt -70.57 -26.02 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.579 -0.282 . . . . 3.39 110.97 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.573 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.6 mt -62.33 -49.44 83.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.753 -0.462 . . . . 6.75 109.753 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.11 86.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 3.81 110.433 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.5 tm? -62.21 -47.06 86.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.557 -0.747 . . . . 2.46 110.259 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' B' ' 22' ' ' TRP . 21.1 tp -66.27 -36.58 83.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.354 -0.385 . . . . 5.83 110.769 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -63.04 -29.27 70.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.415 -0.357 . . . . 7.69 111.361 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 6.9 pt20 -67.28 -27.67 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 4.23 110.261 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 37.7 tp . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 6.46 110.495 -176.565 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 111.597 0.221 . . . . 2.87 111.597 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.48 -44.85 96.37 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.494 -0.384 . . . . 2.3 112.346 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.63 90.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.06 0.457 . . . . 2.64 111.088 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.66 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 57.8 tp -67.91 -46.83 70.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.55 . . . . 2.19 110.492 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.98 -44.59 97.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.672 -0.694 . . . . 2.17 110.052 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.42 73.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 2.28 111.972 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.66 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.2 p80 -72.02 -27.79 62.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.519 -0.472 . . . . 2.24 110.231 -175.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.15 65.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.51 -0.314 . . . . 1.33 110.319 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.21 85.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.75 110.813 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -59.82 -43.94 94.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.976 -0.556 . . . . 2.66 110.764 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.535 HD12 ' HB ' ' A' ' 36' ' ' VAL . 84.2 mt -80.97 -25.63 37.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.327 . . . . 2.04 110.781 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.42 31.09 9.88 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.606 -0.806 . . . . 1.44 112.98 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 HG13 ' HE1' ' A' ' 30' ' ' PHE . 57.8 t -75.17 112.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.525 -0.546 . . . . 1.4 109.525 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 68.1 mtp180 -123.39 133.49 54.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 3.03 110.54 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.2 mp -132.73 127.39 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 1.67 110.674 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.511 ' HB3' HD11 ' A' ' 56' ' ' LEU . 18.0 p90 -150.85 145.34 25.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.209 -0.663 . . . . 2.43 109.209 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.2 p -93.22 128.92 44.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.208 0.528 . . . . 3.4 111.036 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.35 106.8 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 4.2 109.206 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.5 -107.3 2.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.118 -0.793 . . . . 4.37 111.118 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.402 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.1 -6.78 11.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.206 0.527 . . . . 5.3 110.093 177.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -102.36 118.17 36.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 6.12 110.758 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 7.8 tt -70.38 118.59 13.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.331 -0.988 . . . . 2.68 108.331 170.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.74 129.24 34.88 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.601 -0.518 . . . . 4.59 109.601 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.4 ' HE1' HG13 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -114.75 130.74 56.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.114 -0.494 . . . . 2.52 109.867 -177.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.728 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.35 110.24 14.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.458 -0.571 . . . . 2.89 109.458 177.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.56 130.37 6.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.376 -0.374 . . . . 1.69 110.601 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 36' ' ' VAL . 34.1 Cg_endo -69.24 157.91 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.646 2.231 . . . . 2.21 111.502 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.31 122.92 11.03 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.556 2.17 . . . . 2.47 112.328 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -15.36 27.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.956 -0.64 . . . . 1.81 113.167 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 33' ' ' PRO . 19.1 m -100.3 -8.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.399 0.599 . . . . 1.86 112.162 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.521 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.58 20.8 2.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.181 -0.463 . . . . 1.42 111.46 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -56.3 145.63 56.4 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.141 -0.482 . . . . 1.78 111.147 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.35 -38.45 62.65 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.952 2.434 . . . . 1.87 113.043 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 40.6 tt0 -59.61 -47.94 83.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 2.76 110.398 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.67 -42.81 98.0 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.14 0.495 . . . . 1.65 110.665 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HA ' HD13 ' A' ' 45' ' ' LEU . 9.3 tp-100 -56.89 -40.35 76.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.492 -0.776 . . . . 2.06 110.071 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -72.66 -29.51 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.736 -0.666 . . . . 2.01 110.36 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 15.1 mmm180 -65.88 -38.13 87.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.984 0.421 . . . . 3.9 110.604 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 42' ' ' GLN . 60.6 mt -57.29 -25.52 59.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.309 -0.86 . . . . 1.42 110.043 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -22.88 8.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.546 -0.752 . . . . 2.3 112.981 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 25.82 73.45 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.711 -0.756 . . . . 2.57 111.923 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.491 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -98.38 149.18 22.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.981 0.42 . . . . 2.42 110.706 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.524 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.44 -46.75 69.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.442 -0.799 . . . . 5.86 111.211 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.491 ' HA ' HD13 ' A' ' 53' ' ' ILE . 19.5 p80 -66.16 -33.28 75.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.391 0.615 . . . . 3.23 109.99 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 1.7 tp10 -66.73 -42.71 85.86 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.243 -0.889 . . . . 2.75 109.478 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 67.6 mt -67.89 -29.04 68.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.29 -0.868 . . . . 2.4 111.103 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 49' ' ' ARG . 84.1 mt -58.55 -51.55 70.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.096 0.474 . . . . 3.13 109.855 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.24 68.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.743 -0.662 . . . . 2.03 110.827 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.2 tm? -69.43 -40.78 77.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.722 -0.672 . . . . 1.89 109.678 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 22' ' ' TRP . 1.2 tp -79.17 -30.48 43.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.66 -0.496 . . . . 2.2 109.66 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -67.15 -21.38 65.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 4.58 110.372 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -61.76 -28.94 69.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 1.75 110.847 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -106.82 12.67 28.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.847 -0.741 . . . . 2.94 111.646 178.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 51.1 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 2.58 110.345 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.378 -0.289 . . . . 5.13 112.378 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.34 87.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 6.14 111.263 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.575 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 68.0 tp -64.72 -46.79 80.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 4.74 110.498 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.08 -46.38 84.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.895 -0.593 . . . . 3.19 109.843 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.51 75.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 4.03 111.838 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' HIS . . . . . 0.575 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 1.5 p80 -73.58 -27.57 61.39 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 5.58 110.674 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.04 61.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.681 0.277 . . . . 3.33 110.367 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.07 82.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 4.37 110.8 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 19.8 t -61.41 -42.98 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 6.1 110.833 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.488 HD12 ' HB ' ' B' ' 36' ' ' VAL . 90.2 mt -81.2 -24.37 37.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 6.81 110.937 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.7 7.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.748 -0.739 . . . . 5.35 112.344 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.22 113.44 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 3.76 109.531 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 63.1 mtp180 -124.8 134.81 52.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.358 -0.383 . . . . 7.44 110.858 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' B' ' 30' ' ' PHE . 6.2 mp -134.22 128.64 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 3.8 110.767 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' TRP . . . . . 0.689 ' HB3' HD11 ' B' ' 56' ' ' LEU . 26.6 p90 -151.62 143.78 23.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.658 -0.497 . . . . 7.27 109.658 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.1 p -88.92 126.87 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.17 0.51 . . . . 7.74 111.205 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -118.86 106.23 12.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.922 -0.77 . . . . 9.44 108.922 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.14 -106.45 1.84 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 10.31 111.394 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -3.69 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 9.56 110.313 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 tpt85 -107.76 114.24 28.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 7.94 110.854 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 7.5 tt -68.12 118.9 11.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.5 -0.926 . . . . 5.2 108.5 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -87.34 126.8 35.08 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.679 -0.489 . . . . 8.44 109.679 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -111.57 131.25 55.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.931 -0.577 . . . . 4.16 109.745 -177.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.708 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 7.6 tp-100 -124.89 107.92 11.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.235 -0.439 . . . . 7.26 110.079 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.98 129.85 6.64 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.329 -0.396 . . . . 5.75 110.52 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.492 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.6 Cg_endo -67.1 157.45 61.66 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.544 2.163 . . . . 7.34 111.768 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.29 123.75 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.453 2.102 . . . . 9.22 112.529 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.67 -24.68 14.71 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.694 -0.684 . . . . 8.58 113.401 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 33' ' ' PRO . 10.4 m -95.25 4.59 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.003 0.402 . . . . 7.19 111.36 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' MET . . . . . 0.794 ' HE2' ' HA ' ' B' ' 37' ' ' MET . 0.0 OUTLIER -95.91 18.96 12.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 6.01 110.809 -176.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -57.27 145.88 64.81 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 8.28 111.48 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.36 -41.02 52.62 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.312 2.674 . . . . 7.89 113.167 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 35.1 tt0 -57.98 -48.67 79.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.654 -0.248 . . . . 9.22 110.473 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 9.0 tt -66.1 -38.21 87.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 6.37 110.63 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -60.09 -40.45 89.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.735 -0.468 . . . . 5.19 109.735 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -72.57 -29.75 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.758 -0.656 . . . . 7.5 110.556 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 14.4 mmm180 -66.67 -32.66 74.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.502 -0.317 . . . . 8.73 110.657 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 86.3 mt -62.61 -25.36 68.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 4.2 110.032 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.95 -23.67 7.6 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.642 -0.708 . . . . 5.65 112.699 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.42 24.2 73.65 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.856 -0.688 . . . . 4.5 112.155 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.47 149.78 21.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.627 0.251 . . . . 5.81 111.068 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.629 ' HD3' ' H ' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -67.55 -47.56 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 8.59 111.312 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' HIS . . . . . 0.527 ' HA ' HD13 ' B' ' 53' ' ' ILE . 25.0 p80 -60.41 -32.86 71.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.718 0.294 . . . . 7.48 111.485 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -38.66 75.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 5.72 110.312 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 54.9 mt -70.76 -26.18 63.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.46 -0.336 . . . . 3.39 110.961 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' B' ' 50' ' ' HIS . 83.2 mt -61.76 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.757 -0.46 . . . . 6.75 109.757 174.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.22 80.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.123 0.487 . . . . 3.81 110.676 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.85 -47.6 85.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.489 -0.778 . . . . 2.46 110.168 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' B' ' 22' ' ' TRP . 26.8 tp -67.88 -35.34 78.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.005 0.431 . . . . 5.83 110.717 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.24 -19.47 63.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.274 -0.421 . . . . 7.69 111.256 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.01 -28.22 69.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.55 -0.295 . . . . 4.23 111.424 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . 0.639 ' H ' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.881 0.372 . . . . 6.46 110.897 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.197 -0.361 . . . . 11.72 112.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.67 136.51 5.36 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.881 2.387 . . . . 10.83 112.193 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.6 tp -97.16 -43.53 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.879 0.371 . . . . 10.23 110.313 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.87 -157.68 53.48 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.986 -0.626 . . . . 7.0 112.164 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.4 m -85.47 -66.08 0.94 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.143 -0.317 . . . . 6.3 110.143 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -176.42 -75.95 0.01 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.781 0.324 . . . . 3.83 111.548 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.64 -53.32 28.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 2.87 111.953 -172.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.01 97.17 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.074 -0.584 . . . . 2.3 112.181 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.78 95.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.787 0.327 . . . . 2.64 110.713 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.644 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 49.7 tp -63.07 -47.5 82.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 2.19 110.788 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.08 -47.78 84.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 2.17 110.155 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -50.57 73.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 2.28 112.005 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.644 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.8 p80 -72.78 -29.07 62.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 2.24 110.866 -173.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.15 65.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 1.33 110.528 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.65 -40.68 69.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.985 -0.552 . . . . 1.75 110.919 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.2 t -65.24 -42.58 93.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 2.66 111.077 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.79 -25.09 59.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.05 0.452 . . . . 2.04 110.317 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.63 6.66 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.565 -0.743 . . . . 1.44 112.587 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.59 ' O ' HD12 ' A' ' 55' ' ' LEU . 17.9 t -90.63 102.37 13.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 109.505 -0.554 . . . . 1.4 109.505 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.447 ' HE ' ' NE2' ' A' ' 58' ' ' GLN . 3.8 mpt_? -115.03 128.74 56.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.771 -0.455 . . . . 3.03 109.771 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.639 ' O ' HD22 ' A' ' 56' ' ' LEU . 5.4 mp -126.11 120.7 30.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.98 -0.378 . . . . 1.67 109.98 175.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 56' ' ' LEU . 28.8 p90 -136.22 145.77 46.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 2.43 110.49 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.0 p -91.22 124.16 43.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.23 0.538 . . . . 3.4 110.193 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.07 101.17 7.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.162 -0.472 . . . . 4.2 110.076 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.29 -102.58 0.96 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.768 -0.73 . . . . 4.37 111.67 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.622 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 4.8 pt-20 -101.27 -21.97 14.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.3 111.274 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 10.6 tpp180 -121.33 136.51 54.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.174 -0.611 . . . . 6.12 112.349 -170.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.5 tt -80.01 129.15 34.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.079 -0.964 . . . . 2.68 109.453 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.474 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 8.0 mpt_? -99.69 136.95 38.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.255 -0.43 . . . . 4.59 109.865 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.98 130.68 56.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.905 -0.589 . . . . 2.52 109.673 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 51.8 tp60 -111.75 109.61 19.54 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.029 -0.73 . . . . 2.89 109.029 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 113.56 4.92 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.179 -0.464 . . . . 1.69 111.347 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.564 ' O ' HG23 ' A' ' 36' ' ' VAL . 39.8 Cg_exo -58.22 149.56 71.89 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.93 2.42 . . . . 2.21 111.971 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.47 123.64 12.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.503 2.135 . . . . 2.47 112.052 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.15 -34.37 5.66 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.546 -0.835 . . . . 1.81 112.945 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 33' ' ' PRO . 23.1 m -81.69 -21.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.321 . . . . 1.86 111.559 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.408 ' HA ' ' HE3' ' A' ' 37' ' ' MET . 8.7 tpp -82.8 22.58 0.9 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.242 0.544 . . . . 1.42 111.402 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -52.53 141.49 34.08 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 1.78 110.42 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.5 -33.19 29.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.14 2.56 . . . . 1.87 113.856 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 32.5 tt0 -72.21 -33.61 67.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.645 -0.422 . . . . 2.76 110.708 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 36' ' ' VAL . 2.3 tt -65.96 -40.79 91.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.21 0.529 . . . . 1.65 109.812 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' HA ' HD13 ' A' ' 45' ' ' LEU . 63.7 tp60 -59.65 -35.53 74.59 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.269 -0.878 . . . . 2.06 110.069 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.4 t -69.2 -29.65 67.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.651 -0.704 . . . . 2.01 110.107 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.9 mmt180 -70.89 -39.83 72.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.779 -0.452 . . . . 3.9 109.779 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 42' ' ' GLN . 69.4 mt -58.77 -39.44 81.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.064 -0.517 . . . . 1.42 109.796 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.0 -22.39 9.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.743 -0.662 . . . . 2.3 112.658 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 33.61 81.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.108 -0.568 . . . . 2.57 111.96 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' HB2' ' CD ' ' A' ' 51' ' ' GLU . . . -100.8 153.43 19.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.051 0.453 . . . . 2.42 110.745 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.5 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.6 ptm180 -68.8 -50.03 53.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.609 0.966 . . . . 5.86 113.609 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -57.37 -47.8 80.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.6 0.592 . . . . 3.23 112.6 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.511 ' HG2' ' N ' ' A' ' 52' ' ' LEU . 3.1 pm0 -72.59 -36.99 68.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.935 -0.306 . . . . 2.75 110.205 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 56' ' ' LEU . 43.3 mt -64.86 -38.76 92.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.695 -0.402 . . . . 2.4 110.038 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 49' ' ' ARG . 82.5 mt -55.61 -41.62 65.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.186 0.517 . . . . 3.13 109.895 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -26.14 65.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 2.03 111.078 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 19' ' ' VAL . 2.7 mm? -70.85 -31.89 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.946 -0.302 . . . . 1.89 111.237 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -75.71 -38.27 58.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.127 0.489 . . . . 2.2 110.339 171.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -51.87 -28.62 16.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.597 -1.183 . . . . 4.58 111.202 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 3.4 pt20 -65.96 -40.48 91.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.369 -0.378 . . . . 1.75 110.713 175.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.444 ' CD1' ' HG2' ' A' ' 20' ' ' ARG . 19.7 mt -86.81 -13.56 44.72 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.798 1.407 . . . . 2.94 114.798 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.466 ' HA ' HE21 ' A' ' 60' ' ' GLN . 0.0 OUTLIER -51.32 105.84 0.57 Allowed Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 113.076 0.769 . . . . 2.58 113.076 -168.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -100.53 3.21 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.706 2.938 . . . . 2.79 112.742 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.441 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 9.7 p -61.09 -31.65 71.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 4.27 111.954 -173.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 m 57.06 45.6 20.67 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.277 0.561 . . . . 6.16 110.809 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.441 ' HG2' ' HB2' ' A' ' 62' ' ' SER . 31.7 mm-40 -81.19 41.63 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.804 -0.635 . . . . 8.21 111.258 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.68 -67.32 3.75 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.691 -0.766 . . . . 10.39 112.272 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.12 49.01 4.15 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.27 -0.49 . . . . 11.32 112.216 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 t -104.94 112.01 24.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.463 -0.569 . . . . 13.15 109.463 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 67.91 -177.7 0.21 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.764 -0.653 . . . . 15.23 110.501 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -100.89 -47.62 4.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.115 -0.328 . . . . 16.48 110.115 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 56.92 73.7 0.77 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.706 -0.679 . . . . 16.82 111.056 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.452 ' C ' ' H ' ' A' ' 73' ' ' ALA . 2.4 Cg_endo -82.87 -25.54 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.071 2.514 . . . . 18.72 112.168 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 68.96 -29.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.188 0.995 . . . . 19.82 112.383 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.452 ' H ' ' C ' ' A' ' 71' ' ' PRO . . . -83.37 68.99 9.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.287 0.565 . . . . 20.52 110.099 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -84.94 -33.04 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 24.23 109.469 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -118.89 -169.93 1.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.065 -0.97 . . . . 22.26 109.024 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.19 -6.02 4.65 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.322 -0.942 . . . . 23.19 112.57 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.403 ' HB3' HD11 ' A' ' 78' ' ' LEU . 31.9 ttm180 -171.77 -33.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.095 0.474 . . . . 26.68 109.923 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 117.909 -1.043 . . . . 26.21 109.833 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 111.806 -0.518 . . . . 15.12 111.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.38 121.59 9.06 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.673 2.249 . . . . 14.6 111.396 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.84 -59.99 2.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.412 -0.358 . . . . 14.06 110.476 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.77 166.03 27.16 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.886 -0.673 . . . . 11.24 111.556 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 41.2 m 72.21 -48.87 0.69 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.298 0.639 . . . . 9.8 111.717 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -90.52 109.89 21.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.847 -0.427 . . . . 8.47 109.847 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.6 84.72 2.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.027 0.441 . . . . 5.96 111.296 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.98 -37.21 60.54 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.004 -0.617 . . . . 5.13 112.214 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.37 95.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.922 0.391 . . . . 6.14 110.649 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.552 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 49.6 tp -63.52 -46.84 84.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.015 -0.538 . . . . 4.74 110.436 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.61 -49.95 75.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 3.19 110.079 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.6 -53.32 59.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 4.03 112.125 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.552 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 3.5 p80 -69.86 -31.6 69.52 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.445 -0.502 . . . . 5.58 111.068 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.19 -40.23 74.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.137 0.494 . . . . 3.33 110.343 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.67 74.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 4.37 110.761 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -62.04 -45.87 91.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 6.1 111.282 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.97 -24.96 61.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.729 0.3 . . . . 6.81 111.087 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.04 39.72 6.86 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.646 -0.788 . . . . 5.35 112.263 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.421 ' O ' HD12 ' B' ' 55' ' ' LEU . 39.6 t -90.95 110.23 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.708 -0.479 . . . . 3.76 109.708 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.591 ' HE ' ' NE2' ' B' ' 58' ' ' GLN . 3.7 mpt_? -127.65 136.71 51.99 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.885 -0.326 . . . . 7.44 110.782 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.51 ' O ' HD22 ' B' ' 56' ' ' LEU . 5.3 mp -130.02 122.4 28.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.247 -0.649 . . . . 3.8 109.247 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.588 ' HB3' HD13 ' B' ' 56' ' ' LEU . 34.5 p90 -138.35 139.29 38.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 7.27 110.913 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.8 p -84.34 117.38 29.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 7.74 110.002 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.497 ' HB3' HH11 ' B' ' 29' ' ' ARG . 8.9 tp10 -112.13 101.18 9.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.864 -0.607 . . . . 9.44 109.544 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.8 -95.47 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.109 -0.567 . . . . 10.31 112.526 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -104.2 -25.6 12.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.999 0.428 . . . . 9.56 111.18 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -122.56 130.09 52.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 7.94 111.342 -166.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.3 tt -77.0 126.71 31.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.662 -0.699 . . . . 5.2 109.57 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.497 HH11 ' HB3' ' B' ' 24' ' ' GLU . 7.5 mpt_? -96.76 137.82 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.174 -0.467 . . . . 8.44 110.045 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.449 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -117.29 130.63 56.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.767 -0.651 . . . . 4.16 109.838 -176.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -110.47 109.73 20.2 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.095 -0.705 . . . . 7.26 109.095 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.5 112.5 5.99 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 5.75 111.255 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.507 ' O ' HG23 ' B' ' 36' ' ' VAL . 33.0 Cg_exo -59.37 146.17 95.67 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.616 2.211 . . . . 7.34 111.673 174.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.13 123.32 12.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.285 1.99 . . . . 9.22 112.129 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.09 -34.25 5.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.657 -0.783 . . . . 8.58 112.831 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 33' ' ' PRO . 13.9 m -83.03 -18.46 10.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.082 0.441 . . . . 7.19 111.316 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.416 ' HA ' ' HE3' ' B' ' 37' ' ' MET . 10.5 tpp -84.55 20.75 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.212 0.53 . . . . 6.01 111.501 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.7 p -50.62 136.34 25.2 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 8.28 110.475 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.58 -38.49 21.83 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.78 2.987 . . . . 7.89 114.499 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 31.3 tt0 -66.86 -29.45 69.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.643 -0.423 . . . . 9.22 110.94 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.411 HD12 ' O ' ' B' ' 36' ' ' VAL . 7.0 tt -73.1 -35.1 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.866 -0.42 . . . . 6.37 109.866 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -60.97 -36.33 79.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.477 0.656 . . . . 5.19 109.348 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -67.2 -31.92 72.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.378 -0.828 . . . . 7.5 110.313 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 38.0 mmt180 -68.54 -40.25 80.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.293 -0.412 . . . . 8.73 109.936 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.481 ' HA ' HD13 ' B' ' 10' ' ' LEU . 83.2 mt -61.19 -37.73 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 4.2 110.284 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.91 -22.53 11.5 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.628 -0.715 . . . . 5.65 112.714 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.47 30.17 74.83 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.006 -0.616 . . . . 4.5 112.517 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.35 158.74 15.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.044 0.449 . . . . 5.81 110.658 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.622 ' HD2' ' OE1' ' A' ' 26' ' ' GLU . 8.4 ptm180 -68.47 -50.25 53.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.589 0.959 . . . . 8.59 113.589 -172.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -58.33 -50.09 74.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.818 0.673 . . . . 7.48 112.818 -167.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -68.43 -40.81 81.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.309 -0.256 . . . . 5.72 110.309 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.598 ' O ' HD23 ' B' ' 56' ' ' LEU . 53.4 mt -63.72 -36.31 83.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.557 -0.292 . . . . 3.39 111.082 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.8 mt -57.43 -42.39 80.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.13 0.49 . . . . 6.75 110.073 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.09 72.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.88 -0.6 . . . . 3.81 110.981 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.578 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.4 mm? -66.37 -28.83 68.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.17 -0.468 . . . . 2.46 111.422 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.598 HD23 ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER -79.65 -33.85 40.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 5.83 110.192 172.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -57.11 -32.03 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 7.69 111.443 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.591 ' NE2' ' HE ' ' B' ' 20' ' ' ARG . 28.6 pt20 -67.45 -26.69 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.591 -0.277 . . . . 4.23 111.574 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.58 -15.46 21.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.382 0.512 . . . . 6.46 112.382 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . 0.692 ' HA ' HE21 ' B' ' 60' ' ' GLN . 0.0 OUTLIER -51.02 105.25 0.5 Allowed Pre-proline 0 N--CA 1.467 0.386 0 O-C-N 123.698 0.624 . . . . 7.71 112.299 -170.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -100.6 3.6 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.497 2.798 . . . . 8.76 112.298 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.494 ' HB2' ' HG2' ' B' ' 64' ' ' GLN . 11.0 p -59.99 -30.03 68.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.713 -0.676 . . . . 8.96 111.721 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 13.6 m 56.57 42.13 27.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.133 0.492 . . . . 10.1 110.653 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.494 ' HG2' ' HB2' ' B' ' 62' ' ' SER . 29.8 mm-40 -82.49 47.28 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.984 -0.553 . . . . 11.21 111.232 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.79 -72.42 2.71 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.119 -0.563 . . . . 12.71 112.461 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.98 45.12 2.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.149 -0.548 . . . . 13.61 112.584 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.6 t -95.94 116.95 29.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.937 -0.764 . . . . 15.17 108.937 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 65.11 -171.44 0.19 Allowed 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.514 0.509 . . . . 17.11 110.758 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -106.46 -51.03 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.641 -0.503 . . . . 18.3 109.641 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . 61.59 82.48 0.22 Allowed Pre-proline 0 C--N 1.332 -0.18 0 O-C-N 124.024 0.828 . . . . 19.0 110.958 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.32 14.69 1.53 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.355 2.703 . . . . 20.29 112.217 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 p -90.4 151.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.804 -0.634 . . . . 21.43 110.128 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 71.94 6.43 5.61 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.348 0.659 . . . . 22.9 111.872 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -149.06 131.42 15.63 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.551 -0.537 . . . . 25.46 109.551 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.458 ' HB2' HD11 ' B' ' 78' ' ' LEU . 20.3 m120 -92.17 89.88 7.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.846 0.355 . . . . 24.7 110.867 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.05 -115.38 7.52 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.872 -0.604 . . . . 24.61 112.771 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -101.71 87.3 3.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.68 0.276 . . . . 27.58 110.415 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' B' ' 75' ' ' ASN . 75.1 mt . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.589 -0.719 . . . . 27.27 109.487 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.954 -0.459 . . . . 11.72 111.954 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.64 121.54 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.619 2.213 . . . . 10.83 112.686 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -98.75 -3.26 36.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.006 -0.543 . . . . 10.23 110.11 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.2 167.5 35.07 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.767 -0.651 . . . . 7.0 111.925 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 t -105.37 124.55 49.74 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.382 -0.599 . . . . 6.3 109.382 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 p -124.32 162.68 23.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.033 0.383 . . . . 3.83 112.033 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 72.69 -66.33 0.31 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.072 0.949 . . . . 2.87 112.585 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.43 -42.08 88.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.562 -0.351 . . . . 2.3 112.697 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.28 90.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.942 0.401 . . . . 2.64 110.802 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.99 -46.58 74.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 2.19 110.235 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.317 -0.856 . . . . 2.17 110.221 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.26 79.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.983 0.421 . . . . 2.28 110.992 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.59 -28.95 61.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.95 -0.568 . . . . 2.24 110.956 -174.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.4 -41.08 49.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 1.33 110.317 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.99 82.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.475 . . . . 1.75 111.058 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -66.71 -30.38 70.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.871 -0.604 . . . . 2.66 110.661 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.19 -26.1 26.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.166 -0.47 . . . . 2.04 110.841 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.23 30.81 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.794 -0.717 . . . . 1.44 113.123 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.44 HG23 HD21 ' A' ' 41' ' ' LEU . 44.1 t -74.39 113.23 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.275 -0.639 . . . . 1.4 109.275 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.644 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 98.6 mtt180 -124.56 135.91 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.448 -0.342 . . . . 3.03 110.944 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.94 131.71 42.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 1.67 110.167 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.469 ' HB3' HD12 ' A' ' 56' ' ' LEU . 30.5 p90 -151.63 152.65 33.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.717 -0.475 . . . . 2.43 109.717 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.9 p -99.49 126.78 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.335 0.588 . . . . 3.4 110.54 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.67 105.86 10.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.79 -0.641 . . . . 4.2 109.77 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.16 -107.8 2.42 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.829 -0.7 . . . . 4.37 111.397 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.08 -8.35 15.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.811 0.339 . . . . 5.3 110.243 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 10.2 tpp180 -116.31 134.28 55.07 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.635 0.605 . . . . 6.12 112.635 -170.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 8.3 tt -76.96 124.98 28.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.102 -0.954 . . . . 2.68 108.939 171.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 11.7 mmm180 -97.94 135.32 39.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.592 -0.522 . . . . 4.59 109.592 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.35 132.08 55.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.993 0.425 . . . . 2.52 110.533 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.752 ' HA ' HE21 ' A' ' 31' ' ' GLN . 0.0 OUTLIER -123.13 114.27 20.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.194 -0.457 . . . . 2.89 109.951 174.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.03 126.43 4.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.277 -0.42 . . . . 1.69 110.736 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 36' ' ' VAL . 30.2 Cg_exo -63.89 157.13 54.2 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.914 2.41 . . . . 2.21 111.904 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.61 123.14 12.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.361 2.041 . . . . 2.47 112.342 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 38' ' ' THR . . . 111.36 -37.32 3.76 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.671 -0.695 . . . . 1.81 113.413 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.548 HG23 ' HD2' ' A' ' 33' ' ' PRO . 18.6 m -77.1 -15.73 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.385 0.513 . . . . 1.86 112.385 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.41 20.98 0.81 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.822 0.344 . . . . 1.42 111.232 -173.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 35' ' ' GLY . 16.9 p -50.86 142.02 17.44 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.372 -0.376 . . . . 1.78 110.944 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -52.06 -34.41 57.46 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.925 2.417 . . . . 1.87 112.961 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -71.29 -29.81 65.49 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 2.76 110.372 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 36' ' ' VAL . 3.0 tt -71.76 -37.13 70.56 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.748 0.785 . . . . 1.65 109.69 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -58.69 -36.5 74.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.788 -1.097 . . . . 2.06 109.664 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.4 t -71.84 -30.09 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.427 -0.806 . . . . 2.01 110.618 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.2 mmt180 -63.71 -44.94 92.15 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.865 -0.42 . . . . 3.9 109.865 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.347 -0.842 . . . . 1.42 109.467 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.64 -22.57 8.79 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.456 -0.793 . . . . 2.3 113.064 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.517 ' O ' ' HG2' ' B' ' 27' ' ' ARG . . . 71.73 20.14 78.44 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.768 -0.729 . . . . 2.57 112.007 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -81.56 147.47 29.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.854 -0.338 . . . . 2.42 110.285 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.551 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.3 ptm180 -70.73 -51.91 24.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.371 -0.377 . . . . 5.86 111.863 -174.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -61.84 -32.32 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.506 0.669 . . . . 3.23 110.581 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.8 tp10 -72.46 -43.34 63.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.03 -0.987 . . . . 2.75 109.974 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.9 mt -71.66 -24.85 61.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.714 -0.676 . . . . 2.4 111.152 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 49' ' ' ARG . 73.9 mt -61.23 -49.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.926 -0.398 . . . . 3.13 109.926 173.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.63 67.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.203 0.525 . . . . 2.03 110.614 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -70.01 -39.43 75.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 1.89 109.317 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.508 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 3.8 tp -79.17 -31.27 43.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.763 -0.653 . . . . 2.2 109.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -64.38 -24.0 67.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 4.58 110.535 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -60.18 -31.38 70.07 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.528 ' HG ' ' HD3' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -105.81 4.96 30.37 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.968 -0.693 . . . . 2.94 111.461 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.508 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 99.1 mt-30 -87.03 144.56 36.66 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.535 . . . . 2.58 110.054 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 22.6 Cg_exo -65.21 -25.26 57.73 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.918 2.412 . . . . 2.79 112.6 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -90.79 105.81 18.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.061 0.458 . . . . 4.27 109.917 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.2 p -136.01 -52.61 0.74 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.696 -0.684 . . . . 6.16 110.041 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 69.44 113.41 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.049 0.843 . . . . 8.21 111.548 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.79 19.1 18.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.944 -0.646 . . . . 10.39 112.281 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.0 50.04 3.85 Favored Glycine 0 C--O 1.229 -0.192 0 C-N-CA 121.185 -0.531 . . . . 11.32 112.592 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.6 m -146.22 6.78 1.0 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.375 0.607 . . . . 13.15 110.363 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.5 mp -99.48 110.28 22.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 15.23 109.668 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 63.64 -173.01 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 123.589 0.555 . . . . 16.48 110.394 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . 73.09 129.85 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 121.594 0.711 . . . . 16.82 112.519 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 1.9 Cg_endo -83.28 60.98 7.09 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.464 2.776 . . . . 18.72 110.745 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.5 106.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.5 -0.773 . . . . 19.82 111.184 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.42 -88.93 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.053 -0.976 . . . . 20.52 111.35 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -168.92 19.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.389 -0.597 . . . . 24.23 109.389 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 59.56 89.85 0.06 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.692 -0.686 . . . . 22.26 110.474 -171.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.87 141.99 28.06 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.785 -0.721 . . . . 23.19 111.762 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -92.23 112.19 24.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.923 0.392 . . . . 26.68 111.244 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.214 -0.898 . . . . 26.21 109.356 175.668 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 N-CA-C 112.171 -0.371 . . . . 15.12 112.171 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.19 -28.95 55.89 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.815 2.343 . . . . 14.6 112.009 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 41.6 tp -159.26 -77.95 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.98 -0.554 . . . . 14.06 110.038 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.19 46.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.448 -0.661 . . . . 11.24 111.448 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -124.73 21.5 8.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.889 0.376 . . . . 9.8 111.048 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.9 p -161.16 24.99 0.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.351 -0.386 . . . . 8.47 111.476 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 60.44 42.64 14.23 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.44 0.638 . . . . 5.96 110.36 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.89 -35.41 86.72 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.29 -0.868 . . . . 5.13 112.924 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.79 90.62 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.82 0.343 . . . . 6.14 110.709 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 64.5 tp -72.68 -46.06 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.12 -0.491 . . . . 4.74 110.188 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.26 -51.4 70.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.719 -0.673 . . . . 3.19 110.27 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.17 85.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 4.03 111.156 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.46 -40.28 89.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.937 -0.574 . . . . 5.58 111.004 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.15 63.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 3.33 110.823 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.29 -46.62 87.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 4.37 111.676 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 30.1 m -64.6 -28.35 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 6.1 111.363 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.414 ' O ' ' HG2' ' B' ' 33' ' ' PRO . 70.3 mt -86.33 -25.27 25.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 6.81 110.599 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.64 26.32 27.66 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.79 -0.719 . . . . 5.35 112.606 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.84 111.25 12.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.552 -0.536 . . . . 3.76 109.552 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 98.5 mtt180 -125.01 139.36 53.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.359 -0.382 . . . . 7.44 111.055 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.459 HD23 ' CE2' ' B' ' 30' ' ' PHE . 5.9 mp -135.29 134.38 39.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 3.8 109.964 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.515 ' HB3' HD12 ' B' ' 56' ' ' LEU . 36.5 p90 -153.07 154.82 35.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.944 -0.391 . . . . 7.27 109.944 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.9 p -99.34 123.39 52.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.531 . . . . 7.74 110.566 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -119.39 102.85 8.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.5 -0.555 . . . . 9.44 109.5 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.09 -109.32 2.76 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.382 -0.687 . . . . 10.31 111.382 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.68 -6.82 15.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.908 0.385 . . . . 9.56 110.506 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.517 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 9.4 tpp180 -118.22 127.46 53.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.206 0.526 . . . . 7.94 111.823 -169.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.462 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 8.7 tt -73.8 126.75 31.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 5.2 108.97 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.454 ' HB2' ' CE2' ' B' ' 22' ' ' TRP . 9.1 mmm180 -99.85 135.05 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.557 -0.535 . . . . 8.44 109.557 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.459 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.7 OUTLIER -112.23 134.29 53.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.309 -0.405 . . . . 4.16 110.194 -176.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.754 ' HA ' HE21 ' B' ' 31' ' ' GLN . 0.0 OUTLIER -124.2 112.63 17.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.145 -0.479 . . . . 7.26 109.89 175.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.89 122.06 4.2 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.342 -0.39 . . . . 5.75 110.491 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.508 ' O ' HG21 ' B' ' 36' ' ' VAL . 32.5 Cg_exo -59.94 154.09 52.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.882 2.388 . . . . 7.34 112.12 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.8 122.97 12.66 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.534 2.156 . . . . 9.22 112.347 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.74 -37.15 3.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.655 -0.783 . . . . 8.58 113.091 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.508 HG21 ' O ' ' B' ' 33' ' ' PRO . 11.0 m -80.17 -7.38 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.0 0.4 . . . . 7.19 111.587 -175.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.888 ' HA ' ' HE3' ' B' ' 37' ' ' MET . 0.2 OUTLIER -84.18 18.82 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.81 0.338 . . . . 6.01 111.174 -175.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 19.5 p -49.94 141.44 14.5 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 8.28 111.471 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -52.69 -34.89 66.11 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.23 2.62 . . . . 7.89 113.175 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 0.0 OUTLIER -72.11 -30.08 64.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.768 -0.373 . . . . 9.22 110.344 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.592 ' HA ' ' HG2' ' B' ' 44' ' ' ARG . 8.9 tt -74.11 -32.5 63.23 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.735 -0.469 . . . . 6.37 109.735 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -60.39 -36.62 78.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.773 -0.649 . . . . 5.19 109.341 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -72.28 -29.86 64.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.353 -0.84 . . . . 7.5 110.497 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.592 ' HG2' ' HA ' ' B' ' 41' ' ' LEU . 35.9 mmt180 -63.32 -48.0 79.87 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 8.73 109.83 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -58.61 -43.03 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.435 -0.802 . . . . 4.2 109.916 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.49 -24.01 6.84 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.188 -0.915 . . . . 5.65 112.742 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.24 12.71 83.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.945 -0.645 . . . . 4.5 112.546 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -73.37 148.42 43.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.244 -0.28 . . . . 5.81 110.244 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 53' ' ' ILE . 12.0 ptm180 -69.4 -51.09 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.34 -0.391 . . . . 8.59 111.987 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.8 -31.18 72.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.935 0.398 . . . . 7.48 111.263 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.2 OUTLIER -71.44 -40.47 70.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.38 . . . . 5.72 110.302 -178.497 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 82.1 mt -76.04 -23.94 55.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 3.39 111.211 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 49' ' ' ARG . 76.8 mt -61.28 -48.38 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.732 -0.47 . . . . 6.75 109.732 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.48 -36.89 82.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 3.81 110.343 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.408 ' HB3' ' HA ' ' B' ' 52' ' ' LEU . 3.1 tm? -59.81 -45.51 92.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 2.46 110.013 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' B' ' 22' ' ' TRP . 43.0 tp -68.41 -35.59 77.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.035 0.445 . . . . 5.83 110.575 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.15 -22.58 66.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 7.69 111.271 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -62.55 -31.14 71.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.634 -0.257 . . . . 4.23 111.439 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.63 ' H ' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -105.81 4.57 29.95 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 6.46 111.618 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' B' ' 56' ' ' LEU . 95.7 mt-30 -86.03 145.83 41.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 7.71 110.229 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.74 -17.8 42.22 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.078 2.519 . . . . 8.76 112.323 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 28.7 t -97.56 103.16 15.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.237 0.542 . . . . 8.96 110.657 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.8 p -134.2 -47.92 0.78 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.614 -0.721 . . . . 10.1 110.406 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 64.63 98.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.561 -0.745 . . . . 11.21 111.951 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.54 23.25 37.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.645 -0.788 . . . . 12.71 112.885 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.06 50.59 4.32 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.185 -0.531 . . . . 13.61 112.521 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -150.36 18.27 0.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.157 0.503 . . . . 15.17 110.345 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 10.1 mp -110.56 113.38 25.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.705 -0.679 . . . . 17.11 109.556 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 62.73 -166.75 0.22 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.62 0.575 . . . . 18.3 111.091 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . 58.61 79.1 0.32 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 121.175 0.512 . . . . 19.0 111.156 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.15 20.02 1.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.11 2.54 . . . . 20.29 112.689 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -74.83 97.64 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.429 0.633 . . . . 21.43 111.128 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.64 -68.36 0.29 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.367 -0.833 . . . . 22.9 109.222 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 178.31 -33.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.639 -0.71 . . . . 25.46 110.571 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -83.44 71.52 10.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.642 0.734 . . . . 24.7 109.817 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.27 34.8 0.39 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.321 -1.112 . . . . 24.61 110.321 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -115.88 -38.91 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.074 -0.563 . . . . 27.58 109.858 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.698 -0.668 . . . . 27.27 109.397 177.289 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.053 -0.419 . . . . 11.72 112.053 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.62 -31.55 26.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.661 2.241 . . . . 10.83 112.083 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.57 102.89 14.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.126 -0.694 . . . . 10.23 109.126 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.16 -113.2 4.24 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.928 -1.269 . . . . 7.0 109.928 -170.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.3 p 178.22 -46.6 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.542 0.21 . . . . 6.3 110.479 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.1 m 68.57 7.92 6.36 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.704 -0.68 . . . . 3.83 109.996 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.54 -40.07 77.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.494 -0.775 . . . . 2.87 110.421 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.39 -40.45 85.79 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 123.442 0.464 . . . . 2.3 112.404 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.1 76.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.976 0.417 . . . . 2.64 111.116 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.705 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 59.2 tp -66.28 -46.55 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 2.19 110.506 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.23 -48.72 80.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.678 -0.692 . . . . 2.17 110.277 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.76 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.454 -0.339 . . . . 2.28 111.663 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.705 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.1 p80 -76.5 -26.92 55.8 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.829 0.347 . . . . 2.24 110.794 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.71 -35.63 51.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.122 -0.231 . . . . 1.33 110.538 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.6 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 1.75 111.384 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.8 p -65.78 -41.78 91.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 2.66 110.449 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.491 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 50.0 mt -77.87 -26.38 49.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 2.04 110.022 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.2 18.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.724 -0.671 . . . . 1.44 113.348 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.39 135.48 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.86 -0.793 . . . . 1.4 108.86 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.665 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 71.4 mtt180 -130.81 126.63 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.693 -0.194 . . . . 3.03 110.653 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 52' ' ' LEU . 6.1 mp -133.52 117.15 16.8 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 1.67 111.815 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' HB3' HD22 ' A' ' 56' ' ' LEU . 26.7 p90 -129.75 149.08 51.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 2.43 109.315 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.09 128.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.347 0.594 . . . . 3.4 111.349 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.436 ' HB3' ' NE ' ' A' ' 29' ' ' ARG . 38.1 tt0 -120.75 116.5 25.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.747 -0.834 . . . . 4.2 108.747 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.42 -109.46 2.9 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.092 -1.203 . . . . 4.37 110.092 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.69 -15.0 10.8 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.808 0.337 . . . . 5.3 110.291 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -92.43 144.46 25.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.563 0.697 . . . . 6.12 111.445 -172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.615 HD23 ' HB3' ' A' ' 21' ' ' LEU . 3.4 tm? -85.96 129.28 34.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.969 -1.014 . . . . 2.68 109.903 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' NE ' ' HB3' ' A' ' 24' ' ' GLU . 4.2 mpt_? -97.25 130.07 44.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.136 -0.691 . . . . 4.59 109.136 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.438 ' CE2' HD23 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -114.26 131.32 56.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.508 -0.314 . . . . 2.52 110.882 -171.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 6.1 tp-100 -130.15 123.87 31.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.196 -0.456 . . . . 2.89 109.919 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.47 138.06 11.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.397 -0.365 . . . . 1.69 110.816 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' HG21 ' A' ' 36' ' ' VAL . 27.5 Cg_endo -68.03 155.31 70.09 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.6 2.2 . . . . 2.21 111.25 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.04 122.47 10.97 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 122.38 2.053 . . . . 2.47 112.464 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.5 -28.78 9.21 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.712 -0.676 . . . . 1.81 113.31 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.59 HG21 ' O ' ' A' ' 33' ' ' PRO . 22.9 m -83.74 -11.75 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.878 0.696 . . . . 1.86 112.878 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.503 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -83.55 20.42 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.696 0.284 . . . . 1.42 111.747 -173.517 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 p -53.1 147.09 18.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 1.78 111.444 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.7 -33.84 51.2 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 1.87 113.508 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.1 tt0 -70.78 -35.14 72.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.515 -0.474 . . . . 2.76 110.499 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.432 HD13 ' O ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -64.36 -41.15 96.88 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 121.032 0.444 . . . . 1.65 109.827 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.618 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -59.86 -37.36 79.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.06 109.946 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -67.68 -28.84 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 2.01 110.35 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.602 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 35.2 mmt180 -73.18 -43.98 60.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.311 -0.404 . . . . 3.9 110.17 176.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 53.9 mt -62.51 -42.93 99.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.364 0.602 . . . . 1.42 109.431 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.21 -23.06 7.44 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.607 -0.724 . . . . 2.3 112.778 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.18 16.31 76.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.917 -0.659 . . . . 2.57 111.761 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.588 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -76.63 148.77 36.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.944 0.402 . . . . 2.42 110.357 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.0 ptp180 -69.11 -51.04 42.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 5.86 111.943 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -61.87 -33.67 74.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 3.23 110.226 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.455 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -67.99 -46.5 71.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.253 -0.885 . . . . 2.75 110.476 -177.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.675 HD21 HD21 ' A' ' 21' ' ' LEU . 72.9 mt -66.23 -30.27 70.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.383 -0.826 . . . . 2.4 111.175 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 49' ' ' ARG . 89.2 mt -60.97 -43.55 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.713 0.768 . . . . 3.13 110.017 174.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.166 -0.925 . . . . 2.03 110.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.417 HD11 ' O ' ' A' ' 55' ' ' LEU . 2.7 tm? -64.55 -38.14 89.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.832 -1.173 . . . . 1.89 107.832 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.49 HD22 ' HB3' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -69.68 -39.66 76.84 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.267 -1.333 . . . . 2.2 112.214 174.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.2 mtt180 -50.97 -29.7 12.99 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.157 -0.474 . . . . 4.58 111.42 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -54.09 -47.85 71.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.323 0.582 . . . . 1.75 110.784 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.423 HD21 ' O ' ' A' ' 59' ' ' LEU . 7.9 tt -84.74 -32.42 23.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 2.94 110.394 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -75.35 118.18 68.8 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.636 -0.711 . . . . 2.58 110.9 -173.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.89 140.01 44.87 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.57 2.18 . . . . 2.79 111.997 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -99.77 -13.62 19.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.461 -0.336 . . . . 4.27 110.566 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.4 m 62.79 93.62 0.05 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.871 -0.604 . . . . 6.16 110.487 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -102.03 -68.19 0.84 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.766 -0.652 . . . . 8.21 110.794 -172.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.03 -162.51 21.06 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.822 -0.704 . . . . 10.39 111.538 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.75 112.12 3.68 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.651 -0.785 . . . . 11.32 112.242 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 t -161.54 104.06 1.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 13.15 110.62 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.2 tp -123.16 8.61 9.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.579 0.704 . . . . 15.23 109.444 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 69' ' ' LEU . 3.6 mm? -84.24 -24.02 30.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.408 -0.815 . . . . 16.48 111.472 -177.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.88 119.88 34.75 Favored Pre-proline 0 C--N 1.319 -0.75 0 C-N-CA 120.631 -0.427 . . . . 16.82 110.492 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.87 39.28 0.83 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.129 2.553 . . . . 18.72 111.811 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 p -61.06 103.15 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.44 -0.8 . . . . 19.82 111.786 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.54 8.26 2.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.801 -1.09 . . . . 20.52 112.323 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.45 30.25 12.53 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.694 0.397 . . . . 24.23 111.279 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -68.63 100.3 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.38 . . . . 22.26 110.45 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.41 108.37 2.47 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.865 -0.683 . . . . 23.19 111.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -79.42 -18.77 51.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.261 0.553 . . . . 26.68 110.096 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.1 pt? . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.421 -0.799 . . . . 26.21 109.376 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 111.853 -0.499 . . . . 15.12 111.853 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.6 117.75 5.26 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.582 2.188 . . . . 14.6 112.762 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 93.8 mt -130.24 139.34 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 14.06 110.432 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . 0.424 ' O ' ' HG ' ' B' ' 11' ' ' LEU . . . 97.33 153.47 29.28 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.998 -0.62 . . . . 11.24 112.075 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -97.39 119.42 35.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.898 0.38 . . . . 9.8 110.571 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.592 ' HB3' HD22 ' B' ' 11' ' ' LEU . 22.9 t -155.54 41.52 0.41 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.678 -0.692 . . . . 8.47 109.253 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 70.2 116.78 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.418 -0.81 . . . . 5.96 109.55 -170.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.25 -48.93 26.15 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.669 -0.696 . . . . 5.13 114.296 -171.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -48.14 78.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.092 0.446 . . . . 6.14 111.278 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.564 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 64.8 tp -63.47 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 4.74 110.688 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.592 HD22 ' HB3' ' B' ' 6' ' ' SER . 2.2 tm? -62.48 -47.95 81.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 3.19 110.291 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.78 84.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 4.03 111.845 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.564 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 2.4 p80 -75.39 -27.33 59.03 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.342 -0.543 . . . . 5.58 111.169 -175.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.89 -38.78 52.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.871 -0.332 . . . . 3.33 110.848 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.65 76.99 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.288 -0.414 . . . . 4.37 111.311 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 23.3 p -64.22 -40.35 95.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 6.1 110.686 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.598 HD11 ' HB ' ' B' ' 36' ' ' VAL . 90.6 mt -75.22 -25.29 58.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 6.81 110.296 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.33 19.77 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.679 -0.772 . . . . 5.35 112.716 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.6 133.12 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.293 -0.632 . . . . 3.76 109.293 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.768 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 69.4 mtt180 -130.86 128.91 41.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.678 -0.237 . . . . 7.44 110.981 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.681 HD21 HD21 ' B' ' 52' ' ' LEU . 6.2 mp -134.29 122.74 23.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.995 -0.372 . . . . 3.8 109.995 173.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.412 ' HB3' HD22 ' B' ' 56' ' ' LEU . 30.4 p90 -137.2 148.15 46.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.78 -0.452 . . . . 7.27 109.78 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.12 128.17 49.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.422 0.63 . . . . 7.74 111.345 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.475 ' HB3' ' NE ' ' B' ' 29' ' ' ARG . 37.4 tt0 -118.83 117.14 28.07 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.154 -1.054 . . . . 9.44 108.154 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.25 -108.9 2.64 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.453 -1.059 . . . . 10.31 110.453 -168.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -15.15 10.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.232 0.539 . . . . 9.56 110.132 173.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.15 142.02 27.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.407 0.623 . . . . 7.94 111.167 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.6 HD12 HD22 ' B' ' 21' ' ' LEU . 3.2 tm? -86.19 132.28 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.097 -0.956 . . . . 5.2 110.224 -174.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.475 ' NE ' ' HB3' ' B' ' 24' ' ' GLU . 3.8 mpt_? -100.82 130.96 46.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.203 -0.666 . . . . 8.44 109.203 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.528 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -113.9 131.75 56.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.748 0.309 . . . . 4.16 110.828 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.768 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 6.3 tp-100 -130.55 121.26 25.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.78 -0.452 . . . . 7.26 109.78 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.61 134.49 8.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.484 -0.325 . . . . 5.75 110.939 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.49 ' O ' HG21 ' B' ' 36' ' ' VAL . 29.8 Cg_endo -63.97 154.73 68.43 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.491 2.127 . . . . 7.34 111.865 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.38 122.96 12.56 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.424 2.083 . . . . 9.22 112.779 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.22 -32.13 6.7 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.81 -0.709 . . . . 8.58 113.402 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.598 ' HB ' HD11 ' B' ' 17' ' ' LEU . 10.7 m -85.29 2.99 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.183 0.438 . . . . 7.19 112.183 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.857 ' HE2' ' HA ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -93.46 19.35 8.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.894 0.378 . . . . 6.01 111.03 -176.052 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -53.46 145.51 27.58 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.547 . . . . 8.28 111.966 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.86 -39.51 39.42 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.356 2.704 . . . . 7.89 113.536 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 32.4 tt0 -65.62 -36.65 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.866 -0.334 . . . . 9.22 110.59 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.424 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 5.6 tt -68.26 -34.12 75.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.059 -0.348 . . . . 6.37 110.059 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -62.89 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 5.19 109.991 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 31.7 t -68.74 -34.11 75.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 7.5 110.183 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.595 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 28.2 mmt180 -63.84 -43.68 95.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.114 -0.494 . . . . 8.73 109.946 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 69.8 mt -65.97 -43.71 87.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 4.2 109.933 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 -22.16 9.57 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.572 -0.74 . . . . 5.65 112.408 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.14 19.74 78.69 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.877 -0.678 . . . . 4.5 111.42 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.627 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.85 149.41 36.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.826 0.346 . . . . 5.81 110.7 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' B' ' 53' ' ' ILE . 3.4 ptp180 -69.49 -50.32 46.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.206 -0.452 . . . . 8.59 111.735 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -64.73 -30.43 71.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.748 0.309 . . . . 7.48 111.456 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.542 ' HB2' ' HB1' ' B' ' 48' ' ' ALA . 0.3 OUTLIER -69.61 -45.35 68.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 5.72 110.814 -179.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.681 HD21 HD21 ' B' ' 21' ' ' LEU . 61.2 mt -67.32 -28.08 67.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 3.39 110.911 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.505 HG13 ' O ' ' B' ' 49' ' ' ARG . 90.9 mt -63.41 -48.67 86.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.114 0.483 . . . . 6.75 110.017 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . 0.582 ' CB ' ' HB2' ' B' ' 6' ' ' SER . . . -68.4 -36.08 78.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 3.81 110.734 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.425 ' O ' HD11 ' B' ' 55' ' ' LEU . 2.1 tm? -55.93 -39.95 72.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.509 -0.768 . . . . 2.46 109.399 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.486 HD21 ' O ' ' B' ' 21' ' ' LEU . 0.8 OUTLIER -74.69 -27.65 60.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 5.83 110.234 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' B' ' 54' ' ' ALA . 80.1 mtt180 -62.58 -26.33 68.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.494 -0.321 . . . . 7.69 111.114 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -57.31 -39.71 76.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.349 0.595 . . . . 4.23 110.872 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 tt -91.99 -31.38 15.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.48 -0.782 . . . . 6.46 110.332 -176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -74.76 117.68 64.35 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.711 -0.677 . . . . 7.71 111.046 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.57 138.09 37.6 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.713 2.275 . . . . 8.76 112.112 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.463 ' HB3' ' OE1' ' B' ' 64' ' ' GLN . 41.7 t -98.48 -15.32 19.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.165 -0.47 . . . . 8.96 110.34 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 23.9 m 64.07 95.0 0.05 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.38 0.609 . . . . 10.1 110.191 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.463 ' OE1' ' HB3' ' B' ' 62' ' ' SER . 1.6 mp0 -100.95 -66.58 0.9 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.896 -0.593 . . . . 11.21 110.942 -173.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.44 -166.34 26.69 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.477 -0.649 . . . . 12.71 111.477 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.25 104.67 2.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.887 -0.673 . . . . 13.61 111.899 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -151.55 103.76 3.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.809 0.338 . . . . 15.17 110.309 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.25 5.03 6.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.362 0.601 . . . . 17.11 110.232 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.43 -25.7 33.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.953 -0.567 . . . . 18.3 110.315 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.29 71.81 82.12 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.657 -0.701 . . . . 19.0 109.946 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -89.42 -1.04 6.04 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.889 2.393 . . . . 20.29 112.196 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 24.3 t 58.64 69.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.512 0.672 . . . . 21.43 109.62 -174.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.04 96.13 5.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.098 -0.955 . . . . 22.9 110.34 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -81.77 139.13 34.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.909 -0.587 . . . . 25.46 109.763 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 73.72 92.44 0.08 Allowed 'General case' 0 C--O 1.232 0.155 0 O-C-N 123.896 0.747 . . . . 24.7 109.424 -174.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.01 57.79 4.83 Favored Glycine 0 N--CA 1.453 -0.173 0 CA-C-N 115.531 -0.759 . . . . 24.61 113.491 -171.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -106.41 95.65 5.91 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.808 -0.442 . . . . 27.58 109.808 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.605 -0.712 . . . . 27.27 109.888 -178.243 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 119.841 -0.422 . . . . 11.72 112.05 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.77 105.23 0.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.791 2.327 . . . . 10.83 111.913 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 4' ' ' GLY . 1.1 tm? -130.89 126.94 37.47 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.422 -0.585 . . . . 10.23 109.422 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' N ' HD11 ' A' ' 3' ' ' LEU . . . 165.38 54.06 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.47 -0.872 . . . . 7.0 112.501 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -80.43 96.53 6.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.393 0.616 . . . . 6.3 109.423 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.4 m -139.02 38.88 2.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.501 -0.772 . . . . 3.83 109.614 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.2 -51.91 67.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.026 -0.534 . . . . 2.87 110.913 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.13 -39.14 95.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.137 -0.554 . . . . 2.3 112.24 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.75 -42.86 85.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.06 0.457 . . . . 2.64 110.682 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.677 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 45.9 tp -64.65 -47.13 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.813 -0.63 . . . . 2.19 110.268 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.21 -46.5 88.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.628 -0.715 . . . . 2.17 110.062 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -50.98 71.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 2.28 111.673 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.677 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 3.8 p80 -76.83 -27.96 55.35 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.657 -0.417 . . . . 2.24 110.954 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.11 66.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.068 -0.253 . . . . 1.33 110.496 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.75 92.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.131 0.491 . . . . 1.75 110.764 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -65.08 -33.39 75.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.498 -0.774 . . . . 2.66 110.845 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.497 HD12 ' HB ' ' A' ' 36' ' ' VAL . 83.8 mt -85.73 -26.32 25.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.108 0.48 . . . . 2.04 109.949 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.72 35.73 35.13 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.442 -0.799 . . . . 1.44 112.476 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.474 ' O ' HD11 ' A' ' 55' ' ' LEU . 97.4 t -69.38 108.67 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.335 -0.987 . . . . 1.4 108.335 170.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 51.7 mtt180 -112.18 133.64 54.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.155 0.502 . . . . 3.03 111.625 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.715 HD22 HD23 ' A' ' 52' ' ' LEU . 5.9 mp -130.41 136.69 49.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.892 -1.049 . . . . 1.67 109.728 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.51 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 22.9 p90 -158.2 137.92 12.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.49 -0.777 . . . . 2.43 109.257 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -85.33 121.63 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.665 -0.494 . . . . 3.4 109.665 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 33.1 tt0 -115.77 102.38 9.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.777 -0.647 . . . . 4.2 109.843 -175.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.67 -90.39 0.39 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.485 -0.779 . . . . 4.37 111.938 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -111.43 -28.71 8.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.546 0.212 . . . . 5.3 111.338 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -117.07 142.48 46.93 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.946 -0.701 . . . . 6.12 112.252 -169.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.615 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -69.3 124.34 23.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.867 -1.061 . . . . 2.68 108.565 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 15.5 mmm180 -101.45 136.36 41.42 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.601 -0.518 . . . . 4.59 109.601 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.8 135.67 55.1 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.539 -0.541 . . . . 2.52 109.539 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 25.2 tp60 -131.56 106.56 8.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.859 -0.422 . . . . 2.89 109.859 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.43 123.67 28.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 1.69 111.196 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HD2' HG21 ' A' ' 36' ' ' VAL . 31.5 Cg_exo -61.51 160.01 29.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.649 2.233 . . . . 2.21 111.581 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.704 ' HB3' HG21 ' B' ' 38' ' ' THR . 28.4 Cg_endo -63.97 122.73 10.86 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.35 2.033 . . . . 2.47 112.753 -176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.551 ' O ' HG23 ' A' ' 38' ' ' THR . . . 97.55 -37.66 3.38 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.875 -0.679 . . . . 1.81 114.06 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' HB ' HD12 ' A' ' 17' ' ' LEU . 26.7 m -68.63 -14.01 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.285 0.846 . . . . 1.86 113.285 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.8 tpp -86.01 23.51 1.48 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.892 0.377 . . . . 1.42 111.41 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.621 HG21 ' HB3' ' B' ' 34' ' ' PRO . 43.7 p -50.74 145.77 10.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.44 -0.346 . . . . 1.78 110.764 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.532 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 52.1 Cg_exo -53.18 -28.97 44.09 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.915 2.41 . . . . 1.87 113.435 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 38.7 tt0 -67.97 -48.33 66.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.886 -0.413 . . . . 2.76 109.886 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.26 -37.23 86.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.428 0.633 . . . . 1.65 109.883 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -56.42 -41.15 75.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.92 -1.036 . . . . 2.06 109.85 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 2.01 110.663 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 3.4 mmp_? -67.61 -38.04 83.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.487 -0.324 . . . . 3.9 110.432 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.7 mt -64.6 -43.26 94.36 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.152 -0.684 . . . . 1.42 109.152 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.65 -23.78 6.31 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 2.3 113.448 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.92 14.38 75.88 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 2.57 111.825 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.536 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -84.0 150.15 25.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.991 -0.374 . . . . 2.42 109.991 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' A' ' 53' ' ' ILE . 19.1 ptp180 -69.35 -50.56 45.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 111.773 0.286 . . . . 5.86 111.773 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.493 ' HA ' HD13 ' A' ' 53' ' ' ILE . 8.9 p80 -56.96 -35.73 69.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.052 0.454 . . . . 3.23 110.529 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.09 -51.12 67.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.368 -0.833 . . . . 2.75 109.852 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.715 HD23 HD22 ' A' ' 21' ' ' LEU . 80.8 mt -69.18 -25.65 64.45 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.672 -1.149 . . . . 2.4 111.016 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.5 mt -59.74 -47.7 90.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.789 0.328 . . . . 3.13 110.304 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -31.49 71.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.342 0.591 . . . . 2.03 110.494 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 2.1 tm? -71.54 -41.34 69.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.201 1.001 . . . . 1.89 108.461 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.592 HD21 ' O ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -62.93 -43.14 99.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.808 -1.542 . . . . 2.2 110.135 178.388 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.38 -29.26 70.59 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.576 -1.193 . . . . 4.58 111.616 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.6 pt20 -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.659 -0.417 . . . . 1.75 110.847 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 21.52 17.15 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.805 0.336 . . . . 2.94 110.552 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -73.68 122.63 88.07 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.485 -0.561 . . . . 2.58 109.485 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.52 152.41 73.51 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.137 2.558 . . . . 2.79 113.793 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 p -97.43 164.76 12.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.343 -0.844 . . . . 4.27 110.691 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.9 m -102.65 142.18 34.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.358 -0.383 . . . . 6.16 110.427 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -19.09 6.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.233 -0.439 . . . . 8.21 111.227 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.28 -72.64 2.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.417 -0.897 . . . . 10.39 111.787 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.27 -52.03 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.487 -0.863 . . . . 11.32 112.865 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m 66.6 99.63 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.353 0.597 . . . . 13.15 111.835 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.1 tp -123.66 151.46 43.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.789 -0.641 . . . . 15.23 109.708 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -128.19 147.33 50.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.911 -0.403 . . . . 16.48 109.911 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.01 113.01 57.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.621 -0.263 . . . . 16.82 110.573 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -86.46 44.77 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.102 2.535 . . . . 18.72 112.576 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.12 0.23 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.614 0.721 . . . . 19.82 110.041 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.04 -25.51 63.78 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.416 -0.811 . . . . 20.52 111.741 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -106.13 96.04 6.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.986 -0.376 . . . . 24.23 109.986 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -114.82 165.33 12.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.966 0.412 . . . . 22.26 111.357 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.53 -161.11 9.4 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.765 -0.652 . . . . 23.19 111.699 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.36 149.04 50.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.86 -0.422 . . . . 26.68 109.86 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.418 ' N ' HD13 ' A' ' 78' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.702 -0.666 . . . . 26.21 109.776 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.038 -0.425 . . . . 15.12 112.038 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.56 149.23 18.61 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.642 2.228 . . . . 14.6 112.37 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' B' ' 5' ' ' SER . 0.7 OUTLIER -105.28 -46.8 4.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.315 -0.624 . . . . 14.06 109.315 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.82 17.23 71.13 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-N 115.833 -0.621 . . . . 11.24 113.177 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.55 ' HB3' HD23 ' B' ' 3' ' ' LEU . 15.0 p -69.11 113.93 6.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.474 0.176 . . . . 9.8 111.474 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 29.8 p 44.32 -90.52 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.596 1.158 . . . . 8.47 113.426 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.3 -39.63 73.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 5.96 111.899 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.49 -47.01 92.56 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.6 -0.809 . . . . 5.13 112.812 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.72 -43.46 62.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.815 0.34 . . . . 6.14 110.747 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.507 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 69.1 tp -59.05 -47.54 84.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 4.74 110.76 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.92 -45.58 94.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.545 . . . . 3.19 110.048 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.9 63.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 4.03 112.323 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.507 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 8.9 p80 -76.81 -28.42 55.56 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 5.58 111.299 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -45.32 69.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.711 0.291 . . . . 3.33 110.583 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.25 95.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 4.37 111.182 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -61.83 -39.33 91.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 6.1 111.096 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.561 HD12 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -79.47 -26.63 41.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.796 -0.361 . . . . 6.81 110.594 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.76 33.03 19.99 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.849 -0.691 . . . . 5.35 112.495 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.407 ' O ' HD11 ' B' ' 55' ' ' LEU . 77.4 t -75.86 104.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.124 -0.695 . . . . 3.76 109.124 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 50.3 mtt180 -110.81 135.05 51.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.083 0.468 . . . . 7.44 111.9 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.606 HD22 HD23 ' B' ' 52' ' ' LEU . 6.2 mp -131.0 140.86 50.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.437 -0.801 . . . . 3.8 108.961 171.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.576 ' HA ' HD23 ' B' ' 56' ' ' LEU . 30.0 p90 -159.44 141.67 13.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.745 -0.465 . . . . 7.27 109.745 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.05 115.89 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.328 0.585 . . . . 7.74 109.793 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.454 ' HB2' ' HG3' ' B' ' 29' ' ' ARG . 27.4 tt0 -112.25 103.97 12.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 9.44 109.909 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.1 -90.7 0.51 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.752 -0.658 . . . . 10.31 112.342 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -115.7 -29.53 6.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.953 0.406 . . . . 9.56 110.871 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' B' ' 27' ' ' ARG . 5.9 tpp180 -115.08 138.83 50.44 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.291 -0.563 . . . . 7.94 111.651 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.549 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -68.48 126.34 29.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.405 -0.816 . . . . 5.2 108.984 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' B' ' 24' ' ' GLU . 14.1 mmm180 -102.97 135.24 45.02 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.799 -0.445 . . . . 8.44 109.799 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.507 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.1 t80 -119.76 132.44 55.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 4.16 109.54 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 24.9 tp60 -128.23 102.78 6.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.451 . . . . 7.26 109.781 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -116.45 122.59 31.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.957 -0.565 . . . . 5.75 111.335 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.46 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 31.4 Cg_exo -61.82 158.54 37.41 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.752 2.301 . . . . 7.34 111.748 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.621 ' HB3' HG21 ' A' ' 38' ' ' THR . 33.8 Cg_endo -64.86 123.4 11.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.404 2.069 . . . . 9.22 112.771 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.483 ' O ' HG23 ' B' ' 38' ' ' THR . . . 98.27 -36.92 3.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.968 -0.634 . . . . 8.58 113.777 172.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.561 ' HB ' HD12 ' B' ' 17' ' ' LEU . 24.8 m -72.09 -12.74 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.658 0.614 . . . . 7.19 112.658 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 19.3 tpp -86.2 22.58 1.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.923 0.392 . . . . 6.01 111.419 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.704 HG21 ' HB3' ' A' ' 34' ' ' PRO . 22.9 p -48.73 143.55 7.91 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.273 -0.421 . . . . 8.28 111.049 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.39 -27.5 39.83 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.236 2.624 . . . . 7.89 113.443 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.82 -50.68 61.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 9.22 109.949 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 tt -66.89 -33.45 75.62 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 6.37 109.817 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -56.83 -42.68 80.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.842 -0.617 . . . . 5.19 109.731 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.52 -29.65 63.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.499 -0.773 . . . . 7.5 110.702 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.633 ' CZ ' ' HA ' ' B' ' 44' ' ' ARG . 3.1 mmp_? -67.17 -38.79 86.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 8.73 110.482 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.99 -43.33 96.04 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.25 -0.648 . . . . 4.2 109.25 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.17 -23.85 6.72 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.436 -0.802 . . . . 5.65 113.354 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.16 12.25 79.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.71 -0.757 . . . . 4.5 112.007 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.495 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -80.46 151.36 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.265 -0.272 . . . . 5.81 110.265 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 18.0 ptp180 -68.31 -45.2 73.65 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.869 -0.332 . . . . 8.59 111.493 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -63.22 -35.61 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.227 -0.189 . . . . 7.48 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -46.47 82.52 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.071 0.462 . . . . 5.72 110.422 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.606 HD23 HD22 ' B' ' 21' ' ' LEU . 68.8 mt -69.97 -24.56 63.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 3.39 111.391 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 77.8 mt -65.07 -48.74 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.765 0.317 . . . . 6.75 110.264 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.56 95.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.316 0.579 . . . . 3.81 110.022 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.407 HD11 ' O ' ' B' ' 19' ' ' VAL . 1.1 tm? -58.88 -47.06 86.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.211 -0.904 . . . . 2.46 109.751 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' B' ' 22' ' ' TRP . 0.1 OUTLIER -55.39 -45.29 76.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.469 0.652 . . . . 5.83 110.604 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -64.72 -28.92 69.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 7.69 112.022 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -63.69 -30.01 71.17 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.769 0.318 . . . . 4.23 111.266 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.25 16.99 22.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.722 0.296 . . . . 6.46 110.771 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -70.37 121.16 82.48 Favored Pre-proline 0 C--O 1.236 0.392 0 N-CA-C 109.633 -0.506 . . . . 7.71 109.633 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.33 160.24 24.1 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.252 2.635 . . . . 8.76 113.24 -173.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 56.5 p -104.21 169.24 8.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.368 -0.833 . . . . 8.96 110.475 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 50.2 m -104.85 143.84 32.58 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.705 -0.479 . . . . 10.1 109.705 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.41 -18.8 4.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.959 0.409 . . . . 11.21 110.851 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.1 -83.23 1.36 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.904 -0.589 . . . . 12.71 111.79 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.48 -49.42 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.009 -0.615 . . . . 13.61 111.609 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 18.8 m 67.79 94.06 0.07 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.526 0.679 . . . . 15.17 111.52 176.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 48.4 tp -120.05 145.36 46.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.616 -0.72 . . . . 17.11 109.981 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.505 HD22 ' H ' ' B' ' 69' ' ' LEU . 2.7 pt? -121.2 141.92 50.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.868 0.366 . . . . 18.3 110.323 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' B' ' 71' ' ' PRO . . . -97.73 139.11 21.14 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.306 -0.627 . . . . 19.0 109.306 173.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 70' ' ' ALA . 16.8 Cg_exo -67.37 77.01 0.49 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.776 2.317 . . . . 20.29 112.848 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 5.6 p -83.17 79.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.222 1.01 . . . . 21.43 110.413 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.31 8.01 1.58 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.055 -0.975 . . . . 22.9 110.118 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -103.27 152.7 21.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.605 -0.725 . . . . 25.46 109.817 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -71.26 124.08 23.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.118 0.485 . . . . 24.7 111.144 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.17 16.66 29.84 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.855 -0.611 . . . . 24.61 111.749 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 62.41 82.23 0.18 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.353 0.597 . . . . 27.58 112.092 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.406 -0.807 . . . . 27.27 108.928 174.371 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.665 -0.574 . . . . 11.72 111.665 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.89 -45.45 16.62 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.509 2.14 . . . . 10.83 111.136 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.1 tp -96.62 101.13 12.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.772 -0.649 . . . . 10.23 109.951 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.01 104.19 0.25 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.098 -0.801 . . . . 7.0 111.098 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m -58.64 -76.6 0.04 OUTLIER 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.117 0.414 . . . . 6.3 112.117 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 t -167.8 111.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.9 0.381 . . . . 3.83 110.517 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.481 ' O ' ' HG ' ' A' ' 11' ' ' LEU . . . -114.43 -46.29 2.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 2.87 110.121 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.53 -44.23 96.92 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.698 -0.683 . . . . 2.3 112.482 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.16 98.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.033 0.444 . . . . 2.64 111.055 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.633 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 39.9 tp -64.83 -46.67 80.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.829 -0.623 . . . . 2.19 110.755 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 7' ' ' ALA . 87.7 mt -58.73 -51.04 71.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.119 -0.491 . . . . 2.17 109.941 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.451 -0.795 . . . . 2.28 112.175 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.633 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 5.6 p80 -71.7 -28.09 63.47 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.625 -0.43 . . . . 2.24 110.841 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.85 39.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.035 0.445 . . . . 1.33 110.504 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.7 85.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 1.75 110.927 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -69.21 -22.95 63.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 2.66 110.776 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 98.9 mt -84.23 -25.52 29.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.232 0.539 . . . . 2.04 109.776 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.29 16.12 25.94 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.831 -0.7 . . . . 1.44 112.899 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.98 115.11 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.582 -0.525 . . . . 1.4 109.582 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.736 ' HD3' HD13 ' A' ' 59' ' ' LEU . 95.5 mtt180 -131.11 134.14 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.25 -0.432 . . . . 3.03 111.544 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.5 mp -128.82 133.46 48.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.123 -0.489 . . . . 1.67 109.856 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' HB3' HD13 ' A' ' 56' ' ' LEU . 22.8 p90 -151.92 149.1 28.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.179 -0.304 . . . . 2.43 110.179 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.6 p -87.86 128.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 3.4 109.818 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 32.8 tt0 -132.73 110.97 10.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.116 -0.493 . . . . 4.2 110.152 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.58 -101.46 1.0 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.766 -0.731 . . . . 4.37 111.712 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' OE1' ' HD3' ' B' ' 49' ' ' ARG . 0.3 OUTLIER -116.78 -3.79 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.575 0.213 . . . . 5.3 111.575 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.501 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 11.9 tpp180 -134.58 152.12 51.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.391 0.615 . . . . 6.12 111.912 -174.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.4 tt -80.81 132.66 35.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.302 -0.863 . . . . 2.68 109.751 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.501 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.3 mpt_? -99.71 140.57 33.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 4.59 109.836 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.08 130.95 53.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.071 -0.715 . . . . 2.52 109.071 -177.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.452 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 62.7 tp60 -122.77 119.66 31.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.624 -0.51 . . . . 2.89 109.624 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.11 129.13 5.24 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.798 0.332 . . . . 1.69 110.851 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.539 ' HD2' HG23 ' A' ' 36' ' ' VAL . 31.5 Cg_exo -61.48 154.47 59.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.681 2.254 . . . . 2.21 112.166 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.51 122.51 9.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.113 1.876 . . . . 2.47 112.115 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.88 -33.98 5.47 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.7 -0.762 . . . . 1.81 113.101 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.566 ' O ' HD21 ' A' ' 41' ' ' LEU . 34.1 m -79.69 -12.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.245 0.522 . . . . 1.86 112.1 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.61 21.71 0.79 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.086 -0.506 . . . . 1.42 111.243 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.7 p -50.4 139.5 19.66 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.329 -0.396 . . . . 1.78 110.971 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.507 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 83.3 Cg_exo -47.22 -39.36 26.75 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.314 2.676 . . . . 1.87 113.282 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.597 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 39.3 tt0 -63.08 -40.68 98.38 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.207 -0.197 . . . . 2.76 110.517 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.566 HD21 ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -62.95 -40.04 96.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.793 0.33 . . . . 1.65 110.362 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.47 ' HA ' HD13 ' A' ' 45' ' ' LEU . 5.8 mt-30 -64.8 -39.48 93.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.249 0.547 . . . . 2.06 110.129 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -66.79 -29.63 69.62 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.094 -0.957 . . . . 2.01 109.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 51.0 mtt-85 -75.19 -38.61 60.72 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 115.882 -0.599 . . . . 3.9 110.079 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 42' ' ' GLN . 97.4 mt -55.69 -44.32 77.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.189 -0.671 . . . . 1.42 109.189 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.28 -23.24 5.52 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.579 -0.737 . . . . 2.3 113.134 168.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.71 74.18 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.737 -0.744 . . . . 2.57 111.484 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -85.08 149.52 25.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.652 0.263 . . . . 2.42 110.57 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.625 ' HD3' ' OE1' ' B' ' 26' ' ' GLU . 7.6 ptt180 -67.47 -51.65 48.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.375 . . . . 5.86 111.984 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -57.23 -39.34 75.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.384 0.611 . . . . 3.23 110.036 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.77 -55.83 22.98 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.853 -1.067 . . . . 2.75 110.351 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 93.3 mt -70.33 -26.65 63.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.091 -0.959 . . . . 2.4 111.854 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 49' ' ' ARG . 70.7 mt -62.02 -52.29 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 3.13 110.227 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.29 70.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.401 0.62 . . . . 2.03 110.23 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.586 ' O ' HD12 ' A' ' 55' ' ' LEU . 3.5 tm? -68.46 -29.46 68.1 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.196 -0.911 . . . . 1.89 109.929 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -82.72 -32.85 27.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.058 0.456 . . . . 2.2 110.602 174.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.76 -21.9 63.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 4.58 111.67 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -69.15 -22.63 63.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.916 0.389 . . . . 1.75 111.03 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.736 HD13 ' HD3' ' A' ' 20' ' ' ARG . 10.4 tt -73.98 -27.59 61.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.244 -0.651 . . . . 2.94 109.244 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -68.24 146.94 98.24 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.58 110.357 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.8 84.69 0.11 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.894 2.396 . . . . 2.79 112.46 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -137.04 -66.69 0.51 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 4.27 109.63 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 t -143.26 140.31 30.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.372 -0.603 . . . . 6.16 109.372 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -121.95 153.93 37.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.921 0.391 . . . . 8.21 110.571 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.41 160.94 26.07 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.3 -0.72 . . . . 10.39 111.3 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.85 112.61 0.53 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.424 -0.893 . . . . 11.32 112.58 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 m -93.47 -3.32 53.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.628 0.252 . . . . 13.15 110.706 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.19 -81.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.753 -0.658 . . . . 15.23 111.078 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.89 162.45 18.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 16.48 110.446 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -133.3 123.42 17.7 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.316 -0.402 . . . . 16.82 110.226 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 2.7 Cg_exo -77.26 35.87 0.51 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.269 2.646 . . . . 18.72 112.721 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 p -75.75 87.73 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 122.159 0.981 . . . . 19.82 110.554 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.67 173.63 7.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.143 -0.935 . . . . 20.52 110.362 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 74' ' ' ARG . 12.5 ptt180 -76.13 78.47 2.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.778 0.799 . . . . 24.23 110.768 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -87.12 -50.42 6.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.859 -1.064 . . . . 22.26 110.2 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.68 161.54 37.44 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.812 -0.709 . . . . 23.19 111.826 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -94.1 34.4 1.26 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.142 0.496 . . . . 26.68 110.759 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.2 tp . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.734 -0.65 . . . . 26.21 109.987 178.078 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 CA-C-O 120.005 -0.331 . . . . 15.12 112.637 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.52 127.08 24.5 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.982 2.455 . . . . 14.6 112.738 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.75 -102.9 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.186 -0.915 . . . . 14.06 111.385 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.47 -100.69 0.44 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.612 -0.804 . . . . 11.24 111.595 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 45.3 m -109.41 -50.77 2.95 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.046 -0.353 . . . . 9.8 110.046 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m 61.66 38.8 15.01 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.777 -0.647 . . . . 8.47 111.138 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' B' ' 11' ' ' LEU . . . 60.76 43.95 11.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.3 0.572 . . . . 5.96 110.205 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.62 -40.63 79.58 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.136 -0.938 . . . . 5.13 113.369 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.72 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.0 0.4 . . . . 6.14 110.96 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.45 -46.6 89.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 4.74 110.354 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' B' ' 7' ' ' ALA . 87.1 mt -61.89 -49.94 74.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.001 -0.545 . . . . 3.19 110.792 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.06 -53.04 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.551 . . . . 4.03 112.337 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.535 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 5.0 p80 -70.73 -28.42 64.7 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.283 -0.567 . . . . 5.58 110.903 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.95 59.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.066 0.46 . . . . 3.33 110.406 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.11 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.691 -0.686 . . . . 4.37 110.85 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -67.69 -26.74 66.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 6.1 110.547 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' B' ' 13' ' ' HIS . 92.5 mt -81.27 -24.88 36.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 6.81 110.42 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.28 15.47 25.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 5.35 112.809 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -73.95 114.92 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.939 -0.393 . . . . 3.76 109.939 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.749 ' HD3' HD13 ' B' ' 59' ' ' LEU . 94.6 mtt180 -131.05 136.99 48.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.315 -0.402 . . . . 7.44 111.491 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.487 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.7 mp -129.91 136.42 49.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 3.8 109.751 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.712 ' HB3' HD13 ' B' ' 56' ' ' LEU . 28.8 p90 -153.9 150.07 27.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.792 0.329 . . . . 7.27 110.381 175.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.2 p -88.03 130.69 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.482 -0.562 . . . . 7.74 109.482 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.664 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 35.0 tt0 -134.89 114.37 12.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.236 -0.438 . . . . 9.44 110.272 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -102.86 0.85 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.984 -0.627 . . . . 10.31 111.912 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.625 ' OE1' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -0.08 12.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.572 0.225 . . . . 9.56 111.266 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.513 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 10.7 tpp180 -140.14 146.77 39.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.106 -0.638 . . . . 7.94 111.395 -171.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.42 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.2 tt -79.13 135.71 36.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.515 . . . . 5.2 110.332 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.664 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 4.8 mpt_? -101.09 137.86 38.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 8.44 110.134 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.487 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.6 t80 -119.01 131.49 56.0 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.355 -0.609 . . . . 4.16 109.355 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -126.18 114.02 17.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.833 -0.432 . . . . 7.26 109.833 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.39 130.49 7.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 5.75 111.265 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.49 ' O ' HG21 ' B' ' 36' ' ' VAL . 32.1 Cg_exo -61.98 151.71 79.74 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.806 2.337 . . . . 7.34 112.302 175.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.507 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 34.9 Cg_endo -65.86 123.26 11.08 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.158 1.905 . . . . 9.22 112.326 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.42 -33.07 5.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.758 -0.734 . . . . 8.58 112.945 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.571 ' O ' HD21 ' B' ' 41' ' ' LEU . 22.5 m -83.99 -7.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.181 0.49 . . . . 7.19 111.53 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.803 ' HA ' ' HE3' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.43 20.22 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.399 . . . . 6.01 111.289 -175.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 14.9 p -50.67 138.91 22.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 8.28 111.338 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.01 -41.4 33.18 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.486 2.791 . . . . 7.89 113.473 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.581 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 42.5 tt0 -57.74 -40.74 80.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.506 0.194 . . . . 9.22 111.043 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.571 HD21 ' O ' ' B' ' 36' ' ' VAL . 2.5 tp -64.37 -42.39 96.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.86 0.362 . . . . 6.37 110.081 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.489 ' HA ' HD13 ' B' ' 45' ' ' LEU . 22.8 mt-30 -63.66 -36.99 85.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 5.19 109.97 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 17.2 t -68.02 -37.02 80.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.666 -0.697 . . . . 7.5 109.955 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 56.5 mtt-85 -66.56 -40.36 88.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.418 -0.355 . . . . 8.73 110.422 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' B' ' 42' ' ' GLN . 91.7 mt -56.92 -43.76 81.74 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-O 121.285 0.564 . . . . 4.2 109.732 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.19 -23.42 6.15 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.474 -0.784 . . . . 5.65 112.95 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.99 28.14 73.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.994 -0.622 . . . . 4.5 111.664 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.44 150.26 24.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.528 0.204 . . . . 5.81 110.467 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.501 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 11.0 ptt-85 -65.89 -50.21 65.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.338 -0.392 . . . . 8.59 111.403 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -57.48 -42.11 82.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.752 -0.204 . . . . 7.48 111.398 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -54.22 40.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.448 -0.342 . . . . 5.72 110.809 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.434 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 75.8 mt -67.91 -27.67 66.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.286 0.476 . . . . 3.39 112.286 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.462 HG13 ' O ' ' B' ' 49' ' ' ARG . 72.0 mt -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.808 -0.357 . . . . 6.75 110.09 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.75 -36.08 77.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.413 0.625 . . . . 3.81 110.486 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.486 ' O ' ' HG3' ' B' ' 58' ' ' GLN . 2.9 tm? -63.39 -29.21 70.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 2.46 110.134 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.712 HD13 ' HB3' ' B' ' 22' ' ' TRP . 22.9 tp -79.25 -32.38 43.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 5.83 110.694 173.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.59 -20.23 65.34 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.013 0.375 . . . . 7.69 112.013 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' B' ' 55' ' ' LEU . 1.5 pp0? -73.36 -17.93 61.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.768 -0.373 . . . . 4.23 110.893 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.749 HD13 ' HD3' ' B' ' 20' ' ' ARG . 10.1 tt -75.3 -26.82 59.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.398 -0.593 . . . . 6.46 109.398 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 22.0 mt-30 -71.64 147.9 92.41 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.657 -0.701 . . . . 7.71 110.335 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 26.4 Cg_exo -62.53 93.22 0.14 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.749 2.3 . . . . 8.76 112.372 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 12.6 t -147.31 -66.42 0.26 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 8.96 109.417 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 26.4 t -142.77 137.98 30.12 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.381 -0.6 . . . . 10.1 109.381 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -120.74 157.53 29.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.555 -0.293 . . . . 11.21 110.422 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -145.88 157.66 27.44 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.928 -0.653 . . . . 12.71 111.769 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.66 116.84 0.74 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.633 -0.794 . . . . 13.61 112.473 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 56.6 m -97.69 -3.89 38.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.655 0.264 . . . . 15.17 110.516 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 69.68 -82.9 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.529 -0.76 . . . . 17.11 110.825 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 pp -164.08 159.71 20.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.187 -0.46 . . . . 18.3 109.982 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.15 114.67 38.72 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.302 -0.408 . . . . 19.0 110.245 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.14 -35.94 90.57 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.911 2.408 . . . . 20.29 112.032 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 p -166.85 150.07 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.496 -0.775 . . . . 21.43 109.315 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.5 102.11 10.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.014 -0.365 . . . . 22.9 110.014 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.625 ' H ' ' HD3' ' B' ' 74' ' ' ARG . 0.0 OUTLIER -50.93 121.23 5.7 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.364 0.602 . . . . 25.46 110.663 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -91.21 122.02 33.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.733 -0.667 . . . . 24.7 111.007 -175.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.17 -83.89 0.62 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.632 -0.987 . . . . 24.61 110.632 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.436 ' NE ' ' HA ' ' B' ' 77' ' ' ARG . 5.6 mmp_? -132.41 82.54 2.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.604 -0.517 . . . . 27.58 109.604 171.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.405 -0.807 . . . . 27.27 111.201 179.472 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.436 -0.666 . . . . 11.72 111.436 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.37 -55.19 3.84 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.651 2.234 . . . . 10.83 112.049 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.8 tp -163.07 107.74 1.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.963 -0.562 . . . . 10.23 110.035 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.95 88.06 1.6 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.49 -0.862 . . . . 7.0 112.837 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.5 t 71.93 128.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.741 0.781 . . . . 6.3 112.88 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.1 m -98.56 -16.68 19.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.818 -0.808 . . . . 3.83 108.818 169.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.54 -34.12 65.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.937 -1.029 . . . . 2.87 110.379 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.1 92.87 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.579 -0.609 . . . . 2.3 111.579 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.22 85.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 2.64 110.306 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.691 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 36.6 tp -61.76 -46.84 87.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.918 -0.583 . . . . 2.19 110.042 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.4 -47.57 85.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.493 -0.776 . . . . 2.17 109.933 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.42 73.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.449 . . . . 2.28 112.043 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.691 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 4.5 p80 -74.75 -27.76 60.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.649 -0.421 . . . . 2.24 110.625 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 -45.36 71.69 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.203 -0.295 . . . . 1.33 110.203 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 1.75 110.935 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -65.34 -31.98 73.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 2.66 111.235 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.626 HD13 ' HB ' ' A' ' 36' ' ' VAL . 74.6 mt -85.35 -26.43 26.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 2.04 110.166 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.35 33.23 26.22 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.51 -0.768 . . . . 1.44 112.804 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.693 HG22 HD23 ' A' ' 41' ' ' LEU . 54.0 t -71.71 121.06 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.81 -0.811 . . . . 1.4 108.81 173.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.776 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 74.7 mtt180 -126.5 131.71 51.56 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.378 -0.23 . . . . 3.03 110.378 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 HD12 ' A' ' 28' ' ' LEU . 6.1 mp -132.33 125.52 31.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.729 -0.471 . . . . 1.67 109.729 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -143.11 134.45 26.07 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.917 0.389 . . . . 2.43 109.984 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -92.77 125.41 45.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 3.4 109.959 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.25 118.16 28.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.907 -0.588 . . . . 4.2 109.661 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.05 -97.04 0.56 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.688 -0.687 . . . . 4.37 111.664 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -116.63 -16.29 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.734 0.302 . . . . 5.3 111.444 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 11.9 tpp180 -114.76 135.2 54.43 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.836 -0.746 . . . . 6.12 112.643 -167.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.577 HD12 HD22 ' A' ' 21' ' ' LEU . 3.4 tm? -78.24 124.76 28.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.505 -1.225 . . . . 2.68 108.84 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.96 143.97 30.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.001 -0.37 . . . . 4.59 110.001 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.66 131.89 55.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 2.52 110.702 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.776 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 5.2 tp-100 -126.36 114.33 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.872 -0.603 . . . . 2.89 109.692 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.83 126.85 4.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.864 0.364 . . . . 1.69 111.343 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.572 ' O ' HG21 ' A' ' 36' ' ' VAL . 24.0 Cg_exo -65.38 155.83 66.61 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.904 2.402 . . . . 2.21 112.053 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.09 123.79 13.91 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.728 2.285 . . . . 2.47 112.563 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.15 -31.88 6.68 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 1.81 113.2 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.626 ' HB ' HD13 ' A' ' 17' ' ' LEU . 15.4 m -85.11 -19.87 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.091 0.446 . . . . 1.86 112.157 -174.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.502 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.39 20.29 0.89 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.42 111.43 -171.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.3 p -51.75 142.16 24.77 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 1.78 110.894 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.68 -38.29 28.88 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.207 2.605 . . . . 1.87 113.244 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 55.4 tt0 -61.54 -39.98 93.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 2.76 111.056 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.693 HD23 HG22 ' A' ' 19' ' ' VAL . 1.9 tp -60.35 -44.55 95.44 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.882 0.372 . . . . 1.65 110.134 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.655 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.36 -39.01 75.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 2.06 110.125 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -68.84 -29.84 68.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.578 . . . . 2.01 110.504 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 27.4 mmt180 -73.1 -40.9 64.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.99 -0.374 . . . . 3.9 109.99 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 50.8 mt -60.19 -38.46 83.34 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.544 0.688 . . . . 1.42 109.161 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.3 -23.23 8.57 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.183 -0.917 . . . . 2.3 113.062 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.14 19.32 71.96 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.934 -0.651 . . . . 2.57 112.064 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.471 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . . . -82.87 149.66 26.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.899 -0.408 . . . . 2.42 109.899 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.556 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.4 ptp85 -69.06 -50.62 46.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.487 -0.324 . . . . 5.86 111.521 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.447 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 8.6 p80 -61.59 -32.97 73.1 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.095 0.474 . . . . 3.23 110.836 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -66.25 -51.24 59.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.326 -0.852 . . . . 2.75 110.309 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.452 HD21 HD21 ' A' ' 21' ' ' LEU . 91.2 mt -69.08 -26.52 64.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.925 -1.034 . . . . 2.4 111.124 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.4 mt -61.0 -48.16 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 3.13 109.998 174.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.63 66.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 2.03 110.609 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 55' ' ' LEU . 2.7 tm? -69.39 -38.13 77.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 1.89 109.398 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.5 tp -79.46 -26.8 41.65 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.452 0.644 . . . . 2.2 109.633 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -65.29 -26.77 68.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 4.58 110.437 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.57 -27.89 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 1.75 110.274 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.461 HD23 ' HG2' ' A' ' 20' ' ' ARG . 51.0 mt -74.24 -19.19 60.59 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.581 -0.736 . . . . 2.94 110.911 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 45.0 mt-30 -90.94 106.14 14.68 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.798 -0.637 . . . . 2.58 109.875 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 9.7 Cg_exo -69.98 85.15 0.66 Allowed 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.124 2.549 . . . . 2.79 112.931 -175.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.8 m 59.11 -108.59 0.41 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.448 -0.796 . . . . 4.27 110.801 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.6 m -138.05 2.34 2.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.94 0.4 . . . . 6.16 110.879 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.417 HE21 ' HB2' ' A' ' 64' ' ' GLN . 1.5 mp0 -132.69 -76.17 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.007 -0.368 . . . . 8.21 110.007 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.454 ' HA2' ' HB2' ' A' ' 61' ' ' PRO . . . -175.96 -51.36 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.531 -0.843 . . . . 10.39 112.383 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.54 101.84 0.56 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.169 -0.539 . . . . 11.32 112.741 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.6 m -99.63 92.18 5.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.991 0.424 . . . . 13.15 110.183 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.8 tp -152.64 168.01 27.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.081 -0.509 . . . . 15.23 109.778 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 mt -77.3 -63.46 1.37 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.962 -0.755 . . . . 16.48 108.962 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 48.83 93.64 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 114.377 -1.283 . . . . 16.82 113.415 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.95 25.41 0.56 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.818 2.345 . . . . 18.72 111.949 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.4 p -73.27 109.87 6.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.626 0.727 . . . . 19.82 110.228 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.61 -177.88 6.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.428 -0.805 . . . . 20.52 110.108 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -93.09 7.94 42.11 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.809 -0.441 . . . . 24.23 109.809 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 67.59 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.211 -0.904 . . . . 22.26 110.942 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.5 69.81 1.99 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.76 -0.733 . . . . 23.19 112.656 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.498 ' HG3' ' HG ' ' A' ' 78' ' ' LEU . 5.1 ptp180 -70.21 -18.37 63.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.102 0.477 . . . . 26.68 110.041 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.498 ' HG ' ' HG3' ' A' ' 77' ' ' ARG . 85.6 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.249 -0.881 . . . . 26.21 109.818 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.222 -0.351 . . . . 15.12 112.222 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.429 ' HA ' ' NH1' ' B' ' 44' ' ' ARG . 92.2 Cg_endo -86.98 -12.32 5.05 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.855 2.37 . . . . 14.6 113.015 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.98 -85.59 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 122.954 0.502 . . . . 14.06 111.234 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.42 -174.73 25.64 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.713 -0.555 . . . . 11.24 111.713 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 15.6 m 60.37 20.45 10.03 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.861 0.464 . . . . 9.8 111.556 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m -119.43 83.13 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.266 0.555 . . . . 8.47 111.327 -174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.31 -77.81 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.522 -0.763 . . . . 5.96 109.895 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.44 -38.32 79.9 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.975 -0.631 . . . . 5.13 111.693 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.0 83.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.892 0.377 . . . . 6.14 110.173 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.517 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 58.5 tp -61.51 -46.59 89.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.867 -0.606 . . . . 4.74 109.89 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.31 -49.15 76.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.728 -0.669 . . . . 3.19 109.66 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.78 -53.26 58.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 4.03 112.307 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.517 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 4.0 p80 -73.52 -27.92 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.19 -0.604 . . . . 5.58 110.952 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.17 78.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 3.33 110.445 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.15 94.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 4.37 110.8 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -61.99 -36.7 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.749 -0.66 . . . . 6.1 111.141 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.534 HD13 ' HB ' ' B' ' 36' ' ' VAL . 82.5 mt -82.03 -24.92 35.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 6.81 110.632 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.52 31.65 18.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.045 -0.598 . . . . 5.35 112.673 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.635 HG22 HD23 ' B' ' 41' ' ' LEU . 45.8 t -75.38 123.08 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.689 -0.486 . . . . 3.76 109.689 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.878 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 77.6 mtt180 -129.33 131.11 46.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.531 -0.304 . . . . 7.44 111.107 -173.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.65 HD22 HD12 ' B' ' 28' ' ' LEU . 5.7 mp -134.64 125.74 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.328 -0.396 . . . . 3.8 110.135 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.463 ' HB3' HD11 ' B' ' 56' ' ' LEU . 20.4 p90 -143.5 137.05 28.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 7.27 110.21 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 5.7 p -96.48 118.37 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.183 0.515 . . . . 7.74 110.172 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.3 114.43 26.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.85 -0.614 . . . . 9.44 109.664 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.36 -98.89 1.05 Allowed Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 111.327 -0.709 . . . . 10.31 111.327 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -116.99 -16.53 10.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.852 0.358 . . . . 9.56 111.598 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.436 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 7.5 tpp180 -115.53 128.44 55.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.409 0.623 . . . . 7.94 111.962 -166.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.65 HD12 HD22 ' B' ' 21' ' ' LEU . 3.3 tm? -74.62 124.39 26.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.801 -1.09 . . . . 5.2 109.551 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -100.38 145.31 28.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.295 -0.261 . . . . 8.44 110.295 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.457 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -120.14 131.67 55.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 4.16 110.57 -174.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.878 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 5.6 tp-100 -125.32 114.39 18.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.433 -0.58 . . . . 7.26 109.433 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -151.58 122.17 3.67 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 5.75 111.031 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.531 ' O ' HG21 ' B' ' 36' ' ' VAL . 31.4 Cg_exo -60.27 152.92 63.14 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.917 2.411 . . . . 7.34 112.181 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.07 124.05 15.05 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.512 2.141 . . . . 9.22 112.409 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.75 -29.03 8.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.705 -0.76 . . . . 8.58 112.926 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.551 ' O ' HD21 ' B' ' 41' ' ' LEU . 6.4 m -89.0 -14.61 9.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.533 -0.393 . . . . 7.19 111.293 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.871 ' HE1' ' HA ' ' B' ' 37' ' ' MET . 0.4 OUTLIER -82.25 18.45 1.41 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.89 0.376 . . . . 6.01 111.239 -174.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.8 p -52.08 142.91 25.94 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 8.28 111.114 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . 0.422 ' HG3' ' OE1' ' A' ' 31' ' ' GLN . 71.4 Cg_exo -49.33 -37.16 39.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.263 2.642 . . . . 7.89 113.302 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 38.0 tt0 -61.43 -38.26 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.077 -0.249 . . . . 9.22 111.13 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.635 HD23 HG22 ' B' ' 19' ' ' VAL . 2.9 tp -62.79 -40.36 97.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.869 0.366 . . . . 6.37 110.115 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.714 ' HA ' HE21 ' B' ' 42' ' ' GLN . 0.0 OUTLIER -59.62 -39.64 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 5.19 109.857 176.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 24.5 t -68.29 -32.35 72.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.773 . . . . 7.5 110.703 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 23.7 mmt180 -71.71 -41.67 68.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 8.73 110.093 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 78.3 mt -61.28 -39.6 91.01 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.858 -0.61 . . . . 4.2 109.779 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.06 -23.16 8.26 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.532 -0.758 . . . . 5.65 112.807 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.89 72.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.077 -0.582 . . . . 4.5 112.381 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' B' ' 51' ' ' GLU . . . -76.1 150.43 37.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.047 -0.353 . . . . 5.81 110.047 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.512 ' O ' HG13 ' B' ' 53' ' ' ILE . 8.8 ptp85 -65.27 -48.99 71.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.579 -0.282 . . . . 8.59 111.034 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -66.66 -32.07 73.15 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.299 . . . . 7.48 111.806 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' B' ' 48' ' ' ALA . 0.4 OUTLIER -64.97 -44.27 89.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 5.72 110.534 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.85 -25.0 55.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.047 -0.524 . . . . 3.39 111.506 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.512 HG13 ' O ' ' B' ' 49' ' ' ARG . 80.0 mt -63.54 -47.46 91.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.672 -0.492 . . . . 6.75 109.672 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.21 74.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 3.81 110.233 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.491 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.8 tm? -62.53 -44.57 96.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.761 -0.654 . . . . 2.46 109.778 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' B' ' 22' ' ' TRP . 28.2 tp -68.58 -30.95 69.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.3 0.571 . . . . 5.83 110.763 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -66.55 -29.66 69.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.074 -0.512 . . . . 7.69 110.911 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 8.2 pt20 -68.03 -24.59 65.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 4.23 110.381 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.434 HD23 ' HG2' ' B' ' 20' ' ' ARG . 55.7 mt -74.98 -17.63 60.51 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.805 -0.634 . . . . 6.46 110.453 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . 0.452 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 43.9 mt-30 -91.47 107.06 19.07 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.626 -0.715 . . . . 7.71 109.492 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.571 ' HB2' ' HA2' ' B' ' 65' ' ' GLY . 6.9 Cg_exo -73.04 82.89 1.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.159 2.573 . . . . 8.76 112.225 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m 56.77 -143.06 0.73 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.666 -0.697 . . . . 8.96 109.571 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 23.5 m -100.12 -6.96 25.44 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.804 -0.358 . . . . 10.1 111.384 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' B' ' 64' ' ' GLN . 1.5 mp0 -122.49 -78.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.685 0.278 . . . . 11.21 110.565 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' B' ' 61' ' ' PRO . . . -179.7 -50.64 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.988 -0.625 . . . . 12.71 111.94 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.78 100.04 0.35 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.868 -0.682 . . . . 13.61 112.381 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.8 m -98.54 103.62 15.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.991 -0.374 . . . . 15.17 109.991 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.3 tp -162.29 163.52 28.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.459 . . . . 17.11 109.811 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 mt -73.43 -62.15 1.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.018 -0.734 . . . . 18.3 109.018 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . 56.67 95.98 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 115.134 -0.939 . . . . 19.0 112.776 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.38 -18.14 62.05 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.636 2.224 . . . . 20.29 111.136 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.87 113.64 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.389 -0.823 . . . . 21.43 109.924 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.64 176.19 6.1 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.023 -0.535 . . . . 22.9 110.803 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -65.53 -37.38 86.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.885 0.374 . . . . 25.46 111.051 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -75.37 95.16 3.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.173 -0.467 . . . . 24.7 110.385 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.26 -8.27 6.29 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.419 -0.896 . . . . 24.61 112.852 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -74.7 -72.74 0.27 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.196 0.498 . . . . 27.58 109.921 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 tp . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.687 -0.673 . . . . 27.27 110.001 175.754 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.868 -0.493 . . . . 11.72 111.868 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.421 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 18.1 Cg_exo -66.54 -36.65 25.19 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.073 2.515 . . . . 10.83 112.573 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.42 -45.79 29.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.485 -0.325 . . . . 10.23 110.432 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.24 155.67 26.26 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.566 -0.826 . . . . 7.0 112.661 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.8 m -101.57 -30.22 11.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.179 0.514 . . . . 6.3 110.353 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.627 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 66.3 m -85.72 95.82 9.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.9 -0.591 . . . . 3.83 110.815 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.25 -48.65 6.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.152 -0.477 . . . . 2.87 110.449 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.37 -37.58 94.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.943 -0.571 . . . . 2.3 111.947 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.627 ' HB2' ' HB3' ' A' ' 6' ' ' SER . . . -59.35 -41.55 89.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 2.64 110.748 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.747 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 32.6 tp -64.22 -47.33 80.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 2.19 110.152 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.81 -49.09 77.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.443 -0.798 . . . . 2.17 109.999 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -50.48 71.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.813 -0.63 . . . . 2.28 112.238 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.747 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 4.2 p80 -73.13 -27.49 61.71 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.454 -0.498 . . . . 2.24 110.55 -174.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.68 68.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.818 0.342 . . . . 1.33 110.392 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -31.82 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 1.75 110.696 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.977 -0.556 . . . . 2.66 110.762 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.583 HD13 ' HB ' ' A' ' 36' ' ' VAL . 97.6 mt -79.96 -25.89 40.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.094 0.474 . . . . 2.04 110.257 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.15 42.63 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.984 -0.627 . . . . 1.44 112.276 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.67 121.28 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 109.353 -0.61 . . . . 1.4 109.353 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 76.8 mtt180 -122.25 135.23 54.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.77 -0.456 . . . . 3.03 109.77 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.794 HD21 HD21 ' A' ' 52' ' ' LEU . 6.0 mp -135.85 124.36 23.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 1.67 110.183 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.458 ' HB3' HD13 ' A' ' 56' ' ' LEU . 23.8 p90 -140.84 140.6 34.66 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.894 -0.41 . . . . 2.43 109.894 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.51 123.0 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.943 0.401 . . . . 3.4 110.147 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.635 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -110.34 101.84 10.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.025 -0.731 . . . . 4.2 109.025 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.01 -86.15 0.22 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.766 -0.652 . . . . 4.37 112.1 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.63 -32.03 5.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.207 0.527 . . . . 5.3 110.78 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.31 133.37 50.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 6.12 112.029 -167.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.594 HD13 HD22 ' A' ' 21' ' ' LEU . 3.2 tm? -69.6 126.15 28.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.882 -1.054 . . . . 2.68 109.445 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.635 ' NH1' ' HB3' ' A' ' 24' ' ' GLU . 7.3 mpt_? -98.58 131.11 45.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.628 -0.508 . . . . 4.59 109.628 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CE2' HD23 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -108.45 145.99 33.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.063 -0.517 . . . . 2.52 110.201 -175.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 8.6 tp-100 -145.41 110.49 5.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.981 -0.378 . . . . 2.89 109.981 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.03 135.68 11.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.565 -0.289 . . . . 1.69 110.848 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.564 ' O ' HG21 ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.26 156.98 37.42 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.89 2.394 . . . . 2.21 112.179 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.47 ' HB3' HG22 ' B' ' 38' ' ' THR . 20.0 Cg_endo -63.1 123.95 13.08 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.437 2.092 . . . . 2.47 112.35 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.64 -37.23 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.81 113.275 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.583 ' HB ' HD13 ' A' ' 17' ' ' LEU . 33.3 m -75.06 -11.92 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.609 0.596 . . . . 1.86 112.609 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -82.16 21.51 0.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.187 -0.46 . . . . 1.42 111.711 -173.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.595 HG22 ' HB3' ' B' ' 34' ' ' PRO . 35.2 p -50.64 143.91 13.58 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 116.608 -0.269 . . . . 1.78 110.954 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.51 -32.91 65.48 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.54 2.16 . . . . 1.87 111.954 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.531 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 18.4 tp10 -57.93 -50.21 74.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.856 -0.611 . . . . 2.76 110.2 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 36' ' ' VAL . 2.4 tp -61.79 -47.53 84.73 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.65 110.293 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.414 ' HA ' HD11 ' A' ' 45' ' ' LEU . 25.3 tp60 -57.13 -39.25 74.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 2.06 111.204 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.9 t -71.44 -29.55 65.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.381 -0.372 . . . . 2.01 110.391 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 96.3 mtt180 -77.76 -28.73 50.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 3.9 110.94 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 42' ' ' GLN . 87.2 mt -64.86 -33.85 76.99 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.784 -0.821 . . . . 1.42 108.784 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 -24.03 6.79 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.078 -0.965 . . . . 2.3 113.044 171.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.87 11.6 60.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.967 -0.635 . . . . 2.57 112.12 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -78.42 150.47 33.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.137 -0.32 . . . . 2.42 110.137 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.553 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -67.46 -50.15 60.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.298 -0.41 . . . . 5.86 111.16 -173.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.62 -34.54 78.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 3.23 110.808 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -66.1 -48.67 70.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.699 -0.682 . . . . 2.75 109.844 -178.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.794 HD21 HD21 ' A' ' 21' ' ' LEU . 76.8 mt -72.07 -24.2 61.47 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.05 -0.977 . . . . 2.4 111.238 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 49' ' ' ARG . 74.7 mt -62.37 -43.92 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.769 -0.456 . . . . 3.13 109.769 172.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.06 -25.76 65.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 2.03 110.319 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB2' ' HA ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -71.56 -29.76 65.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 1.89 110.202 -178.303 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.578 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 5.5 tp -84.27 -40.15 18.36 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.444 -0.798 . . . . 2.2 110.619 172.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -56.89 -28.97 62.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.276 -0.875 . . . . 4.58 111.156 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.632 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 11.8 pt20 -68.21 -20.36 64.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.357 -0.838 . . . . 1.75 111.594 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.8 tp -89.23 -6.44 56.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.352 -0.385 . . . . 2.94 110.718 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 14.7 mm100 -67.83 120.58 74.78 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.235 -0.439 . . . . 2.58 110.605 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 12.8 Cg_exo -69.94 94.62 0.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.622 2.214 . . . . 2.79 112.004 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.7 p -73.24 -15.86 61.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.922 -0.581 . . . . 4.27 111.008 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -65.48 149.4 50.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.115 -0.493 . . . . 6.16 110.329 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -96.47 23.81 6.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.84 0.353 . . . . 8.21 111.523 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.81 -68.81 2.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.661 -0.781 . . . . 10.39 112.494 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.66 -167.97 24.94 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.747 -0.739 . . . . 11.32 111.722 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.5 t -137.59 63.68 1.54 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.37 0.605 . . . . 13.15 110.473 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.44 92.23 3.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 15.23 110.333 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.93 -49.15 9.93 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.377 -0.601 . . . . 16.48 109.377 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.74 102.04 5.92 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.305 -0.861 . . . . 16.82 110.421 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.29 48.55 2.92 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.717 2.278 . . . . 18.72 110.885 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.75 122.34 33.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.224 -0.898 . . . . 19.82 111.299 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.1 -60.76 1.77 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.605 -0.725 . . . . 20.52 111.426 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -108.03 75.61 1.0 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.063 -0.517 . . . . 24.23 111.774 -173.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 71.07 -69.9 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.508 -0.769 . . . . 22.26 110.806 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.34 25.1 62.22 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.378 -0.374 . . . . 23.19 113.843 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 59.66 78.5 0.27 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.568 0.699 . . . . 26.68 110.992 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.5 tp . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.468 -0.787 . . . . 26.21 109.812 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.23 -0.348 . . . . 15.12 112.23 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.9 109.12 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.137 2.558 . . . . 14.6 112.087 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 39.9 tp -110.12 -14.92 14.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.128 0.49 . . . . 14.06 110.092 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.72 13.03 19.71 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 121.077 -0.582 . . . . 11.24 112.758 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.1 m 67.28 -85.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.288 0.635 . . . . 9.8 111.659 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.9 p -101.45 90.49 4.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.139 0.495 . . . . 8.47 111.432 -175.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.04 -30.33 8.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.631 -0.713 . . . . 5.96 109.314 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.18 -36.15 91.42 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.42 -0.809 . . . . 5.13 112.096 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.22 88.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.886 0.374 . . . . 6.14 110.705 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.539 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 63.3 tp -64.22 -46.94 81.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.006 -0.543 . . . . 4.74 110.141 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' B' ' 58' ' ' GLN . 3.2 tm? -59.57 -49.2 78.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 3.19 110.544 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.11 -53.28 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 4.03 111.979 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.539 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 3.3 p80 -71.79 -27.03 62.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.605 -0.438 . . . . 5.58 111.068 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.5 73.2 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.199 -0.297 . . . . 3.33 110.199 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -36.54 83.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.03 -0.532 . . . . 4.37 110.473 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -58.64 -39.45 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.695 -0.684 . . . . 6.1 110.701 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -82.61 -25.22 33.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 6.81 110.871 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.0 27.91 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.781 -0.723 . . . . 5.35 111.939 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.7 t -77.71 121.84 31.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.687 -0.486 . . . . 3.76 109.687 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.587 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 78.1 mtt180 -122.59 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.317 -0.401 . . . . 7.44 110.427 -175.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.714 HD21 HD21 ' B' ' 52' ' ' LEU . 5.9 mp -136.27 124.7 23.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 3.8 110.219 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.696 ' HB3' HD13 ' B' ' 56' ' ' LEU . 30.0 p90 -142.23 140.81 32.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 7.27 110.329 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.39 123.16 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.227 0.537 . . . . 7.74 110.337 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.601 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 2.8 tm-20 -111.91 100.66 9.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.884 -0.784 . . . . 9.44 108.884 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.55 -87.42 0.27 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.801 -0.636 . . . . 10.31 112.137 -177.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -116.25 -31.82 5.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.308 0.575 . . . . 9.56 110.725 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -106.26 128.42 53.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 7.94 111.659 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.576 HD13 HD22 ' B' ' 21' ' ' LEU . 3.2 tm? -64.97 123.5 19.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.874 -1.057 . . . . 5.2 109.648 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.601 ' NH1' ' HB3' ' B' ' 24' ' ' GLU . 8.1 mpt_? -95.75 130.5 42.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.749 -0.463 . . . . 8.44 109.749 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.552 ' CE2' HD23 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -106.49 150.13 26.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.059 -0.519 . . . . 4.16 110.134 -176.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.587 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 8.4 tp-100 -149.16 112.06 4.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.742 -0.466 . . . . 7.26 109.742 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.67 135.04 10.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.628 -0.26 . . . . 5.75 110.78 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.505 ' O ' HG21 ' B' ' 36' ' ' VAL . 32.0 Cg_exo -60.54 153.62 59.82 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.752 2.301 . . . . 7.34 112.458 176.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.595 ' HB3' HG22 ' A' ' 38' ' ' THR . 19.3 Cg_endo -60.83 123.19 12.47 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.557 2.172 . . . . 9.22 112.52 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.71 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.674 -0.774 . . . . 8.58 113.281 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' B' ' 17' ' ' LEU . 18.9 m -80.62 -7.53 10.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 117.03 0.415 . . . . 7.19 111.935 -173.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.825 ' HA ' ' HE3' ' B' ' 37' ' ' MET . 0.6 OUTLIER -82.84 20.14 1.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.344 -0.389 . . . . 6.01 111.692 -173.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.47 HG22 ' HB3' ' A' ' 34' ' ' PRO . 38.0 p -51.28 144.75 15.06 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.719 0.295 . . . . 8.28 111.603 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.96 -30.59 59.51 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.805 2.336 . . . . 7.89 112.188 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 17.6 tp10 -59.56 -50.0 75.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.932 -0.576 . . . . 9.22 109.789 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.567 HD23 ' O ' ' B' ' 36' ' ' VAL . 3.1 tp -63.5 -45.8 89.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 6.37 110.14 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -56.97 -41.03 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 5.19 111.036 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -70.0 -31.75 69.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.301 -0.408 . . . . 7.5 110.622 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 99.4 mtt180 -76.9 -28.84 55.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.523 -0.308 . . . . 8.73 110.883 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 94.5 mt -64.62 -33.56 76.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.114 -0.699 . . . . 4.2 109.114 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.93 -23.09 8.17 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.127 -0.942 . . . . 5.65 112.824 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.1 8.64 54.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.983 -0.627 . . . . 4.5 112.208 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.47 149.82 36.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.975 0.417 . . . . 5.81 110.429 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.554 ' O ' HG13 ' B' ' 53' ' ' ILE . 0.3 OUTLIER -62.72 -49.96 72.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.838 -0.619 . . . . 8.59 111.665 -175.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -66.18 -33.48 75.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.644 0.239 . . . . 7.48 111.644 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.95 -45.01 75.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 5.72 110.51 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.714 HD21 HD21 ' B' ' 21' ' ' LEU . 53.2 mt -73.97 -23.74 59.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.483 . . . . 3.39 111.34 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.554 HG13 ' O ' ' B' ' 49' ' ' ARG . 71.3 mt -64.16 -41.9 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.615 -0.513 . . . . 6.75 109.615 171.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.18 -31.44 70.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 3.81 110.534 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.651 ' HB2' ' HA ' ' B' ' 52' ' ' LEU . 1.1 mm? -63.32 -34.52 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.838 -0.619 . . . . 2.46 110.82 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.696 HD13 ' HB3' ' B' ' 22' ' ' TRP . 34.5 tp -79.46 -41.8 26.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 5.83 110.506 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -61.45 -20.84 63.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.482 -0.781 . . . . 7.69 111.638 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 24.7 pt20 -77.72 -20.85 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.788 0.328 . . . . 4.23 110.613 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.2 tp -85.46 -11.72 53.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 6.46 110.362 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -64.13 117.78 39.8 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.475 -0.784 . . . . 7.71 110.547 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.32 108.02 1.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.616 2.21 . . . . 8.76 111.651 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.3 p -88.71 -13.23 40.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.449 0.642 . . . . 8.96 109.356 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -62.41 149.45 42.49 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.318 -0.855 . . . . 10.1 110.296 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -97.31 27.12 4.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.754 0.311 . . . . 11.21 111.715 -174.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.53 -60.63 4.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.865 -0.683 . . . . 12.71 112.364 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.28 -174.33 46.25 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.102 -0.57 . . . . 13.61 111.933 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -131.44 79.72 1.89 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.451 . . . . 15.17 110.679 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 9.7 mp -124.19 85.85 2.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.034 -0.53 . . . . 17.11 110.289 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.67 -44.67 27.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.088 0.47 . . . . 18.3 109.973 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.6 89.52 11.77 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 19.0 110.673 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.03 177.12 8.16 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.022 2.481 . . . . 20.29 111.971 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -155.79 139.89 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 21.43 110.055 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.18 96.1 4.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.36 -0.382 . . . . 22.9 110.648 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -76.87 114.28 15.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 25.46 110.543 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -128.48 95.59 4.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 24.7 111.032 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.7 -150.43 46.42 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.945 -0.645 . . . . 24.61 112.737 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -101.28 -38.56 8.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.076 0.465 . . . . 27.58 109.829 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.748 -0.66 . . . . 27.27 110.209 -178.209 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 111.63 -0.588 . . . . 11.72 111.63 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.01 -14.27 32.02 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.667 2.244 . . . . 10.83 112.827 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.85 169.21 18.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.76 0.314 . . . . 10.23 110.862 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.03 -71.02 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.521 -1.031 . . . . 7.0 110.521 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 p -156.35 154.19 30.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.157 -0.683 . . . . 6.3 109.157 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -79.01 76.05 5.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.315 0.579 . . . . 3.83 109.71 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.62 -45.43 75.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.569 -0.742 . . . . 2.87 111.476 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.62 -46.93 92.6 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.127 -0.559 . . . . 2.3 112.37 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.0 -41.31 77.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 2.64 110.995 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.662 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 28.2 tp -62.9 -47.3 83.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 2.19 110.667 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.14 -44.46 95.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.843 -0.617 . . . . 2.17 109.584 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.17 80.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.008 -0.542 . . . . 2.28 112.148 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.662 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 7.0 p80 -71.67 -28.4 63.71 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.415 -0.514 . . . . 2.24 110.617 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.29 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 1.33 109.927 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.0 75.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.75 110.762 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 t -65.54 -38.14 88.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.081 -0.509 . . . . 2.66 110.224 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 92.2 mt -73.99 -24.77 59.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 2.04 109.941 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.56 31.93 17.36 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.618 -0.719 . . . . 1.44 112.461 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.2 t -71.2 132.89 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.965 -0.754 . . . . 1.4 108.965 174.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 44.6 mtt180 -129.99 134.15 47.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.914 -0.402 . . . . 3.03 109.914 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.667 HD22 HD11 ' A' ' 52' ' ' LEU . 6.0 mp -137.14 127.36 26.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.67 109.563 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.508 ' HB3' HD11 ' A' ' 56' ' ' LEU . 24.2 p90 -146.61 137.01 23.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.013 0.435 . . . . 2.43 110.325 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -79.56 124.0 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.149 0.499 . . . . 3.4 110.402 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.24 105.25 8.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 4.2 109.568 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.66 -112.22 4.33 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.395 -0.907 . . . . 4.37 111.403 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -104.19 -18.8 14.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.3 110.8 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -107.05 127.05 53.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.495 0.664 . . . . 6.12 111.35 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.481 HD21 HD23 ' A' ' 21' ' ' LEU . 9.7 tt -74.68 114.42 13.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.479 -0.782 . . . . 2.68 109.269 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.456 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 9.1 mmm180 -80.47 139.53 36.37 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.752 -0.462 . . . . 4.59 109.752 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.428 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -124.25 132.72 53.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 2.52 109.73 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.728 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 56.7 tp60 -127.47 114.75 17.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.574 -0.528 . . . . 2.89 109.574 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -142.53 127.71 10.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.342 -0.39 . . . . 1.69 110.893 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.501 ' O ' HG21 ' A' ' 36' ' ' VAL . 32.1 Cg_exo -60.42 156.49 40.97 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.934 2.422 . . . . 2.21 111.705 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HB3' HG23 ' B' ' 38' ' ' THR . 30.0 Cg_endo -65.76 123.36 11.25 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.268 1.979 . . . . 2.47 112.39 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 38' ' ' THR . . . 106.89 -37.13 3.98 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.777 -0.725 . . . . 1.81 113.406 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.501 HG21 ' O ' ' A' ' 33' ' ' PRO . 35.8 m -75.82 -15.69 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.682 0.623 . . . . 1.86 112.682 -173.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.422 ' HA ' ' HE1' ' A' ' 37' ' ' MET . 9.1 tpp -84.57 23.27 1.16 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.294 0.569 . . . . 1.42 111.311 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.672 HG23 ' HB3' ' B' ' 34' ' ' PRO . 17.8 p -50.7 143.73 14.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.78 110.39 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.79 -30.17 45.82 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.801 2.334 . . . . 1.87 112.435 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 8.4 tp10 -60.54 -47.4 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 2.76 110.106 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 36' ' ' VAL . 4.0 tp -58.08 -49.55 76.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.793 0.33 . . . . 1.65 110.572 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.531 ' HA ' HD12 ' A' ' 45' ' ' LEU . 18.3 tp60 -60.45 -36.11 77.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.939 -0.573 . . . . 2.06 110.754 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.5 t -64.18 -32.61 74.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.012 0.434 . . . . 2.01 110.039 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 19.9 mmt180 -78.92 -40.38 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 3.9 110.873 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 42' ' ' GLN . 84.6 mt -52.82 -37.24 59.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.979 -0.748 . . . . 1.42 108.979 171.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.69 -22.84 8.32 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.231 -0.895 . . . . 2.3 112.048 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.71 14.21 72.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.978 -0.63 . . . . 2.57 112.229 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 51' ' ' GLU . . . -79.38 148.42 32.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.935 -0.394 . . . . 2.42 109.935 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 1.6 ptm180 -69.76 -51.2 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.459 -0.337 . . . . 5.86 111.745 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -56.99 -34.86 68.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.148 0.499 . . . . 3.23 110.564 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.41 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -65.82 -49.96 66.37 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.639 -0.709 . . . . 2.75 110.316 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.667 HD11 HD22 ' A' ' 21' ' ' LEU . 87.4 mt -75.21 -24.54 57.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.965 -1.016 . . . . 2.4 111.284 -174.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.9 mt -63.68 -42.91 97.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.852 -0.425 . . . . 3.13 109.852 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.57 76.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.316 0.579 . . . . 2.03 110.133 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.652 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.4 tm? -70.74 -31.67 68.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 1.89 109.508 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.7 tp -79.2 -36.72 39.7 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.993 -0.549 . . . . 2.2 109.737 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -55.5 -29.62 59.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 4.58 111.251 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.652 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.3 pt20 -56.1 -34.3 65.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.5 -0.318 . . . . 1.75 111.183 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.674 HD11 ' HB3' ' A' ' 20' ' ' ARG . 79.2 mt -83.72 -5.46 59.2 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.887 0.328 . . . . 2.94 111.887 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 97.1 mt-30 -90.35 127.05 54.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 110.337 -0.246 . . . . 2.58 110.337 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 8.1 Cg_exo -72.52 34.19 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.363 2.709 . . . . 2.79 112.911 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 60' ' ' GLN . 23.2 t -90.62 25.66 2.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.166 0.507 . . . . 4.27 109.843 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 m -60.55 125.23 22.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.38 -0.827 . . . . 6.16 111.725 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -123.44 -146.98 0.37 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.449 -0.796 . . . . 8.21 109.237 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.54 76.16 0.98 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.526 -0.845 . . . . 10.39 111.847 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.25 -128.22 8.37 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.267 -0.733 . . . . 11.32 111.267 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.5 t -99.01 7.64 45.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.008 0.432 . . . . 13.15 109.973 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.99 152.38 26.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.149 -0.478 . . . . 15.23 110.056 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -121.86 8.77 9.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.08 0.467 . . . . 16.48 110.589 -175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -81.65 135.75 49.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 16.82 111.687 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 4.4 Cg_exo -77.81 90.24 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.264 2.643 . . . . 18.72 109.98 173.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 p -105.92 138.12 32.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.532 -0.758 . . . . 19.82 110.92 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.38 -67.87 0.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.594 . . . . 20.52 111.346 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -170.02 54.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.682 0.754 . . . . 24.23 109.97 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.435 HD21 ' HB2' ' A' ' 78' ' ' LEU . 7.1 p-10 -149.76 126.06 10.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.607 -0.724 . . . . 22.26 110.686 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.55 -42.36 99.75 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.377 -0.828 . . . . 23.19 113.063 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -162.99 86.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.835 0.35 . . . . 26.68 110.897 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.435 ' HB2' HD21 ' A' ' 75' ' ' ASN . 35.7 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 115.689 -0.687 . . . . 26.21 109.849 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 112.07 -0.412 . . . . 15.12 112.07 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.33 148.13 93.78 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.912 2.408 . . . . 14.6 112.669 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 52.1 tp 66.24 -83.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.635 -0.711 . . . . 14.06 111.469 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.13 -82.53 0.35 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.885 -0.674 . . . . 11.24 111.7 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t 58.66 40.22 23.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.876 -0.416 . . . . 9.8 109.876 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 54.1 m 70.04 -53.96 0.62 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.266 -0.879 . . . . 8.47 111.118 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.85 113.92 5.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.683 0.278 . . . . 5.96 110.495 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.76 98.69 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 116.048 -0.524 . . . . 5.13 112.945 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.2 93.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 6.14 110.81 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 56.0 tp -60.85 -47.52 86.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.056 -0.52 . . . . 4.74 110.47 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.97 -43.44 92.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.732 -0.667 . . . . 3.19 109.653 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.33 -51.43 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.639 . . . . 4.03 112.315 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 14.2 p80 -72.52 -28.22 62.73 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.334 -0.546 . . . . 5.58 110.934 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.85 -43.43 75.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.189 0.519 . . . . 3.33 110.054 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.71 76.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.477 -0.783 . . . . 4.37 110.806 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -67.57 -34.33 76.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.053 -0.521 . . . . 6.1 110.308 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.548 HD11 ' HB ' ' B' ' 36' ' ' VAL . 86.7 mt -75.85 -24.34 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 6.81 110.426 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.86 28.43 21.2 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.785 -0.722 . . . . 5.35 112.389 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 46.2 t -72.11 132.74 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.471 -0.566 . . . . 3.76 109.471 177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.835 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 76.6 mtt180 -130.48 132.9 45.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.592 0.234 . . . . 7.44 110.971 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.62 HD22 HD11 ' B' ' 52' ' ' LEU . 5.7 mp -137.98 127.45 24.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.843 -0.429 . . . . 3.8 109.843 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.648 ' HB3' HD11 ' B' ' 56' ' ' LEU . 29.3 p90 -147.78 139.97 24.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.932 0.396 . . . . 7.27 110.361 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.3 p -78.65 130.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.155 0.502 . . . . 7.74 110.405 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -132.16 101.0 5.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 9.44 109.668 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.74 -110.3 3.27 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.691 -0.766 . . . . 10.31 111.364 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.76 -11.69 16.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.701 0.286 . . . . 9.56 111.077 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.12 123.31 48.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 7.94 111.054 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 9.1 tt -74.64 115.07 13.78 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.329 -0.619 . . . . 5.2 109.329 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -79.89 139.31 37.17 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.006 -0.368 . . . . 8.44 110.006 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.488 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -122.14 133.2 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.457 -0.571 . . . . 4.16 109.457 -177.164 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.835 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 55.3 tp60 -129.81 112.52 13.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.63 -0.508 . . . . 7.26 109.63 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.05 133.1 16.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 5.75 111.136 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.445 ' O ' HG21 ' B' ' 36' ' ' VAL . 37.2 Cg_exo -62.98 153.58 72.58 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.056 2.504 . . . . 7.34 112.007 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.672 ' HB3' HG23 ' A' ' 38' ' ' THR . 30.3 Cg_endo -63.77 123.95 12.82 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.421 2.081 . . . . 9.22 112.725 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 -36.85 4.13 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.597 -0.811 . . . . 8.58 113.455 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' B' ' 17' ' ' LEU . 23.3 m -78.96 -9.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.017 0.377 . . . . 7.19 112.017 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.778 ' HE1' ' HA ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.85 19.98 1.26 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 6.01 111.35 -176.009 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 34' ' ' PRO . 10.6 p -51.04 144.7 13.62 Favored Pre-proline 0 C--O 1.236 0.387 0 CA-C-N 116.442 -0.344 . . . . 8.28 111.094 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.99 -30.71 49.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.819 2.346 . . . . 7.89 112.304 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.547 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 11.7 tp10 -60.42 -43.64 96.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 9.22 110.556 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.543 HD22 ' O ' ' B' ' 36' ' ' VAL . 11.1 tp -62.43 -46.19 89.7 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 110.234 -0.284 . . . . 6.37 110.234 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.421 ' HA ' HD12 ' B' ' 45' ' ' LEU . 18.9 tp60 -61.73 -37.55 84.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.169 -0.469 . . . . 5.19 110.378 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -63.06 -35.17 79.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.38 -0.373 . . . . 7.5 110.343 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.547 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 16.7 mmt180 -77.54 -39.95 44.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 8.73 110.868 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 42' ' ' GLN . 86.3 mt -56.81 -36.01 69.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 4.2 109.625 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.67 -22.95 8.09 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.162 -0.926 . . . . 5.65 112.219 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.44 75.73 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.083 -0.58 . . . . 4.5 111.863 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.69 149.93 29.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.217 -0.29 . . . . 5.81 110.217 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.518 ' O ' HG13 ' B' ' 53' ' ' ILE . 2.0 ptm180 -68.67 -48.86 62.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 8.59 111.182 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -60.07 -36.52 77.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.846 0.313 . . . . 7.48 111.846 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -47.11 80.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.114 0.483 . . . . 5.72 110.718 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.62 HD11 HD22 ' B' ' 21' ' ' LEU . 86.0 mt -75.33 -24.77 57.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 3.39 111.616 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 49' ' ' ARG . 83.1 mt -66.67 -39.57 84.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.946 -0.39 . . . . 6.75 109.946 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.89 83.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.201 0.524 . . . . 3.81 110.207 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.701 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.1 tm? -63.38 -34.93 78.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.247 -0.888 . . . . 2.46 110.02 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.648 HD11 ' HB3' ' B' ' 22' ' ' TRP . 17.8 tp -73.24 -38.67 65.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 5.83 110.473 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -57.18 -28.63 62.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 7.69 111.985 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 17.5 pt20 -60.92 -26.37 67.43 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.887 -0.325 . . . . 4.23 110.905 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.63 -7.28 56.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.331 -0.395 . . . . 6.46 111.052 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . 0.472 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 96.8 mt-30 -90.78 131.64 37.02 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.412 -0.358 . . . . 7.71 110.414 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 7.0 Cg_exo -75.22 30.8 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.77 2.98 . . . . 8.76 112.82 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' SER . . . . . 0.408 ' H ' ' C ' ' B' ' 60' ' ' GLN . 23.2 t -88.3 22.42 2.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.36 0.6 . . . . 8.96 109.569 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 5.9 m -59.55 117.71 5.21 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.45 -0.796 . . . . 10.1 111.211 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -113.75 -146.94 0.41 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.302 -0.629 . . . . 11.21 109.302 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.13 80.73 0.71 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.916 -0.659 . . . . 12.71 111.574 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.98 -125.12 7.68 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.122 -0.791 . . . . 13.61 111.122 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 22.9 t -105.29 11.27 33.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.174 0.512 . . . . 15.17 110.062 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.13 139.24 30.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.854 -0.612 . . . . 17.11 109.762 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.64 HD23 ' H ' ' B' ' 69' ' ' LEU . 2.3 pt? -102.75 7.21 39.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.407 -0.36 . . . . 18.3 110.934 -176.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' B' ' 71' ' ' PRO . . . -69.53 128.55 92.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 19.0 109.888 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 70' ' ' ALA . 34.4 Cg_exo -57.4 103.38 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.83 2.353 . . . . 20.29 112.615 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.9 m -86.14 96.41 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.634 0.73 . . . . 21.43 110.394 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.29 51.72 0.77 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.421 -0.808 . . . . 22.9 110.658 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 69.17 19.91 7.76 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.784 0.802 . . . . 25.46 110.072 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.55 81.94 5.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.531 -0.758 . . . . 24.7 110.048 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.57 169.19 17.53 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.366 -0.834 . . . . 24.61 111.855 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -88.29 80.05 7.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.337 0.589 . . . . 27.58 109.502 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.293 -0.867 . . . . 27.27 110.199 -176.811 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.037 -0.425 . . . . 11.72 112.037 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 21.0 Cg_exo -65.73 119.28 6.29 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.685 2.257 . . . . 10.83 111.608 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.45 -38.98 25.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.094 -0.503 . . . . 10.23 110.574 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.14 95.39 0.42 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.003 -0.618 . . . . 7.0 112.214 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -78.73 84.04 4.84 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 122.28 0.232 . . . . 6.3 110.964 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.8 m 55.36 74.77 0.35 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.667 -0.697 . . . . 3.83 112.127 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.28 -37.96 81.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 2.87 110.849 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.38 92.36 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.049 -0.523 . . . . 2.3 111.909 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.06 -41.7 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 2.64 110.728 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.682 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 51.0 tp -62.12 -46.4 89.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 2.19 110.317 176.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.16 -47.36 86.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.391 -0.822 . . . . 2.17 110.115 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.33 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 2.28 112.116 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.682 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.9 p80 -69.94 -27.07 64.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.884 0.373 . . . . 2.24 110.216 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.12 -36.88 66.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 1.33 110.284 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.52 83.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.948 -0.569 . . . . 1.75 111.146 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 p -67.0 -21.93 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 2.66 111.515 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.15 -25.07 15.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.189 0.518 . . . . 2.04 110.447 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.76 37.38 13.64 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 1.44 112.636 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.25 120.15 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.992 -0.744 . . . . 1.4 108.992 174.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HB3' HD23 ' A' ' 59' ' ' LEU . 20.7 mtt180 -120.07 128.89 53.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.57 -0.286 . . . . 3.03 110.69 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -133.03 124.11 27.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.484 -0.562 . . . . 1.67 109.484 173.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 27.3 p90 -141.48 143.15 33.68 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.937 -0.394 . . . . 2.43 109.937 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.27 129.81 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.689 -0.486 . . . . 3.4 109.689 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.437 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 14.2 tp10 -136.91 120.2 16.82 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.375 -0.602 . . . . 4.2 109.375 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.9 -105.04 1.36 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.824 -0.703 . . . . 4.37 111.82 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE1' ' HB3' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.86 -3.06 11.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.69 0.255 . . . . 5.3 111.69 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.446 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 9.4 tpp180 -129.19 152.18 49.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 6.12 112.116 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.433 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -75.7 122.34 23.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.046 -0.979 . . . . 2.68 108.618 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.446 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.2 mpt_? -99.03 131.08 45.34 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.366 -0.605 . . . . 4.59 109.366 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.446 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -108.21 154.07 22.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 2.52 110.245 -172.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 23.9 tp60 -153.25 110.43 3.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.805 -0.442 . . . . 2.89 109.805 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -131.74 134.98 26.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.122 -0.49 . . . . 1.69 110.66 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.559 ' HD2' HG23 ' A' ' 36' ' ' VAL . 37.0 Cg_exo -61.91 156.09 51.05 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.612 2.208 . . . . 2.21 111.555 172.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.494 ' HB3' HG22 ' B' ' 38' ' ' THR . 22.9 Cg_endo -63.79 123.3 11.75 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.267 1.978 . . . . 2.47 112.305 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.453 ' O ' HG21 ' A' ' 38' ' ' THR . . . 106.88 -37.68 3.7 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.936 -0.649 . . . . 1.81 113.448 173.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.559 HG23 ' HD2' ' A' ' 33' ' ' PRO . 33.8 m -70.65 -20.3 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.518 0.562 . . . . 1.86 112.518 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.4 tpp -82.61 24.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.022 0.439 . . . . 1.42 111.446 -173.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.474 HG22 ' HB3' ' B' ' 34' ' ' PRO . 8.3 p -49.69 143.08 11.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 1.78 110.872 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.614 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 82.6 Cg_exo -45.76 -40.76 19.51 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.299 2.666 . . . . 1.87 113.773 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 8.9 pt-20 -61.89 -44.61 96.45 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 120.736 0.303 . . . . 2.76 110.525 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.409 ' N ' ' HG3' ' A' ' 40' ' ' GLU . 3.0 tt -67.69 -44.82 76.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.334 0.588 . . . . 1.65 109.908 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -56.17 -41.7 75.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.578 -1.192 . . . . 2.06 110.548 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -72.8 -29.24 63.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.927 -0.579 . . . . 2.01 111.042 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.8 mtp180 -75.84 -28.08 58.11 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.956 -0.298 . . . . 3.9 111.017 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.69 -43.77 98.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.536 -0.542 . . . . 1.42 109.536 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.9 -23.61 5.77 Favored Glycine 0 C--N 1.329 0.158 0 CA-C-N 115.644 -0.707 . . . . 2.3 112.97 171.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.41 18.11 69.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.907 -0.663 . . . . 2.57 112.47 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.606 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -72.72 147.8 45.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.121 -0.325 . . . . 2.42 110.121 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.571 ' O ' HG13 ' A' ' 53' ' ' ILE . 22.9 ptt180 -68.34 -50.67 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.334 -0.393 . . . . 5.86 111.644 -172.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.422 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 11.9 p80 -60.23 -36.06 76.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.739 0.781 . . . . 3.23 110.048 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.63 -42.75 70.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.608 -1.178 . . . . 2.75 110.214 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 63.3 mt -70.4 -25.41 63.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.598 -0.728 . . . . 2.4 110.822 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.1 mt -60.5 -50.03 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.792 -0.447 . . . . 3.13 109.792 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.15 70.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.199 0.523 . . . . 2.03 110.758 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 55' ' ' LEU . 2.6 tm? -71.09 -40.6 71.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.801 . . . . 1.89 109.959 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.2 tp -77.23 -31.31 55.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.952 -0.567 . . . . 2.2 109.756 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -61.81 -31.22 71.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 4.58 110.506 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.61 -29.62 70.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.522 . . . . 1.75 110.613 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.543 HD23 ' HB3' ' A' ' 20' ' ' ARG . 29.7 tp -90.02 -2.87 58.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 2.94 110.553 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 27.9 mt-30 -114.07 130.54 23.81 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.108 -0.496 . . . . 2.58 110.617 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 8.1 Cg_exo -74.18 -9.9 22.24 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.606 2.204 . . . . 2.79 112.095 175.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.5 t -95.96 151.8 19.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.027 -0.533 . . . . 4.27 109.873 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.7 m 66.34 82.85 0.18 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.726 0.641 . . . . 6.16 111.929 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.649 ' N ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -97.82 -22.7 16.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.926 -0.579 . . . . 8.21 110.381 175.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.83 -90.84 0.31 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.825 -0.703 . . . . 10.39 111.795 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.67 119.52 1.88 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.931 -0.652 . . . . 11.32 112.498 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 p -114.6 107.56 15.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.124 0.488 . . . . 13.15 110.616 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.67 91.38 3.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.936 -0.575 . . . . 15.23 109.872 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.77 4.99 1.34 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.449 -0.796 . . . . 16.48 110.757 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -75.65 133.3 73.77 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.083 -0.508 . . . . 16.82 110.647 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 6.3 Cg_exo -73.48 107.05 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.76 2.307 . . . . 18.72 110.466 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.35 104.35 6.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.786 0.803 . . . . 19.82 110.787 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -52.77 15.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.111 -0.95 . . . . 20.52 110.999 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 74' ' ' ARG . 1.3 ptm180 -176.11 -32.67 0.01 OUTLIER 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.157 -0.474 . . . . 24.23 111.152 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.4 m120 66.96 -175.69 0.19 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.358 0.599 . . . . 22.26 111.411 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.44 -123.26 6.38 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 109.732 -1.347 . . . . 23.19 109.732 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -157.22 -46.54 0.07 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.384 -0.969 . . . . 26.68 108.384 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 78' ' ' LEU . 21.5 tp . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.06 -0.973 . . . . 26.21 109.85 172.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 111.756 -0.538 . . . . 15.12 111.756 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.62 153.63 10.32 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.033 2.489 . . . . 14.6 112.578 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 86.6 mt -75.31 -48.13 24.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.844 -0.798 . . . . 14.06 108.844 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.45 -133.81 12.15 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.305 -0.861 . . . . 11.24 113.038 173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.3 m -116.43 103.99 11.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.603 -0.299 . . . . 9.8 111.779 -170.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 29.9 m -81.73 106.63 13.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.991 -1.115 . . . . 8.47 107.991 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . 0.61 ' HB2' ' HB3' ' B' ' 10' ' ' LEU . . . -64.83 106.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.159 -0.473 . . . . 5.96 112.233 -168.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.57 99.35 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.626 -0.715 . . . . 5.13 112.012 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.38 92.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 6.14 110.906 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.628 HD13 ' HE2' ' B' ' 13' ' ' HIS . 57.1 tp -64.29 -45.91 85.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.567 . . . . 4.74 109.844 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.78 -47.08 87.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 3.19 110.114 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -52.85 63.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 4.03 112.291 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.628 ' HE2' HD13 ' B' ' 10' ' ' LEU . 5.0 p80 -72.45 -26.34 61.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.566 -0.453 . . . . 5.58 110.963 -176.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.33 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 3.33 110.093 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -37.39 82.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.79 -0.641 . . . . 4.37 111.292 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 12.3 p -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 6.1 111.282 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.552 HD12 ' HB ' ' B' ' 36' ' ' VAL . 93.4 mt -91.7 -25.17 19.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 6.81 110.548 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.402 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 84.7 35.65 13.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.843 -0.694 . . . . 5.35 112.51 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.4 124.62 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.396 -0.594 . . . . 3.76 109.396 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.62 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 30.4 mtt180 -124.01 127.85 48.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.776 0.322 . . . . 7.44 111.194 -171.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.478 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.1 mp -135.15 124.74 25.08 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.476 -0.564 . . . . 3.8 109.476 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.534 ' HB3' HD12 ' B' ' 56' ' ' LEU . 26.5 p90 -143.63 143.6 31.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.881 0.372 . . . . 7.27 110.712 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.15 124.73 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.123 0.487 . . . . 7.74 110.076 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.584 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 10.8 tp10 -130.98 118.28 20.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.614 -0.513 . . . . 9.44 109.614 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 -104.26 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.76 -0.733 . . . . 10.31 111.803 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -4.86 11.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.79 0.329 . . . . 9.56 111.763 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.441 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 8.5 tpp180 -130.33 148.69 52.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.343 0.592 . . . . 7.94 111.872 -170.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.477 HD11 HD23 ' B' ' 21' ' ' LEU . 3.0 tm? -73.48 115.96 13.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.154 -0.93 . . . . 5.2 108.735 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . 0.584 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 6.2 mpt_? -90.81 132.59 35.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.895 -0.409 . . . . 8.44 109.895 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.478 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.0 OUTLIER -109.78 152.23 25.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.922 -0.581 . . . . 4.16 110.263 -173.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 25.4 tp60 -152.65 110.02 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.836 -0.431 . . . . 7.26 109.836 172.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.09 137.04 29.23 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.288 -0.415 . . . . 5.75 111.115 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.42 ' O ' HG21 ' B' ' 36' ' ' VAL . 38.6 Cg_exo -62.75 154.6 64.7 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.675 2.25 . . . . 7.34 111.796 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.614 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 27.9 Cg_endo -63.22 123.52 12.31 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.306 2.004 . . . . 9.22 112.629 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.461 ' O ' HG21 ' B' ' 38' ' ' THR . . . 105.5 -37.46 3.8 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.661 -0.78 . . . . 8.58 113.499 173.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.552 ' HB ' HD12 ' B' ' 17' ' ' LEU . 19.8 m -73.28 -12.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.108 0.454 . . . . 7.19 111.948 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.5 tpp -89.11 22.43 2.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.958 0.409 . . . . 6.01 111.505 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.494 HG22 ' HB3' ' A' ' 34' ' ' PRO . 18.7 p -49.06 142.93 9.32 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.433 -0.349 . . . . 8.28 111.149 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -43.76 -42.33 11.75 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.964 3.109 . . . . 7.89 114.187 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.658 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 8.5 pt-20 -59.91 -45.65 91.86 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 121.133 -0.227 . . . . 9.22 110.921 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.497 ' N ' ' HG3' ' B' ' 40' ' ' GLU . 9.2 tt -70.34 -39.7 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.908 -0.404 . . . . 6.37 109.908 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . 0.402 ' OE1' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp60 -56.76 -43.51 80.87 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.668 -0.697 . . . . 5.19 110.515 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.3 t -72.14 -31.25 65.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.911 -0.586 . . . . 7.5 110.842 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 65.3 mtp180 -71.51 -28.87 64.2 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.225 -0.19 . . . . 8.73 111.292 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.34 -44.74 86.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.529 0.68 . . . . 4.2 109.328 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.68 -23.75 5.51 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.278 -0.873 . . . . 5.65 112.982 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 18.74 74.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.266 -0.492 . . . . 4.5 112.39 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . 0.614 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -71.55 148.75 46.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.835 0.317 . . . . 5.81 110.425 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.573 ' O ' HG13 ' B' ' 53' ' ' ILE . 17.6 ptt180 -68.15 -46.93 69.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.331 -0.395 . . . . 8.59 111.448 -172.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -63.62 -35.64 81.19 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.702 0.287 . . . . 7.48 111.238 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.9 -38.96 69.85 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.658 -0.417 . . . . 5.72 110.302 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' B' ' 48' ' ' ALA . 46.4 mt -70.57 -26.02 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.579 -0.282 . . . . 3.39 110.97 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.573 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.6 mt -62.33 -49.44 83.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.753 -0.462 . . . . 6.75 109.753 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.11 86.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 3.81 110.433 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.449 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.5 tm? -62.21 -47.06 86.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.557 -0.747 . . . . 2.46 110.259 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.534 HD12 ' HB3' ' B' ' 22' ' ' TRP . 21.1 tp -66.27 -36.58 83.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.354 -0.385 . . . . 5.83 110.769 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -63.04 -29.27 70.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.415 -0.357 . . . . 7.69 111.361 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 6.9 pt20 -67.28 -27.67 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 4.23 110.261 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 37.7 tp -88.93 -6.34 57.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 6.46 110.495 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -112.31 133.93 21.64 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.916 -0.584 . . . . 7.71 110.618 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.81 -13.06 24.33 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.797 2.331 . . . . 8.76 111.506 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 43.4 t -91.58 146.76 23.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.889 -0.596 . . . . 8.96 110.568 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 67.5 m 69.25 89.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.896 0.747 . . . . 10.1 111.706 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . 0.628 HE21 ' N ' ' B' ' 64' ' ' GLN . 0.0 OUTLIER -107.03 -7.48 16.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.484 -0.78 . . . . 11.21 110.029 174.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.95 -105.1 1.74 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.662 -0.699 . . . . 12.71 111.452 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.12 113.98 3.87 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.761 -0.733 . . . . 13.61 112.162 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.9 p -105.28 107.42 18.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.155 0.502 . . . . 15.17 111.141 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 tp -115.64 96.61 5.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.458 . . . . 17.11 109.863 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -145.17 -2.74 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 18.3 110.773 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . 0.808 ' HB2' ' HD3' ' B' ' 71' ' ' PRO . . . -93.38 -59.71 0.21 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.409 -0.36 . . . . 19.0 111.644 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . 0.808 ' HD3' ' HB2' ' B' ' 70' ' ' ALA . 2.9 Cg_exo -76.33 122.48 6.59 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.275 1.983 . . . . 20.29 111.969 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p 38.35 73.93 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.246 1.018 . . . . 21.43 112.671 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.86 83.26 4.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.363 -0.835 . . . . 22.9 110.704 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . 0.468 ' HB2' ' HA ' ' B' ' 77' ' ' ARG . 30.1 mmm180 -127.18 159.03 35.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.916 -0.583 . . . . 25.46 109.429 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -63.47 -47.7 80.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.804 0.335 . . . . 24.7 110.998 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.75 -9.55 56.23 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.659 -0.781 . . . . 24.61 111.641 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . 0.468 ' HA ' ' HB2' ' B' ' 74' ' ' ARG . 63.4 mtm180 71.28 -57.59 0.6 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.007 0.923 . . . . 27.58 111.093 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.092 -0.956 . . . . 27.27 111.087 -179.807 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 111.821 -0.512 . . . . 11.72 111.821 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.81 -178.4 4.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.064 2.509 . . . . 10.83 111.638 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.03 -10.75 59.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.979 0.418 . . . . 10.23 110.385 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.88 152.85 17.91 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.894 -0.594 . . . . 7.0 111.638 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 m -67.34 95.51 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 6.3 110.851 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 p -171.12 163.36 7.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.686 -0.688 . . . . 3.83 109.901 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 73.8 -55.39 0.67 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.937 0.773 . . . . 2.87 111.597 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.48 -44.85 96.37 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.494 -0.384 . . . . 2.3 112.346 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.63 90.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.06 0.457 . . . . 2.64 111.088 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.66 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 57.8 tp -67.91 -46.83 70.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.55 . . . . 2.19 110.492 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.98 -44.59 97.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.672 -0.694 . . . . 2.17 110.052 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.42 73.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 2.28 111.972 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.66 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.2 p80 -72.02 -27.79 62.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.519 -0.472 . . . . 2.24 110.231 -175.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.15 65.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.51 -0.314 . . . . 1.33 110.319 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.21 85.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.75 110.813 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -59.82 -43.94 94.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.976 -0.556 . . . . 2.66 110.764 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.535 HD12 ' HB ' ' A' ' 36' ' ' VAL . 84.2 mt -80.97 -25.63 37.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.327 . . . . 2.04 110.781 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.42 31.09 9.88 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.606 -0.806 . . . . 1.44 112.98 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 HG13 ' HE1' ' A' ' 30' ' ' PHE . 57.8 t -75.17 112.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.525 -0.546 . . . . 1.4 109.525 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 68.1 mtp180 -123.39 133.49 54.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 3.03 110.54 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.2 mp -132.73 127.39 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 1.67 110.674 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.511 ' HB3' HD11 ' A' ' 56' ' ' LEU . 18.0 p90 -150.85 145.34 25.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.209 -0.663 . . . . 2.43 109.209 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.2 p -93.22 128.92 44.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.208 0.528 . . . . 3.4 111.036 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.35 106.8 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 4.2 109.206 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.5 -107.3 2.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.118 -0.793 . . . . 4.37 111.118 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.402 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.1 -6.78 11.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.206 0.527 . . . . 5.3 110.093 177.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -102.36 118.17 36.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 6.12 110.758 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 7.8 tt -70.38 118.59 13.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.331 -0.988 . . . . 2.68 108.331 170.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.74 129.24 34.88 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.601 -0.518 . . . . 4.59 109.601 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.4 ' HE1' HG13 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -114.75 130.74 56.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.114 -0.494 . . . . 2.52 109.867 -177.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.728 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.35 110.24 14.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.458 -0.571 . . . . 2.89 109.458 177.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.56 130.37 6.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.376 -0.374 . . . . 1.69 110.601 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 36' ' ' VAL . 34.1 Cg_endo -69.24 157.91 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.646 2.231 . . . . 2.21 111.502 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.31 122.92 11.03 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.556 2.17 . . . . 2.47 112.328 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -15.36 27.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.956 -0.64 . . . . 1.81 113.167 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 33' ' ' PRO . 19.1 m -100.3 -8.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.399 0.599 . . . . 1.86 112.162 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.521 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.58 20.8 2.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.181 -0.463 . . . . 1.42 111.46 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -56.3 145.63 56.4 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.141 -0.482 . . . . 1.78 111.147 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.35 -38.45 62.65 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.952 2.434 . . . . 1.87 113.043 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 40.6 tt0 -59.61 -47.94 83.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 2.76 110.398 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.67 -42.81 98.0 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.14 0.495 . . . . 1.65 110.665 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HA ' HD13 ' A' ' 45' ' ' LEU . 9.3 tp-100 -56.89 -40.35 76.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.492 -0.776 . . . . 2.06 110.071 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -72.66 -29.51 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.736 -0.666 . . . . 2.01 110.36 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 15.1 mmm180 -65.88 -38.13 87.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.984 0.421 . . . . 3.9 110.604 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 42' ' ' GLN . 60.6 mt -57.29 -25.52 59.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.309 -0.86 . . . . 1.42 110.043 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -22.88 8.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.546 -0.752 . . . . 2.3 112.981 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 25.82 73.45 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.711 -0.756 . . . . 2.57 111.923 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.491 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -98.38 149.18 22.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.981 0.42 . . . . 2.42 110.706 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.524 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.44 -46.75 69.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.442 -0.799 . . . . 5.86 111.211 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.491 ' HA ' HD13 ' A' ' 53' ' ' ILE . 19.5 p80 -66.16 -33.28 75.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.391 0.615 . . . . 3.23 109.99 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 48' ' ' ALA . 1.7 tp10 -66.73 -42.71 85.86 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.243 -0.889 . . . . 2.75 109.478 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 67.6 mt -67.89 -29.04 68.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.29 -0.868 . . . . 2.4 111.103 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 49' ' ' ARG . 84.1 mt -58.55 -51.55 70.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.096 0.474 . . . . 3.13 109.855 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.24 68.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.743 -0.662 . . . . 2.03 110.827 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.2 tm? -69.43 -40.78 77.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.722 -0.672 . . . . 1.89 109.678 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 22' ' ' TRP . 1.2 tp -79.17 -30.48 43.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.66 -0.496 . . . . 2.2 109.66 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -67.15 -21.38 65.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 4.58 110.372 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -61.76 -28.94 69.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 1.75 110.847 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -106.82 12.67 28.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.847 -0.741 . . . . 2.94 111.646 178.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 51.1 mt-30 -97.11 127.29 39.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 2.58 110.345 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 12.5 Cg_exo -70.43 8.31 0.95 Allowed 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.93 2.42 . . . . 2.79 113.086 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.7 m -77.31 -26.17 51.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.895 0.378 . . . . 4.27 110.966 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.1 m -117.93 120.35 37.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 6.16 111.131 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -101.63 153.98 19.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.804 -0.635 . . . . 8.21 109.601 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.34 -39.3 6.85 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.684 -0.77 . . . . 10.39 112.091 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.86 60.29 0.54 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 11.32 112.224 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.9 p -109.61 -18.22 13.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.86 0.362 . . . . 13.15 111.519 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 tp -109.74 118.53 36.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.926 0.393 . . . . 15.23 111.059 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 69' ' ' LEU . 4.3 pp -141.75 133.74 27.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.931 -0.577 . . . . 16.48 109.505 175.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.3 94.27 5.27 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.323 -0.399 . . . . 16.82 111.396 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HB2' ' HB3' ' A' ' 75' ' ' ASN . 2.3 Cg_endo -82.44 72.64 5.96 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.978 2.452 . . . . 18.72 109.858 172.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 p -78.37 -16.17 13.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.263 -0.88 . . . . 19.82 110.524 -173.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.08 -50.54 39.93 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.33 -0.619 . . . . 20.52 109.33 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -169.42 122.87 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.921 -0.581 . . . . 24.23 111.121 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 71' ' ' PRO . 8.2 p30 -126.23 171.47 10.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.73 -0.668 . . . . 22.26 109.306 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.2 101.39 1.24 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.476 -0.869 . . . . 23.19 113.472 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -100.28 -9.04 22.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.993 -0.743 . . . . 26.68 108.993 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.534 -1.212 . . . . 26.21 110.465 -179.636 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 N-CA-C 111.845 -0.502 . . . . 15.12 111.845 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.9 115.3 2.85 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.621 2.214 . . . . 14.6 111.342 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 53.1 tp -121.37 -37.25 2.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.047 -0.524 . . . . 14.06 110.084 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.88 -36.79 51.85 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.94 -0.864 . . . . 11.24 110.94 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.0 t 71.43 135.84 0.04 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.562 0.696 . . . . 9.8 112.698 171.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.5 m -92.25 134.42 34.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.827 -0.805 . . . . 8.47 108.827 171.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.83 94.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.492 0.186 . . . . 5.96 111.423 -175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.62 -50.53 66.68 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.93 -0.652 . . . . 5.13 112.378 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.34 87.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 6.14 111.263 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.575 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 68.0 tp -64.72 -46.79 80.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 4.74 110.498 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.08 -46.38 84.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.895 -0.593 . . . . 3.19 109.843 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.51 75.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 4.03 111.838 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' HIS . . . . . 0.575 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 1.5 p80 -73.58 -27.57 61.39 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 5.58 110.674 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.04 61.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.681 0.277 . . . . 3.33 110.367 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.07 82.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 4.37 110.8 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 19.8 t -61.41 -42.98 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 6.1 110.833 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.488 HD12 ' HB ' ' B' ' 36' ' ' VAL . 90.2 mt -81.2 -24.37 37.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 6.81 110.937 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.7 7.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.748 -0.739 . . . . 5.35 112.344 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.22 113.44 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 3.76 109.531 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 63.1 mtp180 -124.8 134.81 52.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.358 -0.383 . . . . 7.44 110.858 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' B' ' 30' ' ' PHE . 6.2 mp -134.22 128.64 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 3.8 110.767 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' TRP . . . . . 0.689 ' HB3' HD11 ' B' ' 56' ' ' LEU . 26.6 p90 -151.62 143.78 23.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.658 -0.497 . . . . 7.27 109.658 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.1 p -88.92 126.87 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.17 0.51 . . . . 7.74 111.205 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -118.86 106.23 12.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.922 -0.77 . . . . 9.44 108.922 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.14 -106.45 1.84 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 10.31 111.394 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -3.69 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 9.56 110.313 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 tpt85 -107.76 114.24 28.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 7.94 110.854 -176.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.508 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 7.5 tt -68.12 118.9 11.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.5 -0.926 . . . . 5.2 108.5 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -87.34 126.8 35.08 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.679 -0.489 . . . . 8.44 109.679 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -111.57 131.25 55.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.931 -0.577 . . . . 4.16 109.745 -177.072 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.708 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 7.6 tp-100 -124.89 107.92 11.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.235 -0.439 . . . . 7.26 110.079 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.98 129.85 6.64 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.329 -0.396 . . . . 5.75 110.52 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.492 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.6 Cg_endo -67.1 157.45 61.66 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.544 2.163 . . . . 7.34 111.768 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.29 123.75 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.453 2.102 . . . . 9.22 112.529 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.67 -24.68 14.71 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.694 -0.684 . . . . 8.58 113.401 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 33' ' ' PRO . 10.4 m -95.25 4.59 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.003 0.402 . . . . 7.19 111.36 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' MET . . . . . 0.794 ' HE2' ' HA ' ' B' ' 37' ' ' MET . 0.0 OUTLIER -95.91 18.96 12.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 6.01 110.809 -176.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -57.27 145.88 64.81 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 8.28 111.48 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.36 -41.02 52.62 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.312 2.674 . . . . 7.89 113.167 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 35.1 tt0 -57.98 -48.67 79.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.654 -0.248 . . . . 9.22 110.473 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 9.0 tt -66.1 -38.21 87.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 6.37 110.63 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -60.09 -40.45 89.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.735 -0.468 . . . . 5.19 109.735 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -72.57 -29.75 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.758 -0.656 . . . . 7.5 110.556 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 14.4 mmm180 -66.67 -32.66 74.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.502 -0.317 . . . . 8.73 110.657 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 86.3 mt -62.61 -25.36 68.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 4.2 110.032 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.95 -23.67 7.6 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.642 -0.708 . . . . 5.65 112.699 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.42 24.2 73.65 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.856 -0.688 . . . . 4.5 112.155 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.47 149.78 21.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.627 0.251 . . . . 5.81 111.068 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.629 ' HD3' ' H ' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -67.55 -47.56 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 8.59 111.312 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' HIS . . . . . 0.527 ' HA ' HD13 ' B' ' 53' ' ' ILE . 25.0 p80 -60.41 -32.86 71.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.718 0.294 . . . . 7.48 111.485 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -38.66 75.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 5.72 110.312 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 54.9 mt -70.76 -26.18 63.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.46 -0.336 . . . . 3.39 110.961 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . 0.527 HD13 ' HA ' ' B' ' 50' ' ' HIS . 83.2 mt -61.76 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.757 -0.46 . . . . 6.75 109.757 174.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.22 80.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.123 0.487 . . . . 3.81 110.676 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.85 -47.6 85.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.489 -0.778 . . . . 2.46 110.168 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' B' ' 22' ' ' TRP . 26.8 tp -67.88 -35.34 78.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.005 0.431 . . . . 5.83 110.717 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.24 -19.47 63.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.274 -0.421 . . . . 7.69 111.256 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.01 -28.22 69.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.55 -0.295 . . . . 4.23 111.424 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . 0.639 ' H ' HD12 ' B' ' 59' ' ' LEU . 0.0 OUTLIER -107.16 9.55 30.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.881 0.372 . . . . 6.46 110.897 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -93.66 128.32 42.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.377 -0.374 . . . . 7.71 110.107 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.62 9.45 1.26 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.225 2.617 . . . . 8.76 112.643 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 7.1 m -75.91 -32.06 59.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.123 0.487 . . . . 8.96 110.601 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 15.5 m -114.31 121.66 44.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.18 -0.464 . . . . 10.1 111.18 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -102.35 148.57 25.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.492 -0.559 . . . . 11.21 109.492 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.3 -48.56 9.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.73 -0.748 . . . . 12.71 112.646 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.13 62.24 0.43 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.998 -0.62 . . . . 13.61 112.073 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.6 p -105.85 -21.17 13.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.999 0.428 . . . . 15.17 111.048 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 63.5 tp -106.35 122.56 46.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.224 -0.444 . . . . 17.11 110.521 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.51 141.19 30.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.255 -0.43 . . . . 18.3 110.172 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.54 94.08 3.46 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.181 -0.463 . . . . 19.0 110.305 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.87 99.35 1.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.108 2.538 . . . . 20.29 112.097 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.97 -31.92 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.027 -0.533 . . . . 21.43 110.916 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' B' ' 75' ' ' ASN . . . -73.03 113.4 10.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.556 -0.293 . . . . 22.9 110.353 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 70.18 -15.64 0.33 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.896 0.878 . . . . 25.46 112.043 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.501 ' H ' ' C ' ' B' ' 73' ' ' ALA . 28.6 t-20 67.28 -76.3 0.05 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.657 0.783 . . . . 24.7 111.48 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.6 28.87 0.17 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.68 -0.568 . . . . 24.61 111.68 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -107.27 98.09 7.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.007 0.432 . . . . 27.58 110.624 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 57.8 tp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.379 -0.819 . . . . 27.27 109.133 175.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.183 0 N-CA-C 111.953 0.353 . . . . 2.5 111.953 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.01 97.17 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.074 -0.584 . . . . 2.13 112.181 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.78 95.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.787 0.327 . . . . 2.19 110.713 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.648 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 49.7 tp -63.07 -47.5 82.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 1.68 110.788 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.08 -47.78 84.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 1.71 110.155 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -50.57 73.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.75 112.005 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.8 p80 -72.78 -29.07 62.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 1.78 110.866 -173.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.15 65.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 1.09 110.528 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.65 -40.68 69.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.985 -0.552 . . . . 1.46 110.919 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.2 t -65.24 -42.58 93.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 2.28 111.077 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.79 -25.09 59.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.05 0.452 . . . . 1.65 110.317 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.63 6.66 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.565 -0.743 . . . . 1.28 112.587 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 55' ' ' LEU . 17.9 t -90.63 102.37 13.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 109.505 -0.554 . . . . 0.99 109.505 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HE ' ' NE2' ' A' ' 58' ' ' GLN . 3.8 mpt_? -115.03 128.74 56.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.771 -0.455 . . . . 2.67 109.771 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.683 ' O ' HD21 ' A' ' 56' ' ' LEU . 5.4 mp -126.11 120.7 30.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.98 -0.378 . . . . 1.45 109.98 175.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 56' ' ' LEU . 28.8 p90 -136.22 145.77 46.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 2.26 110.49 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.0 p -91.22 124.16 43.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.23 0.538 . . . . 2.92 110.193 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.07 101.17 7.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.162 -0.472 . . . . 4.2 110.076 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.29 -102.58 0.96 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.768 -0.73 . . . . 4.2 111.67 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.635 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 4.8 pt-20 -101.27 -21.97 14.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.15 111.274 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 10.6 tpp180 -121.33 136.51 54.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.174 -0.611 . . . . 5.38 112.349 -170.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.5 tt -80.01 129.15 34.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.079 -0.964 . . . . 2.44 109.453 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 8.0 mpt_? -99.69 136.95 38.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.255 -0.43 . . . . 4.22 109.865 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.98 130.68 56.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.905 -0.589 . . . . 1.69 109.673 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 51.8 tp60 -111.75 109.61 19.54 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.029 -0.73 . . . . 2.68 109.029 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 113.56 4.92 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.179 -0.464 . . . . 1.69 111.347 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 36' ' ' VAL . 39.8 Cg_exo -58.22 149.56 71.89 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.93 2.42 . . . . 1.84 111.971 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.47 123.64 12.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.503 2.135 . . . . 2.31 112.052 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.15 -34.37 5.66 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.546 -0.835 . . . . 1.76 112.945 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 33' ' ' PRO . 23.1 m -81.69 -21.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.321 . . . . 1.49 111.559 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.44 ' HE2' ' HA ' ' A' ' 37' ' ' MET . 8.7 tpp -82.8 22.58 0.9 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.242 0.544 . . . . 1.41 111.402 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -52.53 141.49 34.08 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 1.45 110.42 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.5 -33.19 29.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.14 2.56 . . . . 1.72 113.856 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 32.5 tt0 -72.21 -33.61 67.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.645 -0.422 . . . . 2.76 110.708 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 36' ' ' VAL . 2.3 tt -65.96 -40.79 91.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.21 0.529 . . . . 1.2 109.812 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HA ' HD12 ' A' ' 45' ' ' LEU . 63.7 tp60 -59.65 -35.53 74.59 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.269 -0.878 . . . . 2.06 110.069 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.4 t -69.2 -29.65 67.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.651 -0.704 . . . . 1.57 110.107 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.9 mmt180 -70.89 -39.83 72.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.779 -0.452 . . . . 3.34 109.779 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 42' ' ' GLN . 69.4 mt -58.77 -39.44 81.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.064 -0.517 . . . . 1.25 109.796 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.0 -22.39 9.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.743 -0.662 . . . . 2.3 112.658 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 33.61 81.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.108 -0.568 . . . . 2.57 111.96 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' OE2' ' A' ' 51' ' ' GLU . . . -100.8 153.43 19.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.051 0.453 . . . . 2.08 110.745 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.504 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.6 ptm180 -68.8 -50.03 53.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.609 0.966 . . . . 5.36 113.609 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -57.37 -47.8 80.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.6 0.592 . . . . 2.99 112.6 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 52' ' ' LEU . 3.1 pm0 -72.59 -36.99 68.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.935 -0.306 . . . . 2.75 110.205 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.69 ' O ' HD22 ' A' ' 56' ' ' LEU . 43.3 mt -64.86 -38.76 92.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.695 -0.402 . . . . 1.9 110.038 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 49' ' ' ARG . 82.5 mt -55.61 -41.62 65.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.186 0.517 . . . . 2.74 109.895 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -26.14 65.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 1.5 111.078 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 19' ' ' VAL . 2.7 mm? -70.85 -31.89 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.946 -0.302 . . . . 1.32 111.237 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -75.71 -38.27 58.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.127 0.489 . . . . 1.68 110.339 171.519 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -51.87 -28.62 16.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.597 -1.183 . . . . 4.07 111.202 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.477 ' NE2' ' HE ' ' A' ' 20' ' ' ARG . 3.4 pt20 -65.96 -40.48 91.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.369 -0.378 . . . . 1.75 110.713 175.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD1' ' HG2' ' A' ' 20' ' ' ARG . 19.7 mt -86.81 -13.56 44.72 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.798 1.407 . . . . 2.47 114.798 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 113.076 0.769 . . . . 2.58 113.076 -168.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 N-CA-C 112.214 -0.354 . . . . 4.66 112.214 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.37 95.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.922 0.391 . . . . 5.78 110.649 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.553 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 49.6 tp -63.52 -46.84 84.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.015 -0.538 . . . . 4.38 110.436 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.61 -49.95 75.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 2.86 110.079 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.6 -53.32 59.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 3.74 112.125 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.553 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 3.5 p80 -69.86 -31.6 69.52 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.445 -0.502 . . . . 5.05 111.068 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.19 -40.23 74.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.137 0.494 . . . . 3.33 110.343 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.67 74.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 4.37 110.761 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -62.04 -45.87 91.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 6.1 111.282 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.97 -24.96 61.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.729 0.3 . . . . 6.49 111.087 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.04 39.72 6.86 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.646 -0.788 . . . . 4.73 112.263 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.429 ' O ' HD12 ' B' ' 55' ' ' LEU . 39.6 t -90.95 110.23 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.708 -0.479 . . . . 3.6 109.708 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -127.65 136.71 51.99 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.885 -0.326 . . . . 6.8 110.782 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.508 ' O ' HD21 ' B' ' 56' ' ' LEU . 5.3 mp -130.02 122.4 28.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.247 -0.649 . . . . 3.8 109.247 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' TRP . . . . . 0.578 ' HB3' HD11 ' B' ' 56' ' ' LEU . 34.5 p90 -138.35 139.29 38.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 6.8 110.913 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.8 p -84.34 117.38 29.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 7.74 110.002 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB3' HH11 ' B' ' 29' ' ' ARG . 8.9 tp10 -112.13 101.18 9.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.864 -0.607 . . . . 9.44 109.544 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.8 -95.47 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.109 -0.567 . . . . 9.66 112.526 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 4.5 pt-20 -104.2 -25.6 12.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.999 0.428 . . . . 9.32 111.18 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -122.56 130.09 52.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 7.34 111.342 -166.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.3 tt -77.0 126.71 31.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.662 -0.699 . . . . 5.18 109.57 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.52 HH11 ' HB3' ' B' ' 24' ' ' GLU . 7.5 mpt_? -96.76 137.82 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.174 -0.467 . . . . 8.07 110.045 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -117.29 130.63 56.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.767 -0.651 . . . . 4.16 109.838 -176.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -110.47 109.73 20.2 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.095 -0.705 . . . . 6.72 109.095 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.5 112.5 5.99 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 5.75 111.255 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.522 ' O ' HG22 ' B' ' 36' ' ' VAL . 33.0 Cg_exo -59.37 146.17 95.67 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.616 2.211 . . . . 6.98 111.673 174.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.13 123.32 12.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.285 1.99 . . . . 8.85 112.129 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.09 -34.25 5.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.657 -0.783 . . . . 8.09 112.831 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.522 HG22 ' O ' ' B' ' 33' ' ' PRO . 13.9 m -83.03 -18.46 10.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.082 0.441 . . . . 7.0 111.316 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' B' ' 37' ' ' MET . 10.5 tpp -84.55 20.75 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.212 0.53 . . . . 5.73 111.501 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.7 p -50.62 136.34 25.2 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 7.96 110.475 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.58 -38.49 21.83 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.78 2.987 . . . . 7.3 114.499 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 31.3 tt0 -66.86 -29.45 69.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.643 -0.423 . . . . 9.22 110.94 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.421 HD13 ' O ' ' B' ' 36' ' ' VAL . 7.0 tt -73.1 -35.1 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.866 -0.42 . . . . 6.17 109.866 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -60.97 -36.33 79.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.477 0.656 . . . . 4.84 109.348 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -67.2 -31.92 72.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.378 -0.828 . . . . 7.35 110.313 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 38.0 mmt180 -68.54 -40.25 80.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.293 -0.412 . . . . 8.28 109.936 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.489 ' HA ' HD11 ' B' ' 10' ' ' LEU . 83.2 mt -61.19 -37.73 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 4.13 110.284 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.91 -22.53 11.5 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.628 -0.715 . . . . 5.58 112.714 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.47 30.17 74.83 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.006 -0.616 . . . . 4.5 112.517 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.35 158.74 15.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.044 0.449 . . . . 5.41 110.658 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.635 ' HD2' ' OE1' ' A' ' 26' ' ' GLU . 8.4 ptm180 -68.47 -50.25 53.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.589 0.959 . . . . 8.22 113.589 -172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -58.33 -50.09 74.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.818 0.673 . . . . 7.16 112.818 -167.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -68.43 -40.81 81.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.309 -0.256 . . . . 5.72 110.309 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.601 ' O ' HD22 ' B' ' 56' ' ' LEU . 53.4 mt -63.72 -36.31 83.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.557 -0.292 . . . . 3.06 111.082 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.533 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.8 mt -57.43 -42.39 80.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.13 0.49 . . . . 6.4 110.073 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.09 72.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.88 -0.6 . . . . 3.73 110.981 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.4 mm? -66.37 -28.83 68.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.17 -0.468 . . . . 2.46 111.422 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.601 HD22 ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER -79.65 -33.85 40.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 5.56 110.192 172.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -57.11 -32.03 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 7.19 111.443 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 4.2 pt20 -67.45 -26.69 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.591 -0.277 . . . . 4.23 111.574 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.33 -0.252 0 N-CA-C 112.382 0.512 . . . . 6.46 112.382 -175.176 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.585 0.587 . . . . 2.5 112.585 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.43 -42.08 88.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.562 -0.351 . . . . 2.13 112.697 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.28 90.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.942 0.401 . . . . 2.19 110.802 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.99 -46.58 74.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 1.68 110.235 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.317 -0.856 . . . . 1.71 110.221 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.26 79.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.983 0.421 . . . . 1.75 110.992 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.59 -28.95 61.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.95 -0.568 . . . . 1.78 110.956 -174.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.4 -41.08 49.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 1.09 110.317 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.99 82.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.475 . . . . 1.46 111.058 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -66.71 -30.38 70.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.871 -0.604 . . . . 2.28 110.661 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.19 -26.1 26.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.166 -0.47 . . . . 1.65 110.841 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.23 30.81 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.794 -0.717 . . . . 1.28 113.123 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 41' ' ' LEU . 44.1 t -74.39 113.23 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.275 -0.639 . . . . 0.99 109.275 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 98.6 mtt180 -124.56 135.91 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.448 -0.342 . . . . 2.67 110.944 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -131.94 131.71 42.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 1.45 110.167 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' HB3' HD13 ' A' ' 56' ' ' LEU . 30.5 p90 -151.63 152.65 33.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.717 -0.475 . . . . 2.26 109.717 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.9 p -99.49 126.78 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.335 0.588 . . . . 2.92 110.54 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.67 105.86 10.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.79 -0.641 . . . . 4.2 109.77 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.16 -107.8 2.42 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.829 -0.7 . . . . 4.2 111.397 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.08 -8.35 15.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.811 0.339 . . . . 5.15 110.243 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 10.2 tpp180 -116.31 134.28 55.07 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.635 0.605 . . . . 5.38 112.635 -170.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 8.3 tt -76.96 124.98 28.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.102 -0.954 . . . . 2.44 108.939 171.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 11.7 mmm180 -97.94 135.32 39.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.592 -0.522 . . . . 4.22 109.592 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.35 132.08 55.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.993 0.425 . . . . 1.69 110.533 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 8.5 tp60 -123.13 114.27 20.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.194 -0.457 . . . . 2.68 109.951 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.03 126.43 4.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.277 -0.42 . . . . 1.69 110.736 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD2' HG21 ' A' ' 36' ' ' VAL . 30.2 Cg_exo -63.89 157.13 54.2 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.914 2.41 . . . . 1.84 111.904 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.61 123.14 12.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.361 2.041 . . . . 2.31 112.342 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 38' ' ' THR . . . 111.36 -37.32 3.76 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.671 -0.695 . . . . 1.76 113.413 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.627 HG21 ' HD2' ' A' ' 33' ' ' PRO . 18.6 m -77.1 -15.73 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.385 0.513 . . . . 1.49 112.385 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.493 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.41 20.98 0.81 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.822 0.344 . . . . 1.41 111.232 -173.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 35' ' ' GLY . 16.9 p -50.86 142.02 17.44 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.372 -0.376 . . . . 1.45 110.944 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -52.06 -34.41 57.46 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.925 2.417 . . . . 1.72 112.961 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -71.29 -29.81 65.49 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 2.76 110.372 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 3.0 tt -71.76 -37.13 70.56 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.748 0.785 . . . . 1.2 109.69 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -58.69 -36.5 74.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.788 -1.097 . . . . 2.06 109.664 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.4 t -71.84 -30.09 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.427 -0.806 . . . . 1.57 110.618 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.2 mmt180 -63.71 -44.94 92.15 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.865 -0.42 . . . . 3.34 109.865 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.347 -0.842 . . . . 1.25 109.467 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.64 -22.57 8.79 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.456 -0.793 . . . . 2.3 113.064 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' B' ' 27' ' ' ARG . . . 71.73 20.14 78.44 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.768 -0.729 . . . . 2.57 112.007 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -81.56 147.47 29.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.854 -0.338 . . . . 2.08 110.285 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.3 ptm180 -70.73 -51.91 24.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.371 -0.377 . . . . 5.36 111.863 -174.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -61.84 -32.32 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.506 0.669 . . . . 2.99 110.581 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.8 tp10 -72.46 -43.34 63.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.03 -0.987 . . . . 2.75 109.974 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 81.9 mt -71.66 -24.85 61.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.714 -0.676 . . . . 1.9 111.152 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 49' ' ' ARG . 73.9 mt -61.23 -49.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.926 -0.398 . . . . 2.74 109.926 173.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.63 67.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.203 0.525 . . . . 1.5 110.614 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.5 tm? -70.01 -39.43 75.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 1.32 109.317 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.512 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 3.8 tp -79.17 -31.27 43.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.763 -0.653 . . . . 1.68 109.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -64.38 -24.0 67.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 4.07 110.535 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -60.18 -31.38 70.07 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.606 HD13 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -105.81 4.96 30.37 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.968 -0.693 . . . . 2.47 111.461 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 99.1 mt-30 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.535 . . . . 2.58 110.054 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 CA-C-O 120.155 -0.247 . . . . 4.66 112.924 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.79 90.62 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.82 0.343 . . . . 5.78 110.709 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 64.5 tp -72.68 -46.06 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.12 -0.491 . . . . 4.38 110.188 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.26 -51.4 70.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.719 -0.673 . . . . 2.86 110.27 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.17 85.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 3.74 111.156 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.46 -40.28 89.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.937 -0.574 . . . . 5.05 111.004 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.15 63.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 3.33 110.823 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.29 -46.62 87.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 4.37 111.676 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 30.1 m -64.6 -28.35 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 6.1 111.363 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' B' ' 33' ' ' PRO . 70.3 mt -86.33 -25.27 25.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 6.49 110.599 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.64 26.32 27.66 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.79 -0.719 . . . . 4.73 112.606 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.84 111.25 12.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.552 -0.536 . . . . 3.6 109.552 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.654 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 98.5 mtt180 -125.01 139.36 53.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.359 -0.382 . . . . 6.8 111.055 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.447 HD21 ' CE2' ' B' ' 30' ' ' PHE . 5.9 mp -135.29 134.38 39.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 3.8 109.964 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' TRP . . . . . 0.542 ' HB3' HD13 ' B' ' 56' ' ' LEU . 36.5 p90 -153.07 154.82 35.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.944 -0.391 . . . . 6.8 109.944 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.9 p -99.34 123.39 52.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.531 . . . . 7.74 110.566 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -119.39 102.85 8.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.5 -0.555 . . . . 9.44 109.5 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.09 -109.32 2.76 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.382 -0.687 . . . . 9.66 111.382 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.68 -6.82 15.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.908 0.385 . . . . 9.32 110.506 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 9.4 tpp180 -118.22 127.46 53.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.206 0.526 . . . . 7.34 111.823 -169.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 8.7 tt -73.8 126.75 31.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 5.18 108.97 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.464 ' HB2' ' CE2' ' B' ' 22' ' ' TRP . 9.1 mmm180 -99.85 135.05 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.557 -0.535 . . . . 8.07 109.557 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.447 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.7 OUTLIER -112.23 134.29 53.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.309 -0.405 . . . . 4.16 110.194 -176.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.654 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 8.6 tp60 -124.2 112.63 17.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.145 -0.479 . . . . 6.72 109.89 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -149.89 122.06 4.2 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.342 -0.39 . . . . 5.75 110.491 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.518 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.5 Cg_exo -59.94 154.09 52.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.882 2.388 . . . . 6.98 112.12 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.8 122.97 12.66 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.534 2.156 . . . . 8.85 112.347 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.74 -37.15 3.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.655 -0.783 . . . . 8.09 113.091 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 33' ' ' PRO . 11.0 m -80.17 -7.38 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.0 0.4 . . . . 7.0 111.587 -175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.65 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.2 OUTLIER -84.18 18.82 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.81 0.338 . . . . 5.73 111.174 -175.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' B' ' 39' ' ' PRO . 19.5 p -49.94 141.44 14.5 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 7.96 111.471 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 38' ' ' THR . 62.6 Cg_exo -52.69 -34.89 66.11 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.23 2.62 . . . . 7.3 113.175 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 0.0 OUTLIER -72.11 -30.08 64.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.768 -0.373 . . . . 9.22 110.344 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.604 ' HA ' ' HG2' ' B' ' 44' ' ' ARG . 8.9 tt -74.11 -32.5 63.23 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.735 -0.469 . . . . 6.17 109.735 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -60.39 -36.62 78.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.773 -0.649 . . . . 4.84 109.341 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -72.28 -29.86 64.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.353 -0.84 . . . . 7.35 110.497 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.604 ' HG2' ' HA ' ' B' ' 41' ' ' LEU . 35.9 mmt180 -63.32 -48.0 79.87 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 8.28 109.83 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -58.61 -43.03 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.435 -0.802 . . . . 4.13 109.916 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.49 -24.01 6.84 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.188 -0.915 . . . . 5.58 112.742 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.24 12.71 83.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.945 -0.645 . . . . 4.5 112.546 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -73.37 148.42 43.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.244 -0.28 . . . . 5.41 110.244 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 53' ' ' ILE . 12.0 ptm180 -69.4 -51.09 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.34 -0.391 . . . . 8.22 111.987 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.8 -31.18 72.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.935 0.398 . . . . 7.16 111.263 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.2 OUTLIER -71.44 -40.47 70.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.38 . . . . 5.72 110.302 -178.497 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 82.1 mt -76.04 -23.94 55.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 3.06 111.211 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 49' ' ' ARG . 76.8 mt -61.28 -48.38 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.732 -0.47 . . . . 6.4 109.732 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.48 -36.89 82.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 3.73 110.343 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' B' ' 52' ' ' LEU . 3.1 tm? -59.81 -45.51 92.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 2.46 110.013 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.542 HD13 ' HB3' ' B' ' 22' ' ' TRP . 43.0 tp -68.41 -35.59 77.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.035 0.445 . . . . 5.56 110.575 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.15 -22.58 66.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 7.19 111.271 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -62.55 -31.14 71.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.634 -0.257 . . . . 4.23 111.439 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.722 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 6.46 111.618 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 110.421 -0.215 . . . . 2.5 110.421 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.39 -40.45 85.79 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 123.442 0.464 . . . . 2.13 112.404 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.1 76.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.976 0.417 . . . . 2.19 111.116 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.705 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 59.2 tp -66.28 -46.55 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 1.68 110.506 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.23 -48.72 80.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.678 -0.692 . . . . 1.71 110.277 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.76 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.454 -0.339 . . . . 1.75 111.663 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.705 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.1 p80 -76.5 -26.92 55.8 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.829 0.347 . . . . 1.78 110.794 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.71 -35.63 51.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.122 -0.231 . . . . 1.09 110.538 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.6 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 1.46 111.384 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.8 p -65.78 -41.78 91.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 2.28 110.449 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 50.0 mt -77.87 -26.38 49.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 1.65 110.022 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.2 18.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.724 -0.671 . . . . 1.28 113.348 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.39 135.48 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.86 -0.793 . . . . 0.99 108.86 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.676 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 71.4 mtt180 -130.81 126.63 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.693 -0.194 . . . . 2.67 110.653 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.702 HD22 HD22 ' A' ' 52' ' ' LEU . 6.1 mp -133.52 117.15 16.8 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 1.45 111.815 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HB3' HD21 ' A' ' 56' ' ' LEU . 26.7 p90 -129.75 149.08 51.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 2.26 109.315 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.09 128.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.347 0.594 . . . . 2.92 111.349 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' ' NE ' ' A' ' 29' ' ' ARG . 38.1 tt0 -120.75 116.5 25.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.747 -0.834 . . . . 4.2 108.747 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.42 -109.46 2.9 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.092 -1.203 . . . . 4.2 110.092 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.69 -15.0 10.8 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.808 0.337 . . . . 5.15 110.291 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -92.43 144.46 25.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.563 0.697 . . . . 5.38 111.445 -172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 21' ' ' LEU . 3.4 tm? -85.96 129.28 34.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.969 -1.014 . . . . 2.44 109.903 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.447 ' NE ' ' HB3' ' A' ' 24' ' ' GLU . 4.2 mpt_? -97.25 130.07 44.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.136 -0.691 . . . . 4.22 109.136 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.432 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -114.26 131.32 56.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.508 -0.314 . . . . 1.69 110.882 -171.046 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.676 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 6.1 tp-100 -130.15 123.87 31.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.196 -0.456 . . . . 2.68 109.919 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.47 138.06 11.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.397 -0.365 . . . . 1.69 110.816 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' VAL . 27.5 Cg_endo -68.03 155.31 70.09 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.6 2.2 . . . . 1.84 111.25 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.04 122.47 10.97 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 122.38 2.053 . . . . 2.31 112.464 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.5 -28.78 9.21 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.712 -0.676 . . . . 1.76 113.31 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 33' ' ' PRO . 22.9 m -83.74 -11.75 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.878 0.696 . . . . 1.49 112.878 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -83.55 20.42 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.696 0.284 . . . . 1.41 111.747 -173.517 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 p -53.1 147.09 18.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 1.45 111.444 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.7 -33.84 51.2 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 1.72 113.508 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.1 tt0 -70.78 -35.14 72.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.515 -0.474 . . . . 2.76 110.499 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -64.36 -41.15 96.88 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 121.032 0.444 . . . . 1.2 109.827 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.682 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -59.86 -37.36 79.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.06 109.946 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -67.68 -28.84 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 1.57 110.35 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 35.2 mmt180 -73.18 -43.98 60.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.311 -0.404 . . . . 3.34 110.17 176.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 53.9 mt -62.51 -42.93 99.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.364 0.602 . . . . 1.25 109.431 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.21 -23.06 7.44 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.607 -0.724 . . . . 2.3 112.778 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.18 16.31 76.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.917 -0.659 . . . . 2.57 111.761 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.6 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -76.63 148.77 36.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.944 0.402 . . . . 2.08 110.357 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.0 ptp180 -69.11 -51.04 42.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 5.36 111.943 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -61.87 -33.67 74.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 2.99 110.226 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -67.99 -46.5 71.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.253 -0.885 . . . . 2.75 110.476 -177.187 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.702 HD22 HD22 ' A' ' 21' ' ' LEU . 72.9 mt -66.23 -30.27 70.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.383 -0.826 . . . . 1.9 111.175 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 49' ' ' ARG . 89.2 mt -60.97 -43.55 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.713 0.768 . . . . 2.74 110.017 174.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.166 -0.925 . . . . 1.5 110.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 55' ' ' LEU . 2.7 tm? -64.55 -38.14 89.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.832 -1.173 . . . . 1.32 107.832 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -69.68 -39.66 76.84 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.267 -1.333 . . . . 1.68 112.214 174.104 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 57' ' ' ARG . 73.2 mtt180 -50.97 -29.7 12.99 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.157 -0.474 . . . . 4.07 111.42 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -54.09 -47.85 71.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.323 0.582 . . . . 1.75 110.784 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 59' ' ' LEU . 7.9 tt -84.74 -32.42 23.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 2.47 110.394 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.636 -0.711 . . . . 2.58 110.9 -173.977 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.251 0 N-CA-C 114.296 0.478 . . . . 4.66 114.296 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -48.14 78.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.092 0.446 . . . . 5.78 111.278 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.519 HD12 ' CE1' ' B' ' 13' ' ' HIS . 64.8 tp -63.47 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 4.38 110.688 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.48 -47.95 81.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 2.86 110.291 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.78 84.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 3.74 111.845 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.519 ' CE1' HD12 ' B' ' 10' ' ' LEU . 8.3 p-80 -75.39 -27.33 59.03 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.342 -0.543 . . . . 5.05 111.169 -175.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.89 -38.78 52.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.871 -0.332 . . . . 3.33 110.848 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.65 76.99 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.288 -0.414 . . . . 4.37 111.311 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 23.3 p -64.22 -40.35 95.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 6.1 110.686 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.6 mt -75.22 -25.29 58.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 6.49 110.296 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.33 19.77 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.679 -0.772 . . . . 4.73 112.716 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.6 133.12 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.293 -0.632 . . . . 3.6 109.293 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 69.4 mtt180 -130.86 128.91 41.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.678 -0.237 . . . . 6.8 110.981 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.685 HD22 HD22 ' B' ' 52' ' ' LEU . 6.2 mp -134.29 122.74 23.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.995 -0.372 . . . . 3.8 109.995 173.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -137.2 148.15 46.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.78 -0.452 . . . . 6.8 109.78 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.12 128.17 49.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.422 0.63 . . . . 7.74 111.345 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.486 ' HB3' ' NE ' ' B' ' 29' ' ' ARG . 37.4 tt0 -118.83 117.14 28.07 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.154 -1.054 . . . . 9.44 108.154 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.25 -108.9 2.64 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.453 -1.059 . . . . 9.66 110.453 -168.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -15.15 10.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.232 0.539 . . . . 9.32 110.132 173.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.15 142.02 27.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.407 0.623 . . . . 7.34 111.167 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.593 HD11 HD23 ' B' ' 21' ' ' LEU . 3.2 tm? -86.19 132.28 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.097 -0.956 . . . . 5.18 110.224 -174.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.486 ' NE ' ' HB3' ' B' ' 24' ' ' GLU . 3.8 mpt_? -100.82 130.96 46.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.203 -0.666 . . . . 8.07 109.203 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.539 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -113.9 131.75 56.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.748 0.309 . . . . 4.16 110.828 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.786 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 6.3 tp-100 -130.55 121.26 25.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.78 -0.452 . . . . 6.72 109.78 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.61 134.49 8.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.484 -0.325 . . . . 5.75 110.939 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.499 ' O ' HG22 ' B' ' 36' ' ' VAL . 29.8 Cg_endo -63.97 154.73 68.43 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.491 2.127 . . . . 6.98 111.865 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.38 122.96 12.56 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.424 2.083 . . . . 8.85 112.779 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.22 -32.13 6.7 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.81 -0.709 . . . . 8.09 113.402 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' B' ' 17' ' ' LEU . 10.7 m -85.29 2.99 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.183 0.438 . . . . 7.0 112.183 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.662 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -93.46 19.35 8.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.894 0.378 . . . . 5.73 111.03 -176.052 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -53.46 145.51 27.58 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.547 . . . . 7.96 111.966 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.86 -39.51 39.42 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.356 2.704 . . . . 7.3 113.536 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 32.4 tt0 -65.62 -36.65 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.866 -0.334 . . . . 9.22 110.59 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 5.6 tt -68.26 -34.12 75.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.059 -0.348 . . . . 6.17 110.059 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -62.89 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 4.84 109.991 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 31.7 t -68.74 -34.11 75.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 7.35 110.183 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 28.2 mmt180 -63.84 -43.68 95.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.114 -0.494 . . . . 8.28 109.946 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 69.8 mt -65.97 -43.71 87.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 4.13 109.933 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 -22.16 9.57 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.572 -0.74 . . . . 5.58 112.408 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.14 19.74 78.69 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.877 -0.678 . . . . 4.5 111.42 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.85 149.41 36.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.826 0.346 . . . . 5.41 110.7 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' B' ' 53' ' ' ILE . 3.4 ptp180 -69.49 -50.32 46.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.206 -0.452 . . . . 8.22 111.735 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -64.73 -30.43 71.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.748 0.309 . . . . 7.16 111.456 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.3 OUTLIER -69.61 -45.35 68.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 5.72 110.814 -179.304 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.685 HD22 HD22 ' B' ' 21' ' ' LEU . 61.2 mt -67.32 -28.08 67.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 3.06 110.911 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.505 HG13 ' O ' ' B' ' 49' ' ' ARG . 90.9 mt -63.41 -48.67 86.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.114 0.483 . . . . 6.4 110.017 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ALA . . . . . 0.497 ' HA ' ' HD2' ' B' ' 57' ' ' ARG . . . -68.4 -36.08 78.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 3.73 110.734 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.435 ' O ' HD13 ' B' ' 55' ' ' LEU . 2.1 tm? -55.93 -39.95 72.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.509 -0.768 . . . . 2.46 109.399 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.534 HD23 ' O ' ' B' ' 21' ' ' LEU . 0.8 OUTLIER -74.69 -27.65 60.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 5.56 110.234 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 54' ' ' ALA . 80.1 mtt180 -62.58 -26.33 68.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.494 -0.321 . . . . 7.19 111.114 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -57.31 -39.71 76.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.349 0.595 . . . . 4.23 110.872 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.48 -0.782 . . . . 6.46 110.332 -176.491 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 -0.027 0 CA-C-O 120.597 0.237 . . . . 2.5 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.13 -39.14 95.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.137 -0.554 . . . . 2.13 112.24 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.75 -42.86 85.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.06 0.457 . . . . 2.19 110.682 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 13' ' ' HIS . 45.9 tp -64.65 -47.13 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.813 -0.63 . . . . 1.68 110.268 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.21 -46.5 88.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.628 -0.715 . . . . 1.71 110.062 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -50.98 71.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 1.75 111.673 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.558 ' CE1' HD12 ' A' ' 10' ' ' LEU . 8.2 p-80 -76.83 -27.96 55.35 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.657 -0.417 . . . . 1.78 110.954 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.11 66.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.068 -0.253 . . . . 1.09 110.496 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.75 92.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.131 0.491 . . . . 1.46 110.764 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -65.08 -33.39 75.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.498 -0.774 . . . . 2.28 110.845 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 36' ' ' VAL . 83.8 mt -85.73 -26.32 25.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.108 0.48 . . . . 1.65 109.949 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.72 35.73 35.13 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.442 -0.799 . . . . 1.28 112.476 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.499 ' O ' HD11 ' A' ' 55' ' ' LEU . 97.4 t -69.38 108.67 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.335 -0.987 . . . . 0.99 108.335 170.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 51.7 mtt180 -112.18 133.64 54.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.155 0.502 . . . . 2.67 111.625 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 52' ' ' LEU . 5.9 mp -130.41 136.69 49.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.892 -1.049 . . . . 1.45 109.728 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.591 ' HA ' HD21 ' A' ' 56' ' ' LEU . 22.9 p90 -158.2 137.92 12.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.49 -0.777 . . . . 2.26 109.257 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -85.33 121.63 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.665 -0.494 . . . . 2.92 109.665 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 33.1 tt0 -115.77 102.38 9.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.777 -0.647 . . . . 4.2 109.843 -175.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.67 -90.39 0.39 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.485 -0.779 . . . . 4.2 111.938 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -111.43 -28.71 8.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.546 0.212 . . . . 5.15 111.338 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -117.07 142.48 46.93 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.946 -0.701 . . . . 5.38 112.252 -169.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.642 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -69.3 124.34 23.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.867 -1.061 . . . . 2.44 108.565 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 15.5 mmm180 -101.45 136.36 41.42 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.601 -0.518 . . . . 4.22 109.601 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.8 135.67 55.1 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.539 -0.541 . . . . 1.69 109.539 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 25.2 tp60 -131.56 106.56 8.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.859 -0.422 . . . . 2.68 109.859 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.43 123.67 28.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 1.69 111.196 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 31.5 Cg_exo -61.51 160.01 29.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.649 2.233 . . . . 1.84 111.581 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.725 ' HB3' HG22 ' B' ' 38' ' ' THR . 28.4 Cg_endo -63.97 122.73 10.86 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.35 2.033 . . . . 2.31 112.753 -176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 38' ' ' THR . . . 97.55 -37.66 3.38 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.875 -0.679 . . . . 1.76 114.06 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 17' ' ' LEU . 26.7 m -68.63 -14.01 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.285 0.846 . . . . 1.49 113.285 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.8 tpp -86.01 23.51 1.48 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.892 0.377 . . . . 1.41 111.41 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.645 HG22 ' HB3' ' B' ' 34' ' ' PRO . 43.7 p -50.74 145.77 10.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.44 -0.346 . . . . 1.45 110.764 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 52.1 Cg_exo -53.18 -28.97 44.09 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.915 2.41 . . . . 1.72 113.435 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 38.7 tt0 -67.97 -48.33 66.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.886 -0.413 . . . . 2.76 109.886 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.26 -37.23 86.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.428 0.633 . . . . 1.2 109.883 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -56.42 -41.15 75.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.92 -1.036 . . . . 2.06 109.85 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 1.57 110.663 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 3.4 mmp_? -67.61 -38.04 83.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.487 -0.324 . . . . 3.34 110.432 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.7 mt -64.6 -43.26 94.36 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.152 -0.684 . . . . 1.25 109.152 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.65 -23.78 6.31 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 2.3 113.448 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.92 14.38 75.88 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 2.57 111.825 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -84.0 150.15 25.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.991 -0.374 . . . . 2.08 109.991 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 19.1 ptp180 -69.35 -50.56 45.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 111.773 0.286 . . . . 5.36 111.773 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.507 ' HA ' HD12 ' A' ' 53' ' ' ILE . 8.9 p80 -56.96 -35.73 69.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.052 0.454 . . . . 2.99 110.529 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.09 -51.12 67.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.368 -0.833 . . . . 2.75 109.852 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 21' ' ' LEU . 80.8 mt -69.18 -25.65 64.45 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.672 -1.149 . . . . 1.9 111.016 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.5 mt -59.74 -47.7 90.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.789 0.328 . . . . 2.74 110.304 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -31.49 71.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.342 0.591 . . . . 1.5 110.494 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 19' ' ' VAL . 2.1 tm? -71.54 -41.34 69.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.201 1.001 . . . . 1.32 108.461 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -62.93 -43.14 99.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.808 -1.542 . . . . 1.68 110.135 178.388 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.38 -29.26 70.59 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.576 -1.193 . . . . 4.07 111.616 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.6 pt20 -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.659 -0.417 . . . . 1.75 110.847 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 21.52 17.15 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.805 0.336 . . . . 2.47 110.552 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.485 -0.561 . . . . 2.58 109.485 177.269 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.224 0 N-CA-C 112.812 -0.115 . . . . 4.66 112.812 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.72 -43.46 62.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.815 0.34 . . . . 5.78 110.747 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 69.1 tp -59.05 -47.54 84.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 4.38 110.76 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.92 -45.58 94.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.545 . . . . 2.86 110.048 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.9 63.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 3.74 112.323 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 8.9 p80 -76.81 -28.42 55.56 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 5.05 111.299 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -45.32 69.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.711 0.291 . . . . 3.33 110.583 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.25 95.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 4.37 111.182 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -61.83 -39.33 91.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 6.1 111.096 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.576 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -79.47 -26.63 41.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.796 -0.361 . . . . 6.49 110.594 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.76 33.03 19.99 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.849 -0.691 . . . . 4.73 112.495 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.419 ' O ' HD11 ' B' ' 55' ' ' LEU . 77.4 t -75.86 104.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.124 -0.695 . . . . 3.6 109.124 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 50.3 mtt180 -110.81 135.05 51.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.083 0.468 . . . . 6.8 111.9 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.657 HD22 HD22 ' B' ' 52' ' ' LEU . 6.2 mp -131.0 140.86 50.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.437 -0.801 . . . . 3.8 108.961 171.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' TRP . . . . . 0.636 ' HA ' HD21 ' B' ' 56' ' ' LEU . 30.0 p90 -159.44 141.67 13.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.745 -0.465 . . . . 6.8 109.745 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.05 115.89 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.328 0.585 . . . . 7.74 109.793 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HG3' ' B' ' 29' ' ' ARG . 27.4 tt0 -112.25 103.97 12.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 9.44 109.909 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.1 -90.7 0.51 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.752 -0.658 . . . . 9.66 112.342 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -115.7 -29.53 6.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.953 0.406 . . . . 9.32 110.871 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 27' ' ' ARG . 5.9 tpp180 -115.08 138.83 50.44 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.291 -0.563 . . . . 7.34 111.651 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.569 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -68.48 126.34 29.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.405 -0.816 . . . . 5.18 108.984 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' B' ' 24' ' ' GLU . 14.1 mmm180 -102.97 135.24 45.02 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.799 -0.445 . . . . 8.07 109.799 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.515 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.1 t80 -119.76 132.44 55.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 4.16 109.54 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 6.7 tp-100 -128.23 102.78 6.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.451 . . . . 6.72 109.781 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ALA . . . . . 0.4 ' HB2' ' HE3' ' B' ' 37' ' ' MET . . . -116.45 122.59 31.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.957 -0.565 . . . . 5.75 111.335 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.484 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 31.4 Cg_exo -61.82 158.54 37.41 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.752 2.301 . . . . 6.98 111.748 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.645 ' HB3' HG22 ' A' ' 38' ' ' THR . 33.8 Cg_endo -64.86 123.4 11.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.404 2.069 . . . . 8.85 112.771 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.491 ' O ' HG23 ' B' ' 38' ' ' THR . . . 98.27 -36.92 3.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.968 -0.634 . . . . 8.09 113.777 172.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' B' ' 17' ' ' LEU . 24.8 m -72.09 -12.74 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.658 0.614 . . . . 7.0 112.658 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.4 ' HE3' ' HB2' ' B' ' 32' ' ' ALA . 19.3 tpp -86.2 22.58 1.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.923 0.392 . . . . 5.73 111.419 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 34' ' ' PRO . 22.9 p -48.73 143.55 7.91 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.273 -0.421 . . . . 7.96 111.049 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.39 -27.5 39.83 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.236 2.624 . . . . 7.3 113.443 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.82 -50.68 61.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 9.22 109.949 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 tt -66.89 -33.45 75.62 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 6.17 109.817 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -56.83 -42.68 80.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.842 -0.617 . . . . 4.84 109.731 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.52 -29.65 63.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.499 -0.773 . . . . 7.35 110.702 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.646 ' CZ ' ' HA ' ' B' ' 44' ' ' ARG . 3.1 mmp_? -67.17 -38.79 86.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 8.28 110.482 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.99 -43.33 96.04 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.25 -0.648 . . . . 4.13 109.25 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.17 -23.85 6.72 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.436 -0.802 . . . . 5.58 113.354 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.16 12.25 79.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.71 -0.757 . . . . 4.5 112.007 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -80.46 151.36 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.265 -0.272 . . . . 5.41 110.265 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 18.0 ptp180 -68.31 -45.2 73.65 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.869 -0.332 . . . . 8.22 111.493 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -63.22 -35.61 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.227 -0.189 . . . . 7.16 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -46.47 82.52 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.071 0.462 . . . . 5.72 110.422 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.657 HD22 HD22 ' B' ' 21' ' ' LEU . 68.8 mt -69.97 -24.56 63.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 3.06 111.391 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 77.8 mt -65.07 -48.74 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.765 0.317 . . . . 6.4 110.264 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.56 95.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.316 0.579 . . . . 3.73 110.022 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.419 HD11 ' O ' ' B' ' 19' ' ' VAL . 1.1 tm? -58.88 -47.06 86.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.211 -0.904 . . . . 2.46 109.751 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' B' ' 22' ' ' TRP . 0.1 OUTLIER -55.39 -45.29 76.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.469 0.652 . . . . 5.56 110.604 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -64.72 -28.92 69.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 7.19 112.022 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -63.69 -30.01 71.17 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.769 0.318 . . . . 4.23 111.266 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.722 0.296 . . . . 6.46 110.771 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 11' ' ' LEU . . . . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.966 0.413 . . . . 2.5 110.121 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.53 -44.23 96.92 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.698 -0.683 . . . . 2.13 112.482 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.16 98.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.033 0.444 . . . . 2.19 111.055 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.544 HD12 ' CE1' ' A' ' 13' ' ' HIS . 39.9 tp -64.83 -46.67 80.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.829 -0.623 . . . . 1.68 110.755 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 7' ' ' ALA . 87.7 mt -58.73 -51.04 71.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.119 -0.491 . . . . 1.71 109.941 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.451 -0.795 . . . . 1.75 112.175 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.583 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 11.7 p-80 -71.7 -28.09 63.47 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.625 -0.43 . . . . 1.78 110.841 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.85 39.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.035 0.445 . . . . 1.09 110.504 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.7 85.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 1.46 110.927 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -69.21 -22.95 63.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 2.28 110.776 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 98.9 mt -84.23 -25.52 29.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.232 0.539 . . . . 1.65 109.776 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.29 16.12 25.94 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.831 -0.7 . . . . 1.28 112.899 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.98 115.11 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.582 -0.525 . . . . 0.99 109.582 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.756 ' HD3' HD12 ' A' ' 59' ' ' LEU . 95.5 mtt180 -131.11 134.14 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.25 -0.432 . . . . 2.67 111.544 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.5 mp -128.82 133.46 48.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.123 -0.489 . . . . 1.45 109.856 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.519 ' HB3' HD13 ' A' ' 56' ' ' LEU . 22.8 p90 -151.92 149.1 28.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.179 -0.304 . . . . 2.26 110.179 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.6 p -87.86 128.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 2.92 109.818 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 32.8 tt0 -132.73 110.97 10.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.116 -0.493 . . . . 4.2 110.152 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.58 -101.46 1.0 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.766 -0.731 . . . . 4.2 111.712 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.508 ' OE1' ' HD3' ' B' ' 49' ' ' ARG . 0.3 OUTLIER -116.78 -3.79 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.575 0.213 . . . . 5.15 111.575 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.517 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 11.9 tpp180 -134.58 152.12 51.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.391 0.615 . . . . 5.38 111.912 -174.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.4 tt -80.81 132.66 35.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.302 -0.863 . . . . 2.44 109.751 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.517 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.3 mpt_? -99.71 140.57 33.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 4.22 109.836 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -122.08 130.95 53.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.071 -0.715 . . . . 1.69 109.071 -177.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 62.7 tp60 -122.77 119.66 31.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.624 -0.51 . . . . 2.68 109.624 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.11 129.13 5.24 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.798 0.332 . . . . 1.69 110.851 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' A' ' 36' ' ' VAL . 31.5 Cg_exo -61.48 154.47 59.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.681 2.254 . . . . 1.84 112.166 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.51 122.51 9.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.113 1.876 . . . . 2.31 112.115 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.88 -33.98 5.47 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.7 -0.762 . . . . 1.76 113.101 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.573 ' O ' HD22 ' A' ' 41' ' ' LEU . 34.1 m -79.69 -12.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.245 0.522 . . . . 1.49 112.1 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.61 21.71 0.79 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.086 -0.506 . . . . 1.41 111.243 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.7 p -50.4 139.5 19.66 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.329 -0.396 . . . . 1.45 110.971 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 83.3 Cg_exo -47.22 -39.36 26.75 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.314 2.676 . . . . 1.72 113.282 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 39.3 tt0 -63.08 -40.68 98.38 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.207 -0.197 . . . . 2.76 110.517 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -62.95 -40.04 96.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.793 0.33 . . . . 1.2 110.362 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HA ' HD12 ' A' ' 45' ' ' LEU . 5.8 mt-30 -64.8 -39.48 93.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.249 0.547 . . . . 2.06 110.129 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -66.79 -29.63 69.62 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.094 -0.957 . . . . 1.57 109.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 51.0 mtt-85 -75.19 -38.61 60.72 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 115.882 -0.599 . . . . 3.34 110.079 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 42' ' ' GLN . 97.4 mt -55.69 -44.32 77.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.189 -0.671 . . . . 1.25 109.189 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.28 -23.24 5.52 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.579 -0.737 . . . . 2.3 113.134 168.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.71 74.18 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.737 -0.744 . . . . 2.57 111.484 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -85.08 149.52 25.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.652 0.263 . . . . 2.08 110.57 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.644 ' HD3' ' OE1' ' B' ' 26' ' ' GLU . 7.6 ptt180 -67.47 -51.65 48.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.375 . . . . 5.36 111.984 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -57.23 -39.34 75.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.384 0.611 . . . . 2.99 110.036 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.77 -55.83 22.98 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.853 -1.067 . . . . 2.75 110.351 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 93.3 mt -70.33 -26.65 63.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.091 -0.959 . . . . 1.9 111.854 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 49' ' ' ARG . 70.7 mt -62.02 -52.29 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.74 110.227 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.29 70.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.401 0.62 . . . . 1.5 110.23 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 55' ' ' LEU . 3.5 tm? -68.46 -29.46 68.1 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.196 -0.911 . . . . 1.32 109.929 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -82.72 -32.85 27.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.058 0.456 . . . . 1.68 110.602 174.086 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.76 -21.9 63.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 4.07 111.67 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -69.15 -22.63 63.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.916 0.389 . . . . 1.75 111.03 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.756 HD12 ' HD3' ' A' ' 20' ' ' ARG . 10.4 tt -73.98 -27.59 61.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.244 -0.651 . . . . 2.47 109.244 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.58 110.357 178.671 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 CA-C-O 120.008 -0.329 . . . . 4.66 113.369 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.72 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.0 0.4 . . . . 5.78 110.96 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.45 -46.6 89.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 4.38 110.354 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.89 -49.94 74.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.001 -0.545 . . . . 2.86 110.792 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.06 -53.04 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.551 . . . . 3.74 112.337 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.543 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 16.6 p-80 -70.73 -28.42 64.7 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.283 -0.567 . . . . 5.05 110.903 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.95 59.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.066 0.46 . . . . 3.33 110.406 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.11 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.691 -0.686 . . . . 4.37 110.85 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -67.69 -26.74 66.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 6.1 110.547 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' B' ' 13' ' ' HIS . 92.5 mt -81.27 -24.88 36.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 6.49 110.42 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.28 15.47 25.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 4.73 112.809 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -73.95 114.92 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.939 -0.393 . . . . 3.6 109.939 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.752 ' HD3' HD12 ' B' ' 59' ' ' LEU . 94.6 mtt180 -131.05 136.99 48.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.315 -0.402 . . . . 6.8 111.491 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.7 mp -129.91 136.42 49.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 3.8 109.751 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' TRP . . . . . 0.742 ' HB3' HD13 ' B' ' 56' ' ' LEU . 28.8 p90 -153.9 150.07 27.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.792 0.329 . . . . 6.8 110.381 175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.2 p -88.03 130.69 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.482 -0.562 . . . . 7.74 109.482 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.681 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 35.0 tt0 -134.89 114.37 12.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.236 -0.438 . . . . 9.44 110.272 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -102.86 0.85 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.984 -0.627 . . . . 9.66 111.912 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.644 ' OE1' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -0.08 12.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.572 0.225 . . . . 9.32 111.266 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.523 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 10.7 tpp180 -140.14 146.77 39.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.106 -0.638 . . . . 7.34 111.395 -171.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.2 tt -79.13 135.71 36.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.515 . . . . 5.18 110.332 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 4.8 mpt_? -101.09 137.86 38.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 8.07 110.134 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.494 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.6 t80 -119.01 131.49 56.0 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.355 -0.609 . . . . 4.16 109.355 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -126.18 114.02 17.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.833 -0.432 . . . . 6.72 109.833 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.39 130.49 7.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 5.75 111.265 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.498 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.1 Cg_exo -61.98 151.71 79.74 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.806 2.337 . . . . 6.98 112.302 175.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.534 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 34.9 Cg_endo -65.86 123.26 11.08 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.158 1.905 . . . . 8.85 112.326 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.42 -33.07 5.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.758 -0.734 . . . . 8.09 112.945 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.573 ' O ' HD22 ' B' ' 41' ' ' LEU . 22.5 m -83.99 -7.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.181 0.49 . . . . 7.0 111.53 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.554 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.43 20.22 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.399 . . . . 5.73 111.289 -175.162 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 14.9 p -50.67 138.91 22.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 7.96 111.338 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.01 -41.4 33.18 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.486 2.791 . . . . 7.3 113.473 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 42.5 tt0 -57.74 -40.74 80.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.506 0.194 . . . . 9.22 111.043 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.573 HD22 ' O ' ' B' ' 36' ' ' VAL . 2.5 tp -64.37 -42.39 96.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.86 0.362 . . . . 6.17 110.081 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.498 ' HA ' HD12 ' B' ' 45' ' ' LEU . 22.8 mt-30 -63.66 -36.99 85.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 4.84 109.97 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 17.2 t -68.02 -37.02 80.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.666 -0.697 . . . . 7.35 109.955 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 56.5 mtt-85 -66.56 -40.36 88.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.418 -0.355 . . . . 8.28 110.422 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' B' ' 42' ' ' GLN . 91.7 mt -56.92 -43.76 81.74 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-O 121.285 0.564 . . . . 4.13 109.732 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.19 -23.42 6.15 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.474 -0.784 . . . . 5.58 112.95 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.99 28.14 73.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.994 -0.622 . . . . 4.5 111.664 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.44 150.26 24.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.528 0.204 . . . . 5.41 110.467 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.508 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 11.0 ptt-85 -65.89 -50.21 65.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.338 -0.392 . . . . 8.22 111.403 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -57.48 -42.11 82.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.752 -0.204 . . . . 7.16 111.398 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -54.22 40.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.448 -0.342 . . . . 5.72 110.809 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 75.8 mt -67.91 -27.67 66.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.286 0.476 . . . . 3.06 112.286 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 49' ' ' ARG . 72.0 mt -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.808 -0.357 . . . . 6.4 110.09 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.75 -36.08 77.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.413 0.625 . . . . 3.73 110.486 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' B' ' 58' ' ' GLN . 2.9 tm? -63.39 -29.21 70.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 2.46 110.134 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' B' ' 22' ' ' TRP . 22.9 tp -79.25 -32.38 43.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 5.56 110.694 173.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.59 -20.23 65.34 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.013 0.375 . . . . 7.19 112.013 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' B' ' 55' ' ' LEU . 1.5 pp0? -73.36 -17.93 61.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.768 -0.373 . . . . 4.23 110.893 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.752 HD12 ' HD3' ' B' ' 20' ' ' ARG . 10.1 tt . . . . . 0 C--N 1.329 -0.285 0 N-CA-C 109.398 -0.593 . . . . 6.46 109.398 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 110.379 -0.23 . . . . 2.5 110.379 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.1 92.87 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.579 -0.609 . . . . 2.13 111.579 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.22 85.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 2.19 110.306 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 13' ' ' HIS . 36.6 tp -61.76 -46.84 87.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.918 -0.583 . . . . 1.68 110.042 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.4 -47.57 85.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.493 -0.776 . . . . 1.71 109.933 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.42 73.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.449 . . . . 1.75 112.043 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.569 ' CE1' HD12 ' A' ' 10' ' ' LEU . 10.6 p-80 -74.75 -27.76 60.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.649 -0.421 . . . . 1.78 110.625 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 -45.36 71.69 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.203 -0.295 . . . . 1.09 110.203 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 1.46 110.935 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -65.34 -31.98 73.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 2.28 111.235 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.6 HD13 ' HB ' ' A' ' 36' ' ' VAL . 74.6 mt -85.35 -26.43 26.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 1.65 110.166 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.35 33.23 26.22 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.51 -0.768 . . . . 1.28 112.804 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.668 HG21 HD21 ' A' ' 41' ' ' LEU . 54.0 t -71.71 121.06 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.81 -0.811 . . . . 0.99 108.81 173.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.788 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 74.7 mtt180 -126.5 131.71 51.56 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.378 -0.23 . . . . 2.67 110.378 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.594 HD23 HD11 ' A' ' 28' ' ' LEU . 6.1 mp -132.33 125.52 31.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.729 -0.471 . . . . 1.45 109.729 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -143.11 134.45 26.07 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.917 0.389 . . . . 2.26 109.984 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -92.77 125.41 45.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 2.92 109.959 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.25 118.16 28.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.907 -0.588 . . . . 4.2 109.661 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.05 -97.04 0.56 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.688 -0.687 . . . . 4.2 111.664 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -116.63 -16.29 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.734 0.302 . . . . 5.15 111.444 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -114.76 135.2 54.43 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.836 -0.746 . . . . 5.38 112.643 -167.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.594 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -78.24 124.76 28.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.505 -1.225 . . . . 2.44 108.84 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.96 143.97 30.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.001 -0.37 . . . . 4.22 110.001 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.638 ' H ' ' NE2' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -119.66 131.89 55.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 1.69 110.702 -174.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.788 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 5.2 tp-100 -126.36 114.33 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.872 -0.603 . . . . 2.68 109.692 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.83 126.85 4.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.864 0.364 . . . . 1.69 111.343 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' HG22 ' A' ' 36' ' ' VAL . 24.0 Cg_exo -65.38 155.83 66.61 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.904 2.402 . . . . 1.84 112.053 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.09 123.79 13.91 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.728 2.285 . . . . 2.31 112.563 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.15 -31.88 6.68 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 1.76 113.2 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.6 ' HB ' HD13 ' A' ' 17' ' ' LEU . 15.4 m -85.11 -19.87 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.091 0.446 . . . . 1.49 112.157 -174.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.511 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.39 20.29 0.89 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.41 111.43 -171.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.3 p -51.75 142.16 24.77 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 1.45 110.894 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.68 -38.29 28.88 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.207 2.605 . . . . 1.72 113.244 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 55.4 tt0 -61.54 -39.98 93.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 2.76 111.056 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.668 HD21 HG21 ' A' ' 19' ' ' VAL . 1.9 tp -60.35 -44.55 95.44 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.882 0.372 . . . . 1.2 110.134 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.5 tp60 -57.36 -39.01 75.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 2.06 110.125 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -68.84 -29.84 68.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.578 . . . . 1.57 110.504 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 27.4 mmt180 -73.1 -40.9 64.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.99 -0.374 . . . . 3.34 109.99 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 50.8 mt -60.19 -38.46 83.34 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.544 0.688 . . . . 1.25 109.161 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.3 -23.23 8.57 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.183 -0.917 . . . . 2.3 113.062 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.14 19.32 71.96 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.934 -0.651 . . . . 2.57 112.064 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -82.87 149.66 26.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.899 -0.408 . . . . 2.08 109.899 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.4 ptp85 -69.06 -50.62 46.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.487 -0.324 . . . . 5.36 111.521 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.457 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 8.6 p80 -61.59 -32.97 73.1 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.095 0.474 . . . . 2.99 110.836 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -66.25 -51.24 59.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.326 -0.852 . . . . 2.75 110.309 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.486 HD22 HD22 ' A' ' 21' ' ' LEU . 91.2 mt -69.08 -26.52 64.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.925 -1.034 . . . . 1.9 111.124 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.4 mt -61.0 -48.16 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 2.74 109.998 174.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.63 66.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 1.5 110.609 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 55' ' ' LEU . 2.7 tm? -69.39 -38.13 77.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 1.32 109.398 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.5 tp -79.46 -26.8 41.65 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.452 0.644 . . . . 1.68 109.633 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -65.29 -26.77 68.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 4.07 110.437 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.57 -27.89 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 1.75 110.274 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 20' ' ' ARG . 51.0 mt -74.24 -19.19 60.59 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.581 -0.736 . . . . 2.47 110.911 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.798 -0.637 . . . . 2.58 109.875 178.552 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 111.693 -0.563 . . . . 4.66 111.693 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.0 83.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.892 0.377 . . . . 5.78 110.173 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.439 HD12 ' CE1' ' B' ' 13' ' ' HIS . 58.5 tp -61.51 -46.59 89.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.867 -0.606 . . . . 4.38 109.89 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.31 -49.15 76.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.728 -0.669 . . . . 2.86 109.66 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.78 -53.26 58.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 3.74 112.307 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.439 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.1 p-80 -73.52 -27.92 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.19 -0.604 . . . . 5.05 110.952 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.17 78.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 3.33 110.445 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.15 94.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 4.37 110.8 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -61.99 -36.7 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.749 -0.66 . . . . 6.1 111.141 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' B' ' 36' ' ' VAL . 82.5 mt -82.03 -24.92 35.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 6.49 110.632 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 86.52 31.65 18.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.045 -0.598 . . . . 4.73 112.673 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.621 HG21 HD21 ' B' ' 41' ' ' LEU . 45.8 t -75.38 123.08 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.689 -0.486 . . . . 3.6 109.689 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.889 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 77.6 mtt180 -129.33 131.11 46.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.531 -0.304 . . . . 6.8 111.107 -173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.669 HD23 HD11 ' B' ' 28' ' ' LEU . 5.7 mp -134.64 125.74 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.328 -0.396 . . . . 3.8 110.135 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' TRP . . . . . 0.497 ' HB3' HD13 ' B' ' 56' ' ' LEU . 20.4 p90 -143.5 137.05 28.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 6.8 110.21 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 5.7 p -96.48 118.37 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.183 0.515 . . . . 7.74 110.172 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.3 114.43 26.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.85 -0.614 . . . . 9.44 109.664 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.36 -98.89 1.05 Allowed Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 111.327 -0.709 . . . . 9.66 111.327 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -116.99 -16.53 10.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.852 0.358 . . . . 9.32 111.598 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 7.5 tpp180 -115.53 128.44 55.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.409 0.623 . . . . 7.34 111.962 -166.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.669 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -74.62 124.39 26.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.801 -1.09 . . . . 5.18 109.551 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -100.38 145.31 28.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.295 -0.261 . . . . 8.07 110.295 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.472 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -120.14 131.67 55.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 4.16 110.57 -174.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.889 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 5.6 tp-100 -125.32 114.39 18.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.433 -0.58 . . . . 6.72 109.433 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -151.58 122.17 3.67 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 5.75 111.031 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.539 ' O ' HG22 ' B' ' 36' ' ' VAL . 31.4 Cg_exo -60.27 152.92 63.14 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.917 2.411 . . . . 6.98 112.181 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.07 124.05 15.05 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.512 2.141 . . . . 8.85 112.409 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.75 -29.03 8.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.705 -0.76 . . . . 8.09 112.926 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.557 ' O ' HD22 ' B' ' 41' ' ' LEU . 6.4 m -89.0 -14.61 9.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.533 -0.393 . . . . 7.0 111.293 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.59 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.4 OUTLIER -82.25 18.45 1.41 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.89 0.376 . . . . 5.73 111.239 -174.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.8 p -52.08 142.91 25.94 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 7.96 111.114 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' PRO . . . . . 0.432 ' HG3' ' OE1' ' A' ' 31' ' ' GLN . 71.4 Cg_exo -49.33 -37.16 39.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.263 2.642 . . . . 7.3 113.302 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 38.0 tt0 -61.43 -38.26 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.077 -0.249 . . . . 9.22 111.13 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.621 HD21 HG21 ' B' ' 19' ' ' VAL . 2.9 tp -62.79 -40.36 97.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.869 0.366 . . . . 6.17 110.115 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 30' ' ' PHE . 7.8 tp60 -59.62 -39.64 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 4.84 109.857 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 24.5 t -68.29 -32.35 72.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.773 . . . . 7.35 110.703 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 23.7 mmt180 -71.71 -41.67 68.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 8.28 110.093 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 78.3 mt -61.28 -39.6 91.01 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.858 -0.61 . . . . 4.13 109.779 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.06 -23.16 8.26 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.532 -0.758 . . . . 5.58 112.807 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.89 72.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.077 -0.582 . . . . 4.5 112.381 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -76.1 150.43 37.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.047 -0.353 . . . . 5.41 110.047 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 53' ' ' ILE . 8.8 ptp85 -65.27 -48.99 71.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.579 -0.282 . . . . 8.22 111.034 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -66.66 -32.07 73.15 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.299 . . . . 7.16 111.806 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.4 OUTLIER -64.97 -44.27 89.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 5.72 110.534 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.85 -25.0 55.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.047 -0.524 . . . . 3.06 111.506 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 49' ' ' ARG . 80.0 mt -63.54 -47.46 91.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.672 -0.492 . . . . 6.4 109.672 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.21 74.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 3.73 110.233 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.8 tm? -62.53 -44.57 96.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.761 -0.654 . . . . 2.46 109.778 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' B' ' 22' ' ' TRP . 28.2 tp -68.58 -30.95 69.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.3 0.571 . . . . 5.56 110.763 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -66.55 -29.66 69.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.074 -0.512 . . . . 7.19 110.911 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 8.2 pt20 -68.03 -24.59 65.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 4.23 110.381 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.434 HD12 HD12 ' B' ' 56' ' ' LEU . 55.7 mt . . . . . 0 CA--C 1.516 -0.349 0 CA-C-N 115.805 -0.634 . . . . 6.46 110.453 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.833 0.349 . . . . 2.5 110.449 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.37 -37.58 94.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.943 -0.571 . . . . 2.13 111.947 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.55 89.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 2.19 110.748 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.552 ' HA ' ' ND1' ' A' ' 13' ' ' HIS . 32.6 tp -64.22 -47.33 80.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 1.68 110.152 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.81 -49.09 77.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.443 -0.798 . . . . 1.71 109.999 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -50.48 71.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.813 -0.63 . . . . 1.75 112.238 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.552 ' ND1' ' HA ' ' A' ' 10' ' ' LEU . 11.8 p-80 -73.13 -27.49 61.71 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.454 -0.498 . . . . 1.78 110.55 -174.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.68 68.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.818 0.342 . . . . 1.09 110.392 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -31.82 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 1.46 110.696 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.977 -0.556 . . . . 2.28 110.762 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.603 HD13 ' HB ' ' A' ' 36' ' ' VAL . 97.6 mt -79.96 -25.89 40.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.094 0.474 . . . . 1.65 110.257 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.15 42.63 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.984 -0.627 . . . . 1.28 112.276 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.67 121.28 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 109.353 -0.61 . . . . 0.99 109.353 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 76.8 mtt180 -122.25 135.23 54.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.77 -0.456 . . . . 2.67 109.77 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.806 HD22 HD22 ' A' ' 52' ' ' LEU . 6.0 mp -135.85 124.36 23.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 1.45 110.183 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.485 ' HB3' HD13 ' A' ' 56' ' ' LEU . 23.8 p90 -140.84 140.6 34.66 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.894 -0.41 . . . . 2.26 109.894 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.51 123.0 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.943 0.401 . . . . 2.92 110.147 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.647 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -110.34 101.84 10.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.025 -0.731 . . . . 4.2 109.025 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.01 -86.15 0.22 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.766 -0.652 . . . . 4.2 112.1 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.63 -32.03 5.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.207 0.527 . . . . 5.15 110.78 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.31 133.37 50.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 5.38 112.029 -167.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.616 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -69.6 126.15 28.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.882 -1.054 . . . . 2.44 109.445 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.647 ' NH1' ' HB3' ' A' ' 24' ' ' GLU . 7.3 mpt_? -98.58 131.11 45.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.628 -0.508 . . . . 4.22 109.628 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.417 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -108.45 145.99 33.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.063 -0.517 . . . . 1.69 110.201 -175.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 57.3 tp60 -145.41 110.49 5.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.981 -0.378 . . . . 2.68 109.981 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -146.03 135.68 11.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.565 -0.289 . . . . 1.69 110.848 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' HG22 ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.26 156.98 37.42 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.89 2.394 . . . . 1.84 112.179 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' B' ' 38' ' ' THR . 20.0 Cg_endo -63.1 123.95 13.08 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.437 2.092 . . . . 2.31 112.35 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.64 -37.23 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.76 113.275 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.603 ' HB ' HD13 ' A' ' 17' ' ' LEU . 33.3 m -75.06 -11.92 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.609 0.596 . . . . 1.49 112.609 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -82.16 21.51 0.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.187 -0.46 . . . . 1.41 111.711 -173.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.621 HG22 ' HB3' ' B' ' 34' ' ' PRO . 35.2 p -50.64 143.91 13.58 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 116.608 -0.269 . . . . 1.45 110.954 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 50.6 Cg_exo -53.51 -32.91 65.48 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.54 2.16 . . . . 1.72 111.954 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 18.4 tp10 -57.93 -50.21 74.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.856 -0.611 . . . . 2.76 110.2 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 36' ' ' VAL . 2.4 tp -61.79 -47.53 84.73 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.2 110.293 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HA ' HD12 ' A' ' 45' ' ' LEU . 25.3 tp60 -57.13 -39.25 74.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 2.06 111.204 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.9 t -71.44 -29.55 65.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.381 -0.372 . . . . 1.57 110.391 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 96.3 mtt180 -77.76 -28.73 50.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 3.34 110.94 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 42' ' ' GLN . 87.2 mt -64.86 -33.85 76.99 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.784 -0.821 . . . . 1.25 108.784 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 -24.03 6.79 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.078 -0.965 . . . . 2.3 113.044 171.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.87 11.6 60.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.967 -0.635 . . . . 2.57 112.12 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -78.42 150.47 33.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.137 -0.32 . . . . 2.08 110.137 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -67.46 -50.15 60.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.298 -0.41 . . . . 5.36 111.16 -173.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.62 -34.54 78.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 2.99 110.808 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -66.1 -48.67 70.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.699 -0.682 . . . . 2.75 109.844 -178.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.806 HD22 HD22 ' A' ' 21' ' ' LEU . 76.8 mt -72.07 -24.2 61.47 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.05 -0.977 . . . . 1.9 111.238 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 49' ' ' ARG . 74.7 mt -62.37 -43.92 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.769 -0.456 . . . . 2.74 109.769 172.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.06 -25.76 65.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 1.5 110.319 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.69 ' HB2' ' HA ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -71.56 -29.76 65.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 1.32 110.202 -178.303 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 5.5 tp -84.27 -40.15 18.36 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.444 -0.798 . . . . 1.68 110.619 172.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -56.89 -28.97 62.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.276 -0.875 . . . . 4.07 111.156 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 11.8 pt20 -68.21 -20.36 64.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.357 -0.838 . . . . 1.75 111.594 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.8 tp -89.23 -6.44 56.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.352 -0.385 . . . . 2.47 110.718 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 116.235 -0.439 . . . . 2.58 110.605 -179.86 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 112.096 -0.402 . . . . 4.66 112.096 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.22 88.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.886 0.374 . . . . 5.78 110.705 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.507 HD12 ' CE1' ' B' ' 13' ' ' HIS . 63.3 tp -64.22 -46.94 81.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.006 -0.543 . . . . 4.38 110.141 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' B' ' 58' ' ' GLN . 3.2 tm? -59.57 -49.2 78.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 2.86 110.544 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.11 -53.28 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 3.74 111.979 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.507 ' CE1' HD12 ' B' ' 10' ' ' LEU . 11.3 p-80 -71.79 -27.03 62.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.605 -0.438 . . . . 5.05 111.068 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.5 73.2 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.199 -0.297 . . . . 3.33 110.199 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -36.54 83.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.03 -0.532 . . . . 4.37 110.473 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -58.64 -39.45 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.695 -0.684 . . . . 6.1 110.701 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -82.61 -25.22 33.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 6.49 110.871 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.0 27.91 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.781 -0.723 . . . . 4.73 111.939 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' B' ' 17' ' ' LEU . 47.7 t -77.71 121.84 31.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.687 -0.486 . . . . 3.6 109.687 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 78.1 mtt180 -122.59 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.317 -0.401 . . . . 6.8 110.427 -175.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.723 HD22 HD22 ' B' ' 52' ' ' LEU . 5.9 mp -136.27 124.7 23.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 3.8 110.219 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' TRP . . . . . 0.726 ' HB3' HD13 ' B' ' 56' ' ' LEU . 30.0 p90 -142.23 140.81 32.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 6.8 110.329 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.39 123.16 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.227 0.537 . . . . 7.74 110.337 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.611 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 2.8 tm-20 -111.91 100.66 9.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.884 -0.784 . . . . 9.44 108.884 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.55 -87.42 0.27 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.801 -0.636 . . . . 9.66 112.137 -177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -116.25 -31.82 5.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.308 0.575 . . . . 9.32 110.725 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -106.26 128.42 53.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 7.34 111.659 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.601 HD11 HD23 ' B' ' 21' ' ' LEU . 3.2 tm? -64.97 123.5 19.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.874 -1.057 . . . . 5.18 109.648 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.611 ' NH1' ' HB3' ' B' ' 24' ' ' GLU . 8.1 mpt_? -95.75 130.5 42.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.749 -0.463 . . . . 8.07 109.749 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.544 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -106.49 150.13 26.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.059 -0.519 . . . . 4.16 110.134 -176.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.605 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 56.9 tp60 -149.16 112.06 4.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.742 -0.466 . . . . 6.72 109.742 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -148.67 135.04 10.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.628 -0.26 . . . . 5.75 110.78 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.515 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.0 Cg_exo -60.54 153.62 59.82 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.752 2.301 . . . . 6.98 112.458 176.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.621 ' HB3' HG22 ' A' ' 38' ' ' THR . 19.3 Cg_endo -60.83 123.19 12.47 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.557 2.172 . . . . 8.85 112.52 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.71 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.674 -0.774 . . . . 8.09 113.281 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.635 ' HB ' HD13 ' B' ' 17' ' ' LEU . 18.9 m -80.62 -7.53 10.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 117.03 0.415 . . . . 7.0 111.935 -173.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.57 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.6 OUTLIER -82.84 20.14 1.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.344 -0.389 . . . . 5.73 111.692 -173.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 34' ' ' PRO . 38.0 p -51.28 144.75 15.06 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.719 0.295 . . . . 7.96 111.603 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.96 -30.59 59.51 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.805 2.336 . . . . 7.3 112.188 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 17.6 tp10 -59.56 -50.0 75.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.932 -0.576 . . . . 9.22 109.789 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 36' ' ' VAL . 3.1 tp -63.5 -45.8 89.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 6.17 110.14 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -56.97 -41.03 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 4.84 111.036 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -70.0 -31.75 69.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.301 -0.408 . . . . 7.35 110.622 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 99.4 mtt180 -76.9 -28.84 55.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.523 -0.308 . . . . 8.28 110.883 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 94.5 mt -64.62 -33.56 76.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.114 -0.699 . . . . 4.13 109.114 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.93 -23.09 8.17 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.127 -0.942 . . . . 5.58 112.824 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.1 8.64 54.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.983 -0.627 . . . . 4.5 112.208 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.47 149.82 36.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.975 0.417 . . . . 5.41 110.429 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.555 ' O ' HG13 ' B' ' 53' ' ' ILE . 0.3 OUTLIER -62.72 -49.96 72.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.838 -0.619 . . . . 8.22 111.665 -175.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -66.18 -33.48 75.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.644 0.239 . . . . 7.16 111.644 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.95 -45.01 75.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 5.72 110.51 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.723 HD22 HD22 ' B' ' 21' ' ' LEU . 53.2 mt -73.97 -23.74 59.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.483 . . . . 3.06 111.34 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 49' ' ' ARG . 71.3 mt -64.16 -41.9 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.615 -0.513 . . . . 6.4 109.615 171.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.18 -31.44 70.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 3.73 110.534 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.681 ' HB2' ' HA ' ' B' ' 52' ' ' LEU . 1.1 mm? -63.32 -34.52 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.838 -0.619 . . . . 2.46 110.82 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.726 HD13 ' HB3' ' B' ' 22' ' ' TRP . 34.5 tp -79.46 -41.8 26.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 5.56 110.506 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -61.45 -20.84 63.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.482 -0.781 . . . . 7.19 111.638 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 24.7 pt20 -77.72 -20.85 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.788 0.328 . . . . 4.23 110.613 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.2 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 6.46 110.362 -176.386 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.482 0.182 . . . . 2.5 111.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.62 -46.93 92.6 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.127 -0.559 . . . . 2.13 112.37 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.0 -41.31 77.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 2.19 110.995 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.671 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 28.2 tp -62.9 -47.3 83.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 1.68 110.667 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.14 -44.46 95.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.843 -0.617 . . . . 1.71 109.584 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.17 80.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.008 -0.542 . . . . 1.75 112.148 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.671 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 7.0 p80 -71.67 -28.4 63.71 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.415 -0.514 . . . . 1.78 110.617 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.29 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 1.09 109.927 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.0 75.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.46 110.762 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 t -65.54 -38.14 88.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.081 -0.509 . . . . 2.28 110.224 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 92.2 mt -73.99 -24.77 59.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 1.65 109.941 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.56 31.93 17.36 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.618 -0.719 . . . . 1.28 112.461 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.41 ' O ' HD11 ' A' ' 55' ' ' LEU . 47.2 t -71.2 132.89 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.965 -0.754 . . . . 0.99 108.965 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.741 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 44.6 mtt180 -129.99 134.15 47.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.914 -0.402 . . . . 2.67 109.914 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.694 HD22 HD13 ' A' ' 52' ' ' LEU . 6.0 mp -137.14 127.36 26.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.45 109.563 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.533 ' HB3' HD13 ' A' ' 56' ' ' LEU . 24.2 p90 -146.61 137.01 23.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.013 0.435 . . . . 2.26 110.325 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -79.56 124.0 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.149 0.499 . . . . 2.92 110.402 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.24 105.25 8.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 4.2 109.568 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.66 -112.22 4.33 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.395 -0.907 . . . . 4.2 111.403 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -104.19 -18.8 14.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.15 110.8 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -107.05 127.05 53.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.495 0.664 . . . . 5.38 111.35 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.499 HD21 HD23 ' A' ' 21' ' ' LEU . 9.7 tt -74.68 114.42 13.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.479 -0.782 . . . . 2.44 109.269 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 9.1 mmm180 -80.47 139.53 36.37 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.752 -0.462 . . . . 4.22 109.752 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -124.25 132.72 53.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 1.69 109.73 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.741 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 56.7 tp60 -127.47 114.75 17.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.574 -0.528 . . . . 2.68 109.574 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -142.53 127.71 10.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.342 -0.39 . . . . 1.69 110.893 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 36' ' ' VAL . 32.1 Cg_exo -60.42 156.49 40.97 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.934 2.422 . . . . 1.84 111.705 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' B' ' 38' ' ' THR . 30.0 Cg_endo -65.76 123.36 11.25 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.268 1.979 . . . . 2.31 112.39 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' THR . . . 106.89 -37.13 3.98 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.777 -0.725 . . . . 1.76 113.406 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 33' ' ' PRO . 35.8 m -75.82 -15.69 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.682 0.623 . . . . 1.49 112.682 -173.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.501 ' HE2' ' HA ' ' A' ' 37' ' ' MET . 9.1 tpp -84.57 23.27 1.16 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.294 0.569 . . . . 1.41 111.311 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.679 HG22 ' HB3' ' B' ' 34' ' ' PRO . 17.8 p -50.7 143.73 14.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.45 110.39 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.79 -30.17 45.82 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.801 2.334 . . . . 1.72 112.435 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.626 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 8.4 tp10 -60.54 -47.4 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 2.76 110.106 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 36' ' ' VAL . 4.0 tp -58.08 -49.55 76.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.793 0.33 . . . . 1.2 110.572 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 45' ' ' LEU . 18.3 tp60 -60.45 -36.11 77.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.939 -0.573 . . . . 2.06 110.754 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.5 t -64.18 -32.61 74.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.012 0.434 . . . . 1.57 110.039 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 19.9 mmt180 -78.92 -40.38 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 3.34 110.873 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 42' ' ' GLN . 84.6 mt -52.82 -37.24 59.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.979 -0.748 . . . . 1.25 108.979 171.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.69 -22.84 8.32 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.231 -0.895 . . . . 2.3 112.048 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.71 14.21 72.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.978 -0.63 . . . . 2.57 112.229 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -79.38 148.42 32.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.935 -0.394 . . . . 2.08 109.935 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 1.6 ptm180 -69.76 -51.2 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.459 -0.337 . . . . 5.36 111.745 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -56.99 -34.86 68.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.148 0.499 . . . . 2.99 110.564 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -65.82 -49.96 66.37 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.639 -0.709 . . . . 2.75 110.316 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 21' ' ' LEU . 87.4 mt -75.21 -24.54 57.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.965 -1.016 . . . . 1.9 111.284 -174.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.9 mt -63.68 -42.91 97.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.852 -0.425 . . . . 2.74 109.852 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.57 76.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.316 0.579 . . . . 1.5 110.133 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.653 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.4 tm? -70.74 -31.67 68.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 1.32 109.508 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.623 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.7 tp -79.2 -36.72 39.7 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.993 -0.549 . . . . 1.68 109.737 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -55.5 -29.62 59.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 4.07 111.251 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.3 pt20 -56.1 -34.3 65.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.5 -0.318 . . . . 1.75 111.183 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.67 HD11 ' HB3' ' A' ' 20' ' ' ARG . 79.2 mt -83.72 -5.46 59.2 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.887 0.328 . . . . 2.47 111.887 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 110.337 -0.246 . . . . 2.58 110.337 -177.922 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 120.438 -0.09 . . . . 4.66 112.945 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.2 93.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 5.78 110.81 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.524 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 56.0 tp -60.85 -47.52 86.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.056 -0.52 . . . . 4.38 110.47 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.97 -43.44 92.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.732 -0.667 . . . . 2.86 109.653 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.33 -51.43 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.639 . . . . 3.74 112.315 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.524 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 14.2 p80 -72.52 -28.22 62.73 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.334 -0.546 . . . . 5.05 110.934 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.85 -43.43 75.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.189 0.519 . . . . 3.33 110.054 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.71 76.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.477 -0.783 . . . . 4.37 110.806 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -67.57 -34.33 76.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.053 -0.521 . . . . 6.1 110.308 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.565 HD13 ' HB ' ' B' ' 36' ' ' VAL . 86.7 mt -75.85 -24.34 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 6.49 110.426 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.86 28.43 21.2 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.785 -0.722 . . . . 4.73 112.389 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.407 ' O ' HD11 ' B' ' 55' ' ' LEU . 46.2 t -72.11 132.74 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.471 -0.566 . . . . 3.6 109.471 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.851 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 76.6 mtt180 -130.48 132.9 45.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.592 0.234 . . . . 6.8 110.971 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.585 HD22 HD13 ' B' ' 52' ' ' LEU . 5.7 mp -137.98 127.45 24.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.843 -0.429 . . . . 3.8 109.843 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' TRP . . . . . 0.665 ' HB3' HD13 ' B' ' 56' ' ' LEU . 29.3 p90 -147.78 139.97 24.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.932 0.396 . . . . 6.8 110.361 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.3 p -78.65 130.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.155 0.502 . . . . 7.74 110.405 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -132.16 101.0 5.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 9.44 109.668 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.74 -110.3 3.27 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.691 -0.766 . . . . 9.66 111.364 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.76 -11.69 16.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.701 0.286 . . . . 9.32 111.077 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.12 123.31 48.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 7.34 111.054 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 9.1 tt -74.64 115.07 13.78 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.329 -0.619 . . . . 5.18 109.329 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -79.89 139.31 37.17 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.006 -0.368 . . . . 8.07 110.006 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -122.14 133.2 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.457 -0.571 . . . . 4.16 109.457 -177.164 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.851 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 55.3 tp60 -129.81 112.52 13.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.63 -0.508 . . . . 6.72 109.63 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.05 133.1 16.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 5.75 111.136 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.45 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.2 Cg_exo -62.98 153.58 72.58 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.056 2.504 . . . . 6.98 112.007 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.679 ' HB3' HG22 ' A' ' 38' ' ' THR . 30.3 Cg_endo -63.77 123.95 12.82 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.421 2.081 . . . . 8.85 112.725 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 -36.85 4.13 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.597 -0.811 . . . . 8.09 113.455 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.565 ' HB ' HD13 ' B' ' 17' ' ' LEU . 23.3 m -78.96 -9.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.017 0.377 . . . . 7.0 112.017 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.85 19.98 1.26 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 5.73 111.35 -176.009 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 34' ' ' PRO . 10.6 p -51.04 144.7 13.62 Favored Pre-proline 0 C--O 1.236 0.387 0 CA-C-N 116.442 -0.344 . . . . 7.96 111.094 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.99 -30.71 49.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.819 2.346 . . . . 7.3 112.304 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 11.7 tp10 -60.42 -43.64 96.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 9.22 110.556 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.527 HD22 ' O ' ' B' ' 36' ' ' VAL . 11.1 tp -62.43 -46.19 89.7 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 110.234 -0.284 . . . . 6.17 110.234 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' B' ' 45' ' ' LEU . 18.9 tp60 -61.73 -37.55 84.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.169 -0.469 . . . . 4.84 110.378 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -63.06 -35.17 79.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.38 -0.373 . . . . 7.35 110.343 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 16.7 mmt180 -77.54 -39.95 44.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 8.28 110.868 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' B' ' 42' ' ' GLN . 86.3 mt -56.81 -36.01 69.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 4.13 109.625 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.67 -22.95 8.09 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.162 -0.926 . . . . 5.58 112.219 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.44 75.73 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.083 -0.58 . . . . 4.5 111.863 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.69 149.93 29.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.217 -0.29 . . . . 5.41 110.217 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 53' ' ' ILE . 2.0 ptm180 -68.67 -48.86 62.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 8.22 111.182 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -60.07 -36.52 77.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.846 0.313 . . . . 7.16 111.846 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -47.11 80.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.114 0.483 . . . . 5.72 110.718 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.585 HD13 HD22 ' B' ' 21' ' ' LEU . 86.0 mt -75.33 -24.77 57.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 3.06 111.616 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 49' ' ' ARG . 83.1 mt -66.67 -39.57 84.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.946 -0.39 . . . . 6.4 109.946 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.89 83.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.201 0.524 . . . . 3.73 110.207 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.71 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.1 tm? -63.38 -34.93 78.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.247 -0.888 . . . . 2.46 110.02 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' B' ' 22' ' ' TRP . 17.8 tp -73.24 -38.67 65.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 5.56 110.473 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -57.18 -28.63 62.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 7.19 111.985 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 17.5 pt20 -60.92 -26.37 67.43 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.887 -0.325 . . . . 4.23 110.905 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.331 -0.395 . . . . 6.46 111.052 -177.119 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.878 0.37 . . . . 2.5 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.38 92.36 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.049 -0.523 . . . . 2.13 111.909 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.06 -41.7 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 2.19 110.728 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.692 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 51.0 tp -62.12 -46.4 89.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 1.68 110.317 176.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.16 -47.36 86.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.391 -0.822 . . . . 1.71 110.115 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.33 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 1.75 112.116 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.692 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.9 p80 -69.94 -27.07 64.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.884 0.373 . . . . 1.78 110.216 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.12 -36.88 66.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 1.09 110.284 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.52 83.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.948 -0.569 . . . . 1.46 111.146 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 p -67.0 -21.93 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 2.28 111.515 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.15 -25.07 15.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.189 0.518 . . . . 1.65 110.447 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.76 37.38 13.64 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 1.28 112.636 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.25 120.15 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.992 -0.744 . . . . 0.99 108.992 174.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.552 ' HB3' HD22 ' A' ' 59' ' ' LEU . 20.7 mtt180 -120.07 128.89 53.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.57 -0.286 . . . . 2.67 110.69 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -133.03 124.11 27.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.484 -0.562 . . . . 1.45 109.484 173.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HB3' HD13 ' A' ' 56' ' ' LEU . 27.3 p90 -141.48 143.15 33.68 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.937 -0.394 . . . . 2.26 109.937 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.27 129.81 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.689 -0.486 . . . . 2.92 109.689 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 14.2 tp10 -136.91 120.2 16.82 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.375 -0.602 . . . . 4.2 109.375 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.9 -105.04 1.36 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.824 -0.703 . . . . 4.2 111.82 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.86 -3.06 11.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.69 0.255 . . . . 5.15 111.69 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 9.4 tpp180 -129.19 152.18 49.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 5.38 112.116 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.461 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -75.7 122.34 23.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.046 -0.979 . . . . 2.44 108.618 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.468 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.2 mpt_? -99.03 131.08 45.34 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.366 -0.605 . . . . 4.22 109.366 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -108.21 154.07 22.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 1.69 110.245 -172.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 7.1 tp-100 -153.25 110.43 3.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.805 -0.442 . . . . 2.68 109.805 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.74 134.98 26.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.122 -0.49 . . . . 1.69 110.66 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.575 ' HD2' HG21 ' A' ' 36' ' ' VAL . 37.0 Cg_exo -61.91 156.09 51.05 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.612 2.208 . . . . 1.84 111.555 172.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.519 ' HB3' HG22 ' B' ' 38' ' ' THR . 22.9 Cg_endo -63.79 123.3 11.75 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.267 1.978 . . . . 2.31 112.305 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' THR . . . 106.88 -37.68 3.7 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.936 -0.649 . . . . 1.76 113.448 173.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG21 ' HD2' ' A' ' 33' ' ' PRO . 33.8 m -70.65 -20.3 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.518 0.562 . . . . 1.49 112.518 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.4 tpp -82.61 24.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.022 0.439 . . . . 1.41 111.446 -173.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.491 HG22 ' HB3' ' B' ' 34' ' ' PRO . 8.3 p -49.69 143.08 11.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 1.45 110.872 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.648 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 82.6 Cg_exo -45.76 -40.76 19.51 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.299 2.666 . . . . 1.72 113.773 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 8.9 pt-20 -61.89 -44.61 96.45 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 120.736 0.303 . . . . 2.76 110.525 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.417 ' N ' ' HG3' ' A' ' 40' ' ' GLU . 3.0 tt -67.69 -44.82 76.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.334 0.588 . . . . 1.2 109.908 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -56.17 -41.7 75.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.578 -1.192 . . . . 2.06 110.548 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -72.8 -29.24 63.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.927 -0.579 . . . . 1.57 111.042 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.8 mtp180 -75.84 -28.08 58.11 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.956 -0.298 . . . . 3.34 111.017 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.69 -43.77 98.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.536 -0.542 . . . . 1.25 109.536 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.9 -23.61 5.77 Favored Glycine 0 C--N 1.329 0.158 0 CA-C-N 115.644 -0.707 . . . . 2.3 112.97 171.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.41 18.11 69.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.907 -0.663 . . . . 2.57 112.47 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -72.72 147.8 45.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.121 -0.325 . . . . 2.08 110.121 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 22.9 ptt180 -68.34 -50.67 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.334 -0.393 . . . . 5.36 111.644 -172.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.433 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 11.9 p80 -60.23 -36.06 76.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.739 0.781 . . . . 2.99 110.048 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.63 -42.75 70.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.608 -1.178 . . . . 2.75 110.214 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 63.3 mt -70.4 -25.41 63.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.598 -0.728 . . . . 1.9 110.822 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.1 mt -60.5 -50.03 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.792 -0.447 . . . . 2.74 109.792 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.15 70.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.199 0.523 . . . . 1.5 110.758 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 55' ' ' LEU . 2.6 tm? -71.09 -40.6 71.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.801 . . . . 1.32 109.959 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.2 tp -77.23 -31.31 55.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.952 -0.567 . . . . 1.68 109.756 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -61.81 -31.22 71.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 4.07 110.506 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.61 -29.62 70.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.522 . . . . 1.75 110.613 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 20' ' ' ARG . 29.7 tp -90.02 -2.87 58.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 2.47 110.553 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.108 -0.496 . . . . 2.58 110.617 -179.292 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.012 -0.435 . . . . 4.66 112.012 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.38 92.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 5.78 110.906 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.476 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 57.1 tp -64.29 -45.91 85.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.567 . . . . 4.38 109.844 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.78 -47.08 87.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 2.86 110.114 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -52.85 63.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 3.74 112.291 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 5.0 p80 -72.45 -26.34 61.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.566 -0.453 . . . . 5.05 110.963 -176.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.33 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 3.33 110.093 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -37.39 82.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.79 -0.641 . . . . 4.37 111.292 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 12.3 p -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 6.1 111.282 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.565 HD13 ' HB ' ' B' ' 36' ' ' VAL . 93.4 mt -91.7 -25.17 19.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 6.49 110.548 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 84.7 35.65 13.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.843 -0.694 . . . . 4.73 112.51 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.4 124.62 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.396 -0.594 . . . . 3.6 109.396 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 30.4 mtt180 -124.01 127.85 48.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.776 0.322 . . . . 6.8 111.194 -171.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.1 mp -135.15 124.74 25.08 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.476 -0.564 . . . . 3.8 109.476 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' TRP . . . . . 0.567 ' HB3' HD13 ' B' ' 56' ' ' LEU . 26.5 p90 -143.63 143.6 31.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.881 0.372 . . . . 6.8 110.712 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.15 124.73 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.123 0.487 . . . . 7.74 110.076 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.597 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 10.8 tp10 -130.98 118.28 20.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.614 -0.513 . . . . 9.44 109.614 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 -104.26 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.76 -0.733 . . . . 9.66 111.803 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -4.86 11.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.79 0.329 . . . . 9.32 111.763 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.463 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 8.5 tpp180 -130.33 148.69 52.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.343 0.592 . . . . 7.34 111.872 -170.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.501 HD11 HD23 ' B' ' 21' ' ' LEU . 3.0 tm? -73.48 115.96 13.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.154 -0.93 . . . . 5.18 108.735 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ARG . . . . . 0.597 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 6.2 mpt_? -90.81 132.59 35.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.895 -0.409 . . . . 8.07 109.895 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.506 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.0 OUTLIER -109.78 152.23 25.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.922 -0.581 . . . . 4.16 110.263 -173.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.634 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 7.0 tp-100 -152.65 110.02 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.836 -0.431 . . . . 6.72 109.836 172.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.09 137.04 29.23 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.288 -0.415 . . . . 5.75 111.115 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.436 ' O ' HG22 ' B' ' 36' ' ' VAL . 38.6 Cg_exo -62.75 154.6 64.7 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.675 2.25 . . . . 6.98 111.796 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.648 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 27.9 Cg_endo -63.22 123.52 12.31 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.306 2.004 . . . . 8.85 112.629 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.471 ' O ' HG23 ' B' ' 38' ' ' THR . . . 105.5 -37.46 3.8 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.661 -0.78 . . . . 8.09 113.499 173.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.565 ' HB ' HD13 ' B' ' 17' ' ' LEU . 19.8 m -73.28 -12.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.108 0.454 . . . . 7.0 111.948 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.5 tpp -89.11 22.43 2.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.958 0.409 . . . . 5.73 111.505 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 34' ' ' PRO . 18.7 p -49.06 142.93 9.32 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.433 -0.349 . . . . 7.96 111.149 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -43.76 -42.33 11.75 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.964 3.109 . . . . 7.3 114.187 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.661 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 8.5 pt-20 -59.91 -45.65 91.86 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 121.133 -0.227 . . . . 9.22 110.921 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.506 ' N ' ' HG3' ' B' ' 40' ' ' GLU . 9.2 tt -70.34 -39.7 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.908 -0.404 . . . . 6.17 109.908 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' GLN . . . . . 0.408 ' OE1' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp60 -56.76 -43.51 80.87 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.668 -0.697 . . . . 4.84 110.515 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.3 t -72.14 -31.25 65.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.911 -0.586 . . . . 7.35 110.842 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 65.3 mtp180 -71.51 -28.87 64.2 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.225 -0.19 . . . . 8.28 111.292 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.34 -44.74 86.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.529 0.68 . . . . 4.13 109.328 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.68 -23.75 5.51 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.278 -0.873 . . . . 5.58 112.982 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 18.74 74.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.266 -0.492 . . . . 4.5 112.39 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ALA . . . . . 0.626 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -71.55 148.75 46.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.835 0.317 . . . . 5.41 110.425 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 17.6 ptt180 -68.15 -46.93 69.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.331 -0.395 . . . . 8.22 111.448 -172.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -63.62 -35.64 81.19 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.702 0.287 . . . . 7.16 111.238 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.9 -38.96 69.85 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.658 -0.417 . . . . 5.72 110.302 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' B' ' 48' ' ' ALA . 46.4 mt -70.57 -26.02 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.579 -0.282 . . . . 3.06 110.97 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.6 mt -62.33 -49.44 83.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.753 -0.462 . . . . 6.4 109.753 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.11 86.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 3.73 110.433 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.5 tm? -62.21 -47.06 86.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.557 -0.747 . . . . 2.46 110.259 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' B' ' 22' ' ' TRP . 21.1 tp -66.27 -36.58 83.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.354 -0.385 . . . . 5.56 110.769 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -63.04 -29.27 70.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.415 -0.357 . . . . 7.19 111.361 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 6.9 pt20 -67.28 -27.67 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 4.23 110.261 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' B' ' 20' ' ' ARG . 37.7 tp . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 6.46 110.495 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 111.597 0.221 . . . . 2.5 111.597 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.48 -44.85 96.37 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.494 -0.384 . . . . 2.13 112.346 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.63 90.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.06 0.457 . . . . 2.19 111.088 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.662 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 57.8 tp -67.91 -46.83 70.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.55 . . . . 1.68 110.492 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.98 -44.59 97.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.672 -0.694 . . . . 1.71 110.052 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.42 73.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 1.75 111.972 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.2 p80 -72.02 -27.79 62.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.519 -0.472 . . . . 1.78 110.231 -175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.15 65.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.51 -0.314 . . . . 1.09 110.319 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.21 85.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.46 110.813 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -59.82 -43.94 94.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.976 -0.556 . . . . 2.28 110.764 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 36' ' ' VAL . 84.2 mt -80.97 -25.63 37.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.327 . . . . 1.65 110.781 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.42 31.09 9.88 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.606 -0.806 . . . . 1.28 112.98 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.406 HG13 ' HE1' ' A' ' 30' ' ' PHE . 57.8 t -75.17 112.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.525 -0.546 . . . . 0.99 109.525 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.743 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 68.1 mtp180 -123.39 133.49 54.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 2.67 110.54 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.2 mp -132.73 127.39 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 1.45 110.674 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HB3' HD13 ' A' ' 56' ' ' LEU . 18.0 p90 -150.85 145.34 25.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.209 -0.663 . . . . 2.26 109.209 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.2 p -93.22 128.92 44.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.208 0.528 . . . . 2.92 111.036 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.35 106.8 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 4.2 109.206 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.5 -107.3 2.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.118 -0.793 . . . . 4.2 111.118 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.1 -6.78 11.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.206 0.527 . . . . 5.15 110.093 177.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -102.36 118.17 36.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 5.38 110.758 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 7.8 tt -70.38 118.59 13.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.331 -0.988 . . . . 2.44 108.331 170.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.74 129.24 34.88 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.601 -0.518 . . . . 4.22 109.601 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.406 ' HE1' HG13 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -114.75 130.74 56.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.114 -0.494 . . . . 1.69 109.867 -177.222 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.743 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 8.3 tp60 -123.35 110.24 14.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.458 -0.571 . . . . 2.68 109.458 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.56 130.37 6.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.376 -0.374 . . . . 1.69 110.601 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' HG22 ' A' ' 36' ' ' VAL . 34.1 Cg_endo -69.24 157.91 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.646 2.231 . . . . 1.84 111.502 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.31 122.92 11.03 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.556 2.17 . . . . 2.31 112.328 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -15.36 27.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.956 -0.64 . . . . 1.76 113.167 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 33' ' ' PRO . 19.1 m -100.3 -8.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.399 0.599 . . . . 1.49 112.162 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.529 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.58 20.8 2.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.181 -0.463 . . . . 1.41 111.46 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -56.3 145.63 56.4 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.141 -0.482 . . . . 1.45 111.147 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.35 -38.45 62.65 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.952 2.434 . . . . 1.72 113.043 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 40.6 tt0 -59.61 -47.94 83.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 2.76 110.398 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.67 -42.81 98.0 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.14 0.495 . . . . 1.2 110.665 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HA ' HD12 ' A' ' 45' ' ' LEU . 9.3 tp-100 -56.89 -40.35 76.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.492 -0.776 . . . . 2.06 110.071 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -72.66 -29.51 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.736 -0.666 . . . . 1.57 110.36 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 15.1 mmm180 -65.88 -38.13 87.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.984 0.421 . . . . 3.34 110.604 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 42' ' ' GLN . 60.6 mt -57.29 -25.52 59.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.309 -0.86 . . . . 1.25 110.043 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -22.88 8.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.546 -0.752 . . . . 2.3 112.981 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 25.82 73.45 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.711 -0.756 . . . . 2.57 111.923 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -98.38 149.18 22.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.981 0.42 . . . . 2.08 110.706 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.532 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.44 -46.75 69.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.442 -0.799 . . . . 5.36 111.211 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.514 ' HA ' HD12 ' A' ' 53' ' ' ILE . 19.5 p80 -66.16 -33.28 75.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.391 0.615 . . . . 2.99 109.99 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.7 tp10 -66.73 -42.71 85.86 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.243 -0.889 . . . . 2.75 109.478 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 67.6 mt -67.89 -29.04 68.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.29 -0.868 . . . . 1.9 111.103 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 49' ' ' ARG . 84.1 mt -58.55 -51.55 70.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.096 0.474 . . . . 2.74 109.855 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.24 68.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.743 -0.662 . . . . 1.5 110.827 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.2 tm? -69.43 -40.78 77.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.722 -0.672 . . . . 1.32 109.678 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 22' ' ' TRP . 1.2 tp -79.17 -30.48 43.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.66 -0.496 . . . . 1.68 109.66 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -67.15 -21.38 65.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 4.07 110.372 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -61.76 -28.94 69.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 1.75 110.847 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -106.82 12.67 28.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.847 -0.741 . . . . 2.47 111.646 178.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 51.1 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 2.58 110.345 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.378 -0.289 . . . . 4.66 112.378 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.34 87.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 5.78 111.263 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.525 HD12 ' CE1' ' B' ' 13' ' ' HIS . 68.0 tp -64.72 -46.79 80.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 4.38 110.498 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.08 -46.38 84.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.895 -0.593 . . . . 2.86 109.843 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.51 75.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 3.74 111.838 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' HIS . . . . . 0.525 ' CE1' HD12 ' B' ' 10' ' ' LEU . 4.7 p-80 -73.58 -27.57 61.39 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 5.05 110.674 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.04 61.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.681 0.277 . . . . 3.33 110.367 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.07 82.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 4.37 110.8 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 19.8 t -61.41 -42.98 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 6.1 110.833 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.2 mt -81.2 -24.37 37.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 6.49 110.937 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.7 7.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.748 -0.739 . . . . 4.73 112.344 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.22 113.44 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 3.6 109.531 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 63.1 mtp180 -124.8 134.81 52.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.358 -0.383 . . . . 6.8 110.858 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.483 HD23 HD21 ' B' ' 28' ' ' LEU . 6.2 mp -134.22 128.64 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 3.8 110.767 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' TRP . . . . . 0.72 ' HB3' HD13 ' B' ' 56' ' ' LEU . 26.6 p90 -151.62 143.78 23.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.658 -0.497 . . . . 6.8 109.658 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.1 p -88.92 126.87 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.17 0.51 . . . . 7.74 111.205 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -118.86 106.23 12.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.922 -0.77 . . . . 9.44 108.922 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.14 -106.45 1.84 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 9.66 111.394 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -3.69 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 9.32 110.313 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ARG . . . . . 0.405 ' NE ' HD11 ' A' ' 52' ' ' LEU . 6.8 tpt85 -107.76 114.24 28.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 7.34 110.854 -176.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 7.5 tt -68.12 118.9 11.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.5 -0.926 . . . . 5.18 108.5 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -87.34 126.8 35.08 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.679 -0.489 . . . . 8.07 109.679 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' PHE . . . . . 0.469 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -111.57 131.25 55.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.931 -0.577 . . . . 4.16 109.745 -177.072 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.72 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 55.4 tp60 -124.89 107.92 11.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.235 -0.439 . . . . 6.72 110.079 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.98 129.85 6.64 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.329 -0.396 . . . . 5.75 110.52 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.499 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.6 Cg_endo -67.1 157.45 61.66 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.544 2.163 . . . . 6.98 111.768 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.29 123.75 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.453 2.102 . . . . 8.85 112.529 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.67 -24.68 14.71 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.694 -0.684 . . . . 8.09 113.401 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' B' ' 17' ' ' LEU . 10.4 m -95.25 4.59 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.003 0.402 . . . . 7.0 111.36 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' MET . . . . . 0.672 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.0 OUTLIER -95.91 18.96 12.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 5.73 110.809 -176.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -57.27 145.88 64.81 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 7.96 111.48 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.36 -41.02 52.62 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.312 2.674 . . . . 7.3 113.167 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 35.1 tt0 -57.98 -48.67 79.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.654 -0.248 . . . . 9.22 110.473 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 9.0 tt -66.1 -38.21 87.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 6.17 110.63 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -60.09 -40.45 89.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.735 -0.468 . . . . 4.84 109.735 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -72.57 -29.75 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.758 -0.656 . . . . 7.35 110.556 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 14.4 mmm180 -66.67 -32.66 74.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.502 -0.317 . . . . 8.28 110.657 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 86.3 mt -62.61 -25.36 68.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 4.13 110.032 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.95 -23.67 7.6 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.642 -0.708 . . . . 5.58 112.699 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.42 24.2 73.65 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.856 -0.688 . . . . 4.5 112.155 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.47 149.78 21.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.627 0.251 . . . . 5.41 111.068 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.68 ' HD3' ' H ' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -67.55 -47.56 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 8.22 111.312 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 50' ' ' HIS . . . . . 0.55 ' HA ' HD12 ' B' ' 53' ' ' ILE . 25.0 p80 -60.41 -32.86 71.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.718 0.294 . . . . 7.16 111.485 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -38.66 75.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 5.72 110.312 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 54.9 mt -70.76 -26.18 63.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.46 -0.336 . . . . 3.06 110.961 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 50' ' ' HIS . 83.2 mt -61.76 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.757 -0.46 . . . . 6.4 109.757 174.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.22 80.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.123 0.487 . . . . 3.73 110.676 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.85 -47.6 85.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.489 -0.778 . . . . 2.46 110.168 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' B' ' 22' ' ' TRP . 26.8 tp -67.88 -35.34 78.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.005 0.431 . . . . 5.56 110.717 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.24 -19.47 63.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.274 -0.421 . . . . 7.19 111.256 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.01 -28.22 69.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.55 -0.295 . . . . 4.23 111.424 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.717 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.881 0.372 . . . . 6.46 110.897 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.197 -0.361 . . . . 11.48 112.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.67 136.51 5.36 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.881 2.387 . . . . 10.23 112.193 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.6 tp -97.16 -43.53 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.879 0.371 . . . . 10.02 110.313 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.87 -157.68 53.48 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.986 -0.626 . . . . 6.89 112.164 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.4 m -85.47 -66.08 0.94 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.143 -0.317 . . . . 6.02 110.143 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -176.42 -75.95 0.01 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.781 0.324 . . . . 3.51 111.548 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.64 -53.32 28.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 2.5 111.953 -172.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.01 97.17 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.074 -0.584 . . . . 2.13 112.181 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.78 95.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.787 0.327 . . . . 2.19 110.713 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.648 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 49.7 tp -63.07 -47.5 82.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 1.68 110.788 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.08 -47.78 84.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 1.71 110.155 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -50.57 73.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.75 112.005 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.8 p80 -72.78 -29.07 62.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 1.78 110.866 -173.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.15 65.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 1.09 110.528 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.65 -40.68 69.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.985 -0.552 . . . . 1.46 110.919 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.2 t -65.24 -42.58 93.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 2.28 111.077 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.79 -25.09 59.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.05 0.452 . . . . 1.65 110.317 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.63 6.66 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.565 -0.743 . . . . 1.28 112.587 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 55' ' ' LEU . 17.9 t -90.63 102.37 13.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 109.505 -0.554 . . . . 0.99 109.505 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HE ' ' NE2' ' A' ' 58' ' ' GLN . 3.8 mpt_? -115.03 128.74 56.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.771 -0.455 . . . . 2.67 109.771 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.683 ' O ' HD21 ' A' ' 56' ' ' LEU . 5.4 mp -126.11 120.7 30.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.98 -0.378 . . . . 1.45 109.98 175.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 56' ' ' LEU . 28.8 p90 -136.22 145.77 46.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 2.26 110.49 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.0 p -91.22 124.16 43.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.23 0.538 . . . . 2.92 110.193 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.07 101.17 7.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.162 -0.472 . . . . 4.2 110.076 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.29 -102.58 0.96 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.768 -0.73 . . . . 4.2 111.67 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.635 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 4.8 pt-20 -101.27 -21.97 14.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.15 111.274 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 10.6 tpp180 -121.33 136.51 54.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.174 -0.611 . . . . 5.38 112.349 -170.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.5 tt -80.01 129.15 34.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.079 -0.964 . . . . 2.44 109.453 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 8.0 mpt_? -99.69 136.95 38.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.255 -0.43 . . . . 4.22 109.865 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.98 130.68 56.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.905 -0.589 . . . . 1.69 109.673 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 51.8 tp60 -111.75 109.61 19.54 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.029 -0.73 . . . . 2.68 109.029 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 113.56 4.92 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.179 -0.464 . . . . 1.69 111.347 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 36' ' ' VAL . 39.8 Cg_exo -58.22 149.56 71.89 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.93 2.42 . . . . 1.84 111.971 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.47 123.64 12.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.503 2.135 . . . . 2.31 112.052 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.15 -34.37 5.66 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.546 -0.835 . . . . 1.76 112.945 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 33' ' ' PRO . 23.1 m -81.69 -21.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.321 . . . . 1.49 111.559 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.44 ' HE2' ' HA ' ' A' ' 37' ' ' MET . 8.7 tpp -82.8 22.58 0.9 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.242 0.544 . . . . 1.41 111.402 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -52.53 141.49 34.08 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 1.45 110.42 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.5 -33.19 29.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.14 2.56 . . . . 1.72 113.856 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 32.5 tt0 -72.21 -33.61 67.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.645 -0.422 . . . . 2.76 110.708 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 36' ' ' VAL . 2.3 tt -65.96 -40.79 91.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.21 0.529 . . . . 1.2 109.812 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HA ' HD12 ' A' ' 45' ' ' LEU . 63.7 tp60 -59.65 -35.53 74.59 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.269 -0.878 . . . . 2.06 110.069 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.4 t -69.2 -29.65 67.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.651 -0.704 . . . . 1.57 110.107 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.9 mmt180 -70.89 -39.83 72.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.779 -0.452 . . . . 3.34 109.779 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 42' ' ' GLN . 69.4 mt -58.77 -39.44 81.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.064 -0.517 . . . . 1.25 109.796 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.0 -22.39 9.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.743 -0.662 . . . . 2.3 112.658 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 33.61 81.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.108 -0.568 . . . . 2.57 111.96 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' OE2' ' A' ' 51' ' ' GLU . . . -100.8 153.43 19.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.051 0.453 . . . . 2.08 110.745 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.504 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.6 ptm180 -68.8 -50.03 53.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.609 0.966 . . . . 5.36 113.609 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -57.37 -47.8 80.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.6 0.592 . . . . 2.99 112.6 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 52' ' ' LEU . 3.1 pm0 -72.59 -36.99 68.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.935 -0.306 . . . . 2.75 110.205 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.69 ' O ' HD22 ' A' ' 56' ' ' LEU . 43.3 mt -64.86 -38.76 92.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.695 -0.402 . . . . 1.9 110.038 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 49' ' ' ARG . 82.5 mt -55.61 -41.62 65.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.186 0.517 . . . . 2.74 109.895 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -26.14 65.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 1.5 111.078 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 19' ' ' VAL . 2.7 mm? -70.85 -31.89 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.946 -0.302 . . . . 1.32 111.237 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -75.71 -38.27 58.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.127 0.489 . . . . 1.68 110.339 171.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -51.87 -28.62 16.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.597 -1.183 . . . . 4.07 111.202 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.477 ' NE2' ' HE ' ' A' ' 20' ' ' ARG . 3.4 pt20 -65.96 -40.48 91.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.369 -0.378 . . . . 1.75 110.713 175.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD1' ' HG2' ' A' ' 20' ' ' ARG . 19.7 mt -86.81 -13.56 44.72 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.798 1.407 . . . . 2.47 114.798 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -51.32 105.84 0.57 Allowed Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 113.076 0.769 . . . . 2.58 113.076 -168.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -100.53 3.21 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.706 2.938 . . . . 2.48 112.742 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.442 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 9.7 p -61.09 -31.65 71.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 4.06 111.954 -173.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 m 57.06 45.6 20.67 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.277 0.561 . . . . 5.86 110.809 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' A' ' 62' ' ' SER . 31.7 mm-40 -81.19 41.63 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.804 -0.635 . . . . 8.21 111.258 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.68 -67.32 3.75 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.691 -0.766 . . . . 10.39 112.272 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.12 49.01 4.15 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.27 -0.49 . . . . 11.32 112.216 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 t -104.94 112.01 24.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.463 -0.569 . . . . 13.15 109.463 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 67.91 -177.7 0.21 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.764 -0.653 . . . . 15.0 110.501 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -100.89 -47.62 4.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.115 -0.328 . . . . 16.24 110.115 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 56.92 73.7 0.77 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.706 -0.679 . . . . 16.76 111.056 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 73' ' ' ALA . 2.4 Cg_endo -82.87 -25.54 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.071 2.514 . . . . 18.72 112.168 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 68.96 -29.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.188 0.995 . . . . 19.52 112.383 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 71' ' ' PRO . . . -83.37 68.99 9.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.287 0.565 . . . . 20.52 110.099 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -84.94 -33.04 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 23.78 109.469 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -118.89 -169.93 1.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.065 -0.97 . . . . 22.18 109.024 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.19 -6.02 4.65 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.322 -0.942 . . . . 23.17 112.57 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -171.77 -33.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.095 0.474 . . . . 26.36 109.923 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' N ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 117.909 -1.043 . . . . 26.21 109.833 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 111.806 -0.518 . . . . 14.86 111.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.38 121.59 9.06 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.673 2.249 . . . . 14.18 111.396 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.84 -59.99 2.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.412 -0.358 . . . . 13.74 110.476 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.77 166.03 27.16 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.886 -0.673 . . . . 11.08 111.556 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 41.2 m 72.21 -48.87 0.69 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.298 0.639 . . . . 9.78 111.717 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -90.52 109.89 21.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.847 -0.427 . . . . 8.38 109.847 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.6 84.72 2.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.027 0.441 . . . . 5.78 111.296 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.98 -37.21 60.54 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.004 -0.617 . . . . 4.66 112.214 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.37 95.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.922 0.391 . . . . 5.78 110.649 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.553 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 49.6 tp -63.52 -46.84 84.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.015 -0.538 . . . . 4.38 110.436 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.61 -49.95 75.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 2.86 110.079 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.6 -53.32 59.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 3.74 112.125 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.553 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 3.5 p80 -69.86 -31.6 69.52 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.445 -0.502 . . . . 5.05 111.068 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.19 -40.23 74.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.137 0.494 . . . . 3.33 110.343 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.67 74.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 4.37 110.761 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -62.04 -45.87 91.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 6.1 111.282 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.97 -24.96 61.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.729 0.3 . . . . 6.49 111.087 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.04 39.72 6.86 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.646 -0.788 . . . . 4.73 112.263 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.429 ' O ' HD12 ' B' ' 55' ' ' LEU . 39.6 t -90.95 110.23 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.708 -0.479 . . . . 3.6 109.708 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -127.65 136.71 51.99 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.885 -0.326 . . . . 6.8 110.782 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.508 ' O ' HD21 ' B' ' 56' ' ' LEU . 5.3 mp -130.02 122.4 28.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.247 -0.649 . . . . 3.8 109.247 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' TRP . . . . . 0.578 ' HB3' HD11 ' B' ' 56' ' ' LEU . 34.5 p90 -138.35 139.29 38.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 6.8 110.913 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.8 p -84.34 117.38 29.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 7.74 110.002 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB3' HH11 ' B' ' 29' ' ' ARG . 8.9 tp10 -112.13 101.18 9.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.864 -0.607 . . . . 9.44 109.544 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.8 -95.47 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.109 -0.567 . . . . 9.66 112.526 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 4.5 pt-20 -104.2 -25.6 12.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.999 0.428 . . . . 9.32 111.18 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -122.56 130.09 52.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 7.34 111.342 -166.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.3 tt -77.0 126.71 31.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.662 -0.699 . . . . 5.18 109.57 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.52 HH11 ' HB3' ' B' ' 24' ' ' GLU . 7.5 mpt_? -96.76 137.82 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.174 -0.467 . . . . 8.07 110.045 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -117.29 130.63 56.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.767 -0.651 . . . . 4.16 109.838 -176.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -110.47 109.73 20.2 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.095 -0.705 . . . . 6.72 109.095 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.5 112.5 5.99 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 5.75 111.255 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.522 ' O ' HG22 ' B' ' 36' ' ' VAL . 33.0 Cg_exo -59.37 146.17 95.67 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.616 2.211 . . . . 6.98 111.673 174.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.13 123.32 12.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.285 1.99 . . . . 8.85 112.129 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.09 -34.25 5.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.657 -0.783 . . . . 8.09 112.831 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.522 HG22 ' O ' ' B' ' 33' ' ' PRO . 13.9 m -83.03 -18.46 10.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.082 0.441 . . . . 7.0 111.316 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' B' ' 37' ' ' MET . 10.5 tpp -84.55 20.75 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.212 0.53 . . . . 5.73 111.501 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.7 p -50.62 136.34 25.2 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 7.96 110.475 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.58 -38.49 21.83 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.78 2.987 . . . . 7.3 114.499 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 31.3 tt0 -66.86 -29.45 69.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.643 -0.423 . . . . 9.22 110.94 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.421 HD13 ' O ' ' B' ' 36' ' ' VAL . 7.0 tt -73.1 -35.1 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.866 -0.42 . . . . 6.17 109.866 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -60.97 -36.33 79.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.477 0.656 . . . . 4.84 109.348 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -67.2 -31.92 72.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.378 -0.828 . . . . 7.35 110.313 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 38.0 mmt180 -68.54 -40.25 80.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.293 -0.412 . . . . 8.28 109.936 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.489 ' HA ' HD11 ' B' ' 10' ' ' LEU . 83.2 mt -61.19 -37.73 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 4.13 110.284 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.91 -22.53 11.5 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.628 -0.715 . . . . 5.58 112.714 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.47 30.17 74.83 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.006 -0.616 . . . . 4.5 112.517 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.35 158.74 15.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.044 0.449 . . . . 5.41 110.658 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.635 ' HD2' ' OE1' ' A' ' 26' ' ' GLU . 8.4 ptm180 -68.47 -50.25 53.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.589 0.959 . . . . 8.22 113.589 -172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -58.33 -50.09 74.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.818 0.673 . . . . 7.16 112.818 -167.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -68.43 -40.81 81.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.309 -0.256 . . . . 5.72 110.309 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.601 ' O ' HD22 ' B' ' 56' ' ' LEU . 53.4 mt -63.72 -36.31 83.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.557 -0.292 . . . . 3.06 111.082 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.533 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.8 mt -57.43 -42.39 80.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.13 0.49 . . . . 6.4 110.073 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.09 72.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.88 -0.6 . . . . 3.73 110.981 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.4 mm? -66.37 -28.83 68.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.17 -0.468 . . . . 2.46 111.422 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.601 HD22 ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER -79.65 -33.85 40.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 5.56 110.192 172.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' CG ' ' B' ' 60' ' ' GLN . 17.7 tpp180 -57.11 -32.03 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 7.19 111.443 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 4.2 pt20 -67.45 -26.69 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.591 -0.277 . . . . 4.23 111.574 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.58 -15.46 21.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.382 0.512 . . . . 6.46 112.382 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.405 ' CG ' ' HA ' ' B' ' 57' ' ' ARG . 21.0 mm-40 -51.02 105.25 0.5 Allowed Pre-proline 0 N--CA 1.467 0.386 0 O-C-N 123.698 0.624 . . . . 7.35 112.299 -170.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -100.6 3.6 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.497 2.798 . . . . 8.17 112.298 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.504 ' HB2' ' HG2' ' B' ' 64' ' ' GLN . 11.0 p -59.99 -30.03 68.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.713 -0.676 . . . . 8.89 111.721 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 13.6 m 56.57 42.13 27.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.133 0.492 . . . . 9.76 110.653 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' B' ' 62' ' ' SER . 29.8 mm-40 -82.49 47.28 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.984 -0.553 . . . . 11.21 111.232 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.79 -72.42 2.71 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.119 -0.563 . . . . 12.71 112.461 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.98 45.12 2.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.149 -0.548 . . . . 13.61 112.584 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.6 t -95.94 116.95 29.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.937 -0.764 . . . . 15.17 108.937 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 65.11 -171.44 0.19 Allowed 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.514 0.509 . . . . 16.82 110.758 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -106.46 -51.03 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.641 -0.503 . . . . 18.11 109.641 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . 61.59 82.48 0.22 Allowed Pre-proline 0 C--N 1.332 -0.18 0 O-C-N 124.024 0.828 . . . . 19.0 110.958 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.32 14.69 1.53 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.355 2.703 . . . . 20.29 112.217 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 p -90.4 151.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.804 -0.634 . . . . 21.13 110.128 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 71.94 6.43 5.61 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.348 0.659 . . . . 22.9 111.872 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -149.06 131.42 15.63 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.551 -0.537 . . . . 25.06 109.551 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.463 ' HB2' HD12 ' B' ' 78' ' ' LEU . 20.3 m120 -92.17 89.88 7.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.846 0.355 . . . . 24.46 110.867 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.05 -115.38 7.52 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.872 -0.604 . . . . 24.61 112.771 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -101.71 87.3 3.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.68 0.276 . . . . 27.27 110.415 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' B' ' 75' ' ' ASN . 75.1 mt . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.589 -0.719 . . . . 26.96 109.487 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.954 -0.459 . . . . 11.48 111.954 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.64 121.54 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.619 2.213 . . . . 10.23 112.686 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -98.75 -3.26 36.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.006 -0.543 . . . . 10.02 110.11 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.2 167.5 35.07 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.767 -0.651 . . . . 6.89 111.925 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 t -105.37 124.55 49.74 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.382 -0.599 . . . . 6.02 109.382 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 p -124.32 162.68 23.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.033 0.383 . . . . 3.51 112.033 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 72.69 -66.33 0.31 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.072 0.949 . . . . 2.5 112.585 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.43 -42.08 88.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.562 -0.351 . . . . 2.13 112.697 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.28 90.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.942 0.401 . . . . 2.19 110.802 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.99 -46.58 74.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 1.68 110.235 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.317 -0.856 . . . . 1.71 110.221 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.26 79.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.983 0.421 . . . . 1.75 110.992 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.59 -28.95 61.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.95 -0.568 . . . . 1.78 110.956 -174.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.4 -41.08 49.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 1.09 110.317 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.99 82.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.475 . . . . 1.46 111.058 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -66.71 -30.38 70.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.871 -0.604 . . . . 2.28 110.661 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.19 -26.1 26.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.166 -0.47 . . . . 1.65 110.841 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.23 30.81 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.794 -0.717 . . . . 1.28 113.123 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 41' ' ' LEU . 44.1 t -74.39 113.23 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.275 -0.639 . . . . 0.99 109.275 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 98.6 mtt180 -124.56 135.91 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.448 -0.342 . . . . 2.67 110.944 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -131.94 131.71 42.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 1.45 110.167 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' HB3' HD13 ' A' ' 56' ' ' LEU . 30.5 p90 -151.63 152.65 33.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.717 -0.475 . . . . 2.26 109.717 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.9 p -99.49 126.78 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.335 0.588 . . . . 2.92 110.54 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.67 105.86 10.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.79 -0.641 . . . . 4.2 109.77 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.16 -107.8 2.42 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.829 -0.7 . . . . 4.2 111.397 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.08 -8.35 15.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.811 0.339 . . . . 5.15 110.243 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 10.2 tpp180 -116.31 134.28 55.07 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.635 0.605 . . . . 5.38 112.635 -170.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 8.3 tt -76.96 124.98 28.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.102 -0.954 . . . . 2.44 108.939 171.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 11.7 mmm180 -97.94 135.32 39.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.592 -0.522 . . . . 4.22 109.592 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.35 132.08 55.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.993 0.425 . . . . 1.69 110.533 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.66 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 8.5 tp60 -123.13 114.27 20.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.194 -0.457 . . . . 2.68 109.951 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.03 126.43 4.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.277 -0.42 . . . . 1.69 110.736 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD2' HG21 ' A' ' 36' ' ' VAL . 30.2 Cg_exo -63.89 157.13 54.2 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.914 2.41 . . . . 1.84 111.904 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.61 123.14 12.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.361 2.041 . . . . 2.31 112.342 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 38' ' ' THR . . . 111.36 -37.32 3.76 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.671 -0.695 . . . . 1.76 113.413 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.627 HG21 ' HD2' ' A' ' 33' ' ' PRO . 18.6 m -77.1 -15.73 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.385 0.513 . . . . 1.49 112.385 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.493 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.41 20.98 0.81 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.822 0.344 . . . . 1.41 111.232 -173.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 35' ' ' GLY . 16.9 p -50.86 142.02 17.44 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.372 -0.376 . . . . 1.45 110.944 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -52.06 -34.41 57.46 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.925 2.417 . . . . 1.72 112.961 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -71.29 -29.81 65.49 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 2.76 110.372 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 3.0 tt -71.76 -37.13 70.56 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.748 0.785 . . . . 1.2 109.69 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -58.69 -36.5 74.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.788 -1.097 . . . . 2.06 109.664 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.4 t -71.84 -30.09 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.427 -0.806 . . . . 1.57 110.618 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.2 mmt180 -63.71 -44.94 92.15 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.865 -0.42 . . . . 3.34 109.865 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.347 -0.842 . . . . 1.25 109.467 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.64 -22.57 8.79 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.456 -0.793 . . . . 2.3 113.064 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' B' ' 27' ' ' ARG . . . 71.73 20.14 78.44 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.768 -0.729 . . . . 2.57 112.007 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -81.56 147.47 29.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.854 -0.338 . . . . 2.08 110.285 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.3 ptm180 -70.73 -51.91 24.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.371 -0.377 . . . . 5.36 111.863 -174.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -61.84 -32.32 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.506 0.669 . . . . 2.99 110.581 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.8 tp10 -72.46 -43.34 63.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.03 -0.987 . . . . 2.75 109.974 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 81.9 mt -71.66 -24.85 61.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.714 -0.676 . . . . 1.9 111.152 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 49' ' ' ARG . 73.9 mt -61.23 -49.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.926 -0.398 . . . . 2.74 109.926 173.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.63 67.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.203 0.525 . . . . 1.5 110.614 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.5 tm? -70.01 -39.43 75.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 1.32 109.317 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.512 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 3.8 tp -79.17 -31.27 43.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.763 -0.653 . . . . 1.68 109.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -64.38 -24.0 67.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 4.07 110.535 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -60.18 -31.38 70.07 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.606 HD13 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -105.81 4.96 30.37 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.968 -0.693 . . . . 2.47 111.461 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 99.1 mt-30 -87.03 144.56 36.66 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.535 . . . . 2.58 110.054 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 22.6 Cg_exo -65.21 -25.26 57.73 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.918 2.412 . . . . 2.48 112.6 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -90.79 105.81 18.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.061 0.458 . . . . 4.06 109.917 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.2 p -136.01 -52.61 0.74 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.696 -0.684 . . . . 5.86 110.041 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 69.44 113.41 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.049 0.843 . . . . 8.21 111.548 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.79 19.1 18.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.944 -0.646 . . . . 10.39 112.281 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.0 50.04 3.85 Favored Glycine 0 C--O 1.229 -0.192 0 C-N-CA 121.185 -0.531 . . . . 11.32 112.592 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.6 m -146.22 6.78 1.0 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.375 0.607 . . . . 13.15 110.363 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.5 mp -99.48 110.28 22.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 15.0 109.668 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 63.64 -173.01 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 123.589 0.555 . . . . 16.24 110.394 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . 73.09 129.85 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 121.594 0.711 . . . . 16.76 112.519 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 1.9 Cg_endo -83.28 60.98 7.09 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.464 2.776 . . . . 18.72 110.745 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.5 106.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.5 -0.773 . . . . 19.52 111.184 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.42 -88.93 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.053 -0.976 . . . . 20.52 111.35 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -168.92 19.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.389 -0.597 . . . . 23.78 109.389 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 59.56 89.85 0.06 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.692 -0.686 . . . . 22.18 110.474 -171.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.87 141.99 28.06 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.785 -0.721 . . . . 23.17 111.762 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -92.23 112.19 24.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.923 0.392 . . . . 26.36 111.244 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.214 -0.898 . . . . 26.21 109.356 175.668 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 N-CA-C 112.171 -0.371 . . . . 14.86 112.171 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.19 -28.95 55.89 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.815 2.343 . . . . 14.18 112.009 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 41.6 tp -159.26 -77.95 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.98 -0.554 . . . . 13.74 110.038 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.19 46.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.448 -0.661 . . . . 11.08 111.448 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -124.73 21.5 8.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.889 0.376 . . . . 9.78 111.048 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.9 p -161.16 24.99 0.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.351 -0.386 . . . . 8.38 111.476 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 60.44 42.64 14.23 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.44 0.638 . . . . 5.78 110.36 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.89 -35.41 86.72 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.29 -0.868 . . . . 4.66 112.924 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.79 90.62 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.82 0.343 . . . . 5.78 110.709 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 64.5 tp -72.68 -46.06 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.12 -0.491 . . . . 4.38 110.188 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.26 -51.4 70.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.719 -0.673 . . . . 2.86 110.27 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.17 85.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 3.74 111.156 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.46 -40.28 89.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.937 -0.574 . . . . 5.05 111.004 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.15 63.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 3.33 110.823 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.29 -46.62 87.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 4.37 111.676 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 30.1 m -64.6 -28.35 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 6.1 111.363 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' B' ' 33' ' ' PRO . 70.3 mt -86.33 -25.27 25.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 6.49 110.599 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.64 26.32 27.66 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.79 -0.719 . . . . 4.73 112.606 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.84 111.25 12.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.552 -0.536 . . . . 3.6 109.552 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.654 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 98.5 mtt180 -125.01 139.36 53.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.359 -0.382 . . . . 6.8 111.055 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.447 HD21 ' CE2' ' B' ' 30' ' ' PHE . 5.9 mp -135.29 134.38 39.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 3.8 109.964 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' TRP . . . . . 0.542 ' HB3' HD13 ' B' ' 56' ' ' LEU . 36.5 p90 -153.07 154.82 35.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.944 -0.391 . . . . 6.8 109.944 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.9 p -99.34 123.39 52.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.531 . . . . 7.74 110.566 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -119.39 102.85 8.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.5 -0.555 . . . . 9.44 109.5 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.09 -109.32 2.76 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.382 -0.687 . . . . 9.66 111.382 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.68 -6.82 15.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.908 0.385 . . . . 9.32 110.506 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 9.4 tpp180 -118.22 127.46 53.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.206 0.526 . . . . 7.34 111.823 -169.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 8.7 tt -73.8 126.75 31.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 5.18 108.97 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.464 ' HB2' ' CE2' ' B' ' 22' ' ' TRP . 9.1 mmm180 -99.85 135.05 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.557 -0.535 . . . . 8.07 109.557 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.447 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.7 OUTLIER -112.23 134.29 53.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.309 -0.405 . . . . 4.16 110.194 -176.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.654 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 8.6 tp60 -124.2 112.63 17.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.145 -0.479 . . . . 6.72 109.89 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -149.89 122.06 4.2 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.342 -0.39 . . . . 5.75 110.491 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.518 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.5 Cg_exo -59.94 154.09 52.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.882 2.388 . . . . 6.98 112.12 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.8 122.97 12.66 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.534 2.156 . . . . 8.85 112.347 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.74 -37.15 3.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.655 -0.783 . . . . 8.09 113.091 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 33' ' ' PRO . 11.0 m -80.17 -7.38 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.0 0.4 . . . . 7.0 111.587 -175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.65 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.2 OUTLIER -84.18 18.82 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.81 0.338 . . . . 5.73 111.174 -175.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' B' ' 39' ' ' PRO . 19.5 p -49.94 141.44 14.5 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 7.96 111.471 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 38' ' ' THR . 62.6 Cg_exo -52.69 -34.89 66.11 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.23 2.62 . . . . 7.3 113.175 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 0.0 OUTLIER -72.11 -30.08 64.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.768 -0.373 . . . . 9.22 110.344 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.604 ' HA ' ' HG2' ' B' ' 44' ' ' ARG . 8.9 tt -74.11 -32.5 63.23 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.735 -0.469 . . . . 6.17 109.735 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -60.39 -36.62 78.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.773 -0.649 . . . . 4.84 109.341 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -72.28 -29.86 64.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.353 -0.84 . . . . 7.35 110.497 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.604 ' HG2' ' HA ' ' B' ' 41' ' ' LEU . 35.9 mmt180 -63.32 -48.0 79.87 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 8.28 109.83 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -58.61 -43.03 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.435 -0.802 . . . . 4.13 109.916 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.49 -24.01 6.84 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.188 -0.915 . . . . 5.58 112.742 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.24 12.71 83.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.945 -0.645 . . . . 4.5 112.546 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -73.37 148.42 43.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.244 -0.28 . . . . 5.41 110.244 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 53' ' ' ILE . 12.0 ptm180 -69.4 -51.09 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.34 -0.391 . . . . 8.22 111.987 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.8 -31.18 72.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.935 0.398 . . . . 7.16 111.263 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.2 OUTLIER -71.44 -40.47 70.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.38 . . . . 5.72 110.302 -178.497 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 82.1 mt -76.04 -23.94 55.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 3.06 111.211 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 49' ' ' ARG . 76.8 mt -61.28 -48.38 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.732 -0.47 . . . . 6.4 109.732 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.48 -36.89 82.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 3.73 110.343 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' B' ' 52' ' ' LEU . 3.1 tm? -59.81 -45.51 92.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 2.46 110.013 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.542 HD13 ' HB3' ' B' ' 22' ' ' TRP . 43.0 tp -68.41 -35.59 77.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.035 0.445 . . . . 5.56 110.575 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.15 -22.58 66.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 7.19 111.271 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -62.55 -31.14 71.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.634 -0.257 . . . . 4.23 111.439 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.722 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER -105.81 4.57 29.95 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 6.46 111.618 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' B' ' 56' ' ' LEU . 95.7 mt-30 -86.03 145.83 41.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 7.35 110.229 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 15.7 Cg_exo -68.74 -17.8 42.22 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.078 2.519 . . . . 8.17 112.323 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 28.7 t -97.56 103.16 15.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.237 0.542 . . . . 8.89 110.657 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.8 p -134.2 -47.92 0.78 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.614 -0.721 . . . . 9.76 110.406 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 64.63 98.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.561 -0.745 . . . . 11.21 111.951 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.54 23.25 37.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.645 -0.788 . . . . 12.71 112.885 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.06 50.59 4.32 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.185 -0.531 . . . . 13.61 112.521 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -150.36 18.27 0.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.157 0.503 . . . . 15.17 110.345 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 10.1 mp -110.56 113.38 25.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.705 -0.679 . . . . 16.82 109.556 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' B' ' 69' ' ' LEU . 3.7 mm? 62.73 -166.75 0.22 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.62 0.575 . . . . 18.11 111.091 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.405 ' H ' ' HB3' ' B' ' 69' ' ' LEU . . . 58.61 79.1 0.32 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 121.175 0.512 . . . . 19.0 111.156 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.15 20.02 1.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.11 2.54 . . . . 20.29 112.689 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -74.83 97.64 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.429 0.633 . . . . 21.13 111.128 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.64 -68.36 0.29 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.367 -0.833 . . . . 22.9 109.222 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 178.31 -33.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.639 -0.71 . . . . 25.06 110.571 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -83.44 71.52 10.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.642 0.734 . . . . 24.46 109.817 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.27 34.8 0.39 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.321 -1.112 . . . . 24.61 110.321 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -115.88 -38.91 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.074 -0.563 . . . . 27.27 109.858 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.698 -0.668 . . . . 26.96 109.397 177.289 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.053 -0.419 . . . . 11.48 112.053 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.62 -31.55 26.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.661 2.241 . . . . 10.23 112.083 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.57 102.89 14.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.126 -0.694 . . . . 10.02 109.126 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.16 -113.2 4.24 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.928 -1.269 . . . . 6.89 109.928 -170.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.3 p 178.22 -46.6 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.542 0.21 . . . . 6.02 110.479 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.1 m 68.57 7.92 6.36 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.704 -0.68 . . . . 3.51 109.996 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.54 -40.07 77.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.494 -0.775 . . . . 2.5 110.421 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.39 -40.45 85.79 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 123.442 0.464 . . . . 2.13 112.404 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.1 76.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.976 0.417 . . . . 2.19 111.116 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.705 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 59.2 tp -66.28 -46.55 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 1.68 110.506 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.23 -48.72 80.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.678 -0.692 . . . . 1.71 110.277 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.76 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.454 -0.339 . . . . 1.75 111.663 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.705 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.1 p80 -76.5 -26.92 55.8 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.829 0.347 . . . . 1.78 110.794 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.71 -35.63 51.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.122 -0.231 . . . . 1.09 110.538 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.6 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 1.46 111.384 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.8 p -65.78 -41.78 91.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 2.28 110.449 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 50.0 mt -77.87 -26.38 49.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 1.65 110.022 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.2 18.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.724 -0.671 . . . . 1.28 113.348 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.39 135.48 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.86 -0.793 . . . . 0.99 108.86 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.676 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 71.4 mtt180 -130.81 126.63 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.693 -0.194 . . . . 2.67 110.653 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.702 HD22 HD22 ' A' ' 52' ' ' LEU . 6.1 mp -133.52 117.15 16.8 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 1.45 111.815 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HB3' HD21 ' A' ' 56' ' ' LEU . 26.7 p90 -129.75 149.08 51.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 2.26 109.315 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.09 128.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.347 0.594 . . . . 2.92 111.349 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' ' NE ' ' A' ' 29' ' ' ARG . 38.1 tt0 -120.75 116.5 25.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.747 -0.834 . . . . 4.2 108.747 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.42 -109.46 2.9 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.092 -1.203 . . . . 4.2 110.092 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.69 -15.0 10.8 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.808 0.337 . . . . 5.15 110.291 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -92.43 144.46 25.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.563 0.697 . . . . 5.38 111.445 -172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 21' ' ' LEU . 3.4 tm? -85.96 129.28 34.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.969 -1.014 . . . . 2.44 109.903 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' NE ' ' HB3' ' A' ' 24' ' ' GLU . 4.2 mpt_? -97.25 130.07 44.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.136 -0.691 . . . . 4.22 109.136 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.432 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -114.26 131.32 56.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.508 -0.314 . . . . 1.69 110.882 -171.046 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.676 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 6.1 tp-100 -130.15 123.87 31.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.196 -0.456 . . . . 2.68 109.919 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.47 138.06 11.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.397 -0.365 . . . . 1.69 110.816 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' VAL . 27.5 Cg_endo -68.03 155.31 70.09 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.6 2.2 . . . . 1.84 111.25 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.04 122.47 10.97 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 122.38 2.053 . . . . 2.31 112.464 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.5 -28.78 9.21 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.712 -0.676 . . . . 1.76 113.31 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 33' ' ' PRO . 22.9 m -83.74 -11.75 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.878 0.696 . . . . 1.49 112.878 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -83.55 20.42 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.696 0.284 . . . . 1.41 111.747 -173.517 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 p -53.1 147.09 18.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 1.45 111.444 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.7 -33.84 51.2 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 1.72 113.508 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.1 tt0 -70.78 -35.14 72.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.515 -0.474 . . . . 2.76 110.499 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -64.36 -41.15 96.88 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 121.032 0.444 . . . . 1.2 109.827 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.682 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -59.86 -37.36 79.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.06 109.946 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -67.68 -28.84 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 1.57 110.35 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 35.2 mmt180 -73.18 -43.98 60.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.311 -0.404 . . . . 3.34 110.17 176.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 53.9 mt -62.51 -42.93 99.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.364 0.602 . . . . 1.25 109.431 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.21 -23.06 7.44 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.607 -0.724 . . . . 2.3 112.778 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.18 16.31 76.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.917 -0.659 . . . . 2.57 111.761 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.6 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -76.63 148.77 36.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.944 0.402 . . . . 2.08 110.357 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.0 ptp180 -69.11 -51.04 42.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 5.36 111.943 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -61.87 -33.67 74.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 2.99 110.226 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -67.99 -46.5 71.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.253 -0.885 . . . . 2.75 110.476 -177.187 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.702 HD22 HD22 ' A' ' 21' ' ' LEU . 72.9 mt -66.23 -30.27 70.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.383 -0.826 . . . . 1.9 111.175 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 49' ' ' ARG . 89.2 mt -60.97 -43.55 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.713 0.768 . . . . 2.74 110.017 174.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.166 -0.925 . . . . 1.5 110.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 55' ' ' LEU . 2.7 tm? -64.55 -38.14 89.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.832 -1.173 . . . . 1.32 107.832 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -69.68 -39.66 76.84 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.267 -1.333 . . . . 1.68 112.214 174.104 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 57' ' ' ARG . 73.2 mtt180 -50.97 -29.7 12.99 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.157 -0.474 . . . . 4.07 111.42 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -54.09 -47.85 71.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.323 0.582 . . . . 1.75 110.784 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 59' ' ' LEU . 7.9 tt -84.74 -32.42 23.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 2.47 110.394 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -75.35 118.18 68.8 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.636 -0.711 . . . . 2.58 110.9 -173.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.89 140.01 44.87 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.57 2.18 . . . . 2.48 111.997 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -99.77 -13.62 19.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.461 -0.336 . . . . 4.06 110.566 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.4 m 62.79 93.62 0.05 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.871 -0.604 . . . . 5.86 110.487 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -102.03 -68.19 0.84 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.766 -0.652 . . . . 8.21 110.794 -172.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.03 -162.51 21.06 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.822 -0.704 . . . . 10.39 111.538 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.75 112.12 3.68 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.651 -0.785 . . . . 11.32 112.242 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 t -161.54 104.06 1.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 13.15 110.62 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.2 tp -123.16 8.61 9.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.579 0.704 . . . . 15.0 109.444 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 69' ' ' LEU . 3.6 mm? -84.24 -24.02 30.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.408 -0.815 . . . . 16.24 111.472 -177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.88 119.88 34.75 Favored Pre-proline 0 C--N 1.319 -0.75 0 C-N-CA 120.631 -0.427 . . . . 16.76 110.492 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.87 39.28 0.83 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.129 2.553 . . . . 18.72 111.811 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 p -61.06 103.15 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.44 -0.8 . . . . 19.52 111.786 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.54 8.26 2.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.801 -1.09 . . . . 20.52 112.323 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.45 30.25 12.53 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.694 0.397 . . . . 23.78 111.279 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -68.63 100.3 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.38 . . . . 22.18 110.45 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.41 108.37 2.47 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.865 -0.683 . . . . 23.17 111.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -79.42 -18.77 51.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.261 0.553 . . . . 26.36 110.096 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 78' ' ' LEU . 1.1 pt? . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.421 -0.799 . . . . 26.21 109.376 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 111.853 -0.499 . . . . 14.86 111.853 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.6 117.75 5.26 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.582 2.188 . . . . 14.18 112.762 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 93.8 mt -130.24 139.34 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 13.74 110.432 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLY . . . . . 0.421 ' O ' ' HG ' ' B' ' 11' ' ' LEU . . . 97.33 153.47 29.28 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.998 -0.62 . . . . 11.08 112.075 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -97.39 119.42 35.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.898 0.38 . . . . 9.78 110.571 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.617 ' HB3' HD23 ' B' ' 11' ' ' LEU . 22.9 t -155.54 41.52 0.41 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.678 -0.692 . . . . 8.38 109.253 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 70.2 116.78 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.418 -0.81 . . . . 5.78 109.55 -170.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.25 -48.93 26.15 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.669 -0.696 . . . . 4.66 114.296 -171.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -48.14 78.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.092 0.446 . . . . 5.78 111.278 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.519 HD12 ' CE1' ' B' ' 13' ' ' HIS . 64.8 tp -63.47 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 4.38 110.688 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' B' ' 6' ' ' SER . 2.2 tm? -62.48 -47.95 81.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 2.86 110.291 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.78 84.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 3.74 111.845 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.519 ' CE1' HD12 ' B' ' 10' ' ' LEU . 8.3 p-80 -75.39 -27.33 59.03 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.342 -0.543 . . . . 5.05 111.169 -175.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.89 -38.78 52.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.871 -0.332 . . . . 3.33 110.848 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.65 76.99 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.288 -0.414 . . . . 4.37 111.311 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 23.3 p -64.22 -40.35 95.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 6.1 110.686 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.6 mt -75.22 -25.29 58.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 6.49 110.296 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.33 19.77 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.679 -0.772 . . . . 4.73 112.716 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.6 133.12 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.293 -0.632 . . . . 3.6 109.293 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 69.4 mtt180 -130.86 128.91 41.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.678 -0.237 . . . . 6.8 110.981 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.685 HD22 HD22 ' B' ' 52' ' ' LEU . 6.2 mp -134.29 122.74 23.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.995 -0.372 . . . . 3.8 109.995 173.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -137.2 148.15 46.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.78 -0.452 . . . . 6.8 109.78 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.12 128.17 49.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.422 0.63 . . . . 7.74 111.345 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.486 ' HB3' ' NE ' ' B' ' 29' ' ' ARG . 37.4 tt0 -118.83 117.14 28.07 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.154 -1.054 . . . . 9.44 108.154 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.25 -108.9 2.64 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.453 -1.059 . . . . 9.66 110.453 -168.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -15.15 10.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.232 0.539 . . . . 9.32 110.132 173.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.15 142.02 27.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.407 0.623 . . . . 7.34 111.167 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.593 HD11 HD23 ' B' ' 21' ' ' LEU . 3.2 tm? -86.19 132.28 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.097 -0.956 . . . . 5.18 110.224 -174.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.486 ' NE ' ' HB3' ' B' ' 24' ' ' GLU . 3.8 mpt_? -100.82 130.96 46.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.203 -0.666 . . . . 8.07 109.203 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.539 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -113.9 131.75 56.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.748 0.309 . . . . 4.16 110.828 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.786 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 6.3 tp-100 -130.55 121.26 25.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.78 -0.452 . . . . 6.72 109.78 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.61 134.49 8.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.484 -0.325 . . . . 5.75 110.939 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.499 ' O ' HG22 ' B' ' 36' ' ' VAL . 29.8 Cg_endo -63.97 154.73 68.43 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.491 2.127 . . . . 6.98 111.865 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.38 122.96 12.56 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.424 2.083 . . . . 8.85 112.779 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.22 -32.13 6.7 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.81 -0.709 . . . . 8.09 113.402 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' B' ' 17' ' ' LEU . 10.7 m -85.29 2.99 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.183 0.438 . . . . 7.0 112.183 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.662 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -93.46 19.35 8.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.894 0.378 . . . . 5.73 111.03 -176.052 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -53.46 145.51 27.58 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.547 . . . . 7.96 111.966 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.86 -39.51 39.42 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.356 2.704 . . . . 7.3 113.536 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 32.4 tt0 -65.62 -36.65 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.866 -0.334 . . . . 9.22 110.59 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 5.6 tt -68.26 -34.12 75.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.059 -0.348 . . . . 6.17 110.059 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -62.89 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 4.84 109.991 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 31.7 t -68.74 -34.11 75.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 7.35 110.183 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 28.2 mmt180 -63.84 -43.68 95.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.114 -0.494 . . . . 8.28 109.946 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 69.8 mt -65.97 -43.71 87.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 4.13 109.933 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 -22.16 9.57 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.572 -0.74 . . . . 5.58 112.408 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.14 19.74 78.69 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.877 -0.678 . . . . 4.5 111.42 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.85 149.41 36.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.826 0.346 . . . . 5.41 110.7 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' B' ' 53' ' ' ILE . 3.4 ptp180 -69.49 -50.32 46.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.206 -0.452 . . . . 8.22 111.735 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -64.73 -30.43 71.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.748 0.309 . . . . 7.16 111.456 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.3 OUTLIER -69.61 -45.35 68.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 5.72 110.814 -179.304 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.685 HD22 HD22 ' B' ' 21' ' ' LEU . 61.2 mt -67.32 -28.08 67.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 3.06 110.911 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.505 HG13 ' O ' ' B' ' 49' ' ' ARG . 90.9 mt -63.41 -48.67 86.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.114 0.483 . . . . 6.4 110.017 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' B' ' 6' ' ' SER . . . -68.4 -36.08 78.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 3.73 110.734 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.435 ' O ' HD13 ' B' ' 55' ' ' LEU . 2.1 tm? -55.93 -39.95 72.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.509 -0.768 . . . . 2.46 109.399 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.534 HD23 ' O ' ' B' ' 21' ' ' LEU . 0.8 OUTLIER -74.69 -27.65 60.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 5.56 110.234 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 54' ' ' ALA . 80.1 mtt180 -62.58 -26.33 68.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.494 -0.321 . . . . 7.19 111.114 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -57.31 -39.71 76.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.349 0.595 . . . . 4.23 110.872 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 tt -91.99 -31.38 15.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.48 -0.782 . . . . 6.46 110.332 -176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -74.76 117.68 64.35 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.711 -0.677 . . . . 7.35 111.046 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.57 138.09 37.6 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.713 2.275 . . . . 8.17 112.112 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' SER . . . . . 0.469 ' HB3' ' OE1' ' B' ' 64' ' ' GLN . 41.7 t -98.48 -15.32 19.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.165 -0.47 . . . . 8.89 110.34 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 23.9 m 64.07 95.0 0.05 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.38 0.609 . . . . 9.76 110.191 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLN . . . . . 0.469 ' OE1' ' HB3' ' B' ' 62' ' ' SER . 1.6 mp0 -100.95 -66.58 0.9 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.896 -0.593 . . . . 11.21 110.942 -173.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.44 -166.34 26.69 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.477 -0.649 . . . . 12.71 111.477 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.25 104.67 2.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.887 -0.673 . . . . 13.61 111.899 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -151.55 103.76 3.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.809 0.338 . . . . 15.17 110.309 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.25 5.03 6.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.362 0.601 . . . . 16.82 110.232 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' B' ' 69' ' ' LEU . 4.1 mm? -82.43 -25.7 33.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.953 -0.567 . . . . 18.11 110.315 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.29 71.81 82.12 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.657 -0.701 . . . . 19.0 109.946 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -89.42 -1.04 6.04 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.889 2.393 . . . . 20.29 112.196 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 24.3 t 58.64 69.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.512 0.672 . . . . 21.13 109.62 -174.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.04 96.13 5.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.098 -0.955 . . . . 22.9 110.34 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -81.77 139.13 34.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.909 -0.587 . . . . 25.06 109.763 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 73.72 92.44 0.08 Allowed 'General case' 0 C--O 1.232 0.155 0 O-C-N 123.896 0.747 . . . . 24.46 109.424 -174.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.01 57.79 4.83 Favored Glycine 0 N--CA 1.453 -0.173 0 CA-C-N 115.531 -0.759 . . . . 24.61 113.491 -171.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -106.41 95.65 5.91 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.808 -0.442 . . . . 27.27 109.808 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.605 -0.712 . . . . 26.96 109.888 -178.243 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 119.841 -0.422 . . . . 11.48 112.05 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.77 105.23 0.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.791 2.327 . . . . 10.23 111.913 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.414 HD13 ' N ' ' A' ' 4' ' ' GLY . 1.1 tm? -130.89 126.94 37.47 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.422 -0.585 . . . . 10.02 109.422 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.414 ' N ' HD13 ' A' ' 3' ' ' LEU . . . 165.38 54.06 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.47 -0.872 . . . . 6.89 112.501 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -80.43 96.53 6.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.393 0.616 . . . . 6.02 109.423 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.4 m -139.02 38.88 2.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.501 -0.772 . . . . 3.51 109.614 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.2 -51.91 67.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.026 -0.534 . . . . 2.5 110.913 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.13 -39.14 95.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.137 -0.554 . . . . 2.13 112.24 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.75 -42.86 85.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.06 0.457 . . . . 2.19 110.682 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.558 HD12 ' CE1' ' A' ' 13' ' ' HIS . 45.9 tp -64.65 -47.13 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.813 -0.63 . . . . 1.68 110.268 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.21 -46.5 88.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.628 -0.715 . . . . 1.71 110.062 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -50.98 71.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 1.75 111.673 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.558 ' CE1' HD12 ' A' ' 10' ' ' LEU . 8.2 p-80 -76.83 -27.96 55.35 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.657 -0.417 . . . . 1.78 110.954 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.11 66.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.068 -0.253 . . . . 1.09 110.496 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.75 92.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.131 0.491 . . . . 1.46 110.764 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -65.08 -33.39 75.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.498 -0.774 . . . . 2.28 110.845 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 36' ' ' VAL . 83.8 mt -85.73 -26.32 25.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.108 0.48 . . . . 1.65 109.949 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.72 35.73 35.13 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.442 -0.799 . . . . 1.28 112.476 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.499 ' O ' HD11 ' A' ' 55' ' ' LEU . 97.4 t -69.38 108.67 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.335 -0.987 . . . . 0.99 108.335 170.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 51.7 mtt180 -112.18 133.64 54.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.155 0.502 . . . . 2.67 111.625 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 52' ' ' LEU . 5.9 mp -130.41 136.69 49.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.892 -1.049 . . . . 1.45 109.728 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.591 ' HA ' HD21 ' A' ' 56' ' ' LEU . 22.9 p90 -158.2 137.92 12.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.49 -0.777 . . . . 2.26 109.257 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -85.33 121.63 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.665 -0.494 . . . . 2.92 109.665 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 33.1 tt0 -115.77 102.38 9.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.777 -0.647 . . . . 4.2 109.843 -175.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.67 -90.39 0.39 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.485 -0.779 . . . . 4.2 111.938 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -111.43 -28.71 8.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.546 0.212 . . . . 5.15 111.338 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -117.07 142.48 46.93 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.946 -0.701 . . . . 5.38 112.252 -169.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.642 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -69.3 124.34 23.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.867 -1.061 . . . . 2.44 108.565 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 15.5 mmm180 -101.45 136.36 41.42 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.601 -0.518 . . . . 4.22 109.601 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.8 135.67 55.1 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.539 -0.541 . . . . 1.69 109.539 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 25.2 tp60 -131.56 106.56 8.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.859 -0.422 . . . . 2.68 109.859 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.43 123.67 28.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 1.69 111.196 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 31.5 Cg_exo -61.51 160.01 29.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.649 2.233 . . . . 1.84 111.581 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.725 ' HB3' HG22 ' B' ' 38' ' ' THR . 28.4 Cg_endo -63.97 122.73 10.86 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.35 2.033 . . . . 2.31 112.753 -176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 38' ' ' THR . . . 97.55 -37.66 3.38 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.875 -0.679 . . . . 1.76 114.06 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 17' ' ' LEU . 26.7 m -68.63 -14.01 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.285 0.846 . . . . 1.49 113.285 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.8 tpp -86.01 23.51 1.48 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.892 0.377 . . . . 1.41 111.41 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.645 HG22 ' HB3' ' B' ' 34' ' ' PRO . 43.7 p -50.74 145.77 10.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.44 -0.346 . . . . 1.45 110.764 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 52.1 Cg_exo -53.18 -28.97 44.09 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.915 2.41 . . . . 1.72 113.435 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 38.7 tt0 -67.97 -48.33 66.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.886 -0.413 . . . . 2.76 109.886 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.26 -37.23 86.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.428 0.633 . . . . 1.2 109.883 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -56.42 -41.15 75.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.92 -1.036 . . . . 2.06 109.85 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 1.57 110.663 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 3.4 mmp_? -67.61 -38.04 83.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.487 -0.324 . . . . 3.34 110.432 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.7 mt -64.6 -43.26 94.36 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.152 -0.684 . . . . 1.25 109.152 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.65 -23.78 6.31 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 2.3 113.448 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.92 14.38 75.88 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 2.57 111.825 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -84.0 150.15 25.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.991 -0.374 . . . . 2.08 109.991 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 19.1 ptp180 -69.35 -50.56 45.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 111.773 0.286 . . . . 5.36 111.773 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.507 ' HA ' HD12 ' A' ' 53' ' ' ILE . 8.9 p80 -56.96 -35.73 69.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.052 0.454 . . . . 2.99 110.529 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.09 -51.12 67.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.368 -0.833 . . . . 2.75 109.852 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 21' ' ' LEU . 80.8 mt -69.18 -25.65 64.45 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.672 -1.149 . . . . 1.9 111.016 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.5 mt -59.74 -47.7 90.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.789 0.328 . . . . 2.74 110.304 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -31.49 71.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.342 0.591 . . . . 1.5 110.494 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 19' ' ' VAL . 2.1 tm? -71.54 -41.34 69.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.201 1.001 . . . . 1.32 108.461 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -62.93 -43.14 99.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.808 -1.542 . . . . 1.68 110.135 178.388 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.38 -29.26 70.59 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.576 -1.193 . . . . 4.07 111.616 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.6 pt20 -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.659 -0.417 . . . . 1.75 110.847 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 21.52 17.15 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.805 0.336 . . . . 2.47 110.552 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -73.68 122.63 88.07 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.485 -0.561 . . . . 2.58 109.485 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.52 152.41 73.51 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.137 2.558 . . . . 2.48 113.793 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 p -97.43 164.76 12.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.343 -0.844 . . . . 4.06 110.691 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.9 m -102.65 142.18 34.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.358 -0.383 . . . . 5.86 110.427 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -19.09 6.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.233 -0.439 . . . . 8.21 111.227 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.28 -72.64 2.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.417 -0.897 . . . . 10.39 111.787 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.27 -52.03 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.487 -0.863 . . . . 11.32 112.865 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m 66.6 99.63 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.353 0.597 . . . . 13.15 111.835 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.1 tp -123.66 151.46 43.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.789 -0.641 . . . . 15.0 109.708 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.444 ' H ' HD23 ' A' ' 69' ' ' LEU . 2.6 pt? -128.19 147.33 50.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.911 -0.403 . . . . 16.24 109.911 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.01 113.01 57.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.621 -0.263 . . . . 16.76 110.573 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -86.46 44.77 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.102 2.535 . . . . 18.72 112.576 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.12 0.23 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.614 0.721 . . . . 19.52 110.041 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.04 -25.51 63.78 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.416 -0.811 . . . . 20.52 111.741 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -106.13 96.04 6.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.986 -0.376 . . . . 23.78 109.986 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -114.82 165.33 12.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.966 0.412 . . . . 22.18 111.357 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.53 -161.11 9.4 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.765 -0.652 . . . . 23.17 111.699 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.36 149.04 50.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.86 -0.422 . . . . 26.36 109.86 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 78' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.702 -0.666 . . . . 26.21 109.776 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.038 -0.425 . . . . 14.86 112.038 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.56 149.23 18.61 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.642 2.228 . . . . 14.18 112.37 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' B' ' 5' ' ' SER . 0.7 OUTLIER -105.28 -46.8 4.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.315 -0.624 . . . . 13.74 109.315 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.82 17.23 71.13 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-N 115.833 -0.621 . . . . 11.08 113.177 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.543 ' HB3' HD22 ' B' ' 3' ' ' LEU . 15.0 p -69.11 113.93 6.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.474 0.176 . . . . 9.78 111.474 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 29.8 p 44.32 -90.52 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.596 1.158 . . . . 8.38 113.426 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.3 -39.63 73.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 5.78 111.899 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.49 -47.01 92.56 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.6 -0.809 . . . . 4.66 112.812 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.72 -43.46 62.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.815 0.34 . . . . 5.78 110.747 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 69.1 tp -59.05 -47.54 84.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 4.38 110.76 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.92 -45.58 94.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.545 . . . . 2.86 110.048 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.9 63.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 3.74 112.323 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 8.9 p80 -76.81 -28.42 55.56 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 5.05 111.299 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -45.32 69.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.711 0.291 . . . . 3.33 110.583 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.25 95.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 4.37 111.182 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -61.83 -39.33 91.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 6.1 111.096 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.576 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -79.47 -26.63 41.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.796 -0.361 . . . . 6.49 110.594 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.76 33.03 19.99 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.849 -0.691 . . . . 4.73 112.495 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.419 ' O ' HD11 ' B' ' 55' ' ' LEU . 77.4 t -75.86 104.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.124 -0.695 . . . . 3.6 109.124 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 50.3 mtt180 -110.81 135.05 51.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.083 0.468 . . . . 6.8 111.9 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.657 HD22 HD22 ' B' ' 52' ' ' LEU . 6.2 mp -131.0 140.86 50.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.437 -0.801 . . . . 3.8 108.961 171.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' TRP . . . . . 0.636 ' HA ' HD21 ' B' ' 56' ' ' LEU . 30.0 p90 -159.44 141.67 13.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.745 -0.465 . . . . 6.8 109.745 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.05 115.89 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.328 0.585 . . . . 7.74 109.793 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HG3' ' B' ' 29' ' ' ARG . 27.4 tt0 -112.25 103.97 12.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 9.44 109.909 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.1 -90.7 0.51 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.752 -0.658 . . . . 9.66 112.342 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -115.7 -29.53 6.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.953 0.406 . . . . 9.32 110.871 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 27' ' ' ARG . 5.9 tpp180 -115.08 138.83 50.44 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.291 -0.563 . . . . 7.34 111.651 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.569 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -68.48 126.34 29.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.405 -0.816 . . . . 5.18 108.984 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' B' ' 24' ' ' GLU . 14.1 mmm180 -102.97 135.24 45.02 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.799 -0.445 . . . . 8.07 109.799 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.515 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.1 t80 -119.76 132.44 55.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 4.16 109.54 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 6.7 tp-100 -128.23 102.78 6.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.451 . . . . 6.72 109.781 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.4 ' HB2' ' HE3' ' B' ' 37' ' ' MET . . . -116.45 122.59 31.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.957 -0.565 . . . . 5.75 111.335 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.484 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 31.4 Cg_exo -61.82 158.54 37.41 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.752 2.301 . . . . 6.98 111.748 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.645 ' HB3' HG22 ' A' ' 38' ' ' THR . 33.8 Cg_endo -64.86 123.4 11.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.404 2.069 . . . . 8.85 112.771 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.491 ' O ' HG23 ' B' ' 38' ' ' THR . . . 98.27 -36.92 3.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.968 -0.634 . . . . 8.09 113.777 172.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' B' ' 17' ' ' LEU . 24.8 m -72.09 -12.74 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.658 0.614 . . . . 7.0 112.658 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.4 ' HE3' ' HB2' ' B' ' 32' ' ' ALA . 19.3 tpp -86.2 22.58 1.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.923 0.392 . . . . 5.73 111.419 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 34' ' ' PRO . 22.9 p -48.73 143.55 7.91 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.273 -0.421 . . . . 7.96 111.049 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.39 -27.5 39.83 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.236 2.624 . . . . 7.3 113.443 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.82 -50.68 61.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 9.22 109.949 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 tt -66.89 -33.45 75.62 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 6.17 109.817 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -56.83 -42.68 80.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.842 -0.617 . . . . 4.84 109.731 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.52 -29.65 63.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.499 -0.773 . . . . 7.35 110.702 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.646 ' CZ ' ' HA ' ' B' ' 44' ' ' ARG . 3.1 mmp_? -67.17 -38.79 86.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 8.28 110.482 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.99 -43.33 96.04 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.25 -0.648 . . . . 4.13 109.25 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.17 -23.85 6.72 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.436 -0.802 . . . . 5.58 113.354 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.16 12.25 79.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.71 -0.757 . . . . 4.5 112.007 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -80.46 151.36 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.265 -0.272 . . . . 5.41 110.265 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 18.0 ptp180 -68.31 -45.2 73.65 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.869 -0.332 . . . . 8.22 111.493 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -63.22 -35.61 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.227 -0.189 . . . . 7.16 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -46.47 82.52 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.071 0.462 . . . . 5.72 110.422 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.657 HD22 HD22 ' B' ' 21' ' ' LEU . 68.8 mt -69.97 -24.56 63.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 3.06 111.391 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 77.8 mt -65.07 -48.74 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.765 0.317 . . . . 6.4 110.264 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.56 95.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.316 0.579 . . . . 3.73 110.022 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.419 HD11 ' O ' ' B' ' 19' ' ' VAL . 1.1 tm? -58.88 -47.06 86.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.211 -0.904 . . . . 2.46 109.751 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' B' ' 22' ' ' TRP . 0.1 OUTLIER -55.39 -45.29 76.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.469 0.652 . . . . 5.56 110.604 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -64.72 -28.92 69.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 7.19 112.022 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -63.69 -30.01 71.17 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.769 0.318 . . . . 4.23 111.266 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.25 16.99 22.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.722 0.296 . . . . 6.46 110.771 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -70.37 121.16 82.48 Favored Pre-proline 0 C--O 1.236 0.392 0 N-CA-C 109.633 -0.506 . . . . 7.35 109.633 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.33 160.24 24.1 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.252 2.635 . . . . 8.17 113.24 -173.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 56.5 p -104.21 169.24 8.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.368 -0.833 . . . . 8.89 110.475 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 50.2 m -104.85 143.84 32.58 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.705 -0.479 . . . . 9.76 109.705 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -126.41 -18.8 4.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.959 0.409 . . . . 11.21 110.851 -177.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.1 -83.23 1.36 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.904 -0.589 . . . . 12.71 111.79 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.48 -49.42 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.009 -0.615 . . . . 13.61 111.609 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 18.8 m 67.79 94.06 0.07 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.526 0.679 . . . . 15.17 111.52 176.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 48.4 tp -120.05 145.36 46.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.616 -0.72 . . . . 16.82 109.981 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.58 HD23 ' H ' ' B' ' 69' ' ' LEU . 2.7 pt? -121.2 141.92 50.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.868 0.366 . . . . 18.11 110.323 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' B' ' 71' ' ' PRO . . . -97.73 139.11 21.14 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.306 -0.627 . . . . 19.0 109.306 173.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 70' ' ' ALA . 16.8 Cg_exo -67.37 77.01 0.49 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.776 2.317 . . . . 20.29 112.848 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 5.6 p -83.17 79.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.222 1.01 . . . . 21.13 110.413 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.31 8.01 1.58 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.055 -0.975 . . . . 22.9 110.118 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -103.27 152.7 21.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.605 -0.725 . . . . 25.06 109.817 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -71.26 124.08 23.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.118 0.485 . . . . 24.46 111.144 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.17 16.66 29.84 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.855 -0.611 . . . . 24.61 111.749 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 62.41 82.23 0.18 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.353 0.597 . . . . 27.27 112.092 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.406 -0.807 . . . . 26.96 108.928 174.371 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.665 -0.574 . . . . 11.48 111.665 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.89 -45.45 16.62 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.509 2.14 . . . . 10.23 111.136 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.1 tp -96.62 101.13 12.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.772 -0.649 . . . . 10.02 109.951 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.01 104.19 0.25 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.098 -0.801 . . . . 6.89 111.098 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m -58.64 -76.6 0.04 OUTLIER 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.117 0.414 . . . . 6.02 112.117 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 t -167.8 111.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.9 0.381 . . . . 3.51 110.517 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 11' ' ' LEU . . . -114.43 -46.29 2.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 2.5 110.121 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.53 -44.23 96.92 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.698 -0.683 . . . . 2.13 112.482 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.16 98.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.033 0.444 . . . . 2.19 111.055 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.544 HD12 ' CE1' ' A' ' 13' ' ' HIS . 39.9 tp -64.83 -46.67 80.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.829 -0.623 . . . . 1.68 110.755 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 7' ' ' ALA . 87.7 mt -58.73 -51.04 71.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.119 -0.491 . . . . 1.71 109.941 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.451 -0.795 . . . . 1.75 112.175 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.583 ' O ' ' HG ' ' A' ' 17' ' ' LEU . 11.7 p-80 -71.7 -28.09 63.47 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.625 -0.43 . . . . 1.78 110.841 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.85 39.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.035 0.445 . . . . 1.09 110.504 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.7 85.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 1.46 110.927 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -69.21 -22.95 63.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 2.28 110.776 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 98.9 mt -84.23 -25.52 29.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.232 0.539 . . . . 1.65 109.776 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.29 16.12 25.94 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.831 -0.7 . . . . 1.28 112.899 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.98 115.11 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.582 -0.525 . . . . 0.99 109.582 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.756 ' HD3' HD12 ' A' ' 59' ' ' LEU . 95.5 mtt180 -131.11 134.14 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.25 -0.432 . . . . 2.67 111.544 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.5 mp -128.82 133.46 48.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.123 -0.489 . . . . 1.45 109.856 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.519 ' HB3' HD13 ' A' ' 56' ' ' LEU . 22.8 p90 -151.92 149.1 28.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.179 -0.304 . . . . 2.26 110.179 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.6 p -87.86 128.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 2.92 109.818 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 32.8 tt0 -132.73 110.97 10.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.116 -0.493 . . . . 4.2 110.152 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.58 -101.46 1.0 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.766 -0.731 . . . . 4.2 111.712 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.508 ' OE1' ' HD3' ' B' ' 49' ' ' ARG . 0.3 OUTLIER -116.78 -3.79 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.575 0.213 . . . . 5.15 111.575 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.517 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 11.9 tpp180 -134.58 152.12 51.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.391 0.615 . . . . 5.38 111.912 -174.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.4 tt -80.81 132.66 35.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.302 -0.863 . . . . 2.44 109.751 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.3 mpt_? -99.71 140.57 33.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 4.22 109.836 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -122.08 130.95 53.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.071 -0.715 . . . . 1.69 109.071 -177.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 62.7 tp60 -122.77 119.66 31.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.624 -0.51 . . . . 2.68 109.624 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.11 129.13 5.24 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.798 0.332 . . . . 1.69 110.851 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' A' ' 36' ' ' VAL . 31.5 Cg_exo -61.48 154.47 59.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.681 2.254 . . . . 1.84 112.166 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.51 122.51 9.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.113 1.876 . . . . 2.31 112.115 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.88 -33.98 5.47 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.7 -0.762 . . . . 1.76 113.101 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' O ' HD22 ' A' ' 41' ' ' LEU . 34.1 m -79.69 -12.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.245 0.522 . . . . 1.49 112.1 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.61 21.71 0.79 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.086 -0.506 . . . . 1.41 111.243 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.7 p -50.4 139.5 19.66 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.329 -0.396 . . . . 1.45 110.971 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 83.3 Cg_exo -47.22 -39.36 26.75 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.314 2.676 . . . . 1.72 113.282 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 39.3 tt0 -63.08 -40.68 98.38 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.207 -0.197 . . . . 2.76 110.517 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -62.95 -40.04 96.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.793 0.33 . . . . 1.2 110.362 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HA ' HD12 ' A' ' 45' ' ' LEU . 5.8 mt-30 -64.8 -39.48 93.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.249 0.547 . . . . 2.06 110.129 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -66.79 -29.63 69.62 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.094 -0.957 . . . . 1.57 109.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 51.0 mtt-85 -75.19 -38.61 60.72 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 115.882 -0.599 . . . . 3.34 110.079 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 42' ' ' GLN . 97.4 mt -55.69 -44.32 77.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.189 -0.671 . . . . 1.25 109.189 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.28 -23.24 5.52 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.579 -0.737 . . . . 2.3 113.134 168.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.71 74.18 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.737 -0.744 . . . . 2.57 111.484 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -85.08 149.52 25.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.652 0.263 . . . . 2.08 110.57 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.644 ' HD3' ' OE1' ' B' ' 26' ' ' GLU . 7.6 ptt180 -67.47 -51.65 48.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.375 . . . . 5.36 111.984 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -57.23 -39.34 75.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.384 0.611 . . . . 2.99 110.036 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.77 -55.83 22.98 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.853 -1.067 . . . . 2.75 110.351 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 93.3 mt -70.33 -26.65 63.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.091 -0.959 . . . . 1.9 111.854 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 49' ' ' ARG . 70.7 mt -62.02 -52.29 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.74 110.227 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.29 70.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.401 0.62 . . . . 1.5 110.23 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 55' ' ' LEU . 3.5 tm? -68.46 -29.46 68.1 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.196 -0.911 . . . . 1.32 109.929 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -82.72 -32.85 27.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.058 0.456 . . . . 1.68 110.602 174.086 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.76 -21.9 63.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 4.07 111.67 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -69.15 -22.63 63.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.916 0.389 . . . . 1.75 111.03 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.756 HD12 ' HD3' ' A' ' 20' ' ' ARG . 10.4 tt -73.98 -27.59 61.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.244 -0.651 . . . . 2.47 109.244 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -68.24 146.94 98.24 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.58 110.357 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.8 84.69 0.11 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.894 2.396 . . . . 2.48 112.46 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -137.04 -66.69 0.51 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 4.06 109.63 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 t -143.26 140.31 30.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.372 -0.603 . . . . 5.86 109.372 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -121.95 153.93 37.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.921 0.391 . . . . 8.21 110.571 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.41 160.94 26.07 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.3 -0.72 . . . . 10.39 111.3 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.85 112.61 0.53 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.424 -0.893 . . . . 11.32 112.58 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 m -93.47 -3.32 53.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.628 0.252 . . . . 13.15 110.706 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.19 -81.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.753 -0.658 . . . . 15.0 111.078 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.89 162.45 18.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 16.24 110.446 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -133.3 123.42 17.7 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.316 -0.402 . . . . 16.76 110.226 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 2.7 Cg_exo -77.26 35.87 0.51 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.269 2.646 . . . . 18.72 112.721 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 p -75.75 87.73 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 122.159 0.981 . . . . 19.52 110.554 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.67 173.63 7.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.143 -0.935 . . . . 20.52 110.362 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -76.13 78.47 2.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.778 0.799 . . . . 23.78 110.768 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -87.12 -50.42 6.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.859 -1.064 . . . . 22.18 110.2 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.68 161.54 37.44 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.812 -0.709 . . . . 23.17 111.826 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -94.1 34.4 1.26 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.142 0.496 . . . . 26.36 110.759 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.2 tp . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.734 -0.65 . . . . 26.21 109.987 178.078 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 CA-C-O 120.005 -0.331 . . . . 14.86 112.637 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.52 127.08 24.5 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.982 2.455 . . . . 14.18 112.738 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.75 -102.9 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.186 -0.915 . . . . 13.74 111.385 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.47 -100.69 0.44 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.612 -0.804 . . . . 11.08 111.595 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 45.3 m -109.41 -50.77 2.95 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.046 -0.353 . . . . 9.78 110.046 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m 61.66 38.8 15.01 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.777 -0.647 . . . . 8.38 111.138 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' B' ' 11' ' ' LEU . . . 60.76 43.95 11.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.3 0.572 . . . . 5.78 110.205 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.62 -40.63 79.58 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.136 -0.938 . . . . 4.66 113.369 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.72 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.0 0.4 . . . . 5.78 110.96 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -61.45 -46.6 89.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 4.38 110.354 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' B' ' 7' ' ' ALA . 87.1 mt -61.89 -49.94 74.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.001 -0.545 . . . . 2.86 110.792 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.06 -53.04 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.551 . . . . 3.74 112.337 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.543 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 16.6 p-80 -70.73 -28.42 64.7 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.283 -0.567 . . . . 5.05 110.903 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.95 59.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.066 0.46 . . . . 3.33 110.406 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.11 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.691 -0.686 . . . . 4.37 110.85 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -67.69 -26.74 66.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 6.1 110.547 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' B' ' 13' ' ' HIS . 92.5 mt -81.27 -24.88 36.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 6.49 110.42 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.28 15.47 25.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 4.73 112.809 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -73.95 114.92 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.939 -0.393 . . . . 3.6 109.939 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.752 ' HD3' HD12 ' B' ' 59' ' ' LEU . 94.6 mtt180 -131.05 136.99 48.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.315 -0.402 . . . . 6.8 111.491 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.7 mp -129.91 136.42 49.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 3.8 109.751 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' TRP . . . . . 0.742 ' HB3' HD13 ' B' ' 56' ' ' LEU . 28.8 p90 -153.9 150.07 27.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.792 0.329 . . . . 6.8 110.381 175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.2 p -88.03 130.69 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.482 -0.562 . . . . 7.74 109.482 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.681 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 35.0 tt0 -134.89 114.37 12.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.236 -0.438 . . . . 9.44 110.272 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -102.86 0.85 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.984 -0.627 . . . . 9.66 111.912 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.644 ' OE1' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -0.08 12.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.572 0.225 . . . . 9.32 111.266 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.523 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 10.7 tpp180 -140.14 146.77 39.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.106 -0.638 . . . . 7.34 111.395 -171.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.2 tt -79.13 135.71 36.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.515 . . . . 5.18 110.332 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 4.8 mpt_? -101.09 137.86 38.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 8.07 110.134 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.494 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.6 t80 -119.01 131.49 56.0 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.355 -0.609 . . . . 4.16 109.355 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -126.18 114.02 17.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.833 -0.432 . . . . 6.72 109.833 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.39 130.49 7.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 5.75 111.265 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.498 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.1 Cg_exo -61.98 151.71 79.74 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.806 2.337 . . . . 6.98 112.302 175.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.534 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 34.9 Cg_endo -65.86 123.26 11.08 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.158 1.905 . . . . 8.85 112.326 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.42 -33.07 5.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.758 -0.734 . . . . 8.09 112.945 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.573 ' O ' HD22 ' B' ' 41' ' ' LEU . 22.5 m -83.99 -7.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.181 0.49 . . . . 7.0 111.53 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.554 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.43 20.22 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.399 . . . . 5.73 111.289 -175.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 14.9 p -50.67 138.91 22.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 7.96 111.338 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.01 -41.4 33.18 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.486 2.791 . . . . 7.3 113.473 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 42.5 tt0 -57.74 -40.74 80.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.506 0.194 . . . . 9.22 111.043 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.573 HD22 ' O ' ' B' ' 36' ' ' VAL . 2.5 tp -64.37 -42.39 96.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.86 0.362 . . . . 6.17 110.081 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.498 ' HA ' HD12 ' B' ' 45' ' ' LEU . 22.8 mt-30 -63.66 -36.99 85.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 4.84 109.97 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 17.2 t -68.02 -37.02 80.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.666 -0.697 . . . . 7.35 109.955 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 56.5 mtt-85 -66.56 -40.36 88.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.418 -0.355 . . . . 8.28 110.422 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' B' ' 42' ' ' GLN . 91.7 mt -56.92 -43.76 81.74 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-O 121.285 0.564 . . . . 4.13 109.732 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.19 -23.42 6.15 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.474 -0.784 . . . . 5.58 112.95 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.99 28.14 73.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.994 -0.622 . . . . 4.5 111.664 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.44 150.26 24.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.528 0.204 . . . . 5.41 110.467 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.508 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 11.0 ptt-85 -65.89 -50.21 65.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.338 -0.392 . . . . 8.22 111.403 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -57.48 -42.11 82.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.752 -0.204 . . . . 7.16 111.398 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -54.22 40.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.448 -0.342 . . . . 5.72 110.809 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 75.8 mt -67.91 -27.67 66.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.286 0.476 . . . . 3.06 112.286 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 49' ' ' ARG . 72.0 mt -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.808 -0.357 . . . . 6.4 110.09 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.75 -36.08 77.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.413 0.625 . . . . 3.73 110.486 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' B' ' 58' ' ' GLN . 2.9 tm? -63.39 -29.21 70.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 2.46 110.134 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' B' ' 22' ' ' TRP . 22.9 tp -79.25 -32.38 43.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 5.56 110.694 173.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.59 -20.23 65.34 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.013 0.375 . . . . 7.19 112.013 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' B' ' 55' ' ' LEU . 1.5 pp0? -73.36 -17.93 61.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.768 -0.373 . . . . 4.23 110.893 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.752 HD12 ' HD3' ' B' ' 20' ' ' ARG . 10.1 tt -75.3 -26.82 59.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.398 -0.593 . . . . 6.46 109.398 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 87.6 mt-30 -71.64 147.9 92.41 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.657 -0.701 . . . . 7.35 110.335 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 26.4 Cg_exo -62.53 93.22 0.14 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.749 2.3 . . . . 8.17 112.372 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 12.6 t -147.31 -66.42 0.26 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 8.89 109.417 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 26.4 t -142.77 137.98 30.12 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.381 -0.6 . . . . 9.76 109.381 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -120.74 157.53 29.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.555 -0.293 . . . . 11.21 110.422 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -145.88 157.66 27.44 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.928 -0.653 . . . . 12.71 111.769 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.66 116.84 0.74 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.633 -0.794 . . . . 13.61 112.473 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 56.6 m -97.69 -3.89 38.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.655 0.264 . . . . 15.17 110.516 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' B' ' 68' ' ' LEU . 4.0 mm? 69.68 -82.9 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.529 -0.76 . . . . 16.82 110.825 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 pp -164.08 159.71 20.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.187 -0.46 . . . . 18.11 109.982 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.15 114.67 38.72 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.302 -0.408 . . . . 19.0 110.245 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.14 -35.94 90.57 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.911 2.408 . . . . 20.29 112.032 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 p -166.85 150.07 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.496 -0.775 . . . . 21.13 109.315 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.5 102.11 10.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.014 -0.365 . . . . 22.9 110.014 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.693 ' H ' ' HD3' ' B' ' 74' ' ' ARG . 0.0 OUTLIER -50.93 121.23 5.7 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.364 0.602 . . . . 25.06 110.663 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -91.21 122.02 33.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.733 -0.667 . . . . 24.46 111.007 -175.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.17 -83.89 0.62 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.632 -0.987 . . . . 24.61 110.632 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' B' ' 77' ' ' ARG . 5.6 mmp_? -132.41 82.54 2.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.604 -0.517 . . . . 27.27 109.604 171.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.405 -0.807 . . . . 26.96 111.201 179.472 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.436 -0.666 . . . . 11.48 111.436 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.37 -55.19 3.84 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.651 2.234 . . . . 10.23 112.049 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.8 tp -163.07 107.74 1.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.963 -0.562 . . . . 10.02 110.035 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.95 88.06 1.6 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.49 -0.862 . . . . 6.89 112.837 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.5 t 71.93 128.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.741 0.781 . . . . 6.02 112.88 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.1 m -98.56 -16.68 19.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.818 -0.808 . . . . 3.51 108.818 169.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.54 -34.12 65.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.937 -1.029 . . . . 2.5 110.379 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.1 92.87 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.579 -0.609 . . . . 2.13 111.579 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.22 85.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 2.19 110.306 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 13' ' ' HIS . 36.6 tp -61.76 -46.84 87.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.918 -0.583 . . . . 1.68 110.042 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.4 -47.57 85.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.493 -0.776 . . . . 1.71 109.933 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.42 73.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.449 . . . . 1.75 112.043 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.569 ' CE1' HD12 ' A' ' 10' ' ' LEU . 10.6 p-80 -74.75 -27.76 60.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.649 -0.421 . . . . 1.78 110.625 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 -45.36 71.69 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.203 -0.295 . . . . 1.09 110.203 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 1.46 110.935 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -65.34 -31.98 73.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 2.28 111.235 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.6 HD13 ' HB ' ' A' ' 36' ' ' VAL . 74.6 mt -85.35 -26.43 26.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 1.65 110.166 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.35 33.23 26.22 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.51 -0.768 . . . . 1.28 112.804 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.668 HG21 HD21 ' A' ' 41' ' ' LEU . 54.0 t -71.71 121.06 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.81 -0.811 . . . . 0.99 108.81 173.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.788 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 74.7 mtt180 -126.5 131.71 51.56 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.378 -0.23 . . . . 2.67 110.378 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.594 HD23 HD11 ' A' ' 28' ' ' LEU . 6.1 mp -132.33 125.52 31.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.729 -0.471 . . . . 1.45 109.729 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -143.11 134.45 26.07 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.917 0.389 . . . . 2.26 109.984 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -92.77 125.41 45.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 2.92 109.959 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.25 118.16 28.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.907 -0.588 . . . . 4.2 109.661 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.05 -97.04 0.56 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.688 -0.687 . . . . 4.2 111.664 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -116.63 -16.29 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.734 0.302 . . . . 5.15 111.444 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -114.76 135.2 54.43 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.836 -0.746 . . . . 5.38 112.643 -167.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.594 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -78.24 124.76 28.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.505 -1.225 . . . . 2.44 108.84 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.96 143.97 30.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.001 -0.37 . . . . 4.22 110.001 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.638 ' H ' ' NE2' ' B' ' 42' ' ' GLN . 0.2 OUTLIER -119.66 131.89 55.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 1.69 110.702 -174.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.788 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 5.2 tp-100 -126.36 114.33 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.872 -0.603 . . . . 2.68 109.692 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.83 126.85 4.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.864 0.364 . . . . 1.69 111.343 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' HG22 ' A' ' 36' ' ' VAL . 24.0 Cg_exo -65.38 155.83 66.61 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.904 2.402 . . . . 1.84 112.053 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.09 123.79 13.91 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.728 2.285 . . . . 2.31 112.563 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.15 -31.88 6.68 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 1.76 113.2 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.6 ' HB ' HD13 ' A' ' 17' ' ' LEU . 15.4 m -85.11 -19.87 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.091 0.446 . . . . 1.49 112.157 -174.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.511 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.39 20.29 0.89 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.41 111.43 -171.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.3 p -51.75 142.16 24.77 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 1.45 110.894 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.68 -38.29 28.88 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.207 2.605 . . . . 1.72 113.244 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 55.4 tt0 -61.54 -39.98 93.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 2.76 111.056 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.668 HD21 HG21 ' A' ' 19' ' ' VAL . 1.9 tp -60.35 -44.55 95.44 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.882 0.372 . . . . 1.2 110.134 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.5 tp60 -57.36 -39.01 75.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 2.06 110.125 178.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -68.84 -29.84 68.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.578 . . . . 1.57 110.504 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 27.4 mmt180 -73.1 -40.9 64.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.99 -0.374 . . . . 3.34 109.99 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 50.8 mt -60.19 -38.46 83.34 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.544 0.688 . . . . 1.25 109.161 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.3 -23.23 8.57 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.183 -0.917 . . . . 2.3 113.062 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.14 19.32 71.96 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.934 -0.651 . . . . 2.57 112.064 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -82.87 149.66 26.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.899 -0.408 . . . . 2.08 109.899 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.4 ptp85 -69.06 -50.62 46.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.487 -0.324 . . . . 5.36 111.521 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.457 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 8.6 p80 -61.59 -32.97 73.1 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.095 0.474 . . . . 2.99 110.836 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -66.25 -51.24 59.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.326 -0.852 . . . . 2.75 110.309 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.486 HD22 HD22 ' A' ' 21' ' ' LEU . 91.2 mt -69.08 -26.52 64.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.925 -1.034 . . . . 1.9 111.124 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.4 mt -61.0 -48.16 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 2.74 109.998 174.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.63 66.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 1.5 110.609 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 55' ' ' LEU . 2.7 tm? -69.39 -38.13 77.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 1.32 109.398 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.5 tp -79.46 -26.8 41.65 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.452 0.644 . . . . 1.68 109.633 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -65.29 -26.77 68.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 4.07 110.437 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.57 -27.89 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 1.75 110.274 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 20' ' ' ARG . 51.0 mt -74.24 -19.19 60.59 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.581 -0.736 . . . . 2.47 110.911 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 45.0 mt-30 -90.94 106.14 14.68 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.798 -0.637 . . . . 2.58 109.875 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 9.7 Cg_exo -69.98 85.15 0.66 Allowed 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.124 2.549 . . . . 2.48 112.931 -175.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.8 m 59.11 -108.59 0.41 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.448 -0.796 . . . . 4.06 110.801 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.6 m -138.05 2.34 2.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.94 0.4 . . . . 5.86 110.879 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -132.69 -76.17 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.007 -0.368 . . . . 8.21 110.007 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 61' ' ' PRO . . . -175.96 -51.36 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.531 -0.843 . . . . 10.39 112.383 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.54 101.84 0.56 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.169 -0.539 . . . . 11.32 112.741 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.6 m -99.63 92.18 5.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.991 0.424 . . . . 13.15 110.183 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.8 tp -152.64 168.01 27.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.081 -0.509 . . . . 15.0 109.778 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 mt -77.3 -63.46 1.37 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.962 -0.755 . . . . 16.24 108.962 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HB1' HG12 ' A' ' 72' ' ' VAL . . . 48.83 93.64 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 114.377 -1.283 . . . . 16.76 113.415 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.95 25.41 0.56 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.818 2.345 . . . . 18.72 111.949 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.436 HG12 ' HB1' ' A' ' 70' ' ' ALA . 4.4 p -73.27 109.87 6.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.626 0.727 . . . . 19.52 110.228 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.61 -177.88 6.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.428 -0.805 . . . . 20.52 110.108 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -93.09 7.94 42.11 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.809 -0.441 . . . . 23.78 109.809 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 67.59 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.211 -0.904 . . . . 22.18 110.942 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.5 69.81 1.99 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.76 -0.733 . . . . 23.17 112.656 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.523 ' HG3' ' HG ' ' A' ' 78' ' ' LEU . 5.1 ptp180 -70.21 -18.37 63.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.102 0.477 . . . . 26.36 110.041 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HG ' ' HG3' ' A' ' 77' ' ' ARG . 85.6 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.249 -0.881 . . . . 26.21 109.818 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.222 -0.351 . . . . 14.86 112.222 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.458 ' HA ' ' NH1' ' B' ' 44' ' ' ARG . 92.2 Cg_endo -86.98 -12.32 5.05 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.855 2.37 . . . . 14.18 113.015 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.98 -85.59 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 122.954 0.502 . . . . 13.74 111.234 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.42 -174.73 25.64 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.713 -0.555 . . . . 11.08 111.713 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 15.6 m 60.37 20.45 10.03 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.861 0.464 . . . . 9.78 111.556 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m -119.43 83.13 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.266 0.555 . . . . 8.38 111.327 -174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.31 -77.81 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.522 -0.763 . . . . 5.78 109.895 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.44 -38.32 79.9 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.975 -0.631 . . . . 4.66 111.693 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.0 83.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.892 0.377 . . . . 5.78 110.173 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.439 HD12 ' CE1' ' B' ' 13' ' ' HIS . 58.5 tp -61.51 -46.59 89.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.867 -0.606 . . . . 4.38 109.89 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.31 -49.15 76.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.728 -0.669 . . . . 2.86 109.66 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.78 -53.26 58.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 3.74 112.307 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.439 ' CE1' HD12 ' B' ' 10' ' ' LEU . 14.1 p-80 -73.52 -27.92 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.19 -0.604 . . . . 5.05 110.952 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.17 78.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 3.33 110.445 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.15 94.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 4.37 110.8 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -61.99 -36.7 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.749 -0.66 . . . . 6.1 111.141 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' B' ' 36' ' ' VAL . 82.5 mt -82.03 -24.92 35.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 6.49 110.632 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 86.52 31.65 18.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.045 -0.598 . . . . 4.73 112.673 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.621 HG21 HD21 ' B' ' 41' ' ' LEU . 45.8 t -75.38 123.08 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.689 -0.486 . . . . 3.6 109.689 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.889 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 77.6 mtt180 -129.33 131.11 46.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.531 -0.304 . . . . 6.8 111.107 -173.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.669 HD23 HD11 ' B' ' 28' ' ' LEU . 5.7 mp -134.64 125.74 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.328 -0.396 . . . . 3.8 110.135 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' TRP . . . . . 0.497 ' HB3' HD13 ' B' ' 56' ' ' LEU . 20.4 p90 -143.5 137.05 28.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 6.8 110.21 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 5.7 p -96.48 118.37 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.183 0.515 . . . . 7.74 110.172 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.3 114.43 26.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.85 -0.614 . . . . 9.44 109.664 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.36 -98.89 1.05 Allowed Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 111.327 -0.709 . . . . 9.66 111.327 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -116.99 -16.53 10.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.852 0.358 . . . . 9.32 111.598 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 7.5 tpp180 -115.53 128.44 55.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.409 0.623 . . . . 7.34 111.962 -166.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.669 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -74.62 124.39 26.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.801 -1.09 . . . . 5.18 109.551 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -100.38 145.31 28.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.295 -0.261 . . . . 8.07 110.295 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.472 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -120.14 131.67 55.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 4.16 110.57 -174.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.889 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 5.6 tp-100 -125.32 114.39 18.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.433 -0.58 . . . . 6.72 109.433 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -151.58 122.17 3.67 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 5.75 111.031 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.539 ' O ' HG22 ' B' ' 36' ' ' VAL . 31.4 Cg_exo -60.27 152.92 63.14 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.917 2.411 . . . . 6.98 112.181 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.07 124.05 15.05 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.512 2.141 . . . . 8.85 112.409 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.75 -29.03 8.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.705 -0.76 . . . . 8.09 112.926 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.557 ' O ' HD22 ' B' ' 41' ' ' LEU . 6.4 m -89.0 -14.61 9.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.533 -0.393 . . . . 7.0 111.293 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.59 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.4 OUTLIER -82.25 18.45 1.41 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.89 0.376 . . . . 5.73 111.239 -174.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.8 p -52.08 142.91 25.94 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 7.96 111.114 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' PRO . . . . . 0.432 ' HG3' ' OE1' ' A' ' 31' ' ' GLN . 71.4 Cg_exo -49.33 -37.16 39.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.263 2.642 . . . . 7.3 113.302 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 38.0 tt0 -61.43 -38.26 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.077 -0.249 . . . . 9.22 111.13 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.621 HD21 HG21 ' B' ' 19' ' ' VAL . 2.9 tp -62.79 -40.36 97.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.869 0.366 . . . . 6.17 110.115 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.638 ' NE2' ' H ' ' A' ' 30' ' ' PHE . 7.8 tp60 -59.62 -39.64 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 4.84 109.857 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 24.5 t -68.29 -32.35 72.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.773 . . . . 7.35 110.703 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 23.7 mmt180 -71.71 -41.67 68.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 8.28 110.093 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 78.3 mt -61.28 -39.6 91.01 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.858 -0.61 . . . . 4.13 109.779 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.06 -23.16 8.26 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.532 -0.758 . . . . 5.58 112.807 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.89 72.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.077 -0.582 . . . . 4.5 112.381 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -76.1 150.43 37.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.047 -0.353 . . . . 5.41 110.047 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 53' ' ' ILE . 8.8 ptp85 -65.27 -48.99 71.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.579 -0.282 . . . . 8.22 111.034 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -66.66 -32.07 73.15 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.299 . . . . 7.16 111.806 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.4 OUTLIER -64.97 -44.27 89.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 5.72 110.534 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.85 -25.0 55.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.047 -0.524 . . . . 3.06 111.506 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 49' ' ' ARG . 80.0 mt -63.54 -47.46 91.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.672 -0.492 . . . . 6.4 109.672 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.21 74.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 3.73 110.233 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.8 tm? -62.53 -44.57 96.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.761 -0.654 . . . . 2.46 109.778 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' B' ' 22' ' ' TRP . 28.2 tp -68.58 -30.95 69.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.3 0.571 . . . . 5.56 110.763 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -66.55 -29.66 69.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.074 -0.512 . . . . 7.19 110.911 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 8.2 pt20 -68.03 -24.59 65.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 4.23 110.381 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.434 HD12 HD12 ' B' ' 56' ' ' LEU . 55.7 mt -74.98 -17.63 60.51 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.805 -0.634 . . . . 6.46 110.453 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.453 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 44.8 mt-30 -91.47 107.06 19.07 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.626 -0.715 . . . . 7.35 109.492 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.579 ' HB2' ' HA2' ' B' ' 65' ' ' GLY . 6.9 Cg_exo -73.04 82.89 1.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.159 2.573 . . . . 8.17 112.225 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m 56.77 -143.06 0.73 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.666 -0.697 . . . . 8.89 109.571 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 23.5 m -100.12 -6.96 25.44 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.804 -0.358 . . . . 9.76 111.384 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -122.49 -78.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.685 0.278 . . . . 11.21 110.565 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' B' ' 61' ' ' PRO . . . -179.7 -50.64 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.988 -0.625 . . . . 12.71 111.94 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.78 100.04 0.35 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.868 -0.682 . . . . 13.61 112.381 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.8 m -98.54 103.62 15.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.991 -0.374 . . . . 15.17 109.991 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.3 tp -162.29 163.52 28.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.459 . . . . 16.82 109.811 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 mt -73.43 -62.15 1.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.018 -0.734 . . . . 18.11 109.018 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . 56.67 95.98 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 115.134 -0.939 . . . . 19.0 112.776 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.38 -18.14 62.05 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.636 2.224 . . . . 20.29 111.136 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.87 113.64 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.389 -0.823 . . . . 21.13 109.924 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.64 176.19 6.1 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.023 -0.535 . . . . 22.9 110.803 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -65.53 -37.38 86.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.885 0.374 . . . . 25.06 111.051 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -75.37 95.16 3.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.173 -0.467 . . . . 24.46 110.385 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.26 -8.27 6.29 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.419 -0.896 . . . . 24.61 112.852 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -74.7 -72.74 0.27 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.196 0.498 . . . . 27.27 109.921 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 tp . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.687 -0.673 . . . . 26.96 110.001 175.754 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.868 -0.493 . . . . 11.48 111.868 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 18.1 Cg_exo -66.54 -36.65 25.19 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.073 2.515 . . . . 10.23 112.573 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.42 -45.79 29.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.485 -0.325 . . . . 10.02 110.432 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.24 155.67 26.26 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.566 -0.826 . . . . 6.89 112.661 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.8 m -101.57 -30.22 11.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.179 0.514 . . . . 6.02 110.353 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 66.3 m -85.72 95.82 9.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.9 -0.591 . . . . 3.51 110.815 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.25 -48.65 6.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.152 -0.477 . . . . 2.5 110.449 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.37 -37.58 94.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.943 -0.571 . . . . 2.13 111.947 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.681 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -59.35 -41.55 89.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 2.19 110.748 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.552 ' HA ' ' ND1' ' A' ' 13' ' ' HIS . 32.6 tp -64.22 -47.33 80.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 1.68 110.152 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.81 -49.09 77.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.443 -0.798 . . . . 1.71 109.999 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -50.48 71.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.813 -0.63 . . . . 1.75 112.238 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.552 ' ND1' ' HA ' ' A' ' 10' ' ' LEU . 11.8 p-80 -73.13 -27.49 61.71 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.454 -0.498 . . . . 1.78 110.55 -174.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.68 68.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.818 0.342 . . . . 1.09 110.392 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -31.82 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 1.46 110.696 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.977 -0.556 . . . . 2.28 110.762 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.603 HD13 ' HB ' ' A' ' 36' ' ' VAL . 97.6 mt -79.96 -25.89 40.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.094 0.474 . . . . 1.65 110.257 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.15 42.63 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.984 -0.627 . . . . 1.28 112.276 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.67 121.28 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 109.353 -0.61 . . . . 0.99 109.353 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 76.8 mtt180 -122.25 135.23 54.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.77 -0.456 . . . . 2.67 109.77 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.806 HD22 HD22 ' A' ' 52' ' ' LEU . 6.0 mp -135.85 124.36 23.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 1.45 110.183 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.485 ' HB3' HD13 ' A' ' 56' ' ' LEU . 23.8 p90 -140.84 140.6 34.66 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.894 -0.41 . . . . 2.26 109.894 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.51 123.0 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.943 0.401 . . . . 2.92 110.147 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.647 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -110.34 101.84 10.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.025 -0.731 . . . . 4.2 109.025 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.01 -86.15 0.22 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.766 -0.652 . . . . 4.2 112.1 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.63 -32.03 5.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.207 0.527 . . . . 5.15 110.78 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.31 133.37 50.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 5.38 112.029 -167.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.616 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -69.6 126.15 28.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.882 -1.054 . . . . 2.44 109.445 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.647 ' NH1' ' HB3' ' A' ' 24' ' ' GLU . 7.3 mpt_? -98.58 131.11 45.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.628 -0.508 . . . . 4.22 109.628 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.417 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -108.45 145.99 33.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.063 -0.517 . . . . 1.69 110.201 -175.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 57.3 tp60 -145.41 110.49 5.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.981 -0.378 . . . . 2.68 109.981 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -146.03 135.68 11.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.565 -0.289 . . . . 1.69 110.848 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' HG22 ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.26 156.98 37.42 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.89 2.394 . . . . 1.84 112.179 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' B' ' 38' ' ' THR . 20.0 Cg_endo -63.1 123.95 13.08 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.437 2.092 . . . . 2.31 112.35 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.64 -37.23 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.76 113.275 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.603 ' HB ' HD13 ' A' ' 17' ' ' LEU . 33.3 m -75.06 -11.92 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.609 0.596 . . . . 1.49 112.609 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -82.16 21.51 0.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.187 -0.46 . . . . 1.41 111.711 -173.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.621 HG22 ' HB3' ' B' ' 34' ' ' PRO . 35.2 p -50.64 143.91 13.58 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 116.608 -0.269 . . . . 1.45 110.954 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 50.6 Cg_exo -53.51 -32.91 65.48 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.54 2.16 . . . . 1.72 111.954 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 18.4 tp10 -57.93 -50.21 74.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.856 -0.611 . . . . 2.76 110.2 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 36' ' ' VAL . 2.4 tp -61.79 -47.53 84.73 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.2 110.293 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HA ' HD12 ' A' ' 45' ' ' LEU . 25.3 tp60 -57.13 -39.25 74.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 2.06 111.204 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.9 t -71.44 -29.55 65.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.381 -0.372 . . . . 1.57 110.391 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 96.3 mtt180 -77.76 -28.73 50.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 3.34 110.94 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 42' ' ' GLN . 87.2 mt -64.86 -33.85 76.99 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.784 -0.821 . . . . 1.25 108.784 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 -24.03 6.79 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.078 -0.965 . . . . 2.3 113.044 171.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.87 11.6 60.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.967 -0.635 . . . . 2.57 112.12 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -78.42 150.47 33.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.137 -0.32 . . . . 2.08 110.137 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -67.46 -50.15 60.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.298 -0.41 . . . . 5.36 111.16 -173.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.62 -34.54 78.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 2.99 110.808 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -66.1 -48.67 70.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.699 -0.682 . . . . 2.75 109.844 -178.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.806 HD22 HD22 ' A' ' 21' ' ' LEU . 76.8 mt -72.07 -24.2 61.47 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.05 -0.977 . . . . 1.9 111.238 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 49' ' ' ARG . 74.7 mt -62.37 -43.92 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.769 -0.456 . . . . 2.74 109.769 172.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.06 -25.76 65.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 1.5 110.319 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.69 ' HB2' ' HA ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -71.56 -29.76 65.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 1.32 110.202 -178.303 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 5.5 tp -84.27 -40.15 18.36 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.444 -0.798 . . . . 1.68 110.619 172.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -56.89 -28.97 62.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.276 -0.875 . . . . 4.07 111.156 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 11.8 pt20 -68.21 -20.36 64.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.357 -0.838 . . . . 1.75 111.594 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.8 tp -89.23 -6.44 56.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.352 -0.385 . . . . 2.47 110.718 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 14.7 mm100 -67.83 120.58 74.78 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.235 -0.439 . . . . 2.58 110.605 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 12.8 Cg_exo -69.94 94.62 0.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.622 2.214 . . . . 2.48 112.004 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.7 p -73.24 -15.86 61.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.922 -0.581 . . . . 4.06 111.008 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -65.48 149.4 50.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.115 -0.493 . . . . 5.86 110.329 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -96.47 23.81 6.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.84 0.353 . . . . 8.21 111.523 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.81 -68.81 2.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.661 -0.781 . . . . 10.39 112.494 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.66 -167.97 24.94 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.747 -0.739 . . . . 11.32 111.722 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.5 t -137.59 63.68 1.54 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.37 0.605 . . . . 13.15 110.473 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.44 92.23 3.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.333 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.93 -49.15 9.93 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.377 -0.601 . . . . 16.24 109.377 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.74 102.04 5.92 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.305 -0.861 . . . . 16.76 110.421 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.29 48.55 2.92 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.717 2.278 . . . . 18.72 110.885 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.75 122.34 33.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.224 -0.898 . . . . 19.52 111.299 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.1 -60.76 1.77 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.605 -0.725 . . . . 20.52 111.426 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -108.03 75.61 1.0 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.063 -0.517 . . . . 23.78 111.774 -173.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 71.07 -69.9 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.508 -0.769 . . . . 22.18 110.806 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.34 25.1 62.22 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.378 -0.374 . . . . 23.17 113.843 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 59.66 78.5 0.27 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.568 0.699 . . . . 26.36 110.992 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.5 tp . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.468 -0.787 . . . . 26.21 109.812 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.23 -0.348 . . . . 14.86 112.23 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.9 109.12 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.137 2.558 . . . . 14.18 112.087 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 39.9 tp -110.12 -14.92 14.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.128 0.49 . . . . 13.74 110.092 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.72 13.03 19.71 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 121.077 -0.582 . . . . 11.08 112.758 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.1 m 67.28 -85.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.288 0.635 . . . . 9.78 111.659 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.9 p -101.45 90.49 4.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.139 0.495 . . . . 8.38 111.432 -175.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.04 -30.33 8.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.631 -0.713 . . . . 5.78 109.314 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.18 -36.15 91.42 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.42 -0.809 . . . . 4.66 112.096 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.22 88.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.886 0.374 . . . . 5.78 110.705 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.507 HD12 ' CE1' ' B' ' 13' ' ' HIS . 63.3 tp -64.22 -46.94 81.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.006 -0.543 . . . . 4.38 110.141 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' B' ' 58' ' ' GLN . 3.2 tm? -59.57 -49.2 78.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 2.86 110.544 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.11 -53.28 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 3.74 111.979 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.507 ' CE1' HD12 ' B' ' 10' ' ' LEU . 11.3 p-80 -71.79 -27.03 62.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.605 -0.438 . . . . 5.05 111.068 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.5 73.2 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.199 -0.297 . . . . 3.33 110.199 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -36.54 83.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.03 -0.532 . . . . 4.37 110.473 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -58.64 -39.45 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.695 -0.684 . . . . 6.1 110.701 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -82.61 -25.22 33.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 6.49 110.871 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.0 27.91 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.781 -0.723 . . . . 4.73 111.939 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' B' ' 17' ' ' LEU . 47.7 t -77.71 121.84 31.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.687 -0.486 . . . . 3.6 109.687 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 78.1 mtt180 -122.59 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.317 -0.401 . . . . 6.8 110.427 -175.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.723 HD22 HD22 ' B' ' 52' ' ' LEU . 5.9 mp -136.27 124.7 23.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 3.8 110.219 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' TRP . . . . . 0.726 ' HB3' HD13 ' B' ' 56' ' ' LEU . 30.0 p90 -142.23 140.81 32.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 6.8 110.329 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.39 123.16 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.227 0.537 . . . . 7.74 110.337 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.611 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 2.8 tm-20 -111.91 100.66 9.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.884 -0.784 . . . . 9.44 108.884 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.55 -87.42 0.27 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.801 -0.636 . . . . 9.66 112.137 -177.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -116.25 -31.82 5.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.308 0.575 . . . . 9.32 110.725 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -106.26 128.42 53.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 7.34 111.659 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.601 HD11 HD23 ' B' ' 21' ' ' LEU . 3.2 tm? -64.97 123.5 19.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.874 -1.057 . . . . 5.18 109.648 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.611 ' NH1' ' HB3' ' B' ' 24' ' ' GLU . 8.1 mpt_? -95.75 130.5 42.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.749 -0.463 . . . . 8.07 109.749 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.544 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -106.49 150.13 26.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.059 -0.519 . . . . 4.16 110.134 -176.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.605 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 56.9 tp60 -149.16 112.06 4.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.742 -0.466 . . . . 6.72 109.742 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -148.67 135.04 10.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.628 -0.26 . . . . 5.75 110.78 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.515 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.0 Cg_exo -60.54 153.62 59.82 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.752 2.301 . . . . 6.98 112.458 176.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.621 ' HB3' HG22 ' A' ' 38' ' ' THR . 19.3 Cg_endo -60.83 123.19 12.47 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.557 2.172 . . . . 8.85 112.52 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.71 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.674 -0.774 . . . . 8.09 113.281 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.635 ' HB ' HD13 ' B' ' 17' ' ' LEU . 18.9 m -80.62 -7.53 10.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 117.03 0.415 . . . . 7.0 111.935 -173.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.57 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.6 OUTLIER -82.84 20.14 1.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.344 -0.389 . . . . 5.73 111.692 -173.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 34' ' ' PRO . 38.0 p -51.28 144.75 15.06 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.719 0.295 . . . . 7.96 111.603 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.96 -30.59 59.51 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.805 2.336 . . . . 7.3 112.188 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 17.6 tp10 -59.56 -50.0 75.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.932 -0.576 . . . . 9.22 109.789 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 36' ' ' VAL . 3.1 tp -63.5 -45.8 89.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 6.17 110.14 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -56.97 -41.03 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 4.84 111.036 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -70.0 -31.75 69.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.301 -0.408 . . . . 7.35 110.622 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 99.4 mtt180 -76.9 -28.84 55.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.523 -0.308 . . . . 8.28 110.883 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 94.5 mt -64.62 -33.56 76.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.114 -0.699 . . . . 4.13 109.114 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.93 -23.09 8.17 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.127 -0.942 . . . . 5.58 112.824 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.1 8.64 54.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.983 -0.627 . . . . 4.5 112.208 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.47 149.82 36.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.975 0.417 . . . . 5.41 110.429 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.555 ' O ' HG13 ' B' ' 53' ' ' ILE . 0.3 OUTLIER -62.72 -49.96 72.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.838 -0.619 . . . . 8.22 111.665 -175.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -66.18 -33.48 75.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.644 0.239 . . . . 7.16 111.644 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.95 -45.01 75.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 5.72 110.51 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.723 HD22 HD22 ' B' ' 21' ' ' LEU . 53.2 mt -73.97 -23.74 59.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.483 . . . . 3.06 111.34 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 49' ' ' ARG . 71.3 mt -64.16 -41.9 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.615 -0.513 . . . . 6.4 109.615 171.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.18 -31.44 70.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 3.73 110.534 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.681 ' HB2' ' HA ' ' B' ' 52' ' ' LEU . 1.1 mm? -63.32 -34.52 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.838 -0.619 . . . . 2.46 110.82 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.726 HD13 ' HB3' ' B' ' 22' ' ' TRP . 34.5 tp -79.46 -41.8 26.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 5.56 110.506 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -61.45 -20.84 63.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.482 -0.781 . . . . 7.19 111.638 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 24.7 pt20 -77.72 -20.85 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.788 0.328 . . . . 4.23 110.613 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.2 tp -85.46 -11.72 53.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 6.46 110.362 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 13.7 mm100 -64.13 117.78 39.8 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.475 -0.784 . . . . 7.35 110.547 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 16.8 Cg_exo -67.32 108.02 1.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.616 2.21 . . . . 8.17 111.651 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.3 p -88.71 -13.23 40.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.449 0.642 . . . . 8.89 109.356 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -62.41 149.45 42.49 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.318 -0.855 . . . . 9.76 110.296 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -97.31 27.12 4.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.754 0.311 . . . . 11.21 111.715 -174.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.53 -60.63 4.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.865 -0.683 . . . . 12.71 112.364 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.28 -174.33 46.25 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.102 -0.57 . . . . 13.61 111.933 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -131.44 79.72 1.89 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.451 . . . . 15.17 110.679 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 9.7 mp -124.19 85.85 2.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.034 -0.53 . . . . 16.82 110.289 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.67 -44.67 27.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.088 0.47 . . . . 18.11 109.973 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.6 89.52 11.77 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 19.0 110.673 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.03 177.12 8.16 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.022 2.481 . . . . 20.29 111.971 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -155.79 139.89 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 21.13 110.055 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.18 96.1 4.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.36 -0.382 . . . . 22.9 110.648 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -76.87 114.28 15.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 25.06 110.543 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -128.48 95.59 4.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 24.46 111.032 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.7 -150.43 46.42 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.945 -0.645 . . . . 24.61 112.737 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -101.28 -38.56 8.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.076 0.465 . . . . 27.27 109.829 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.748 -0.66 . . . . 26.96 110.209 -178.209 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 111.63 -0.588 . . . . 11.48 111.63 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.01 -14.27 32.02 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.667 2.244 . . . . 10.23 112.827 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.85 169.21 18.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.76 0.314 . . . . 10.02 110.862 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.03 -71.02 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.521 -1.031 . . . . 6.89 110.521 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 p -156.35 154.19 30.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.157 -0.683 . . . . 6.02 109.157 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -79.01 76.05 5.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.315 0.579 . . . . 3.51 109.71 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.62 -45.43 75.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.569 -0.742 . . . . 2.5 111.476 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.62 -46.93 92.6 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.127 -0.559 . . . . 2.13 112.37 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.0 -41.31 77.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 2.19 110.995 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.671 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 28.2 tp -62.9 -47.3 83.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 1.68 110.667 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.14 -44.46 95.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.843 -0.617 . . . . 1.71 109.584 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.17 80.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.008 -0.542 . . . . 1.75 112.148 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.671 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 7.0 p80 -71.67 -28.4 63.71 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.415 -0.514 . . . . 1.78 110.617 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.29 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 1.09 109.927 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.0 75.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.46 110.762 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 t -65.54 -38.14 88.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.081 -0.509 . . . . 2.28 110.224 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 92.2 mt -73.99 -24.77 59.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 1.65 109.941 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.56 31.93 17.36 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.618 -0.719 . . . . 1.28 112.461 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.41 ' O ' HD11 ' A' ' 55' ' ' LEU . 47.2 t -71.2 132.89 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.965 -0.754 . . . . 0.99 108.965 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.741 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 44.6 mtt180 -129.99 134.15 47.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.914 -0.402 . . . . 2.67 109.914 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.694 HD22 HD13 ' A' ' 52' ' ' LEU . 6.0 mp -137.14 127.36 26.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.45 109.563 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.533 ' HB3' HD13 ' A' ' 56' ' ' LEU . 24.2 p90 -146.61 137.01 23.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.013 0.435 . . . . 2.26 110.325 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -79.56 124.0 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.149 0.499 . . . . 2.92 110.402 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.24 105.25 8.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 4.2 109.568 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.66 -112.22 4.33 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.395 -0.907 . . . . 4.2 111.403 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -104.19 -18.8 14.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.15 110.8 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -107.05 127.05 53.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.495 0.664 . . . . 5.38 111.35 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.499 HD21 HD23 ' A' ' 21' ' ' LEU . 9.7 tt -74.68 114.42 13.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.479 -0.782 . . . . 2.44 109.269 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 9.1 mmm180 -80.47 139.53 36.37 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.752 -0.462 . . . . 4.22 109.752 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -124.25 132.72 53.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 1.69 109.73 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.741 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 56.7 tp60 -127.47 114.75 17.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.574 -0.528 . . . . 2.68 109.574 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -142.53 127.71 10.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.342 -0.39 . . . . 1.69 110.893 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 36' ' ' VAL . 32.1 Cg_exo -60.42 156.49 40.97 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.934 2.422 . . . . 1.84 111.705 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' B' ' 38' ' ' THR . 30.0 Cg_endo -65.76 123.36 11.25 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.268 1.979 . . . . 2.31 112.39 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' THR . . . 106.89 -37.13 3.98 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.777 -0.725 . . . . 1.76 113.406 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 33' ' ' PRO . 35.8 m -75.82 -15.69 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.682 0.623 . . . . 1.49 112.682 -173.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.501 ' HE2' ' HA ' ' A' ' 37' ' ' MET . 9.1 tpp -84.57 23.27 1.16 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.294 0.569 . . . . 1.41 111.311 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.679 HG22 ' HB3' ' B' ' 34' ' ' PRO . 17.8 p -50.7 143.73 14.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.45 110.39 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.79 -30.17 45.82 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.801 2.334 . . . . 1.72 112.435 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.626 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 8.4 tp10 -60.54 -47.4 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 2.76 110.106 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 36' ' ' VAL . 4.0 tp -58.08 -49.55 76.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.793 0.33 . . . . 1.2 110.572 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 45' ' ' LEU . 18.3 tp60 -60.45 -36.11 77.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.939 -0.573 . . . . 2.06 110.754 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.5 t -64.18 -32.61 74.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.012 0.434 . . . . 1.57 110.039 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 19.9 mmt180 -78.92 -40.38 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 3.34 110.873 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 42' ' ' GLN . 84.6 mt -52.82 -37.24 59.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.979 -0.748 . . . . 1.25 108.979 171.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.69 -22.84 8.32 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.231 -0.895 . . . . 2.3 112.048 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.71 14.21 72.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.978 -0.63 . . . . 2.57 112.229 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -79.38 148.42 32.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.935 -0.394 . . . . 2.08 109.935 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 1.6 ptm180 -69.76 -51.2 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.459 -0.337 . . . . 5.36 111.745 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -56.99 -34.86 68.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.148 0.499 . . . . 2.99 110.564 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -65.82 -49.96 66.37 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.639 -0.709 . . . . 2.75 110.316 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 21' ' ' LEU . 87.4 mt -75.21 -24.54 57.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.965 -1.016 . . . . 1.9 111.284 -174.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.9 mt -63.68 -42.91 97.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.852 -0.425 . . . . 2.74 109.852 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.57 76.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.316 0.579 . . . . 1.5 110.133 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.653 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.4 tm? -70.74 -31.67 68.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 1.32 109.508 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.623 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.7 tp -79.2 -36.72 39.7 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.993 -0.549 . . . . 1.68 109.737 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -55.5 -29.62 59.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 4.07 111.251 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.3 pt20 -56.1 -34.3 65.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.5 -0.318 . . . . 1.75 111.183 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.67 HD11 ' HB3' ' A' ' 20' ' ' ARG . 79.2 mt -83.72 -5.46 59.2 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.887 0.328 . . . . 2.47 111.887 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 97.1 mt-30 -90.35 127.05 54.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 110.337 -0.246 . . . . 2.58 110.337 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 8.1 Cg_exo -72.52 34.19 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.363 2.709 . . . . 2.48 112.911 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -90.62 25.66 2.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.166 0.507 . . . . 4.06 109.843 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 m -60.55 125.23 22.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.38 -0.827 . . . . 5.86 111.725 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -123.44 -146.98 0.37 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.449 -0.796 . . . . 8.21 109.237 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.54 76.16 0.98 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.526 -0.845 . . . . 10.39 111.847 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.25 -128.22 8.37 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.267 -0.733 . . . . 11.32 111.267 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.5 t -99.01 7.64 45.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.008 0.432 . . . . 13.15 109.973 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.99 152.38 26.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.056 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.431 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.9 pt? -121.86 8.77 9.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.08 0.467 . . . . 16.24 110.589 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -81.65 135.75 49.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 16.76 111.687 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 4.4 Cg_exo -77.81 90.24 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.264 2.643 . . . . 18.72 109.98 173.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 p -105.92 138.12 32.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.532 -0.758 . . . . 19.52 110.92 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.38 -67.87 0.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.594 . . . . 20.52 111.346 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -170.02 54.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.682 0.754 . . . . 23.78 109.97 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.472 HD22 ' HB2' ' A' ' 78' ' ' LEU . 7.1 p-10 -149.76 126.06 10.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.607 -0.724 . . . . 22.18 110.686 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.55 -42.36 99.75 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.377 -0.828 . . . . 23.17 113.063 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -162.99 86.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.835 0.35 . . . . 26.36 110.897 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.472 ' HB2' HD22 ' A' ' 75' ' ' ASN . 35.7 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 115.689 -0.687 . . . . 26.21 109.849 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 112.07 -0.412 . . . . 14.86 112.07 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.33 148.13 93.78 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.912 2.408 . . . . 14.18 112.669 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 52.1 tp 66.24 -83.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.635 -0.711 . . . . 13.74 111.469 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.13 -82.53 0.35 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.885 -0.674 . . . . 11.08 111.7 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t 58.66 40.22 23.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.876 -0.416 . . . . 9.78 109.876 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 54.1 m 70.04 -53.96 0.62 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.266 -0.879 . . . . 8.38 111.118 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.85 113.92 5.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.683 0.278 . . . . 5.78 110.495 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.76 98.69 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 116.048 -0.524 . . . . 4.66 112.945 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.2 93.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 5.78 110.81 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.524 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 56.0 tp -60.85 -47.52 86.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.056 -0.52 . . . . 4.38 110.47 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.97 -43.44 92.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.732 -0.667 . . . . 2.86 109.653 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.33 -51.43 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.639 . . . . 3.74 112.315 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.524 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 14.2 p80 -72.52 -28.22 62.73 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.334 -0.546 . . . . 5.05 110.934 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.85 -43.43 75.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.189 0.519 . . . . 3.33 110.054 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.71 76.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.477 -0.783 . . . . 4.37 110.806 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -67.57 -34.33 76.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.053 -0.521 . . . . 6.1 110.308 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.565 HD13 ' HB ' ' B' ' 36' ' ' VAL . 86.7 mt -75.85 -24.34 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 6.49 110.426 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.86 28.43 21.2 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.785 -0.722 . . . . 4.73 112.389 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.407 ' O ' HD11 ' B' ' 55' ' ' LEU . 46.2 t -72.11 132.74 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.471 -0.566 . . . . 3.6 109.471 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.851 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 76.6 mtt180 -130.48 132.9 45.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.592 0.234 . . . . 6.8 110.971 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.585 HD22 HD13 ' B' ' 52' ' ' LEU . 5.7 mp -137.98 127.45 24.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.843 -0.429 . . . . 3.8 109.843 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' TRP . . . . . 0.665 ' HB3' HD13 ' B' ' 56' ' ' LEU . 29.3 p90 -147.78 139.97 24.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.932 0.396 . . . . 6.8 110.361 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.3 p -78.65 130.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.155 0.502 . . . . 7.74 110.405 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -132.16 101.0 5.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 9.44 109.668 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.74 -110.3 3.27 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.691 -0.766 . . . . 9.66 111.364 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.76 -11.69 16.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.701 0.286 . . . . 9.32 111.077 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.12 123.31 48.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 7.34 111.054 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 9.1 tt -74.64 115.07 13.78 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.329 -0.619 . . . . 5.18 109.329 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -79.89 139.31 37.17 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.006 -0.368 . . . . 8.07 110.006 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -122.14 133.2 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.457 -0.571 . . . . 4.16 109.457 -177.164 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.851 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 55.3 tp60 -129.81 112.52 13.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.63 -0.508 . . . . 6.72 109.63 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.05 133.1 16.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 5.75 111.136 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.45 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.2 Cg_exo -62.98 153.58 72.58 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.056 2.504 . . . . 6.98 112.007 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.679 ' HB3' HG22 ' A' ' 38' ' ' THR . 30.3 Cg_endo -63.77 123.95 12.82 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.421 2.081 . . . . 8.85 112.725 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 -36.85 4.13 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.597 -0.811 . . . . 8.09 113.455 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.565 ' HB ' HD13 ' B' ' 17' ' ' LEU . 23.3 m -78.96 -9.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.017 0.377 . . . . 7.0 112.017 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.85 19.98 1.26 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 5.73 111.35 -176.009 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 34' ' ' PRO . 10.6 p -51.04 144.7 13.62 Favored Pre-proline 0 C--O 1.236 0.387 0 CA-C-N 116.442 -0.344 . . . . 7.96 111.094 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.99 -30.71 49.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.819 2.346 . . . . 7.3 112.304 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 11.7 tp10 -60.42 -43.64 96.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 9.22 110.556 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.527 HD22 ' O ' ' B' ' 36' ' ' VAL . 11.1 tp -62.43 -46.19 89.7 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 110.234 -0.284 . . . . 6.17 110.234 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' B' ' 45' ' ' LEU . 18.9 tp60 -61.73 -37.55 84.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.169 -0.469 . . . . 4.84 110.378 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -63.06 -35.17 79.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.38 -0.373 . . . . 7.35 110.343 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 16.7 mmt180 -77.54 -39.95 44.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 8.28 110.868 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' B' ' 42' ' ' GLN . 86.3 mt -56.81 -36.01 69.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 4.13 109.625 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.67 -22.95 8.09 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.162 -0.926 . . . . 5.58 112.219 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.44 75.73 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.083 -0.58 . . . . 4.5 111.863 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.69 149.93 29.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.217 -0.29 . . . . 5.41 110.217 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 53' ' ' ILE . 2.0 ptm180 -68.67 -48.86 62.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 8.22 111.182 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -60.07 -36.52 77.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.846 0.313 . . . . 7.16 111.846 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -47.11 80.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.114 0.483 . . . . 5.72 110.718 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.585 HD13 HD22 ' B' ' 21' ' ' LEU . 86.0 mt -75.33 -24.77 57.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 3.06 111.616 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 49' ' ' ARG . 83.1 mt -66.67 -39.57 84.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.946 -0.39 . . . . 6.4 109.946 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.89 83.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.201 0.524 . . . . 3.73 110.207 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.71 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.1 tm? -63.38 -34.93 78.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.247 -0.888 . . . . 2.46 110.02 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' B' ' 22' ' ' TRP . 17.8 tp -73.24 -38.67 65.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 5.56 110.473 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -57.18 -28.63 62.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 7.19 111.985 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 17.5 pt20 -60.92 -26.37 67.43 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.887 -0.325 . . . . 4.23 110.905 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.63 -7.28 56.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.331 -0.395 . . . . 6.46 111.052 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.479 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 96.8 mt-30 -90.78 131.64 37.02 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.412 -0.358 . . . . 7.35 110.414 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 7.0 Cg_exo -75.22 30.8 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.77 2.98 . . . . 8.17 112.82 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -88.3 22.42 2.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.36 0.6 . . . . 8.89 109.569 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 5.9 m -59.55 117.71 5.21 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.45 -0.796 . . . . 9.76 111.211 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -113.75 -146.94 0.41 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.302 -0.629 . . . . 11.21 109.302 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.13 80.73 0.71 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.916 -0.659 . . . . 12.71 111.574 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.98 -125.12 7.68 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.122 -0.791 . . . . 13.61 111.122 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 22.9 t -105.29 11.27 33.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.174 0.512 . . . . 15.17 110.062 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.13 139.24 30.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.854 -0.612 . . . . 16.82 109.762 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.72 HD23 ' H ' ' B' ' 69' ' ' LEU . 2.3 pt? -102.75 7.21 39.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.407 -0.36 . . . . 18.11 110.934 -176.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' B' ' 71' ' ' PRO . . . -69.53 128.55 92.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 19.0 109.888 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 70' ' ' ALA . 34.4 Cg_exo -57.4 103.38 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.83 2.353 . . . . 20.29 112.615 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.9 m -86.14 96.41 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.634 0.73 . . . . 21.13 110.394 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.29 51.72 0.77 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.421 -0.808 . . . . 22.9 110.658 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 69.17 19.91 7.76 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.784 0.802 . . . . 25.06 110.072 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.55 81.94 5.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.531 -0.758 . . . . 24.46 110.048 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.57 169.19 17.53 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.366 -0.834 . . . . 24.61 111.855 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -88.29 80.05 7.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.337 0.589 . . . . 27.27 109.502 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.293 -0.867 . . . . 26.96 110.199 -176.811 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.037 -0.425 . . . . 11.48 112.037 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 21.0 Cg_exo -65.73 119.28 6.29 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.685 2.257 . . . . 10.23 111.608 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.45 -38.98 25.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.094 -0.503 . . . . 10.02 110.574 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.14 95.39 0.42 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.003 -0.618 . . . . 6.89 112.214 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -78.73 84.04 4.84 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 122.28 0.232 . . . . 6.02 110.964 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.8 m 55.36 74.77 0.35 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.667 -0.697 . . . . 3.51 112.127 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.28 -37.96 81.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 2.5 110.849 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.38 92.36 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.049 -0.523 . . . . 2.13 111.909 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.06 -41.7 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 2.19 110.728 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.692 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 51.0 tp -62.12 -46.4 89.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 1.68 110.317 176.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.16 -47.36 86.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.391 -0.822 . . . . 1.71 110.115 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.33 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 1.75 112.116 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.692 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.9 p80 -69.94 -27.07 64.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.884 0.373 . . . . 1.78 110.216 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.12 -36.88 66.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 1.09 110.284 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.52 83.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.948 -0.569 . . . . 1.46 111.146 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 p -67.0 -21.93 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 2.28 111.515 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.15 -25.07 15.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.189 0.518 . . . . 1.65 110.447 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.76 37.38 13.64 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 1.28 112.636 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.25 120.15 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.992 -0.744 . . . . 0.99 108.992 174.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.552 ' HB3' HD22 ' A' ' 59' ' ' LEU . 20.7 mtt180 -120.07 128.89 53.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.57 -0.286 . . . . 2.67 110.69 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -133.03 124.11 27.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.484 -0.562 . . . . 1.45 109.484 173.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HB3' HD13 ' A' ' 56' ' ' LEU . 27.3 p90 -141.48 143.15 33.68 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.937 -0.394 . . . . 2.26 109.937 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.27 129.81 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.689 -0.486 . . . . 2.92 109.689 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 14.2 tp10 -136.91 120.2 16.82 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.375 -0.602 . . . . 4.2 109.375 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.9 -105.04 1.36 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.824 -0.703 . . . . 4.2 111.82 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.86 -3.06 11.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.69 0.255 . . . . 5.15 111.69 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 9.4 tpp180 -129.19 152.18 49.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 5.38 112.116 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.461 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -75.7 122.34 23.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.046 -0.979 . . . . 2.44 108.618 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.2 mpt_? -99.03 131.08 45.34 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.366 -0.605 . . . . 4.22 109.366 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -108.21 154.07 22.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 1.69 110.245 -172.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 7.1 tp-100 -153.25 110.43 3.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.805 -0.442 . . . . 2.68 109.805 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.74 134.98 26.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.122 -0.49 . . . . 1.69 110.66 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.575 ' HD2' HG21 ' A' ' 36' ' ' VAL . 37.0 Cg_exo -61.91 156.09 51.05 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.612 2.208 . . . . 1.84 111.555 172.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.519 ' HB3' HG22 ' B' ' 38' ' ' THR . 22.9 Cg_endo -63.79 123.3 11.75 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.267 1.978 . . . . 2.31 112.305 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' THR . . . 106.88 -37.68 3.7 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.936 -0.649 . . . . 1.76 113.448 173.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG21 ' HD2' ' A' ' 33' ' ' PRO . 33.8 m -70.65 -20.3 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.518 0.562 . . . . 1.49 112.518 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.4 tpp -82.61 24.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.022 0.439 . . . . 1.41 111.446 -173.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.491 HG22 ' HB3' ' B' ' 34' ' ' PRO . 8.3 p -49.69 143.08 11.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 1.45 110.872 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.648 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 82.6 Cg_exo -45.76 -40.76 19.51 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.299 2.666 . . . . 1.72 113.773 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 8.9 pt-20 -61.89 -44.61 96.45 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 120.736 0.303 . . . . 2.76 110.525 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.417 ' N ' ' HG3' ' A' ' 40' ' ' GLU . 3.0 tt -67.69 -44.82 76.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.334 0.588 . . . . 1.2 109.908 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -56.17 -41.7 75.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.578 -1.192 . . . . 2.06 110.548 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -72.8 -29.24 63.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.927 -0.579 . . . . 1.57 111.042 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.8 mtp180 -75.84 -28.08 58.11 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.956 -0.298 . . . . 3.34 111.017 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.69 -43.77 98.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.536 -0.542 . . . . 1.25 109.536 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.9 -23.61 5.77 Favored Glycine 0 C--N 1.329 0.158 0 CA-C-N 115.644 -0.707 . . . . 2.3 112.97 171.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.41 18.11 69.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.907 -0.663 . . . . 2.57 112.47 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -72.72 147.8 45.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.121 -0.325 . . . . 2.08 110.121 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 22.9 ptt180 -68.34 -50.67 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.334 -0.393 . . . . 5.36 111.644 -172.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.433 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 11.9 p80 -60.23 -36.06 76.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.739 0.781 . . . . 2.99 110.048 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.63 -42.75 70.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.608 -1.178 . . . . 2.75 110.214 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 63.3 mt -70.4 -25.41 63.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.598 -0.728 . . . . 1.9 110.822 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.1 mt -60.5 -50.03 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.792 -0.447 . . . . 2.74 109.792 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.15 70.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.199 0.523 . . . . 1.5 110.758 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.425 HD13 ' O ' ' A' ' 55' ' ' LEU . 2.6 tm? -71.09 -40.6 71.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.801 . . . . 1.32 109.959 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.2 tp -77.23 -31.31 55.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.952 -0.567 . . . . 1.68 109.756 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -61.81 -31.22 71.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 4.07 110.506 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.61 -29.62 70.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.522 . . . . 1.75 110.613 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 20' ' ' ARG . 29.7 tp -90.02 -2.87 58.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 2.47 110.553 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 96.0 mt-30 -114.07 130.54 23.81 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.108 -0.496 . . . . 2.58 110.617 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 8.1 Cg_exo -74.18 -9.9 22.24 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.606 2.204 . . . . 2.48 112.095 175.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.5 t -95.96 151.8 19.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.027 -0.533 . . . . 4.06 109.873 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.7 m 66.34 82.85 0.18 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.726 0.641 . . . . 5.86 111.929 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -97.82 -22.7 16.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.926 -0.579 . . . . 8.21 110.381 175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.83 -90.84 0.31 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.825 -0.703 . . . . 10.39 111.795 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.67 119.52 1.88 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.931 -0.652 . . . . 11.32 112.498 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 p -114.6 107.56 15.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.124 0.488 . . . . 13.15 110.616 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.67 91.38 3.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.936 -0.575 . . . . 15.0 109.872 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.77 4.99 1.34 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.449 -0.796 . . . . 16.24 110.757 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -75.65 133.3 73.77 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.083 -0.508 . . . . 16.76 110.647 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 6.3 Cg_exo -73.48 107.05 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.76 2.307 . . . . 18.72 110.466 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.35 104.35 6.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.786 0.803 . . . . 19.52 110.787 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -52.77 15.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.111 -0.95 . . . . 20.52 110.999 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 74' ' ' ARG . 1.3 ptm180 -176.11 -32.67 0.01 OUTLIER 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.157 -0.474 . . . . 23.78 111.152 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.4 m120 66.96 -175.69 0.19 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.358 0.599 . . . . 22.18 111.411 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.44 -123.26 6.38 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 109.732 -1.347 . . . . 23.17 109.732 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -157.22 -46.54 0.07 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.384 -0.969 . . . . 26.36 108.384 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.5 tp . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.06 -0.973 . . . . 26.21 109.85 172.778 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 111.756 -0.538 . . . . 14.86 111.756 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.62 153.63 10.32 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.033 2.489 . . . . 14.18 112.578 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 86.6 mt -75.31 -48.13 24.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.844 -0.798 . . . . 13.74 108.844 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.45 -133.81 12.15 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.305 -0.861 . . . . 11.08 113.038 173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.3 m -116.43 103.99 11.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.603 -0.299 . . . . 9.78 111.779 -170.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 29.9 m -81.73 106.63 13.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.991 -1.115 . . . . 8.38 107.991 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' B' ' 10' ' ' LEU . . . -64.83 106.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.159 -0.473 . . . . 5.78 112.233 -168.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.57 99.35 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.626 -0.715 . . . . 4.66 112.012 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.38 92.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 5.78 110.906 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' B' ' 7' ' ' ALA . 57.1 tp -64.29 -45.91 85.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.567 . . . . 4.38 109.844 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.78 -47.08 87.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 2.86 110.114 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -52.85 63.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 3.74 112.291 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 5.0 p80 -72.45 -26.34 61.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.566 -0.453 . . . . 5.05 110.963 -176.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.33 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 3.33 110.093 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -37.39 82.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.79 -0.641 . . . . 4.37 111.292 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 12.3 p -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 6.1 111.282 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.565 HD13 ' HB ' ' B' ' 36' ' ' VAL . 93.4 mt -91.7 -25.17 19.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 6.49 110.548 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 84.7 35.65 13.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.843 -0.694 . . . . 4.73 112.51 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.4 124.62 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.396 -0.594 . . . . 3.6 109.396 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 30.4 mtt180 -124.01 127.85 48.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.776 0.322 . . . . 6.8 111.194 -171.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.1 mp -135.15 124.74 25.08 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.476 -0.564 . . . . 3.8 109.476 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' TRP . . . . . 0.567 ' HB3' HD13 ' B' ' 56' ' ' LEU . 26.5 p90 -143.63 143.6 31.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.881 0.372 . . . . 6.8 110.712 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.15 124.73 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.123 0.487 . . . . 7.74 110.076 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.597 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 10.8 tp10 -130.98 118.28 20.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.614 -0.513 . . . . 9.44 109.614 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 -104.26 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.76 -0.733 . . . . 9.66 111.803 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -4.86 11.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.79 0.329 . . . . 9.32 111.763 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.463 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 8.5 tpp180 -130.33 148.69 52.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.343 0.592 . . . . 7.34 111.872 -170.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.501 HD11 HD23 ' B' ' 21' ' ' LEU . 3.0 tm? -73.48 115.96 13.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.154 -0.93 . . . . 5.18 108.735 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ARG . . . . . 0.597 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 6.2 mpt_? -90.81 132.59 35.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.895 -0.409 . . . . 8.07 109.895 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.506 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.0 OUTLIER -109.78 152.23 25.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.922 -0.581 . . . . 4.16 110.263 -173.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.634 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 7.0 tp-100 -152.65 110.02 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.836 -0.431 . . . . 6.72 109.836 172.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.09 137.04 29.23 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.288 -0.415 . . . . 5.75 111.115 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.436 ' O ' HG22 ' B' ' 36' ' ' VAL . 38.6 Cg_exo -62.75 154.6 64.7 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.675 2.25 . . . . 6.98 111.796 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.648 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 27.9 Cg_endo -63.22 123.52 12.31 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.306 2.004 . . . . 8.85 112.629 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.471 ' O ' HG23 ' B' ' 38' ' ' THR . . . 105.5 -37.46 3.8 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.661 -0.78 . . . . 8.09 113.499 173.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.565 ' HB ' HD13 ' B' ' 17' ' ' LEU . 19.8 m -73.28 -12.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.108 0.454 . . . . 7.0 111.948 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.5 tpp -89.11 22.43 2.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.958 0.409 . . . . 5.73 111.505 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 34' ' ' PRO . 18.7 p -49.06 142.93 9.32 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.433 -0.349 . . . . 7.96 111.149 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -43.76 -42.33 11.75 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.964 3.109 . . . . 7.3 114.187 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.661 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 8.5 pt-20 -59.91 -45.65 91.86 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 121.133 -0.227 . . . . 9.22 110.921 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.506 ' N ' ' HG3' ' B' ' 40' ' ' GLU . 9.2 tt -70.34 -39.7 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.908 -0.404 . . . . 6.17 109.908 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' GLN . . . . . 0.408 ' OE1' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp60 -56.76 -43.51 80.87 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.668 -0.697 . . . . 4.84 110.515 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.3 t -72.14 -31.25 65.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.911 -0.586 . . . . 7.35 110.842 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 65.3 mtp180 -71.51 -28.87 64.2 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.225 -0.19 . . . . 8.28 111.292 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.34 -44.74 86.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.529 0.68 . . . . 4.13 109.328 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.68 -23.75 5.51 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.278 -0.873 . . . . 5.58 112.982 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 18.74 74.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.266 -0.492 . . . . 4.5 112.39 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ALA . . . . . 0.626 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -71.55 148.75 46.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.835 0.317 . . . . 5.41 110.425 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 17.6 ptt180 -68.15 -46.93 69.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.331 -0.395 . . . . 8.22 111.448 -172.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -63.62 -35.64 81.19 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.702 0.287 . . . . 7.16 111.238 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.9 -38.96 69.85 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.658 -0.417 . . . . 5.72 110.302 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' B' ' 48' ' ' ALA . 46.4 mt -70.57 -26.02 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.579 -0.282 . . . . 3.06 110.97 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.6 mt -62.33 -49.44 83.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.753 -0.462 . . . . 6.4 109.753 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.11 86.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 3.73 110.433 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.5 tm? -62.21 -47.06 86.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.557 -0.747 . . . . 2.46 110.259 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' B' ' 22' ' ' TRP . 21.1 tp -66.27 -36.58 83.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.354 -0.385 . . . . 5.56 110.769 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -63.04 -29.27 70.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.415 -0.357 . . . . 7.19 111.361 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 6.9 pt20 -67.28 -27.67 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 4.23 110.261 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' B' ' 20' ' ' ARG . 37.7 tp -88.93 -6.34 57.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 6.46 110.495 -176.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.414 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 95.9 mt-30 -112.31 133.93 21.64 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.916 -0.584 . . . . 7.35 110.618 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 7.4 Cg_exo -73.81 -13.06 24.33 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.797 2.331 . . . . 8.17 111.506 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 43.4 t -91.58 146.76 23.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.889 -0.596 . . . . 8.89 110.568 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 67.5 m 69.25 89.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.896 0.747 . . . . 9.76 111.706 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -107.03 -7.48 16.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.484 -0.78 . . . . 11.21 110.029 174.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.95 -105.1 1.74 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.662 -0.699 . . . . 12.71 111.452 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.12 113.98 3.87 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.761 -0.733 . . . . 13.61 112.162 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.9 p -105.28 107.42 18.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.155 0.502 . . . . 15.17 111.141 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 tp -115.64 96.61 5.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.458 . . . . 16.82 109.863 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.404 HD23 ' N ' ' B' ' 69' ' ' LEU . 2.3 pt? -145.17 -2.74 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 18.11 110.773 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.813 ' HB3' ' HD3' ' B' ' 71' ' ' PRO . . . -93.38 -59.71 0.21 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.409 -0.36 . . . . 19.0 111.644 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' B' ' 70' ' ' ALA . 2.9 Cg_exo -76.33 122.48 6.59 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.275 1.983 . . . . 20.29 111.969 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p 38.35 73.93 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.246 1.018 . . . . 21.13 112.671 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.86 83.26 4.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.363 -0.835 . . . . 22.9 110.704 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' B' ' 77' ' ' ARG . 30.1 mmm180 -127.18 159.03 35.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.916 -0.583 . . . . 25.06 109.429 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -63.47 -47.7 80.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.804 0.335 . . . . 24.46 110.998 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.75 -9.55 56.23 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.659 -0.781 . . . . 24.61 111.641 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.472 ' HA ' ' HB2' ' B' ' 74' ' ' ARG . 63.4 mtm180 71.28 -57.59 0.6 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.007 0.923 . . . . 27.27 111.093 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.092 -0.956 . . . . 26.96 111.087 -179.807 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 111.821 -0.512 . . . . 11.48 111.821 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.81 -178.4 4.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.064 2.509 . . . . 10.23 111.638 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.03 -10.75 59.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.979 0.418 . . . . 10.02 110.385 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.88 152.85 17.91 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.894 -0.594 . . . . 6.89 111.638 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 m -67.34 95.51 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 6.02 110.851 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 p -171.12 163.36 7.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.686 -0.688 . . . . 3.51 109.901 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 73.8 -55.39 0.67 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.937 0.773 . . . . 2.5 111.597 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.48 -44.85 96.37 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.494 -0.384 . . . . 2.13 112.346 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.63 90.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.06 0.457 . . . . 2.19 111.088 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.662 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 57.8 tp -67.91 -46.83 70.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.55 . . . . 1.68 110.492 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.98 -44.59 97.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.672 -0.694 . . . . 1.71 110.052 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.42 73.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 1.75 111.972 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.2 p80 -72.02 -27.79 62.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.519 -0.472 . . . . 1.78 110.231 -175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.15 65.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.51 -0.314 . . . . 1.09 110.319 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.21 85.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.46 110.813 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -59.82 -43.94 94.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.976 -0.556 . . . . 2.28 110.764 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 36' ' ' VAL . 84.2 mt -80.97 -25.63 37.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.327 . . . . 1.65 110.781 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.42 31.09 9.88 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.606 -0.806 . . . . 1.28 112.98 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.406 HG13 ' HE1' ' A' ' 30' ' ' PHE . 57.8 t -75.17 112.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.525 -0.546 . . . . 0.99 109.525 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.743 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 68.1 mtp180 -123.39 133.49 54.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 2.67 110.54 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.2 mp -132.73 127.39 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 1.45 110.674 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HB3' HD13 ' A' ' 56' ' ' LEU . 18.0 p90 -150.85 145.34 25.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.209 -0.663 . . . . 2.26 109.209 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.2 p -93.22 128.92 44.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.208 0.528 . . . . 2.92 111.036 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.35 106.8 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 4.2 109.206 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.5 -107.3 2.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.118 -0.793 . . . . 4.2 111.118 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.1 -6.78 11.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.206 0.527 . . . . 5.15 110.093 177.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -102.36 118.17 36.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 5.38 110.758 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 7.8 tt -70.38 118.59 13.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.331 -0.988 . . . . 2.44 108.331 170.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.74 129.24 34.88 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.601 -0.518 . . . . 4.22 109.601 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.406 ' HE1' HG13 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -114.75 130.74 56.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.114 -0.494 . . . . 1.69 109.867 -177.222 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.743 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 8.3 tp60 -123.35 110.24 14.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.458 -0.571 . . . . 2.68 109.458 177.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.56 130.37 6.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.376 -0.374 . . . . 1.69 110.601 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' HG22 ' A' ' 36' ' ' VAL . 34.1 Cg_endo -69.24 157.91 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.646 2.231 . . . . 1.84 111.502 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.31 122.92 11.03 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.556 2.17 . . . . 2.31 112.328 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -15.36 27.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.956 -0.64 . . . . 1.76 113.167 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 33' ' ' PRO . 19.1 m -100.3 -8.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.399 0.599 . . . . 1.49 112.162 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.529 ' HA ' ' CE ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.58 20.8 2.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.181 -0.463 . . . . 1.41 111.46 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -56.3 145.63 56.4 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.141 -0.482 . . . . 1.45 111.147 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.35 -38.45 62.65 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.952 2.434 . . . . 1.72 113.043 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 40.6 tt0 -59.61 -47.94 83.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 2.76 110.398 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.67 -42.81 98.0 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.14 0.495 . . . . 1.2 110.665 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HA ' HD12 ' A' ' 45' ' ' LEU . 9.3 tp-100 -56.89 -40.35 76.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.492 -0.776 . . . . 2.06 110.071 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -72.66 -29.51 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.736 -0.666 . . . . 1.57 110.36 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 15.1 mmm180 -65.88 -38.13 87.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.984 0.421 . . . . 3.34 110.604 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 42' ' ' GLN . 60.6 mt -57.29 -25.52 59.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.309 -0.86 . . . . 1.25 110.043 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -22.88 8.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.546 -0.752 . . . . 2.3 112.981 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 25.82 73.45 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.711 -0.756 . . . . 2.57 111.923 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -98.38 149.18 22.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.981 0.42 . . . . 2.08 110.706 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.532 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.44 -46.75 69.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.442 -0.799 . . . . 5.36 111.211 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.514 ' HA ' HD12 ' A' ' 53' ' ' ILE . 19.5 p80 -66.16 -33.28 75.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.391 0.615 . . . . 2.99 109.99 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.7 tp10 -66.73 -42.71 85.86 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.243 -0.889 . . . . 2.75 109.478 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 67.6 mt -67.89 -29.04 68.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.29 -0.868 . . . . 1.9 111.103 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 49' ' ' ARG . 84.1 mt -58.55 -51.55 70.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.096 0.474 . . . . 2.74 109.855 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.24 68.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.743 -0.662 . . . . 1.5 110.827 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.2 tm? -69.43 -40.78 77.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.722 -0.672 . . . . 1.32 109.678 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 22' ' ' TRP . 1.2 tp -79.17 -30.48 43.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.66 -0.496 . . . . 1.68 109.66 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -67.15 -21.38 65.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 4.07 110.372 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -61.76 -28.94 69.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 1.75 110.847 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.583 HD13 ' H ' ' A' ' 59' ' ' LEU . 0.0 OUTLIER -106.82 12.67 28.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.847 -0.741 . . . . 2.47 111.646 178.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 51.1 mt-30 -97.11 127.29 39.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 2.58 110.345 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 12.5 Cg_exo -70.43 8.31 0.95 Allowed 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.93 2.42 . . . . 2.48 113.086 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.7 m -77.31 -26.17 51.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.895 0.378 . . . . 4.06 110.966 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.1 m -117.93 120.35 37.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 5.86 111.131 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -101.63 153.98 19.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.804 -0.635 . . . . 8.21 109.601 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.34 -39.3 6.85 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.684 -0.77 . . . . 10.39 112.091 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.86 60.29 0.54 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 11.32 112.224 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.9 p -109.61 -18.22 13.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.86 0.362 . . . . 13.15 111.519 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 tp -109.74 118.53 36.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.926 0.393 . . . . 15.0 111.059 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 69' ' ' LEU . 4.3 pp -141.75 133.74 27.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.931 -0.577 . . . . 16.24 109.505 175.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.3 94.27 5.27 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.323 -0.399 . . . . 16.76 111.396 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HB2' ' HB3' ' A' ' 75' ' ' ASN . 2.3 Cg_endo -82.44 72.64 5.96 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.978 2.452 . . . . 18.72 109.858 172.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 p -78.37 -16.17 13.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.263 -0.88 . . . . 19.52 110.524 -173.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.08 -50.54 39.93 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.33 -0.619 . . . . 20.52 109.33 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -169.42 122.87 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.921 -0.581 . . . . 23.78 111.121 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 71' ' ' PRO . 8.2 p30 -126.23 171.47 10.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.73 -0.668 . . . . 22.18 109.306 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.2 101.39 1.24 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.476 -0.869 . . . . 23.17 113.472 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -100.28 -9.04 22.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.993 -0.743 . . . . 26.36 108.993 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.534 -1.212 . . . . 26.21 110.465 -179.636 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 N-CA-C 111.845 -0.502 . . . . 14.86 111.845 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.9 115.3 2.85 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.621 2.214 . . . . 14.18 111.342 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 53.1 tp -121.37 -37.25 2.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.047 -0.524 . . . . 13.74 110.084 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.88 -36.79 51.85 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.94 -0.864 . . . . 11.08 110.94 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.0 t 71.43 135.84 0.04 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.562 0.696 . . . . 9.78 112.698 171.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.5 m -92.25 134.42 34.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.827 -0.805 . . . . 8.38 108.827 171.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.83 94.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.492 0.186 . . . . 5.78 111.423 -175.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.62 -50.53 66.68 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.93 -0.652 . . . . 4.66 112.378 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.34 87.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 5.78 111.263 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.525 HD12 ' CE1' ' B' ' 13' ' ' HIS . 68.0 tp -64.72 -46.79 80.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 4.38 110.498 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.08 -46.38 84.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.895 -0.593 . . . . 2.86 109.843 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.51 75.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 3.74 111.838 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' HIS . . . . . 0.525 ' CE1' HD12 ' B' ' 10' ' ' LEU . 4.7 p-80 -73.58 -27.57 61.39 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 5.05 110.674 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.04 61.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.681 0.277 . . . . 3.33 110.367 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.07 82.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 4.37 110.8 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 19.8 t -61.41 -42.98 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 6.1 110.833 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.2 mt -81.2 -24.37 37.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 6.49 110.937 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.7 7.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.748 -0.739 . . . . 4.73 112.344 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.22 113.44 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 3.6 109.531 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 63.1 mtp180 -124.8 134.81 52.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.358 -0.383 . . . . 6.8 110.858 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.483 HD23 HD21 ' B' ' 28' ' ' LEU . 6.2 mp -134.22 128.64 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 3.8 110.767 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' TRP . . . . . 0.72 ' HB3' HD13 ' B' ' 56' ' ' LEU . 26.6 p90 -151.62 143.78 23.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.658 -0.497 . . . . 6.8 109.658 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.1 p -88.92 126.87 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.17 0.51 . . . . 7.74 111.205 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -118.86 106.23 12.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.922 -0.77 . . . . 9.44 108.922 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.14 -106.45 1.84 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 9.66 111.394 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -3.69 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 9.32 110.313 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.405 ' NE ' HD11 ' A' ' 52' ' ' LEU . 6.8 tpt85 -107.76 114.24 28.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 7.34 110.854 -176.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 7.5 tt -68.12 118.9 11.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.5 -0.926 . . . . 5.18 108.5 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -87.34 126.8 35.08 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.679 -0.489 . . . . 8.07 109.679 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' PHE . . . . . 0.469 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -111.57 131.25 55.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.931 -0.577 . . . . 4.16 109.745 -177.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.72 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 55.4 tp60 -124.89 107.92 11.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.235 -0.439 . . . . 6.72 110.079 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.98 129.85 6.64 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.329 -0.396 . . . . 5.75 110.52 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.499 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.6 Cg_endo -67.1 157.45 61.66 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.544 2.163 . . . . 6.98 111.768 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.29 123.75 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.453 2.102 . . . . 8.85 112.529 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.67 -24.68 14.71 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.694 -0.684 . . . . 8.09 113.401 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' B' ' 17' ' ' LEU . 10.4 m -95.25 4.59 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.003 0.402 . . . . 7.0 111.36 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' MET . . . . . 0.672 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.0 OUTLIER -95.91 18.96 12.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 5.73 110.809 -176.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -57.27 145.88 64.81 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 7.96 111.48 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.36 -41.02 52.62 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.312 2.674 . . . . 7.3 113.167 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 35.1 tt0 -57.98 -48.67 79.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.654 -0.248 . . . . 9.22 110.473 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 9.0 tt -66.1 -38.21 87.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 6.17 110.63 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -60.09 -40.45 89.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.735 -0.468 . . . . 4.84 109.735 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -72.57 -29.75 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.758 -0.656 . . . . 7.35 110.556 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 14.4 mmm180 -66.67 -32.66 74.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.502 -0.317 . . . . 8.28 110.657 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 86.3 mt -62.61 -25.36 68.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 4.13 110.032 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.95 -23.67 7.6 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.642 -0.708 . . . . 5.58 112.699 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.42 24.2 73.65 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.856 -0.688 . . . . 4.5 112.155 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.47 149.78 21.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.627 0.251 . . . . 5.41 111.068 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.68 ' HD3' ' H ' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -67.55 -47.56 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 8.22 111.312 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 50' ' ' HIS . . . . . 0.55 ' HA ' HD12 ' B' ' 53' ' ' ILE . 25.0 p80 -60.41 -32.86 71.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.718 0.294 . . . . 7.16 111.485 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -38.66 75.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 5.72 110.312 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 54.9 mt -70.76 -26.18 63.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.46 -0.336 . . . . 3.06 110.961 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 50' ' ' HIS . 83.2 mt -61.76 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.757 -0.46 . . . . 6.4 109.757 174.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.22 80.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.123 0.487 . . . . 3.73 110.676 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.85 -47.6 85.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.489 -0.778 . . . . 2.46 110.168 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' B' ' 22' ' ' TRP . 26.8 tp -67.88 -35.34 78.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.005 0.431 . . . . 5.56 110.717 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.24 -19.47 63.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.274 -0.421 . . . . 7.19 111.256 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.01 -28.22 69.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.55 -0.295 . . . . 4.23 111.424 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.717 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER -107.16 9.55 30.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.881 0.372 . . . . 6.46 110.897 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' B' ' 56' ' ' LEU . 52.3 mt-30 -93.66 128.32 42.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.377 -0.374 . . . . 7.35 110.107 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.62 9.45 1.26 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.225 2.617 . . . . 8.17 112.643 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 7.1 m -75.91 -32.06 59.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.123 0.487 . . . . 8.89 110.601 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 15.5 m -114.31 121.66 44.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.18 -0.464 . . . . 9.76 111.18 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -102.35 148.57 25.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.492 -0.559 . . . . 11.21 109.492 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.3 -48.56 9.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.73 -0.748 . . . . 12.71 112.646 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.13 62.24 0.43 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.998 -0.62 . . . . 13.61 112.073 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.6 p -105.85 -21.17 13.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.999 0.428 . . . . 15.17 111.048 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 63.5 tp -106.35 122.56 46.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.224 -0.444 . . . . 16.82 110.521 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.51 141.19 30.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.255 -0.43 . . . . 18.11 110.172 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.54 94.08 3.46 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.181 -0.463 . . . . 19.0 110.305 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.87 99.35 1.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.108 2.538 . . . . 20.29 112.097 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.97 -31.92 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.027 -0.533 . . . . 21.13 110.916 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' B' ' 75' ' ' ASN . . . -73.03 113.4 10.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.556 -0.293 . . . . 22.9 110.353 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 70.18 -15.64 0.33 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.896 0.878 . . . . 25.06 112.043 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' B' ' 73' ' ' ALA . 28.6 t-20 67.28 -76.3 0.05 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.657 0.783 . . . . 24.46 111.48 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.6 28.87 0.17 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.68 -0.568 . . . . 24.61 111.68 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -107.27 98.09 7.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.007 0.432 . . . . 27.27 110.624 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 57.8 tp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.379 -0.819 . . . . 26.96 109.133 175.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.183 0 N-CA-C 111.953 0.353 . . . . 2.5 111.953 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.01 97.17 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.074 -0.584 . . . . 2.1299999999999999 112.181 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.78 95.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.787 0.327 . . . . 2.1899999999999999 110.713 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.648 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 49.7 tp -63.07 -47.5 82.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 1.6799999999999999 110.788 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.08 -47.78 84.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 1.71 110.155 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -50.57 73.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.75 112.005 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.8 p80 -72.78 -29.07 62.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 1.78 110.866 -173.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.15 65.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 1.0900000000000001 110.528 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.65 -40.68 69.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.985 -0.552 . . . . 1.46 110.919 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.2 t -65.24 -42.58 93.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 2.2799999999999998 111.077 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.79 -25.09 59.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.05 0.452 . . . . 1.6499999999999999 110.317 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.63 6.66 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.565 -0.743 . . . . 1.28 112.587 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 55' ' ' LEU . 17.9 t -90.63 102.37 13.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 109.505 -0.554 . . . . 0.98999999999999999 109.505 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HE ' ' NE2' ' A' ' 58' ' ' GLN . 3.8 mpt_? -115.03 128.74 56.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.771 -0.455 . . . . 2.6699999999999999 109.771 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.683 ' O ' HD21 ' A' ' 56' ' ' LEU . 5.4 mp -126.11 120.7 30.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.98 -0.378 . . . . 1.45 109.98 175.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 56' ' ' LEU . 28.8 p90 -136.22 145.77 46.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 2.2599999999999998 110.49 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.0 p -91.22 124.16 43.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.23 0.538 . . . . 2.9199999999999999 110.193 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.07 101.17 7.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.162 -0.472 . . . . 4.2000000000000002 110.076 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.29 -102.58 0.96 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.768 -0.73 . . . . 4.2000000000000002 111.67 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.635 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 4.8 pt-20 -101.27 -21.97 14.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.1500000000000004 111.274 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 10.6 tpp180 -121.33 136.51 54.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.174 -0.611 . . . . 5.3799999999999999 112.349 -170.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.5 tt -80.01 129.15 34.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.079 -0.964 . . . . 2.4399999999999999 109.453 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 8.0 mpt_? -99.69 136.95 38.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.255 -0.43 . . . . 4.2199999999999998 109.865 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.98 130.68 56.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.905 -0.589 . . . . 1.6899999999999999 109.673 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 51.8 tp60 -111.75 109.61 19.54 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.029 -0.73 . . . . 2.6800000000000002 109.029 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 113.56 4.92 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.179 -0.464 . . . . 1.6899999999999999 111.347 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 36' ' ' VAL . 39.8 Cg_exo -58.22 149.56 71.89 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.93 2.42 . . . . 1.8400000000000001 111.971 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.47 123.64 12.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.503 2.135 . . . . 2.3100000000000001 112.052 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.15 -34.37 5.66 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.546 -0.835 . . . . 1.76 112.945 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 33' ' ' PRO . 23.1 m -81.69 -21.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.321 . . . . 1.49 111.559 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.44 ' HE2' ' HA ' ' A' ' 37' ' ' MET . 8.7 tpp -82.8 22.58 0.9 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.242 0.544 . . . . 1.4099999999999999 111.402 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -52.53 141.49 34.08 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 1.45 110.42 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.5 -33.19 29.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.14 2.56 . . . . 1.72 113.856 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 32.5 tt0 -72.21 -33.61 67.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.645 -0.422 . . . . 2.7599999999999998 110.708 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 36' ' ' VAL . 2.3 tt -65.96 -40.79 91.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.21 0.529 . . . . 1.2 109.812 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HA ' HD12 ' A' ' 45' ' ' LEU . 63.7 tp60 -59.65 -35.53 74.59 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.269 -0.878 . . . . 2.0600000000000001 110.069 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.4 t -69.2 -29.65 67.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.651 -0.704 . . . . 1.5700000000000001 110.107 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.9 mmt180 -70.89 -39.83 72.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.779 -0.452 . . . . 3.3399999999999999 109.779 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 42' ' ' GLN . 69.4 mt -58.77 -39.44 81.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.064 -0.517 . . . . 1.25 109.796 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.0 -22.39 9.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.743 -0.662 . . . . 2.2999999999999998 112.658 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 33.61 81.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.108 -0.568 . . . . 2.5699999999999998 111.96 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' OE2' ' A' ' 51' ' ' GLU . . . -100.8 153.43 19.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.051 0.453 . . . . 2.0800000000000001 110.745 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.504 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.6 ptm180 -68.8 -50.03 53.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.609 0.966 . . . . 5.3600000000000003 113.609 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -57.37 -47.8 80.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.6 0.592 . . . . 2.9900000000000002 112.6 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 52' ' ' LEU . 3.1 pm0 -72.59 -36.99 68.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.935 -0.306 . . . . 2.75 110.205 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.69 ' O ' HD22 ' A' ' 56' ' ' LEU . 43.3 mt -64.86 -38.76 92.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.695 -0.402 . . . . 1.8999999999999999 110.038 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 49' ' ' ARG . 82.5 mt -55.61 -41.62 65.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.186 0.517 . . . . 2.7400000000000002 109.895 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -26.14 65.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 1.5 111.078 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 19' ' ' VAL . 2.7 mm? -70.85 -31.89 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.946 -0.302 . . . . 1.3200000000000001 111.237 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -75.71 -38.27 58.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.127 0.489 . . . . 1.6799999999999999 110.339 171.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -51.87 -28.62 16.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.597 -1.183 . . . . 4.0700000000000003 111.202 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.477 ' NE2' ' HE ' ' A' ' 20' ' ' ARG . 3.4 pt20 -65.96 -40.48 91.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.369 -0.378 . . . . 1.75 110.713 175.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD1' ' HG2' ' A' ' 20' ' ' ARG . 19.7 mt -86.81 -13.56 44.72 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.798 1.407 . . . . 2.4700000000000002 114.798 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.476 HE21 ' HA ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.99 0 N-CA-C 113.076 0.769 . . . . 2.5800000000000001 113.076 -168.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.509 0 N-CA-C 112.214 -0.354 . . . . 4.6600000000000001 112.214 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.37 95.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.922 0.391 . . . . 5.7800000000000002 110.649 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.553 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 49.6 tp -63.52 -46.84 84.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.015 -0.538 . . . . 4.3799999999999999 110.436 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.61 -49.95 75.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 2.8599999999999999 110.079 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.6 -53.32 59.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 3.7400000000000002 112.125 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.553 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 3.5 p80 -69.86 -31.6 69.52 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.445 -0.502 . . . . 5.0499999999999998 111.068 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.19 -40.23 74.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.137 0.494 . . . . 3.3300000000000001 110.343 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.67 74.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 4.3700000000000001 110.761 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -62.04 -45.87 91.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 6.0999999999999996 111.282 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.97 -24.96 61.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.729 0.3 . . . . 6.4900000000000002 111.087 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.04 39.72 6.86 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.646 -0.788 . . . . 4.7300000000000004 112.263 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.429 ' O ' HD12 ' B' ' 55' ' ' LEU . 39.6 t -90.95 110.23 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.708 -0.479 . . . . 3.6000000000000001 109.708 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.631 ' HE ' ' NE2' ' B' ' 58' ' ' GLN . 3.7 mpt_? -127.65 136.71 51.99 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.885 -0.326 . . . . 6.7999999999999998 110.782 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.508 ' O ' HD21 ' B' ' 56' ' ' LEU . 5.3 mp -130.02 122.4 28.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.247 -0.649 . . . . 3.7999999999999998 109.247 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . 0.578 ' HB3' HD11 ' B' ' 56' ' ' LEU . 34.5 p90 -138.35 139.29 38.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 6.7999999999999998 110.913 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.8 p -84.34 117.38 29.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 7.7400000000000002 110.002 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB3' HH11 ' B' ' 29' ' ' ARG . 8.9 tp10 -112.13 101.18 9.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.864 -0.607 . . . . 9.4399999999999995 109.544 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.8 -95.47 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.109 -0.567 . . . . 9.6600000000000001 112.526 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 4.5 pt-20 -104.2 -25.6 12.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.999 0.428 . . . . 9.3200000000000003 111.18 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -122.56 130.09 52.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 7.3399999999999999 111.342 -166.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.3 tt -77.0 126.71 31.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.662 -0.699 . . . . 5.1799999999999997 109.57 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.52 HH11 ' HB3' ' B' ' 24' ' ' GLU . 7.5 mpt_? -96.76 137.82 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.174 -0.467 . . . . 8.0700000000000003 110.045 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -117.29 130.63 56.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.767 -0.651 . . . . 4.1600000000000001 109.838 -176.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -110.47 109.73 20.2 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.095 -0.705 . . . . 6.7199999999999998 109.095 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.5 112.5 5.99 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 5.75 111.255 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.522 ' O ' HG22 ' B' ' 36' ' ' VAL . 33.0 Cg_exo -59.37 146.17 95.67 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.616 2.211 . . . . 6.9800000000000004 111.673 174.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.13 123.32 12.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.285 1.99 . . . . 8.8499999999999996 112.129 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.09 -34.25 5.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.657 -0.783 . . . . 8.0899999999999999 112.831 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.522 HG22 ' O ' ' B' ' 33' ' ' PRO . 13.9 m -83.03 -18.46 10.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.082 0.441 . . . . 7.0 111.316 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' B' ' 37' ' ' MET . 10.5 tpp -84.55 20.75 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.212 0.53 . . . . 5.7300000000000004 111.501 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.7 p -50.62 136.34 25.2 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 7.96 110.475 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.58 -38.49 21.83 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.78 2.987 . . . . 7.2999999999999998 114.499 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 31.3 tt0 -66.86 -29.45 69.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.643 -0.423 . . . . 9.2200000000000006 110.94 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.421 HD13 ' O ' ' B' ' 36' ' ' VAL . 7.0 tt -73.1 -35.1 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.866 -0.42 . . . . 6.1699999999999999 109.866 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -60.97 -36.33 79.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.477 0.656 . . . . 4.8399999999999999 109.348 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -67.2 -31.92 72.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.378 -0.828 . . . . 7.3499999999999996 110.313 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 38.0 mmt180 -68.54 -40.25 80.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.293 -0.412 . . . . 8.2799999999999994 109.936 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.489 ' HA ' HD11 ' B' ' 10' ' ' LEU . 83.2 mt -61.19 -37.73 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 4.1299999999999999 110.284 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.91 -22.53 11.5 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.628 -0.715 . . . . 5.5800000000000001 112.714 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.47 30.17 74.83 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.006 -0.616 . . . . 4.5 112.517 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.35 158.74 15.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.044 0.449 . . . . 5.4100000000000001 110.658 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.635 ' HD2' ' OE1' ' A' ' 26' ' ' GLU . 8.4 ptm180 -68.47 -50.25 53.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.589 0.959 . . . . 8.2200000000000006 113.589 -172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -58.33 -50.09 74.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.818 0.673 . . . . 7.1600000000000001 112.818 -167.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -68.43 -40.81 81.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.309 -0.256 . . . . 5.7199999999999998 110.309 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.601 ' O ' HD22 ' B' ' 56' ' ' LEU . 53.4 mt -63.72 -36.31 83.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.557 -0.292 . . . . 3.0600000000000001 111.082 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.533 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.8 mt -57.43 -42.39 80.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.13 0.49 . . . . 6.4000000000000004 110.073 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.09 72.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.88 -0.6 . . . . 3.73 110.981 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.4 mm? -66.37 -28.83 68.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.17 -0.468 . . . . 2.46 111.422 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.601 HD22 ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER -79.65 -33.85 40.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 5.5599999999999996 110.192 172.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -57.11 -32.03 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 7.1900000000000004 111.443 -177.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.631 ' NE2' ' HE ' ' B' ' 20' ' ' ARG . 28.6 pt20 -67.45 -26.69 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.591 -0.277 . . . . 4.2300000000000004 111.574 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.33 -0.252 0 N-CA-C 112.382 0.512 . . . . 6.46 112.382 -175.176 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 112.585 0.587 . . . . 2.5 112.585 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.43 -42.08 88.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.562 -0.351 . . . . 2.1299999999999999 112.697 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.28 90.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.942 0.401 . . . . 2.1899999999999999 110.802 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.99 -46.58 74.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 1.6799999999999999 110.235 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.317 -0.856 . . . . 1.71 110.221 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.26 79.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.983 0.421 . . . . 1.75 110.992 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.59 -28.95 61.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.95 -0.568 . . . . 1.78 110.956 -174.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.4 -41.08 49.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 1.0900000000000001 110.317 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.99 82.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.475 . . . . 1.46 111.058 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -66.71 -30.38 70.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.871 -0.604 . . . . 2.2799999999999998 110.661 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.19 -26.1 26.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.166 -0.47 . . . . 1.6499999999999999 110.841 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.23 30.81 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.794 -0.717 . . . . 1.28 113.123 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 41' ' ' LEU . 44.1 t -74.39 113.23 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.275 -0.639 . . . . 0.98999999999999999 109.275 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 98.6 mtt180 -124.56 135.91 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.448 -0.342 . . . . 2.6699999999999999 110.944 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -131.94 131.71 42.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 1.45 110.167 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' HB3' HD13 ' A' ' 56' ' ' LEU . 30.5 p90 -151.63 152.65 33.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.717 -0.475 . . . . 2.2599999999999998 109.717 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.9 p -99.49 126.78 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.335 0.588 . . . . 2.9199999999999999 110.54 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.67 105.86 10.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.79 -0.641 . . . . 4.2000000000000002 109.77 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.16 -107.8 2.42 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.829 -0.7 . . . . 4.2000000000000002 111.397 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.08 -8.35 15.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.811 0.339 . . . . 5.1500000000000004 110.243 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 10.2 tpp180 -116.31 134.28 55.07 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.635 0.605 . . . . 5.3799999999999999 112.635 -170.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 8.3 tt -76.96 124.98 28.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.102 -0.954 . . . . 2.4399999999999999 108.939 171.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 11.7 mmm180 -97.94 135.32 39.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.592 -0.522 . . . . 4.2199999999999998 109.592 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.35 132.08 55.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.993 0.425 . . . . 1.6899999999999999 110.533 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.791 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -123.13 114.27 20.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.194 -0.457 . . . . 2.6800000000000002 109.951 174.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.03 126.43 4.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.277 -0.42 . . . . 1.6899999999999999 110.736 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD2' HG21 ' A' ' 36' ' ' VAL . 30.2 Cg_exo -63.89 157.13 54.2 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.914 2.41 . . . . 1.8400000000000001 111.904 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.61 123.14 12.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.361 2.041 . . . . 2.3100000000000001 112.342 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 38' ' ' THR . . . 111.36 -37.32 3.76 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.671 -0.695 . . . . 1.76 113.413 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.627 HG21 ' HD2' ' A' ' 33' ' ' PRO . 18.6 m -77.1 -15.73 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.385 0.513 . . . . 1.49 112.385 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.41 20.98 0.81 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.822 0.344 . . . . 1.4099999999999999 111.232 -173.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 35' ' ' GLY . 16.9 p -50.86 142.02 17.44 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.372 -0.376 . . . . 1.45 110.944 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -52.06 -34.41 57.46 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.925 2.417 . . . . 1.72 112.961 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -71.29 -29.81 65.49 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 2.7599999999999998 110.372 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 3.0 tt -71.76 -37.13 70.56 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.748 0.785 . . . . 1.2 109.69 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -58.69 -36.5 74.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.788 -1.097 . . . . 2.0600000000000001 109.664 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.4 t -71.84 -30.09 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.427 -0.806 . . . . 1.5700000000000001 110.618 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.2 mmt180 -63.71 -44.94 92.15 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.865 -0.42 . . . . 3.3399999999999999 109.865 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.347 -0.842 . . . . 1.25 109.467 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.64 -22.57 8.79 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.456 -0.793 . . . . 2.2999999999999998 113.064 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' B' ' 27' ' ' ARG . . . 71.73 20.14 78.44 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.768 -0.729 . . . . 2.5699999999999998 112.007 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -81.56 147.47 29.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.854 -0.338 . . . . 2.0800000000000001 110.285 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.3 ptm180 -70.73 -51.91 24.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.371 -0.377 . . . . 5.3600000000000003 111.863 -174.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -61.84 -32.32 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.506 0.669 . . . . 2.9900000000000002 110.581 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.8 tp10 -72.46 -43.34 63.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.03 -0.987 . . . . 2.75 109.974 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 81.9 mt -71.66 -24.85 61.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.714 -0.676 . . . . 1.8999999999999999 111.152 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 49' ' ' ARG . 73.9 mt -61.23 -49.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.926 -0.398 . . . . 2.7400000000000002 109.926 173.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.63 67.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.203 0.525 . . . . 1.5 110.614 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.5 tm? -70.01 -39.43 75.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 1.3200000000000001 109.317 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.512 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 3.8 tp -79.17 -31.27 43.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.763 -0.653 . . . . 1.6799999999999999 109.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -64.38 -24.0 67.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 4.0700000000000003 110.535 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -60.18 -31.38 70.07 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.606 ' H ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -105.81 4.96 30.37 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.968 -0.693 . . . . 2.4700000000000002 111.461 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 99.1 mt-30 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.535 . . . . 2.5800000000000001 110.054 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.449 0 CA-C-O 120.155 -0.247 . . . . 4.6600000000000001 112.924 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.79 90.62 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.82 0.343 . . . . 5.7800000000000002 110.709 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 64.5 tp -72.68 -46.06 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.12 -0.491 . . . . 4.3799999999999999 110.188 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.26 -51.4 70.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.719 -0.673 . . . . 2.8599999999999999 110.27 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.17 85.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 3.7400000000000002 111.156 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.46 -40.28 89.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.937 -0.574 . . . . 5.0499999999999998 111.004 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.15 63.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 3.3300000000000001 110.823 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.29 -46.62 87.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 4.3700000000000001 111.676 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 30.1 m -64.6 -28.35 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 6.0999999999999996 111.363 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' B' ' 33' ' ' PRO . 70.3 mt -86.33 -25.27 25.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 6.4900000000000002 110.599 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.64 26.32 27.66 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.79 -0.719 . . . . 4.7300000000000004 112.606 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.84 111.25 12.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.552 -0.536 . . . . 3.6000000000000001 109.552 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.654 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 98.5 mtt180 -125.01 139.36 53.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.359 -0.382 . . . . 6.7999999999999998 111.055 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.447 HD21 ' CE2' ' B' ' 30' ' ' PHE . 5.9 mp -135.29 134.38 39.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 3.7999999999999998 109.964 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . 0.542 ' HB3' HD13 ' B' ' 56' ' ' LEU . 36.5 p90 -153.07 154.82 35.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.944 -0.391 . . . . 6.7999999999999998 109.944 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.9 p -99.34 123.39 52.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.531 . . . . 7.7400000000000002 110.566 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -119.39 102.85 8.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.5 -0.555 . . . . 9.4399999999999995 109.5 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.09 -109.32 2.76 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.382 -0.687 . . . . 9.6600000000000001 111.382 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.68 -6.82 15.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.908 0.385 . . . . 9.3200000000000003 110.506 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 9.4 tpp180 -118.22 127.46 53.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.206 0.526 . . . . 7.3399999999999999 111.823 -169.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 8.7 tt -73.8 126.75 31.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 5.1799999999999997 108.97 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.464 ' HB2' ' CE2' ' B' ' 22' ' ' TRP . 9.1 mmm180 -99.85 135.05 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.557 -0.535 . . . . 8.0700000000000003 109.557 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.447 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.7 OUTLIER -112.23 134.29 53.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.309 -0.405 . . . . 4.1600000000000001 110.194 -176.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.791 ' HA ' HE21 ' B' ' 31' ' ' GLN . 0.0 OUTLIER -124.2 112.63 17.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.145 -0.479 . . . . 6.7199999999999998 109.89 175.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -149.89 122.06 4.2 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.342 -0.39 . . . . 5.75 110.491 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.518 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.5 Cg_exo -59.94 154.09 52.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.882 2.388 . . . . 6.9800000000000004 112.12 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.8 122.97 12.66 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.534 2.156 . . . . 8.8499999999999996 112.347 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.74 -37.15 3.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.655 -0.783 . . . . 8.0899999999999999 113.091 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 33' ' ' PRO . 11.0 m -80.17 -7.38 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.0 0.4 . . . . 7.0 111.587 -175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.65 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.2 OUTLIER -84.18 18.82 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.81 0.338 . . . . 5.7300000000000004 111.174 -175.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' B' ' 39' ' ' PRO . 19.5 p -49.94 141.44 14.5 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 7.96 111.471 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 38' ' ' THR . 62.6 Cg_exo -52.69 -34.89 66.11 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.23 2.62 . . . . 7.2999999999999998 113.175 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 0.0 OUTLIER -72.11 -30.08 64.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.768 -0.373 . . . . 9.2200000000000006 110.344 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.604 ' HA ' ' HG2' ' B' ' 44' ' ' ARG . 8.9 tt -74.11 -32.5 63.23 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.735 -0.469 . . . . 6.1699999999999999 109.735 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -60.39 -36.62 78.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.773 -0.649 . . . . 4.8399999999999999 109.341 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -72.28 -29.86 64.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.353 -0.84 . . . . 7.3499999999999996 110.497 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.604 ' HG2' ' HA ' ' B' ' 41' ' ' LEU . 35.9 mmt180 -63.32 -48.0 79.87 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 8.2799999999999994 109.83 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -58.61 -43.03 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.435 -0.802 . . . . 4.1299999999999999 109.916 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.49 -24.01 6.84 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.188 -0.915 . . . . 5.5800000000000001 112.742 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.24 12.71 83.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.945 -0.645 . . . . 4.5 112.546 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -73.37 148.42 43.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.244 -0.28 . . . . 5.4100000000000001 110.244 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 53' ' ' ILE . 12.0 ptm180 -69.4 -51.09 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.34 -0.391 . . . . 8.2200000000000006 111.987 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.8 -31.18 72.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.935 0.398 . . . . 7.1600000000000001 111.263 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.2 OUTLIER -71.44 -40.47 70.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.38 . . . . 5.7199999999999998 110.302 -178.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 82.1 mt -76.04 -23.94 55.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 3.0600000000000001 111.211 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 49' ' ' ARG . 76.8 mt -61.28 -48.38 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.732 -0.47 . . . . 6.4000000000000004 109.732 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.48 -36.89 82.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 3.73 110.343 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' B' ' 52' ' ' LEU . 3.1 tm? -59.81 -45.51 92.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 2.46 110.013 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.542 HD13 ' HB3' ' B' ' 22' ' ' TRP . 43.0 tp -68.41 -35.59 77.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.035 0.445 . . . . 5.5599999999999996 110.575 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.15 -22.58 66.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 7.1900000000000004 111.271 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -62.55 -31.14 71.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.634 -0.257 . . . . 4.2300000000000004 111.439 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.722 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 6.46 111.618 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 110.421 -0.215 . . . . 2.5 110.421 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.39 -40.45 85.79 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 123.442 0.464 . . . . 2.1299999999999999 112.404 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.1 76.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.976 0.417 . . . . 2.1899999999999999 111.116 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.705 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 59.2 tp -66.28 -46.55 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 1.6799999999999999 110.506 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.23 -48.72 80.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.678 -0.692 . . . . 1.71 110.277 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.76 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.454 -0.339 . . . . 1.75 111.663 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.705 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.1 p80 -76.5 -26.92 55.8 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.829 0.347 . . . . 1.78 110.794 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.71 -35.63 51.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.122 -0.231 . . . . 1.0900000000000001 110.538 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.6 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 1.46 111.384 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.8 p -65.78 -41.78 91.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 2.2799999999999998 110.449 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 50.0 mt -77.87 -26.38 49.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 1.6499999999999999 110.022 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.2 18.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.724 -0.671 . . . . 1.28 113.348 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.39 135.48 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.86 -0.793 . . . . 0.98999999999999999 108.86 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.676 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 71.4 mtt180 -130.81 126.63 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.693 -0.194 . . . . 2.6699999999999999 110.653 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.702 HD22 HD22 ' A' ' 52' ' ' LEU . 6.1 mp -133.52 117.15 16.8 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 1.45 111.815 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HB3' HD21 ' A' ' 56' ' ' LEU . 26.7 p90 -129.75 149.08 51.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 2.2599999999999998 109.315 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.09 128.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.347 0.594 . . . . 2.9199999999999999 111.349 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' ' NE ' ' A' ' 29' ' ' ARG . 38.1 tt0 -120.75 116.5 25.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.747 -0.834 . . . . 4.2000000000000002 108.747 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.42 -109.46 2.9 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.092 -1.203 . . . . 4.2000000000000002 110.092 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.69 -15.0 10.8 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.808 0.337 . . . . 5.1500000000000004 110.291 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -92.43 144.46 25.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.563 0.697 . . . . 5.3799999999999999 111.445 -172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 21' ' ' LEU . 3.4 tm? -85.96 129.28 34.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.969 -1.014 . . . . 2.4399999999999999 109.903 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.447 ' NE ' ' HB3' ' A' ' 24' ' ' GLU . 4.2 mpt_? -97.25 130.07 44.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.136 -0.691 . . . . 4.2199999999999998 109.136 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.432 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -114.26 131.32 56.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.508 -0.314 . . . . 1.6899999999999999 110.882 -171.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.676 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 6.1 tp-100 -130.15 123.87 31.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.196 -0.456 . . . . 2.6800000000000002 109.919 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.47 138.06 11.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.397 -0.365 . . . . 1.6899999999999999 110.816 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' VAL . 27.5 Cg_endo -68.03 155.31 70.09 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.6 2.2 . . . . 1.8400000000000001 111.25 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.04 122.47 10.97 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 122.38 2.053 . . . . 2.3100000000000001 112.464 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.5 -28.78 9.21 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.712 -0.676 . . . . 1.76 113.31 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 33' ' ' PRO . 22.9 m -83.74 -11.75 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.878 0.696 . . . . 1.49 112.878 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.505 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -83.55 20.42 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.696 0.284 . . . . 1.4099999999999999 111.747 -173.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 p -53.1 147.09 18.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 1.45 111.444 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.7 -33.84 51.2 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 1.72 113.508 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.1 tt0 -70.78 -35.14 72.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.515 -0.474 . . . . 2.7599999999999998 110.499 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -64.36 -41.15 96.88 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 121.032 0.444 . . . . 1.2 109.827 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.682 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -59.86 -37.36 79.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.0600000000000001 109.946 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -67.68 -28.84 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 1.5700000000000001 110.35 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 35.2 mmt180 -73.18 -43.98 60.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.311 -0.404 . . . . 3.3399999999999999 110.17 176.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 53.9 mt -62.51 -42.93 99.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.364 0.602 . . . . 1.25 109.431 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.21 -23.06 7.44 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.607 -0.724 . . . . 2.2999999999999998 112.778 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.18 16.31 76.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.917 -0.659 . . . . 2.5699999999999998 111.761 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.6 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -76.63 148.77 36.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.944 0.402 . . . . 2.0800000000000001 110.357 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.0 ptp180 -69.11 -51.04 42.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 5.3600000000000003 111.943 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -61.87 -33.67 74.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 2.9900000000000002 110.226 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -67.99 -46.5 71.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.253 -0.885 . . . . 2.75 110.476 -177.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.702 HD22 HD22 ' A' ' 21' ' ' LEU . 72.9 mt -66.23 -30.27 70.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.383 -0.826 . . . . 1.8999999999999999 111.175 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 49' ' ' ARG . 89.2 mt -60.97 -43.55 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.713 0.768 . . . . 2.7400000000000002 110.017 174.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.166 -0.925 . . . . 1.5 110.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.7 tm? -64.55 -38.14 89.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.832 -1.173 . . . . 1.3200000000000001 107.832 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -69.68 -39.66 76.84 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.267 -1.333 . . . . 1.6799999999999999 112.214 174.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 57' ' ' ARG . 73.2 mtt180 -50.97 -29.7 12.99 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.157 -0.474 . . . . 4.0700000000000003 111.42 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -54.09 -47.85 71.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.323 0.582 . . . . 1.75 110.784 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 59' ' ' LEU . 7.9 tt -84.74 -32.42 23.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 2.4700000000000002 110.394 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.32 -0.692 0 CA-C-N 115.636 -0.711 . . . . 2.5800000000000001 110.9 -173.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.251 0 N-CA-C 114.296 0.478 . . . . 4.6600000000000001 114.296 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -48.14 78.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.092 0.446 . . . . 5.7800000000000002 111.278 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 64.8 tp -63.47 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 4.3799999999999999 110.688 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.48 -47.95 81.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 2.8599999999999999 110.291 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.78 84.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 3.7400000000000002 111.845 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.569 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 2.4 p80 -75.39 -27.33 59.03 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.342 -0.543 . . . . 5.0499999999999998 111.169 -175.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.89 -38.78 52.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.871 -0.332 . . . . 3.3300000000000001 110.848 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.65 76.99 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.288 -0.414 . . . . 4.3700000000000001 111.311 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 23.3 p -64.22 -40.35 95.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 6.0999999999999996 110.686 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.6 mt -75.22 -25.29 58.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 6.4900000000000002 110.296 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.33 19.77 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.679 -0.772 . . . . 4.7300000000000004 112.716 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.6 133.12 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.293 -0.632 . . . . 3.6000000000000001 109.293 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 69.4 mtt180 -130.86 128.91 41.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.678 -0.237 . . . . 6.7999999999999998 110.981 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.685 HD22 HD22 ' B' ' 52' ' ' LEU . 6.2 mp -134.29 122.74 23.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.995 -0.372 . . . . 3.7999999999999998 109.995 173.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -137.2 148.15 46.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.78 -0.452 . . . . 6.7999999999999998 109.78 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.12 128.17 49.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.422 0.63 . . . . 7.7400000000000002 111.345 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.486 ' HB3' ' NE ' ' B' ' 29' ' ' ARG . 37.4 tt0 -118.83 117.14 28.07 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.154 -1.054 . . . . 9.4399999999999995 108.154 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.25 -108.9 2.64 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.453 -1.059 . . . . 9.6600000000000001 110.453 -168.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -15.15 10.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.232 0.539 . . . . 9.3200000000000003 110.132 173.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.15 142.02 27.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.407 0.623 . . . . 7.3399999999999999 111.167 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.593 HD11 HD23 ' B' ' 21' ' ' LEU . 3.2 tm? -86.19 132.28 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.097 -0.956 . . . . 5.1799999999999997 110.224 -174.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.486 ' NE ' ' HB3' ' B' ' 24' ' ' GLU . 3.8 mpt_? -100.82 130.96 46.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.203 -0.666 . . . . 8.0700000000000003 109.203 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.539 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -113.9 131.75 56.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.748 0.309 . . . . 4.1600000000000001 110.828 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.786 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 6.3 tp-100 -130.55 121.26 25.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.78 -0.452 . . . . 6.7199999999999998 109.78 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.61 134.49 8.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.484 -0.325 . . . . 5.75 110.939 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.499 ' O ' HG22 ' B' ' 36' ' ' VAL . 29.8 Cg_endo -63.97 154.73 68.43 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.491 2.127 . . . . 6.9800000000000004 111.865 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.38 122.96 12.56 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.424 2.083 . . . . 8.8499999999999996 112.779 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.22 -32.13 6.7 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.81 -0.709 . . . . 8.0899999999999999 113.402 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' B' ' 17' ' ' LEU . 10.7 m -85.29 2.99 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.183 0.438 . . . . 7.0 112.183 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.662 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -93.46 19.35 8.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.894 0.378 . . . . 5.7300000000000004 111.03 -176.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -53.46 145.51 27.58 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.547 . . . . 7.96 111.966 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.86 -39.51 39.42 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.356 2.704 . . . . 7.2999999999999998 113.536 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 32.4 tt0 -65.62 -36.65 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.866 -0.334 . . . . 9.2200000000000006 110.59 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 5.6 tt -68.26 -34.12 75.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.059 -0.348 . . . . 6.1699999999999999 110.059 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -62.89 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 4.8399999999999999 109.991 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 31.7 t -68.74 -34.11 75.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 7.3499999999999996 110.183 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 28.2 mmt180 -63.84 -43.68 95.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.114 -0.494 . . . . 8.2799999999999994 109.946 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 69.8 mt -65.97 -43.71 87.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 4.1299999999999999 109.933 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 -22.16 9.57 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.572 -0.74 . . . . 5.5800000000000001 112.408 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.14 19.74 78.69 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.877 -0.678 . . . . 4.5 111.42 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.85 149.41 36.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.826 0.346 . . . . 5.4100000000000001 110.7 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' B' ' 53' ' ' ILE . 3.4 ptp180 -69.49 -50.32 46.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.206 -0.452 . . . . 8.2200000000000006 111.735 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -64.73 -30.43 71.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.748 0.309 . . . . 7.1600000000000001 111.456 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.3 OUTLIER -69.61 -45.35 68.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 5.7199999999999998 110.814 -179.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.685 HD22 HD22 ' B' ' 21' ' ' LEU . 61.2 mt -67.32 -28.08 67.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 3.0600000000000001 110.911 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.505 HG13 ' O ' ' B' ' 49' ' ' ARG . 90.9 mt -63.41 -48.67 86.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.114 0.483 . . . . 6.4000000000000004 110.017 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . 0.497 ' HA ' ' HD2' ' B' ' 57' ' ' ARG . . . -68.4 -36.08 78.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 3.73 110.734 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.435 ' O ' HD13 ' B' ' 55' ' ' LEU . 2.1 tm? -55.93 -39.95 72.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.509 -0.768 . . . . 2.46 109.399 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.534 HD23 ' O ' ' B' ' 21' ' ' LEU . 0.8 OUTLIER -74.69 -27.65 60.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 5.5599999999999996 110.234 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 54' ' ' ALA . 80.1 mtt180 -62.58 -26.33 68.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.494 -0.321 . . . . 7.1900000000000004 111.114 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -57.31 -39.71 76.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.349 0.595 . . . . 4.2300000000000004 110.872 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 tt . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 115.48 -0.782 . . . . 6.46 110.332 -176.491 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 -0.027 0 CA-C-O 120.597 0.237 . . . . 2.5 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.13 -39.14 95.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.137 -0.554 . . . . 2.1299999999999999 112.24 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.75 -42.86 85.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.06 0.457 . . . . 2.1899999999999999 110.682 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.686 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 45.9 tp -64.65 -47.13 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.813 -0.63 . . . . 1.6799999999999999 110.268 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.21 -46.5 88.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.628 -0.715 . . . . 1.71 110.062 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -50.98 71.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 1.75 111.673 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.686 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 3.8 p80 -76.83 -27.96 55.35 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.657 -0.417 . . . . 1.78 110.954 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.11 66.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.068 -0.253 . . . . 1.0900000000000001 110.496 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.75 92.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.131 0.491 . . . . 1.46 110.764 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -65.08 -33.39 75.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.498 -0.774 . . . . 2.2799999999999998 110.845 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 36' ' ' VAL . 83.8 mt -85.73 -26.32 25.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.108 0.48 . . . . 1.6499999999999999 109.949 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.72 35.73 35.13 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.442 -0.799 . . . . 1.28 112.476 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.499 ' O ' HD11 ' A' ' 55' ' ' LEU . 97.4 t -69.38 108.67 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.335 -0.987 . . . . 0.98999999999999999 108.335 170.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 51.7 mtt180 -112.18 133.64 54.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.155 0.502 . . . . 2.6699999999999999 111.625 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 52' ' ' LEU . 5.9 mp -130.41 136.69 49.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.892 -1.049 . . . . 1.45 109.728 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.591 ' HA ' HD21 ' A' ' 56' ' ' LEU . 22.9 p90 -158.2 137.92 12.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.49 -0.777 . . . . 2.2599999999999998 109.257 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -85.33 121.63 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.665 -0.494 . . . . 2.9199999999999999 109.665 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 33.1 tt0 -115.77 102.38 9.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.777 -0.647 . . . . 4.2000000000000002 109.843 -175.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.67 -90.39 0.39 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.485 -0.779 . . . . 4.2000000000000002 111.938 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -111.43 -28.71 8.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.546 0.212 . . . . 5.1500000000000004 111.338 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -117.07 142.48 46.93 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.946 -0.701 . . . . 5.3799999999999999 112.252 -169.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.642 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -69.3 124.34 23.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.867 -1.061 . . . . 2.4399999999999999 108.565 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 15.5 mmm180 -101.45 136.36 41.42 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.601 -0.518 . . . . 4.2199999999999998 109.601 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.8 135.67 55.1 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.539 -0.541 . . . . 1.6899999999999999 109.539 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 25.2 tp60 -131.56 106.56 8.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.859 -0.422 . . . . 2.6800000000000002 109.859 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.43 123.67 28.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 1.6899999999999999 111.196 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 31.5 Cg_exo -61.51 160.01 29.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.649 2.233 . . . . 1.8400000000000001 111.581 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.725 ' HB3' HG22 ' B' ' 38' ' ' THR . 28.4 Cg_endo -63.97 122.73 10.86 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.35 2.033 . . . . 2.3100000000000001 112.753 -176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 38' ' ' THR . . . 97.55 -37.66 3.38 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.875 -0.679 . . . . 1.76 114.06 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 17' ' ' LEU . 26.7 m -68.63 -14.01 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.285 0.846 . . . . 1.49 113.285 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.8 tpp -86.01 23.51 1.48 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.892 0.377 . . . . 1.4099999999999999 111.41 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.645 HG22 ' HB3' ' B' ' 34' ' ' PRO . 43.7 p -50.74 145.77 10.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.44 -0.346 . . . . 1.45 110.764 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 52.1 Cg_exo -53.18 -28.97 44.09 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.915 2.41 . . . . 1.72 113.435 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 38.7 tt0 -67.97 -48.33 66.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.886 -0.413 . . . . 2.7599999999999998 109.886 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.26 -37.23 86.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.428 0.633 . . . . 1.2 109.883 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -56.42 -41.15 75.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.92 -1.036 . . . . 2.0600000000000001 109.85 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 1.5700000000000001 110.663 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 3.4 mmp_? -67.61 -38.04 83.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.487 -0.324 . . . . 3.3399999999999999 110.432 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.7 mt -64.6 -43.26 94.36 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.152 -0.684 . . . . 1.25 109.152 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.65 -23.78 6.31 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 2.2999999999999998 113.448 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.92 14.38 75.88 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 2.5699999999999998 111.825 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -84.0 150.15 25.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.991 -0.374 . . . . 2.0800000000000001 109.991 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 19.1 ptp180 -69.35 -50.56 45.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 111.773 0.286 . . . . 5.3600000000000003 111.773 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.507 ' HA ' HD12 ' A' ' 53' ' ' ILE . 8.9 p80 -56.96 -35.73 69.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.052 0.454 . . . . 2.9900000000000002 110.529 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.09 -51.12 67.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.368 -0.833 . . . . 2.75 109.852 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 21' ' ' LEU . 80.8 mt -69.18 -25.65 64.45 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.672 -1.149 . . . . 1.8999999999999999 111.016 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.5 mt -59.74 -47.7 90.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.789 0.328 . . . . 2.7400000000000002 110.304 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -31.49 71.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.342 0.591 . . . . 1.5 110.494 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 19' ' ' VAL . 2.1 tm? -71.54 -41.34 69.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.201 1.001 . . . . 1.3200000000000001 108.461 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -62.93 -43.14 99.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.808 -1.542 . . . . 1.6799999999999999 110.135 178.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.38 -29.26 70.59 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.576 -1.193 . . . . 4.0700000000000003 111.616 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.6 pt20 -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.659 -0.417 . . . . 1.75 110.847 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 21.52 17.15 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.805 0.336 . . . . 2.4700000000000002 110.552 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.485 -0.561 . . . . 2.5800000000000001 109.485 177.269 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.224 0 N-CA-C 112.812 -0.115 . . . . 4.6600000000000001 112.812 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.72 -43.46 62.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.815 0.34 . . . . 5.7800000000000002 110.747 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 69.1 tp -59.05 -47.54 84.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 4.3799999999999999 110.76 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.92 -45.58 94.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.545 . . . . 2.8599999999999999 110.048 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.9 63.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 3.7400000000000002 112.323 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 8.9 p80 -76.81 -28.42 55.56 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 5.0499999999999998 111.299 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -45.32 69.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.711 0.291 . . . . 3.3300000000000001 110.583 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.25 95.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 4.3700000000000001 111.182 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -61.83 -39.33 91.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 6.0999999999999996 111.096 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.576 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -79.47 -26.63 41.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.796 -0.361 . . . . 6.4900000000000002 110.594 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.76 33.03 19.99 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.849 -0.691 . . . . 4.7300000000000004 112.495 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.419 ' O ' HD11 ' B' ' 55' ' ' LEU . 77.4 t -75.86 104.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.124 -0.695 . . . . 3.6000000000000001 109.124 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 50.3 mtt180 -110.81 135.05 51.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.083 0.468 . . . . 6.7999999999999998 111.9 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.657 HD22 HD22 ' B' ' 52' ' ' LEU . 6.2 mp -131.0 140.86 50.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.437 -0.801 . . . . 3.7999999999999998 108.961 171.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . 0.636 ' HA ' HD21 ' B' ' 56' ' ' LEU . 30.0 p90 -159.44 141.67 13.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.745 -0.465 . . . . 6.7999999999999998 109.745 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.05 115.89 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.328 0.585 . . . . 7.7400000000000002 109.793 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HG3' ' B' ' 29' ' ' ARG . 27.4 tt0 -112.25 103.97 12.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 9.4399999999999995 109.909 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.1 -90.7 0.51 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.752 -0.658 . . . . 9.6600000000000001 112.342 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -115.7 -29.53 6.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.953 0.406 . . . . 9.3200000000000003 110.871 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 27' ' ' ARG . 5.9 tpp180 -115.08 138.83 50.44 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.291 -0.563 . . . . 7.3399999999999999 111.651 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.569 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -68.48 126.34 29.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.405 -0.816 . . . . 5.1799999999999997 108.984 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' B' ' 24' ' ' GLU . 14.1 mmm180 -102.97 135.24 45.02 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.799 -0.445 . . . . 8.0700000000000003 109.799 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.515 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.1 t80 -119.76 132.44 55.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 4.1600000000000001 109.54 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 24.9 tp60 -128.23 102.78 6.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.451 . . . . 6.7199999999999998 109.781 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . 0.4 ' HB2' ' HE3' ' B' ' 37' ' ' MET . . . -116.45 122.59 31.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.957 -0.565 . . . . 5.75 111.335 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.484 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 31.4 Cg_exo -61.82 158.54 37.41 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.752 2.301 . . . . 6.9800000000000004 111.748 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.645 ' HB3' HG22 ' A' ' 38' ' ' THR . 33.8 Cg_endo -64.86 123.4 11.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.404 2.069 . . . . 8.8499999999999996 112.771 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.491 ' O ' HG23 ' B' ' 38' ' ' THR . . . 98.27 -36.92 3.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.968 -0.634 . . . . 8.0899999999999999 113.777 172.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' B' ' 17' ' ' LEU . 24.8 m -72.09 -12.74 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.658 0.614 . . . . 7.0 112.658 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.4 ' HE3' ' HB2' ' B' ' 32' ' ' ALA . 19.3 tpp -86.2 22.58 1.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.923 0.392 . . . . 5.7300000000000004 111.419 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 34' ' ' PRO . 22.9 p -48.73 143.55 7.91 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.273 -0.421 . . . . 7.96 111.049 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.39 -27.5 39.83 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.236 2.624 . . . . 7.2999999999999998 113.443 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.82 -50.68 61.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 9.2200000000000006 109.949 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 tt -66.89 -33.45 75.62 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 6.1699999999999999 109.817 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -56.83 -42.68 80.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.842 -0.617 . . . . 4.8399999999999999 109.731 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.52 -29.65 63.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.499 -0.773 . . . . 7.3499999999999996 110.702 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.646 ' CZ ' ' HA ' ' B' ' 44' ' ' ARG . 3.1 mmp_? -67.17 -38.79 86.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 8.2799999999999994 110.482 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.99 -43.33 96.04 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.25 -0.648 . . . . 4.1299999999999999 109.25 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.17 -23.85 6.72 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.436 -0.802 . . . . 5.5800000000000001 113.354 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.16 12.25 79.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.71 -0.757 . . . . 4.5 112.007 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -80.46 151.36 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.265 -0.272 . . . . 5.4100000000000001 110.265 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 18.0 ptp180 -68.31 -45.2 73.65 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.869 -0.332 . . . . 8.2200000000000006 111.493 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -63.22 -35.61 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.227 -0.189 . . . . 7.1600000000000001 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -46.47 82.52 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.071 0.462 . . . . 5.7199999999999998 110.422 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.657 HD22 HD22 ' B' ' 21' ' ' LEU . 68.8 mt -69.97 -24.56 63.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 3.0600000000000001 111.391 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 77.8 mt -65.07 -48.74 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.765 0.317 . . . . 6.4000000000000004 110.264 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.56 95.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.316 0.579 . . . . 3.73 110.022 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.419 HD11 ' O ' ' B' ' 19' ' ' VAL . 1.1 tm? -58.88 -47.06 86.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.211 -0.904 . . . . 2.46 109.751 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' B' ' 22' ' ' TRP . 0.1 OUTLIER -55.39 -45.29 76.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.469 0.652 . . . . 5.5599999999999996 110.604 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -64.72 -28.92 69.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 7.1900000000000004 112.022 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -63.69 -30.01 71.17 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.769 0.318 . . . . 4.2300000000000004 111.266 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.22 0 CA-C-O 120.722 0.296 . . . . 6.46 110.771 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 11' ' ' LEU . . . . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.966 0.413 . . . . 2.5 110.121 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.53 -44.23 96.92 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.698 -0.683 . . . . 2.1299999999999999 112.482 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.16 98.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.033 0.444 . . . . 2.1899999999999999 111.055 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.638 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 39.9 tp -64.83 -46.67 80.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.829 -0.623 . . . . 1.6799999999999999 110.755 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 7' ' ' ALA . 87.7 mt -58.73 -51.04 71.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.119 -0.491 . . . . 1.71 109.941 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.451 -0.795 . . . . 1.75 112.175 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.638 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 5.6 p80 -71.7 -28.09 63.47 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.625 -0.43 . . . . 1.78 110.841 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.85 39.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.035 0.445 . . . . 1.0900000000000001 110.504 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.7 85.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 1.46 110.927 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -69.21 -22.95 63.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 2.2799999999999998 110.776 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 98.9 mt -84.23 -25.52 29.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.232 0.539 . . . . 1.6499999999999999 109.776 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.29 16.12 25.94 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.831 -0.7 . . . . 1.28 112.899 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.98 115.11 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.582 -0.525 . . . . 0.98999999999999999 109.582 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.756 ' HD3' HD12 ' A' ' 59' ' ' LEU . 95.5 mtt180 -131.11 134.14 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.25 -0.432 . . . . 2.6699999999999999 111.544 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.5 mp -128.82 133.46 48.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.123 -0.489 . . . . 1.45 109.856 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.519 ' HB3' HD13 ' A' ' 56' ' ' LEU . 22.8 p90 -151.92 149.1 28.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.179 -0.304 . . . . 2.2599999999999998 110.179 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.6 p -87.86 128.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 2.9199999999999999 109.818 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 32.8 tt0 -132.73 110.97 10.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.116 -0.493 . . . . 4.2000000000000002 110.152 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.58 -101.46 1.0 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.766 -0.731 . . . . 4.2000000000000002 111.712 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.508 ' OE1' ' HD3' ' B' ' 49' ' ' ARG . 0.3 OUTLIER -116.78 -3.79 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.575 0.213 . . . . 5.1500000000000004 111.575 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.517 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 11.9 tpp180 -134.58 152.12 51.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.391 0.615 . . . . 5.3799999999999999 111.912 -174.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.4 tt -80.81 132.66 35.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.302 -0.863 . . . . 2.4399999999999999 109.751 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.517 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.3 mpt_? -99.71 140.57 33.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 4.2199999999999998 109.836 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -122.08 130.95 53.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.071 -0.715 . . . . 1.6899999999999999 109.071 -177.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 62.7 tp60 -122.77 119.66 31.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.624 -0.51 . . . . 2.6800000000000002 109.624 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.11 129.13 5.24 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.798 0.332 . . . . 1.6899999999999999 110.851 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' A' ' 36' ' ' VAL . 31.5 Cg_exo -61.48 154.47 59.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.681 2.254 . . . . 1.8400000000000001 112.166 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.51 122.51 9.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.113 1.876 . . . . 2.3100000000000001 112.115 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.88 -33.98 5.47 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.7 -0.762 . . . . 1.76 113.101 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.573 ' O ' HD22 ' A' ' 41' ' ' LEU . 34.1 m -79.69 -12.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.245 0.522 . . . . 1.49 112.1 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.61 21.71 0.79 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.086 -0.506 . . . . 1.4099999999999999 111.243 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.7 p -50.4 139.5 19.66 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.329 -0.396 . . . . 1.45 110.971 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 83.3 Cg_exo -47.22 -39.36 26.75 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.314 2.676 . . . . 1.72 113.282 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 39.3 tt0 -63.08 -40.68 98.38 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.207 -0.197 . . . . 2.7599999999999998 110.517 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -62.95 -40.04 96.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.793 0.33 . . . . 1.2 110.362 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HA ' HD12 ' A' ' 45' ' ' LEU . 5.8 mt-30 -64.8 -39.48 93.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.249 0.547 . . . . 2.0600000000000001 110.129 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -66.79 -29.63 69.62 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.094 -0.957 . . . . 1.5700000000000001 109.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 51.0 mtt-85 -75.19 -38.61 60.72 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 115.882 -0.599 . . . . 3.3399999999999999 110.079 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 42' ' ' GLN . 97.4 mt -55.69 -44.32 77.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.189 -0.671 . . . . 1.25 109.189 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.28 -23.24 5.52 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.579 -0.737 . . . . 2.2999999999999998 113.134 168.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.71 74.18 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.737 -0.744 . . . . 2.5699999999999998 111.484 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -85.08 149.52 25.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.652 0.263 . . . . 2.0800000000000001 110.57 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.644 ' HD3' ' OE1' ' B' ' 26' ' ' GLU . 7.6 ptt180 -67.47 -51.65 48.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.375 . . . . 5.3600000000000003 111.984 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -57.23 -39.34 75.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.384 0.611 . . . . 2.9900000000000002 110.036 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.77 -55.83 22.98 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.853 -1.067 . . . . 2.75 110.351 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 93.3 mt -70.33 -26.65 63.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.091 -0.959 . . . . 1.8999999999999999 111.854 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 49' ' ' ARG . 70.7 mt -62.02 -52.29 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.7400000000000002 110.227 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.29 70.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.401 0.62 . . . . 1.5 110.23 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.586 ' O ' HD13 ' A' ' 55' ' ' LEU . 3.5 tm? -68.46 -29.46 68.1 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.196 -0.911 . . . . 1.3200000000000001 109.929 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -82.72 -32.85 27.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.058 0.456 . . . . 1.6799999999999999 110.602 174.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.76 -21.9 63.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 4.0700000000000003 111.67 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -69.15 -22.63 63.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.916 0.389 . . . . 1.75 111.03 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.756 HD12 ' HD3' ' A' ' 20' ' ' ARG . 10.4 tt -73.98 -27.59 61.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.244 -0.651 . . . . 2.4700000000000002 109.244 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.5800000000000001 110.357 178.671 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.472 0 CA-C-O 120.008 -0.329 . . . . 4.6600000000000001 113.369 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.72 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.0 0.4 . . . . 5.7800000000000002 110.96 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 61.6 tp -61.45 -46.6 89.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 4.3799999999999999 110.354 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.89 -49.94 74.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.001 -0.545 . . . . 2.8599999999999999 110.792 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.06 -53.04 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.551 . . . . 3.7400000000000002 112.337 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.543 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 5.0 p80 -70.73 -28.42 64.7 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.283 -0.567 . . . . 5.0499999999999998 110.903 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.95 59.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.066 0.46 . . . . 3.3300000000000001 110.406 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.11 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.691 -0.686 . . . . 4.3700000000000001 110.85 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -67.69 -26.74 66.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 6.0999999999999996 110.547 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' B' ' 13' ' ' HIS . 92.5 mt -81.27 -24.88 36.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 6.4900000000000002 110.42 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.28 15.47 25.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 4.7300000000000004 112.809 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -73.95 114.92 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.939 -0.393 . . . . 3.6000000000000001 109.939 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.752 ' HD3' HD12 ' B' ' 59' ' ' LEU . 94.6 mtt180 -131.05 136.99 48.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.315 -0.402 . . . . 6.7999999999999998 111.491 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.7 mp -129.91 136.42 49.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 3.7999999999999998 109.751 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . 0.742 ' HB3' HD13 ' B' ' 56' ' ' LEU . 28.8 p90 -153.9 150.07 27.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.792 0.329 . . . . 6.7999999999999998 110.381 175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.2 p -88.03 130.69 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.482 -0.562 . . . . 7.7400000000000002 109.482 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.681 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 35.0 tt0 -134.89 114.37 12.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.236 -0.438 . . . . 9.4399999999999995 110.272 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -102.86 0.85 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.984 -0.627 . . . . 9.6600000000000001 111.912 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.644 ' OE1' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -0.08 12.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.572 0.225 . . . . 9.3200000000000003 111.266 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.523 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 10.7 tpp180 -140.14 146.77 39.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.106 -0.638 . . . . 7.3399999999999999 111.395 -171.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.2 tt -79.13 135.71 36.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.515 . . . . 5.1799999999999997 110.332 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 4.8 mpt_? -101.09 137.86 38.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 8.0700000000000003 110.134 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.494 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.6 t80 -119.01 131.49 56.0 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.355 -0.609 . . . . 4.1600000000000001 109.355 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -126.18 114.02 17.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.833 -0.432 . . . . 6.7199999999999998 109.833 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.39 130.49 7.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 5.75 111.265 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.498 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.1 Cg_exo -61.98 151.71 79.74 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.806 2.337 . . . . 6.9800000000000004 112.302 175.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.534 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 34.9 Cg_endo -65.86 123.26 11.08 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.158 1.905 . . . . 8.8499999999999996 112.326 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.42 -33.07 5.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.758 -0.734 . . . . 8.0899999999999999 112.945 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.573 ' O ' HD22 ' B' ' 41' ' ' LEU . 22.5 m -83.99 -7.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.181 0.49 . . . . 7.0 111.53 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.554 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.43 20.22 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.399 . . . . 5.7300000000000004 111.289 -175.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 14.9 p -50.67 138.91 22.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 7.96 111.338 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.01 -41.4 33.18 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.486 2.791 . . . . 7.2999999999999998 113.473 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 42.5 tt0 -57.74 -40.74 80.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.506 0.194 . . . . 9.2200000000000006 111.043 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.573 HD22 ' O ' ' B' ' 36' ' ' VAL . 2.5 tp -64.37 -42.39 96.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.86 0.362 . . . . 6.1699999999999999 110.081 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.498 ' HA ' HD12 ' B' ' 45' ' ' LEU . 22.8 mt-30 -63.66 -36.99 85.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 4.8399999999999999 109.97 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 17.2 t -68.02 -37.02 80.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.666 -0.697 . . . . 7.3499999999999996 109.955 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 56.5 mtt-85 -66.56 -40.36 88.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.418 -0.355 . . . . 8.2799999999999994 110.422 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' B' ' 42' ' ' GLN . 91.7 mt -56.92 -43.76 81.74 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-O 121.285 0.564 . . . . 4.1299999999999999 109.732 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.19 -23.42 6.15 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.474 -0.784 . . . . 5.5800000000000001 112.95 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.99 28.14 73.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.994 -0.622 . . . . 4.5 111.664 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.44 150.26 24.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.528 0.204 . . . . 5.4100000000000001 110.467 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.508 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 11.0 ptt-85 -65.89 -50.21 65.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.338 -0.392 . . . . 8.2200000000000006 111.403 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -57.48 -42.11 82.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.752 -0.204 . . . . 7.1600000000000001 111.398 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -54.22 40.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.448 -0.342 . . . . 5.7199999999999998 110.809 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 75.8 mt -67.91 -27.67 66.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.286 0.476 . . . . 3.0600000000000001 112.286 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 49' ' ' ARG . 72.0 mt -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.808 -0.357 . . . . 6.4000000000000004 110.09 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.75 -36.08 77.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.413 0.625 . . . . 3.73 110.486 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' B' ' 58' ' ' GLN . 2.9 tm? -63.39 -29.21 70.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 2.46 110.134 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' B' ' 22' ' ' TRP . 22.9 tp -79.25 -32.38 43.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 5.5599999999999996 110.694 173.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.59 -20.23 65.34 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.013 0.375 . . . . 7.1900000000000004 112.013 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' B' ' 55' ' ' LEU . 1.5 pp0? -73.36 -17.93 61.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.768 -0.373 . . . . 4.2300000000000004 110.893 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.752 HD12 ' HD3' ' B' ' 20' ' ' ARG . 10.1 tt . . . . . 0 C--N 1.329 -0.285 0 N-CA-C 109.398 -0.593 . . . . 6.46 109.398 176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.232 0 N-CA-C 110.379 -0.23 . . . . 2.5 110.379 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.1 92.87 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.579 -0.609 . . . . 2.1299999999999999 111.579 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.22 85.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 2.1899999999999999 110.306 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.7 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 36.6 tp -61.76 -46.84 87.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.918 -0.583 . . . . 1.6799999999999999 110.042 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.4 -47.57 85.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.493 -0.776 . . . . 1.71 109.933 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.42 73.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.449 . . . . 1.75 112.043 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.7 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 4.5 p80 -74.75 -27.76 60.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.649 -0.421 . . . . 1.78 110.625 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 -45.36 71.69 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.203 -0.295 . . . . 1.0900000000000001 110.203 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 1.46 110.935 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -65.34 -31.98 73.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 2.2799999999999998 111.235 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.6 HD13 ' HB ' ' A' ' 36' ' ' VAL . 74.6 mt -85.35 -26.43 26.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 1.6499999999999999 110.166 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.35 33.23 26.22 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.51 -0.768 . . . . 1.28 112.804 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.668 HG21 HD21 ' A' ' 41' ' ' LEU . 54.0 t -71.71 121.06 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.81 -0.811 . . . . 0.98999999999999999 108.81 173.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.788 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 74.7 mtt180 -126.5 131.71 51.56 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.378 -0.23 . . . . 2.6699999999999999 110.378 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.594 HD23 HD11 ' A' ' 28' ' ' LEU . 6.1 mp -132.33 125.52 31.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.729 -0.471 . . . . 1.45 109.729 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -143.11 134.45 26.07 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.917 0.389 . . . . 2.2599999999999998 109.984 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -92.77 125.41 45.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 2.9199999999999999 109.959 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.25 118.16 28.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.907 -0.588 . . . . 4.2000000000000002 109.661 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.05 -97.04 0.56 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.688 -0.687 . . . . 4.2000000000000002 111.664 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -116.63 -16.29 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.734 0.302 . . . . 5.1500000000000004 111.444 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -114.76 135.2 54.43 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.836 -0.746 . . . . 5.3799999999999999 112.643 -167.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.594 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -78.24 124.76 28.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.505 -1.225 . . . . 2.4399999999999999 108.84 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.96 143.97 30.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.001 -0.37 . . . . 4.2199999999999998 110.001 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.66 131.89 55.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 1.6899999999999999 110.702 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.788 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 5.2 tp-100 -126.36 114.33 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.872 -0.603 . . . . 2.6800000000000002 109.692 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.83 126.85 4.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 111.343 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' HG22 ' A' ' 36' ' ' VAL . 24.0 Cg_exo -65.38 155.83 66.61 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.904 2.402 . . . . 1.8400000000000001 112.053 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.09 123.79 13.91 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.728 2.285 . . . . 2.3100000000000001 112.563 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.15 -31.88 6.68 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 1.76 113.2 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.6 ' HB ' HD13 ' A' ' 17' ' ' LEU . 15.4 m -85.11 -19.87 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.091 0.446 . . . . 1.49 112.157 -174.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.511 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.39 20.29 0.89 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.4099999999999999 111.43 -171.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.3 p -51.75 142.16 24.77 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 1.45 110.894 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.68 -38.29 28.88 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.207 2.605 . . . . 1.72 113.244 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 55.4 tt0 -61.54 -39.98 93.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 2.7599999999999998 111.056 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.668 HD21 HG21 ' A' ' 19' ' ' VAL . 1.9 tp -60.35 -44.55 95.44 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.882 0.372 . . . . 1.2 110.134 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.704 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.36 -39.01 75.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 2.0600000000000001 110.125 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -68.84 -29.84 68.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.578 . . . . 1.5700000000000001 110.504 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 27.4 mmt180 -73.1 -40.9 64.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.99 -0.374 . . . . 3.3399999999999999 109.99 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.494 HD12 HE21 ' A' ' 42' ' ' GLN . 50.8 mt -60.19 -38.46 83.34 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.544 0.688 . . . . 1.25 109.161 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.3 -23.23 8.57 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.183 -0.917 . . . . 2.2999999999999998 113.062 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.14 19.32 71.96 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.934 -0.651 . . . . 2.5699999999999998 112.064 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -82.87 149.66 26.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.899 -0.408 . . . . 2.0800000000000001 109.899 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.4 ptp85 -69.06 -50.62 46.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.487 -0.324 . . . . 5.3600000000000003 111.521 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.457 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 8.6 p80 -61.59 -32.97 73.1 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.095 0.474 . . . . 2.9900000000000002 110.836 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -66.25 -51.24 59.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.326 -0.852 . . . . 2.75 110.309 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.486 HD22 HD22 ' A' ' 21' ' ' LEU . 91.2 mt -69.08 -26.52 64.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.925 -1.034 . . . . 1.8999999999999999 111.124 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.4 mt -61.0 -48.16 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 2.7400000000000002 109.998 174.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.63 66.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 1.5 110.609 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.7 tm? -69.39 -38.13 77.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 1.3200000000000001 109.398 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.5 tp -79.46 -26.8 41.65 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.452 0.644 . . . . 1.6799999999999999 109.633 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -65.29 -26.77 68.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 4.0700000000000003 110.437 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.57 -27.89 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 1.75 110.274 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 20' ' ' ARG . 51.0 mt -74.24 -19.19 60.59 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.581 -0.736 . . . . 2.4700000000000002 110.911 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.798 -0.637 . . . . 2.5800000000000001 109.875 178.552 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 111.693 -0.563 . . . . 4.6600000000000001 111.693 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.0 83.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.892 0.377 . . . . 5.7800000000000002 110.173 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.52 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 58.5 tp -61.51 -46.59 89.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.867 -0.606 . . . . 4.3799999999999999 109.89 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.31 -49.15 76.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.728 -0.669 . . . . 2.8599999999999999 109.66 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.78 -53.26 58.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 3.7400000000000002 112.307 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.52 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 4.0 p80 -73.52 -27.92 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.19 -0.604 . . . . 5.0499999999999998 110.952 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.17 78.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 3.3300000000000001 110.445 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.15 94.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 4.3700000000000001 110.8 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -61.99 -36.7 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.749 -0.66 . . . . 6.0999999999999996 111.141 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' B' ' 36' ' ' VAL . 82.5 mt -82.03 -24.92 35.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 6.4900000000000002 110.632 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 86.52 31.65 18.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.045 -0.598 . . . . 4.7300000000000004 112.673 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.621 HG21 HD21 ' B' ' 41' ' ' LEU . 45.8 t -75.38 123.08 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.689 -0.486 . . . . 3.6000000000000001 109.689 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.889 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 77.6 mtt180 -129.33 131.11 46.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.531 -0.304 . . . . 6.7999999999999998 111.107 -173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.669 HD23 HD11 ' B' ' 28' ' ' LEU . 5.7 mp -134.64 125.74 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.328 -0.396 . . . . 3.7999999999999998 110.135 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . 0.497 ' HB3' HD13 ' B' ' 56' ' ' LEU . 20.4 p90 -143.5 137.05 28.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 6.7999999999999998 110.21 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 5.7 p -96.48 118.37 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.183 0.515 . . . . 7.7400000000000002 110.172 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.3 114.43 26.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.85 -0.614 . . . . 9.4399999999999995 109.664 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.36 -98.89 1.05 Allowed Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 111.327 -0.709 . . . . 9.6600000000000001 111.327 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -116.99 -16.53 10.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.852 0.358 . . . . 9.3200000000000003 111.598 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 7.5 tpp180 -115.53 128.44 55.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.409 0.623 . . . . 7.3399999999999999 111.962 -166.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.669 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -74.62 124.39 26.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.801 -1.09 . . . . 5.1799999999999997 109.551 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -100.38 145.31 28.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.295 -0.261 . . . . 8.0700000000000003 110.295 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.472 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -120.14 131.67 55.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 4.1600000000000001 110.57 -174.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.889 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 5.6 tp-100 -125.32 114.39 18.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.433 -0.58 . . . . 6.7199999999999998 109.433 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -151.58 122.17 3.67 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 5.75 111.031 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.539 ' O ' HG22 ' B' ' 36' ' ' VAL . 31.4 Cg_exo -60.27 152.92 63.14 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.917 2.411 . . . . 6.9800000000000004 112.181 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.07 124.05 15.05 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.512 2.141 . . . . 8.8499999999999996 112.409 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.75 -29.03 8.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.705 -0.76 . . . . 8.0899999999999999 112.926 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.557 ' O ' HD22 ' B' ' 41' ' ' LEU . 6.4 m -89.0 -14.61 9.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.533 -0.393 . . . . 7.0 111.293 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.59 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.4 OUTLIER -82.25 18.45 1.41 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.89 0.376 . . . . 5.7300000000000004 111.239 -174.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.8 p -52.08 142.91 25.94 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 7.96 111.114 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . 0.432 ' HG3' ' OE1' ' A' ' 31' ' ' GLN . 71.4 Cg_exo -49.33 -37.16 39.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.263 2.642 . . . . 7.2999999999999998 113.302 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 38.0 tt0 -61.43 -38.26 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.077 -0.249 . . . . 9.2200000000000006 111.13 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.621 HD21 HG21 ' B' ' 19' ' ' VAL . 2.9 tp -62.79 -40.36 97.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.869 0.366 . . . . 6.1699999999999999 110.115 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.763 HE21 ' HA ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -59.62 -39.64 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 4.8399999999999999 109.857 176.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 24.5 t -68.29 -32.35 72.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.773 . . . . 7.3499999999999996 110.703 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 23.7 mmt180 -71.71 -41.67 68.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 8.2799999999999994 110.093 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 78.3 mt -61.28 -39.6 91.01 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.858 -0.61 . . . . 4.1299999999999999 109.779 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.06 -23.16 8.26 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.532 -0.758 . . . . 5.5800000000000001 112.807 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.89 72.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.077 -0.582 . . . . 4.5 112.381 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -76.1 150.43 37.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.047 -0.353 . . . . 5.4100000000000001 110.047 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 53' ' ' ILE . 8.8 ptp85 -65.27 -48.99 71.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.579 -0.282 . . . . 8.2200000000000006 111.034 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -66.66 -32.07 73.15 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.299 . . . . 7.1600000000000001 111.806 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.4 OUTLIER -64.97 -44.27 89.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 5.7199999999999998 110.534 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.85 -25.0 55.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.047 -0.524 . . . . 3.0600000000000001 111.506 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 49' ' ' ARG . 80.0 mt -63.54 -47.46 91.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.672 -0.492 . . . . 6.4000000000000004 109.672 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.21 74.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 3.73 110.233 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.8 tm? -62.53 -44.57 96.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.761 -0.654 . . . . 2.46 109.778 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' B' ' 22' ' ' TRP . 28.2 tp -68.58 -30.95 69.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.3 0.571 . . . . 5.5599999999999996 110.763 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -66.55 -29.66 69.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.074 -0.512 . . . . 7.1900000000000004 110.911 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 8.2 pt20 -68.03 -24.59 65.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 4.2300000000000004 110.381 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.434 HD12 HD12 ' B' ' 56' ' ' LEU . 55.7 mt . . . . . 0 CA--C 1.516 -0.349 0 CA-C-N 115.805 -0.634 . . . . 6.46 110.453 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.28 0 CA-C-O 120.833 0.349 . . . . 2.5 110.449 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.37 -37.58 94.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.943 -0.571 . . . . 2.1299999999999999 111.947 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.35 -41.55 89.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 2.1899999999999999 110.748 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.751 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 32.6 tp -64.22 -47.33 80.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 1.6799999999999999 110.152 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.81 -49.09 77.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.443 -0.798 . . . . 1.71 109.999 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -50.48 71.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.813 -0.63 . . . . 1.75 112.238 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.751 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 4.2 p80 -73.13 -27.49 61.71 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.454 -0.498 . . . . 1.78 110.55 -174.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.68 68.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.818 0.342 . . . . 1.0900000000000001 110.392 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -31.82 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 1.46 110.696 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.977 -0.556 . . . . 2.2799999999999998 110.762 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.603 HD13 ' HB ' ' A' ' 36' ' ' VAL . 97.6 mt -79.96 -25.89 40.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.094 0.474 . . . . 1.6499999999999999 110.257 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.15 42.63 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.984 -0.627 . . . . 1.28 112.276 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.67 121.28 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 109.353 -0.61 . . . . 0.98999999999999999 109.353 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 76.8 mtt180 -122.25 135.23 54.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.77 -0.456 . . . . 2.6699999999999999 109.77 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.806 HD22 HD22 ' A' ' 52' ' ' LEU . 6.0 mp -135.85 124.36 23.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 1.45 110.183 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.485 ' HB3' HD13 ' A' ' 56' ' ' LEU . 23.8 p90 -140.84 140.6 34.66 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.894 -0.41 . . . . 2.2599999999999998 109.894 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.51 123.0 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.943 0.401 . . . . 2.9199999999999999 110.147 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.647 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -110.34 101.84 10.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.025 -0.731 . . . . 4.2000000000000002 109.025 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.01 -86.15 0.22 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.766 -0.652 . . . . 4.2000000000000002 112.1 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.63 -32.03 5.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.207 0.527 . . . . 5.1500000000000004 110.78 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.31 133.37 50.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 5.3799999999999999 112.029 -167.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.616 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -69.6 126.15 28.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.882 -1.054 . . . . 2.4399999999999999 109.445 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.647 ' NH1' ' HB3' ' A' ' 24' ' ' GLU . 7.3 mpt_? -98.58 131.11 45.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.628 -0.508 . . . . 4.2199999999999998 109.628 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.417 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -108.45 145.99 33.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.063 -0.517 . . . . 1.6899999999999999 110.201 -175.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 8.6 tp-100 -145.41 110.49 5.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.981 -0.378 . . . . 2.6800000000000002 109.981 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -146.03 135.68 11.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.565 -0.289 . . . . 1.6899999999999999 110.848 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' HG22 ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.26 156.98 37.42 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.89 2.394 . . . . 1.8400000000000001 112.179 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' B' ' 38' ' ' THR . 20.0 Cg_endo -63.1 123.95 13.08 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.437 2.092 . . . . 2.3100000000000001 112.35 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.64 -37.23 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.76 113.275 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.603 ' HB ' HD13 ' A' ' 17' ' ' LEU . 33.3 m -75.06 -11.92 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.609 0.596 . . . . 1.49 112.609 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -82.16 21.51 0.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.187 -0.46 . . . . 1.4099999999999999 111.711 -173.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.621 HG22 ' HB3' ' B' ' 34' ' ' PRO . 35.2 p -50.64 143.91 13.58 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 116.608 -0.269 . . . . 1.45 110.954 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 50.6 Cg_exo -53.51 -32.91 65.48 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.54 2.16 . . . . 1.72 111.954 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 18.4 tp10 -57.93 -50.21 74.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.856 -0.611 . . . . 2.7599999999999998 110.2 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 36' ' ' VAL . 2.4 tp -61.79 -47.53 84.73 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.2 110.293 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HA ' HD12 ' A' ' 45' ' ' LEU . 25.3 tp60 -57.13 -39.25 74.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 2.0600000000000001 111.204 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.9 t -71.44 -29.55 65.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.381 -0.372 . . . . 1.5700000000000001 110.391 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 96.3 mtt180 -77.76 -28.73 50.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 3.3399999999999999 110.94 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 42' ' ' GLN . 87.2 mt -64.86 -33.85 76.99 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.784 -0.821 . . . . 1.25 108.784 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 -24.03 6.79 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.078 -0.965 . . . . 2.2999999999999998 113.044 171.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.87 11.6 60.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.967 -0.635 . . . . 2.5699999999999998 112.12 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -78.42 150.47 33.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.137 -0.32 . . . . 2.0800000000000001 110.137 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -67.46 -50.15 60.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.298 -0.41 . . . . 5.3600000000000003 111.16 -173.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.62 -34.54 78.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 2.9900000000000002 110.808 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -66.1 -48.67 70.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.699 -0.682 . . . . 2.75 109.844 -178.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.806 HD22 HD22 ' A' ' 21' ' ' LEU . 76.8 mt -72.07 -24.2 61.47 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.05 -0.977 . . . . 1.8999999999999999 111.238 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 49' ' ' ARG . 74.7 mt -62.37 -43.92 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.769 -0.456 . . . . 2.7400000000000002 109.769 172.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.06 -25.76 65.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 1.5 110.319 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.69 ' HB2' ' HA ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -71.56 -29.76 65.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 1.3200000000000001 110.202 -178.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 5.5 tp -84.27 -40.15 18.36 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.444 -0.798 . . . . 1.6799999999999999 110.619 172.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -56.89 -28.97 62.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.276 -0.875 . . . . 4.0700000000000003 111.156 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 11.8 pt20 -68.21 -20.36 64.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.357 -0.838 . . . . 1.75 111.594 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.8 tp -89.23 -6.44 56.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.352 -0.385 . . . . 2.4700000000000002 110.718 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 116.235 -0.439 . . . . 2.5800000000000001 110.605 -179.86 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 112.096 -0.402 . . . . 4.6600000000000001 112.096 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.22 88.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.886 0.374 . . . . 5.7800000000000002 110.705 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.542 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 63.3 tp -64.22 -46.94 81.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.006 -0.543 . . . . 4.3799999999999999 110.141 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' B' ' 58' ' ' GLN . 3.2 tm? -59.57 -49.2 78.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 2.8599999999999999 110.544 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.11 -53.28 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 3.7400000000000002 111.979 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.542 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 3.3 p80 -71.79 -27.03 62.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.605 -0.438 . . . . 5.0499999999999998 111.068 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.5 73.2 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.199 -0.297 . . . . 3.3300000000000001 110.199 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -36.54 83.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.03 -0.532 . . . . 4.3700000000000001 110.473 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -58.64 -39.45 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.695 -0.684 . . . . 6.0999999999999996 110.701 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -82.61 -25.22 33.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 6.4900000000000002 110.871 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.0 27.91 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.781 -0.723 . . . . 4.7300000000000004 111.939 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' B' ' 17' ' ' LEU . 47.7 t -77.71 121.84 31.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.687 -0.486 . . . . 3.6000000000000001 109.687 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 78.1 mtt180 -122.59 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.317 -0.401 . . . . 6.7999999999999998 110.427 -175.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.723 HD22 HD22 ' B' ' 52' ' ' LEU . 5.9 mp -136.27 124.7 23.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 3.7999999999999998 110.219 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . 0.726 ' HB3' HD13 ' B' ' 56' ' ' LEU . 30.0 p90 -142.23 140.81 32.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 6.7999999999999998 110.329 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.39 123.16 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.227 0.537 . . . . 7.7400000000000002 110.337 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.611 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 2.8 tm-20 -111.91 100.66 9.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.884 -0.784 . . . . 9.4399999999999995 108.884 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.55 -87.42 0.27 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.801 -0.636 . . . . 9.6600000000000001 112.137 -177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -116.25 -31.82 5.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.308 0.575 . . . . 9.3200000000000003 110.725 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -106.26 128.42 53.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 7.3399999999999999 111.659 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.601 HD11 HD23 ' B' ' 21' ' ' LEU . 3.2 tm? -64.97 123.5 19.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.874 -1.057 . . . . 5.1799999999999997 109.648 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.611 ' NH1' ' HB3' ' B' ' 24' ' ' GLU . 8.1 mpt_? -95.75 130.5 42.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.749 -0.463 . . . . 8.0700000000000003 109.749 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.544 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -106.49 150.13 26.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.059 -0.519 . . . . 4.1600000000000001 110.134 -176.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.605 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 8.4 tp-100 -149.16 112.06 4.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.742 -0.466 . . . . 6.7199999999999998 109.742 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -148.67 135.04 10.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.628 -0.26 . . . . 5.75 110.78 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.515 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.0 Cg_exo -60.54 153.62 59.82 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.752 2.301 . . . . 6.9800000000000004 112.458 176.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.621 ' HB3' HG22 ' A' ' 38' ' ' THR . 19.3 Cg_endo -60.83 123.19 12.47 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.557 2.172 . . . . 8.8499999999999996 112.52 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.71 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.674 -0.774 . . . . 8.0899999999999999 113.281 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.635 ' HB ' HD13 ' B' ' 17' ' ' LEU . 18.9 m -80.62 -7.53 10.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 117.03 0.415 . . . . 7.0 111.935 -173.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.57 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.6 OUTLIER -82.84 20.14 1.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.344 -0.389 . . . . 5.7300000000000004 111.692 -173.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 34' ' ' PRO . 38.0 p -51.28 144.75 15.06 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.719 0.295 . . . . 7.96 111.603 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.96 -30.59 59.51 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.805 2.336 . . . . 7.2999999999999998 112.188 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 17.6 tp10 -59.56 -50.0 75.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.932 -0.576 . . . . 9.2200000000000006 109.789 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 36' ' ' VAL . 3.1 tp -63.5 -45.8 89.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 6.1699999999999999 110.14 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -56.97 -41.03 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 4.8399999999999999 111.036 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -70.0 -31.75 69.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.301 -0.408 . . . . 7.3499999999999996 110.622 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 99.4 mtt180 -76.9 -28.84 55.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.523 -0.308 . . . . 8.2799999999999994 110.883 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 94.5 mt -64.62 -33.56 76.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.114 -0.699 . . . . 4.1299999999999999 109.114 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.93 -23.09 8.17 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.127 -0.942 . . . . 5.5800000000000001 112.824 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.1 8.64 54.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.983 -0.627 . . . . 4.5 112.208 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.47 149.82 36.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.975 0.417 . . . . 5.4100000000000001 110.429 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.555 ' O ' HG13 ' B' ' 53' ' ' ILE . 0.3 OUTLIER -62.72 -49.96 72.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.838 -0.619 . . . . 8.2200000000000006 111.665 -175.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -66.18 -33.48 75.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.644 0.239 . . . . 7.1600000000000001 111.644 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.95 -45.01 75.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 5.7199999999999998 110.51 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.723 HD22 HD22 ' B' ' 21' ' ' LEU . 53.2 mt -73.97 -23.74 59.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.483 . . . . 3.0600000000000001 111.34 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 49' ' ' ARG . 71.3 mt -64.16 -41.9 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.615 -0.513 . . . . 6.4000000000000004 109.615 171.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.18 -31.44 70.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 3.73 110.534 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.681 ' HB2' ' HA ' ' B' ' 52' ' ' LEU . 1.1 mm? -63.32 -34.52 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.838 -0.619 . . . . 2.46 110.82 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.726 HD13 ' HB3' ' B' ' 22' ' ' TRP . 34.5 tp -79.46 -41.8 26.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 5.5599999999999996 110.506 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -61.45 -20.84 63.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.482 -0.781 . . . . 7.1900000000000004 111.638 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 24.7 pt20 -77.72 -20.85 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.788 0.328 . . . . 4.2300000000000004 110.613 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.2 tp . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 6.46 110.362 -176.386 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.482 0.182 . . . . 2.5 111.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.62 -46.93 92.6 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.127 -0.559 . . . . 2.1299999999999999 112.37 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.0 -41.31 77.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 2.1899999999999999 110.995 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.671 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 28.2 tp -62.9 -47.3 83.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 1.6799999999999999 110.667 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.14 -44.46 95.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.843 -0.617 . . . . 1.71 109.584 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.17 80.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.008 -0.542 . . . . 1.75 112.148 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.671 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 7.0 p80 -71.67 -28.4 63.71 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.415 -0.514 . . . . 1.78 110.617 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.29 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 1.0900000000000001 109.927 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.0 75.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.46 110.762 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 t -65.54 -38.14 88.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.081 -0.509 . . . . 2.2799999999999998 110.224 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 92.2 mt -73.99 -24.77 59.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 1.6499999999999999 109.941 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.56 31.93 17.36 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.618 -0.719 . . . . 1.28 112.461 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.41 ' O ' HD11 ' A' ' 55' ' ' LEU . 47.2 t -71.2 132.89 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.965 -0.754 . . . . 0.98999999999999999 108.965 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.741 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 44.6 mtt180 -129.99 134.15 47.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.914 -0.402 . . . . 2.6699999999999999 109.914 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.694 HD22 HD13 ' A' ' 52' ' ' LEU . 6.0 mp -137.14 127.36 26.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.45 109.563 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.533 ' HB3' HD13 ' A' ' 56' ' ' LEU . 24.2 p90 -146.61 137.01 23.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.013 0.435 . . . . 2.2599999999999998 110.325 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -79.56 124.0 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.149 0.499 . . . . 2.9199999999999999 110.402 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.24 105.25 8.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 4.2000000000000002 109.568 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.66 -112.22 4.33 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.395 -0.907 . . . . 4.2000000000000002 111.403 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -104.19 -18.8 14.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.1500000000000004 110.8 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -107.05 127.05 53.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.495 0.664 . . . . 5.3799999999999999 111.35 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.499 HD21 HD23 ' A' ' 21' ' ' LEU . 9.7 tt -74.68 114.42 13.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.479 -0.782 . . . . 2.4399999999999999 109.269 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 9.1 mmm180 -80.47 139.53 36.37 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.752 -0.462 . . . . 4.2199999999999998 109.752 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -124.25 132.72 53.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 1.6899999999999999 109.73 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.741 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 56.7 tp60 -127.47 114.75 17.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.574 -0.528 . . . . 2.6800000000000002 109.574 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -142.53 127.71 10.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.342 -0.39 . . . . 1.6899999999999999 110.893 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 36' ' ' VAL . 32.1 Cg_exo -60.42 156.49 40.97 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.934 2.422 . . . . 1.8400000000000001 111.705 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' B' ' 38' ' ' THR . 30.0 Cg_endo -65.76 123.36 11.25 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.268 1.979 . . . . 2.3100000000000001 112.39 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' THR . . . 106.89 -37.13 3.98 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.777 -0.725 . . . . 1.76 113.406 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 33' ' ' PRO . 35.8 m -75.82 -15.69 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.682 0.623 . . . . 1.49 112.682 -173.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.501 ' HE2' ' HA ' ' A' ' 37' ' ' MET . 9.1 tpp -84.57 23.27 1.16 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.294 0.569 . . . . 1.4099999999999999 111.311 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.679 HG22 ' HB3' ' B' ' 34' ' ' PRO . 17.8 p -50.7 143.73 14.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.45 110.39 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.79 -30.17 45.82 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.801 2.334 . . . . 1.72 112.435 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.626 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 8.4 tp10 -60.54 -47.4 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 2.7599999999999998 110.106 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 36' ' ' VAL . 4.0 tp -58.08 -49.55 76.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.793 0.33 . . . . 1.2 110.572 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 45' ' ' LEU . 18.3 tp60 -60.45 -36.11 77.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.939 -0.573 . . . . 2.0600000000000001 110.754 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.5 t -64.18 -32.61 74.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.012 0.434 . . . . 1.5700000000000001 110.039 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 19.9 mmt180 -78.92 -40.38 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 3.3399999999999999 110.873 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 42' ' ' GLN . 84.6 mt -52.82 -37.24 59.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.979 -0.748 . . . . 1.25 108.979 171.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.69 -22.84 8.32 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.231 -0.895 . . . . 2.2999999999999998 112.048 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.71 14.21 72.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.978 -0.63 . . . . 2.5699999999999998 112.229 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -79.38 148.42 32.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.935 -0.394 . . . . 2.0800000000000001 109.935 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 1.6 ptm180 -69.76 -51.2 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.459 -0.337 . . . . 5.3600000000000003 111.745 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -56.99 -34.86 68.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.148 0.499 . . . . 2.9900000000000002 110.564 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -65.82 -49.96 66.37 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.639 -0.709 . . . . 2.75 110.316 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 21' ' ' LEU . 87.4 mt -75.21 -24.54 57.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.965 -1.016 . . . . 1.8999999999999999 111.284 -174.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.9 mt -63.68 -42.91 97.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.852 -0.425 . . . . 2.7400000000000002 109.852 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.57 76.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.316 0.579 . . . . 1.5 110.133 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.653 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.4 tm? -70.74 -31.67 68.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 1.3200000000000001 109.508 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.623 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.7 tp -79.2 -36.72 39.7 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.993 -0.549 . . . . 1.6799999999999999 109.737 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -55.5 -29.62 59.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 4.0700000000000003 111.251 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.3 pt20 -56.1 -34.3 65.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.5 -0.318 . . . . 1.75 111.183 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.67 HD11 ' HB3' ' A' ' 20' ' ' ARG . 79.2 mt -83.72 -5.46 59.2 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.887 0.328 . . . . 2.4700000000000002 111.887 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 110.337 -0.246 . . . . 2.5800000000000001 110.337 -177.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 CA-C-O 120.438 -0.09 . . . . 4.6600000000000001 112.945 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.2 93.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 5.7800000000000002 110.81 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.524 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 56.0 tp -60.85 -47.52 86.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.056 -0.52 . . . . 4.3799999999999999 110.47 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.97 -43.44 92.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.732 -0.667 . . . . 2.8599999999999999 109.653 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.33 -51.43 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.639 . . . . 3.7400000000000002 112.315 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.524 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 14.2 p80 -72.52 -28.22 62.73 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.334 -0.546 . . . . 5.0499999999999998 110.934 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.85 -43.43 75.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.189 0.519 . . . . 3.3300000000000001 110.054 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.71 76.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.477 -0.783 . . . . 4.3700000000000001 110.806 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -67.57 -34.33 76.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.053 -0.521 . . . . 6.0999999999999996 110.308 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.565 HD13 ' HB ' ' B' ' 36' ' ' VAL . 86.7 mt -75.85 -24.34 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 6.4900000000000002 110.426 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.86 28.43 21.2 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.785 -0.722 . . . . 4.7300000000000004 112.389 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.407 ' O ' HD11 ' B' ' 55' ' ' LEU . 46.2 t -72.11 132.74 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.471 -0.566 . . . . 3.6000000000000001 109.471 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.851 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 76.6 mtt180 -130.48 132.9 45.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.592 0.234 . . . . 6.7999999999999998 110.971 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.585 HD22 HD13 ' B' ' 52' ' ' LEU . 5.7 mp -137.98 127.45 24.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.843 -0.429 . . . . 3.7999999999999998 109.843 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . 0.665 ' HB3' HD13 ' B' ' 56' ' ' LEU . 29.3 p90 -147.78 139.97 24.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.932 0.396 . . . . 6.7999999999999998 110.361 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.3 p -78.65 130.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.155 0.502 . . . . 7.7400000000000002 110.405 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -132.16 101.0 5.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 9.4399999999999995 109.668 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.74 -110.3 3.27 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.691 -0.766 . . . . 9.6600000000000001 111.364 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.76 -11.69 16.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.701 0.286 . . . . 9.3200000000000003 111.077 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.12 123.31 48.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 7.3399999999999999 111.054 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 9.1 tt -74.64 115.07 13.78 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.329 -0.619 . . . . 5.1799999999999997 109.329 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -79.89 139.31 37.17 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.006 -0.368 . . . . 8.0700000000000003 110.006 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -122.14 133.2 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.457 -0.571 . . . . 4.1600000000000001 109.457 -177.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.851 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 55.3 tp60 -129.81 112.52 13.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.63 -0.508 . . . . 6.7199999999999998 109.63 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.05 133.1 16.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 5.75 111.136 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.45 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.2 Cg_exo -62.98 153.58 72.58 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.056 2.504 . . . . 6.9800000000000004 112.007 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.679 ' HB3' HG22 ' A' ' 38' ' ' THR . 30.3 Cg_endo -63.77 123.95 12.82 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.421 2.081 . . . . 8.8499999999999996 112.725 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 -36.85 4.13 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.597 -0.811 . . . . 8.0899999999999999 113.455 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.565 ' HB ' HD13 ' B' ' 17' ' ' LEU . 23.3 m -78.96 -9.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.017 0.377 . . . . 7.0 112.017 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.85 19.98 1.26 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 5.7300000000000004 111.35 -176.009 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 34' ' ' PRO . 10.6 p -51.04 144.7 13.62 Favored Pre-proline 0 C--O 1.236 0.387 0 CA-C-N 116.442 -0.344 . . . . 7.96 111.094 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.99 -30.71 49.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.819 2.346 . . . . 7.2999999999999998 112.304 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 11.7 tp10 -60.42 -43.64 96.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 9.2200000000000006 110.556 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.527 HD22 ' O ' ' B' ' 36' ' ' VAL . 11.1 tp -62.43 -46.19 89.7 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 110.234 -0.284 . . . . 6.1699999999999999 110.234 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' B' ' 45' ' ' LEU . 18.9 tp60 -61.73 -37.55 84.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.169 -0.469 . . . . 4.8399999999999999 110.378 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -63.06 -35.17 79.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.38 -0.373 . . . . 7.3499999999999996 110.343 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 16.7 mmt180 -77.54 -39.95 44.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 8.2799999999999994 110.868 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' B' ' 42' ' ' GLN . 86.3 mt -56.81 -36.01 69.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 4.1299999999999999 109.625 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.67 -22.95 8.09 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.162 -0.926 . . . . 5.5800000000000001 112.219 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.44 75.73 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.083 -0.58 . . . . 4.5 111.863 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.69 149.93 29.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.217 -0.29 . . . . 5.4100000000000001 110.217 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 53' ' ' ILE . 2.0 ptm180 -68.67 -48.86 62.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 8.2200000000000006 111.182 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -60.07 -36.52 77.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.846 0.313 . . . . 7.1600000000000001 111.846 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -47.11 80.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.114 0.483 . . . . 5.7199999999999998 110.718 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.585 HD13 HD22 ' B' ' 21' ' ' LEU . 86.0 mt -75.33 -24.77 57.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 3.0600000000000001 111.616 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 49' ' ' ARG . 83.1 mt -66.67 -39.57 84.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.946 -0.39 . . . . 6.4000000000000004 109.946 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.89 83.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.201 0.524 . . . . 3.73 110.207 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.71 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.1 tm? -63.38 -34.93 78.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.247 -0.888 . . . . 2.46 110.02 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' B' ' 22' ' ' TRP . 17.8 tp -73.24 -38.67 65.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 5.5599999999999996 110.473 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -57.18 -28.63 62.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 7.1900000000000004 111.985 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 17.5 pt20 -60.92 -26.37 67.43 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.887 -0.325 . . . . 4.2300000000000004 110.905 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.331 -0.395 . . . . 6.46 111.052 -177.119 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.878 0.37 . . . . 2.5 110.849 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.38 92.36 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.049 -0.523 . . . . 2.1299999999999999 111.909 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.06 -41.7 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 2.1899999999999999 110.728 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.692 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 51.0 tp -62.12 -46.4 89.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 1.6799999999999999 110.317 176.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.16 -47.36 86.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.391 -0.822 . . . . 1.71 110.115 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.33 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 1.75 112.116 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.692 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.9 p80 -69.94 -27.07 64.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.884 0.373 . . . . 1.78 110.216 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.12 -36.88 66.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 1.0900000000000001 110.284 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.52 83.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.948 -0.569 . . . . 1.46 111.146 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 p -67.0 -21.93 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 2.2799999999999998 111.515 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.15 -25.07 15.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.189 0.518 . . . . 1.6499999999999999 110.447 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.76 37.38 13.64 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 1.28 112.636 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.25 120.15 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.992 -0.744 . . . . 0.98999999999999999 108.992 174.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.552 ' HB3' HD22 ' A' ' 59' ' ' LEU . 20.7 mtt180 -120.07 128.89 53.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.57 -0.286 . . . . 2.6699999999999999 110.69 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -133.03 124.11 27.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.484 -0.562 . . . . 1.45 109.484 173.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HB3' HD13 ' A' ' 56' ' ' LEU . 27.3 p90 -141.48 143.15 33.68 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.937 -0.394 . . . . 2.2599999999999998 109.937 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.27 129.81 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.689 -0.486 . . . . 2.9199999999999999 109.689 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 14.2 tp10 -136.91 120.2 16.82 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.375 -0.602 . . . . 4.2000000000000002 109.375 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.9 -105.04 1.36 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.824 -0.703 . . . . 4.2000000000000002 111.82 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.86 -3.06 11.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.69 0.255 . . . . 5.1500000000000004 111.69 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 9.4 tpp180 -129.19 152.18 49.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 5.3799999999999999 112.116 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.461 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -75.7 122.34 23.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.046 -0.979 . . . . 2.4399999999999999 108.618 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.468 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.2 mpt_? -99.03 131.08 45.34 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.366 -0.605 . . . . 4.2199999999999998 109.366 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -108.21 154.07 22.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 1.6899999999999999 110.245 -172.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 23.9 tp60 -153.25 110.43 3.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.805 -0.442 . . . . 2.6800000000000002 109.805 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.74 134.98 26.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.122 -0.49 . . . . 1.6899999999999999 110.66 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.575 ' HD2' HG21 ' A' ' 36' ' ' VAL . 37.0 Cg_exo -61.91 156.09 51.05 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.612 2.208 . . . . 1.8400000000000001 111.555 172.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.519 ' HB3' HG22 ' B' ' 38' ' ' THR . 22.9 Cg_endo -63.79 123.3 11.75 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.267 1.978 . . . . 2.3100000000000001 112.305 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' THR . . . 106.88 -37.68 3.7 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.936 -0.649 . . . . 1.76 113.448 173.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.575 HG21 ' HD2' ' A' ' 33' ' ' PRO . 33.8 m -70.65 -20.3 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.518 0.562 . . . . 1.49 112.518 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.4 tpp -82.61 24.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.022 0.439 . . . . 1.4099999999999999 111.446 -173.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.491 HG22 ' HB3' ' B' ' 34' ' ' PRO . 8.3 p -49.69 143.08 11.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 1.45 110.872 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.648 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 82.6 Cg_exo -45.76 -40.76 19.51 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.299 2.666 . . . . 1.72 113.773 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 8.9 pt-20 -61.89 -44.61 96.45 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 120.736 0.303 . . . . 2.7599999999999998 110.525 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.417 ' N ' ' HG3' ' A' ' 40' ' ' GLU . 3.0 tt -67.69 -44.82 76.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.334 0.588 . . . . 1.2 109.908 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -56.17 -41.7 75.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.578 -1.192 . . . . 2.0600000000000001 110.548 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -72.8 -29.24 63.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.927 -0.579 . . . . 1.5700000000000001 111.042 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.8 mtp180 -75.84 -28.08 58.11 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.956 -0.298 . . . . 3.3399999999999999 111.017 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.69 -43.77 98.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.536 -0.542 . . . . 1.25 109.536 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.9 -23.61 5.77 Favored Glycine 0 C--N 1.329 0.158 0 CA-C-N 115.644 -0.707 . . . . 2.2999999999999998 112.97 171.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.41 18.11 69.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.907 -0.663 . . . . 2.5699999999999998 112.47 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -72.72 147.8 45.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.121 -0.325 . . . . 2.0800000000000001 110.121 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 22.9 ptt180 -68.34 -50.67 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.334 -0.393 . . . . 5.3600000000000003 111.644 -172.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.433 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 11.9 p80 -60.23 -36.06 76.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.739 0.781 . . . . 2.9900000000000002 110.048 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.63 -42.75 70.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.608 -1.178 . . . . 2.75 110.214 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 63.3 mt -70.4 -25.41 63.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.598 -0.728 . . . . 1.8999999999999999 110.822 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.1 mt -60.5 -50.03 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.792 -0.447 . . . . 2.7400000000000002 109.792 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.15 70.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.199 0.523 . . . . 1.5 110.758 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.6 tm? -71.09 -40.6 71.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.801 . . . . 1.3200000000000001 109.959 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.2 tp -77.23 -31.31 55.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.952 -0.567 . . . . 1.6799999999999999 109.756 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -61.81 -31.22 71.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 4.0700000000000003 110.506 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.61 -29.62 70.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.522 . . . . 1.75 110.613 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 20' ' ' ARG . 29.7 tp -90.02 -2.87 58.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 2.4700000000000002 110.553 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 C--N 1.325 -0.492 0 CA-C-N 116.108 -0.496 . . . . 2.5800000000000001 110.617 -179.292 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 112.012 -0.435 . . . . 4.6600000000000001 112.012 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.38 92.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 5.7800000000000002 110.906 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.476 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 57.1 tp -64.29 -45.91 85.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.567 . . . . 4.3799999999999999 109.844 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.78 -47.08 87.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 2.8599999999999999 110.114 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -52.85 63.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 3.7400000000000002 112.291 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 5.0 p80 -72.45 -26.34 61.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.566 -0.453 . . . . 5.0499999999999998 110.963 -176.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.33 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 3.3300000000000001 110.093 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -37.39 82.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.79 -0.641 . . . . 4.3700000000000001 111.292 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 12.3 p -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 6.0999999999999996 111.282 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.565 HD13 ' HB ' ' B' ' 36' ' ' VAL . 93.4 mt -91.7 -25.17 19.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 6.4900000000000002 110.548 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 84.7 35.65 13.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.843 -0.694 . . . . 4.7300000000000004 112.51 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.4 124.62 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.396 -0.594 . . . . 3.6000000000000001 109.396 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 30.4 mtt180 -124.01 127.85 48.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.776 0.322 . . . . 6.7999999999999998 111.194 -171.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.1 mp -135.15 124.74 25.08 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.476 -0.564 . . . . 3.7999999999999998 109.476 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . 0.567 ' HB3' HD13 ' B' ' 56' ' ' LEU . 26.5 p90 -143.63 143.6 31.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.881 0.372 . . . . 6.7999999999999998 110.712 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.15 124.73 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.123 0.487 . . . . 7.7400000000000002 110.076 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.597 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 10.8 tp10 -130.98 118.28 20.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.614 -0.513 . . . . 9.4399999999999995 109.614 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 -104.26 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.76 -0.733 . . . . 9.6600000000000001 111.803 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -4.86 11.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.79 0.329 . . . . 9.3200000000000003 111.763 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.463 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 8.5 tpp180 -130.33 148.69 52.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.343 0.592 . . . . 7.3399999999999999 111.872 -170.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.501 HD11 HD23 ' B' ' 21' ' ' LEU . 3.0 tm? -73.48 115.96 13.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.154 -0.93 . . . . 5.1799999999999997 108.735 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . 0.597 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 6.2 mpt_? -90.81 132.59 35.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.895 -0.409 . . . . 8.0700000000000003 109.895 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.506 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.0 OUTLIER -109.78 152.23 25.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.922 -0.581 . . . . 4.1600000000000001 110.263 -173.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.634 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 25.4 tp60 -152.65 110.02 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.836 -0.431 . . . . 6.7199999999999998 109.836 172.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.09 137.04 29.23 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.288 -0.415 . . . . 5.75 111.115 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.436 ' O ' HG22 ' B' ' 36' ' ' VAL . 38.6 Cg_exo -62.75 154.6 64.7 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.675 2.25 . . . . 6.9800000000000004 111.796 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.648 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 27.9 Cg_endo -63.22 123.52 12.31 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.306 2.004 . . . . 8.8499999999999996 112.629 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.471 ' O ' HG23 ' B' ' 38' ' ' THR . . . 105.5 -37.46 3.8 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.661 -0.78 . . . . 8.0899999999999999 113.499 173.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.565 ' HB ' HD13 ' B' ' 17' ' ' LEU . 19.8 m -73.28 -12.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.108 0.454 . . . . 7.0 111.948 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.5 tpp -89.11 22.43 2.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.958 0.409 . . . . 5.7300000000000004 111.505 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 34' ' ' PRO . 18.7 p -49.06 142.93 9.32 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.433 -0.349 . . . . 7.96 111.149 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -43.76 -42.33 11.75 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.964 3.109 . . . . 7.2999999999999998 114.187 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.661 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 8.5 pt-20 -59.91 -45.65 91.86 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 121.133 -0.227 . . . . 9.2200000000000006 110.921 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.506 ' N ' ' HG3' ' B' ' 40' ' ' GLU . 9.2 tt -70.34 -39.7 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.908 -0.404 . . . . 6.1699999999999999 109.908 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . 0.408 ' OE1' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp60 -56.76 -43.51 80.87 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.668 -0.697 . . . . 4.8399999999999999 110.515 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.3 t -72.14 -31.25 65.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.911 -0.586 . . . . 7.3499999999999996 110.842 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 65.3 mtp180 -71.51 -28.87 64.2 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.225 -0.19 . . . . 8.2799999999999994 111.292 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.34 -44.74 86.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.529 0.68 . . . . 4.1299999999999999 109.328 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.68 -23.75 5.51 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.278 -0.873 . . . . 5.5800000000000001 112.982 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 18.74 74.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.266 -0.492 . . . . 4.5 112.39 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . 0.626 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -71.55 148.75 46.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.835 0.317 . . . . 5.4100000000000001 110.425 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 17.6 ptt180 -68.15 -46.93 69.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.331 -0.395 . . . . 8.2200000000000006 111.448 -172.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -63.62 -35.64 81.19 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.702 0.287 . . . . 7.1600000000000001 111.238 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.9 -38.96 69.85 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.658 -0.417 . . . . 5.7199999999999998 110.302 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' B' ' 48' ' ' ALA . 46.4 mt -70.57 -26.02 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.579 -0.282 . . . . 3.0600000000000001 110.97 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.6 mt -62.33 -49.44 83.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.753 -0.462 . . . . 6.4000000000000004 109.753 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.11 86.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 3.73 110.433 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.5 tm? -62.21 -47.06 86.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.557 -0.747 . . . . 2.46 110.259 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' B' ' 22' ' ' TRP . 21.1 tp -66.27 -36.58 83.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.354 -0.385 . . . . 5.5599999999999996 110.769 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -63.04 -29.27 70.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.415 -0.357 . . . . 7.1900000000000004 111.361 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 6.9 pt20 -67.28 -27.67 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 4.2300000000000004 110.261 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' B' ' 20' ' ' ARG . 37.7 tp . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 6.46 110.495 -176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 111.597 0.221 . . . . 2.5 111.597 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.48 -44.85 96.37 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.494 -0.384 . . . . 2.1299999999999999 112.346 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.63 90.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.06 0.457 . . . . 2.1899999999999999 111.088 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.662 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 57.8 tp -67.91 -46.83 70.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.55 . . . . 1.6799999999999999 110.492 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.98 -44.59 97.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.672 -0.694 . . . . 1.71 110.052 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.42 73.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 1.75 111.972 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.2 p80 -72.02 -27.79 62.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.519 -0.472 . . . . 1.78 110.231 -175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.15 65.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.51 -0.314 . . . . 1.0900000000000001 110.319 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.21 85.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.46 110.813 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -59.82 -43.94 94.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.976 -0.556 . . . . 2.2799999999999998 110.764 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 36' ' ' VAL . 84.2 mt -80.97 -25.63 37.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.327 . . . . 1.6499999999999999 110.781 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.42 31.09 9.88 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.606 -0.806 . . . . 1.28 112.98 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.406 HG13 ' HE1' ' A' ' 30' ' ' PHE . 57.8 t -75.17 112.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.525 -0.546 . . . . 0.98999999999999999 109.525 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.743 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 68.1 mtp180 -123.39 133.49 54.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 2.6699999999999999 110.54 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.2 mp -132.73 127.39 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 1.45 110.674 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HB3' HD13 ' A' ' 56' ' ' LEU . 18.0 p90 -150.85 145.34 25.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.209 -0.663 . . . . 2.2599999999999998 109.209 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.2 p -93.22 128.92 44.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.208 0.528 . . . . 2.9199999999999999 111.036 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.35 106.8 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 4.2000000000000002 109.206 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.5 -107.3 2.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.118 -0.793 . . . . 4.2000000000000002 111.118 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.1 -6.78 11.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.206 0.527 . . . . 5.1500000000000004 110.093 177.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -102.36 118.17 36.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 5.3799999999999999 110.758 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 7.8 tt -70.38 118.59 13.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.331 -0.988 . . . . 2.4399999999999999 108.331 170.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.74 129.24 34.88 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.601 -0.518 . . . . 4.2199999999999998 109.601 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.406 ' HE1' HG13 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -114.75 130.74 56.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.114 -0.494 . . . . 1.6899999999999999 109.867 -177.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.743 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.35 110.24 14.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.458 -0.571 . . . . 2.6800000000000002 109.458 177.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.56 130.37 6.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.376 -0.374 . . . . 1.6899999999999999 110.601 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' HG22 ' A' ' 36' ' ' VAL . 34.1 Cg_endo -69.24 157.91 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.646 2.231 . . . . 1.8400000000000001 111.502 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.31 122.92 11.03 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.556 2.17 . . . . 2.3100000000000001 112.328 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -15.36 27.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.956 -0.64 . . . . 1.76 113.167 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 33' ' ' PRO . 19.1 m -100.3 -8.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.399 0.599 . . . . 1.49 112.162 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.58 20.8 2.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.181 -0.463 . . . . 1.4099999999999999 111.46 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -56.3 145.63 56.4 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.141 -0.482 . . . . 1.45 111.147 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.35 -38.45 62.65 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.952 2.434 . . . . 1.72 113.043 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 40.6 tt0 -59.61 -47.94 83.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 2.7599999999999998 110.398 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.67 -42.81 98.0 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.14 0.495 . . . . 1.2 110.665 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HA ' HD12 ' A' ' 45' ' ' LEU . 9.3 tp-100 -56.89 -40.35 76.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.492 -0.776 . . . . 2.0600000000000001 110.071 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -72.66 -29.51 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.736 -0.666 . . . . 1.5700000000000001 110.36 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 15.1 mmm180 -65.88 -38.13 87.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.984 0.421 . . . . 3.3399999999999999 110.604 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 42' ' ' GLN . 60.6 mt -57.29 -25.52 59.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.309 -0.86 . . . . 1.25 110.043 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -22.88 8.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.546 -0.752 . . . . 2.2999999999999998 112.981 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 25.82 73.45 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.711 -0.756 . . . . 2.5699999999999998 111.923 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -98.38 149.18 22.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.981 0.42 . . . . 2.0800000000000001 110.706 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.532 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.44 -46.75 69.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.442 -0.799 . . . . 5.3600000000000003 111.211 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.514 ' HA ' HD12 ' A' ' 53' ' ' ILE . 19.5 p80 -66.16 -33.28 75.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 109.99 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.7 tp10 -66.73 -42.71 85.86 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.243 -0.889 . . . . 2.75 109.478 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 67.6 mt -67.89 -29.04 68.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.29 -0.868 . . . . 1.8999999999999999 111.103 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 49' ' ' ARG . 84.1 mt -58.55 -51.55 70.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.096 0.474 . . . . 2.7400000000000002 109.855 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.24 68.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.743 -0.662 . . . . 1.5 110.827 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.2 tm? -69.43 -40.78 77.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.722 -0.672 . . . . 1.3200000000000001 109.678 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 22' ' ' TRP . 1.2 tp -79.17 -30.48 43.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.66 -0.496 . . . . 1.6799999999999999 109.66 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -67.15 -21.38 65.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 4.0700000000000003 110.372 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -61.76 -28.94 69.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 1.75 110.847 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.583 ' H ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -106.82 12.67 28.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.847 -0.741 . . . . 2.4700000000000002 111.646 178.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 51.1 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 2.5800000000000001 110.345 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.378 -0.289 . . . . 4.6600000000000001 112.378 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.34 87.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 5.7800000000000002 111.263 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.586 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 68.0 tp -64.72 -46.79 80.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 4.3799999999999999 110.498 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.08 -46.38 84.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.895 -0.593 . . . . 2.8599999999999999 109.843 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.51 75.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 3.7400000000000002 111.838 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' HIS . . . . . 0.586 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 1.5 p80 -73.58 -27.57 61.39 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 5.0499999999999998 110.674 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.04 61.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.681 0.277 . . . . 3.3300000000000001 110.367 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.07 82.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 4.3700000000000001 110.8 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 19.8 t -61.41 -42.98 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 6.0999999999999996 110.833 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.2 mt -81.2 -24.37 37.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 6.4900000000000002 110.937 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.7 7.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.748 -0.739 . . . . 4.7300000000000004 112.344 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.22 113.44 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 3.6000000000000001 109.531 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 63.1 mtp180 -124.8 134.81 52.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.358 -0.383 . . . . 6.7999999999999998 110.858 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.483 HD23 HD21 ' B' ' 28' ' ' LEU . 6.2 mp -134.22 128.64 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 3.7999999999999998 110.767 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' TRP . . . . . 0.72 ' HB3' HD13 ' B' ' 56' ' ' LEU . 26.6 p90 -151.62 143.78 23.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.658 -0.497 . . . . 6.7999999999999998 109.658 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.1 p -88.92 126.87 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.17 0.51 . . . . 7.7400000000000002 111.205 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -118.86 106.23 12.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.922 -0.77 . . . . 9.4399999999999995 108.922 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.14 -106.45 1.84 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 9.6600000000000001 111.394 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -3.69 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 9.3200000000000003 110.313 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ARG . . . . . 0.405 ' NE ' HD11 ' A' ' 52' ' ' LEU . 6.8 tpt85 -107.76 114.24 28.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 7.3399999999999999 110.854 -176.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 7.5 tt -68.12 118.9 11.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.5 -0.926 . . . . 5.1799999999999997 108.5 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -87.34 126.8 35.08 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.679 -0.489 . . . . 8.0700000000000003 109.679 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' PHE . . . . . 0.469 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -111.57 131.25 55.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.931 -0.577 . . . . 4.1600000000000001 109.745 -177.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.72 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 7.6 tp-100 -124.89 107.92 11.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.235 -0.439 . . . . 6.7199999999999998 110.079 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.98 129.85 6.64 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.329 -0.396 . . . . 5.75 110.52 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.499 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.6 Cg_endo -67.1 157.45 61.66 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.544 2.163 . . . . 6.9800000000000004 111.768 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.29 123.75 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.453 2.102 . . . . 8.8499999999999996 112.529 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.67 -24.68 14.71 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.694 -0.684 . . . . 8.0899999999999999 113.401 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' B' ' 17' ' ' LEU . 10.4 m -95.25 4.59 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.003 0.402 . . . . 7.0 111.36 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' MET . . . . . 0.672 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.0 OUTLIER -95.91 18.96 12.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 5.7300000000000004 110.809 -176.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -57.27 145.88 64.81 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 7.96 111.48 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.36 -41.02 52.62 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.312 2.674 . . . . 7.2999999999999998 113.167 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 35.1 tt0 -57.98 -48.67 79.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.654 -0.248 . . . . 9.2200000000000006 110.473 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 9.0 tt -66.1 -38.21 87.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 6.1699999999999999 110.63 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -60.09 -40.45 89.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.735 -0.468 . . . . 4.8399999999999999 109.735 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -72.57 -29.75 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.758 -0.656 . . . . 7.3499999999999996 110.556 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 14.4 mmm180 -66.67 -32.66 74.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.502 -0.317 . . . . 8.2799999999999994 110.657 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 86.3 mt -62.61 -25.36 68.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 4.1299999999999999 110.032 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.95 -23.67 7.6 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.642 -0.708 . . . . 5.5800000000000001 112.699 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.42 24.2 73.65 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.856 -0.688 . . . . 4.5 112.155 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.47 149.78 21.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.627 0.251 . . . . 5.4100000000000001 111.068 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.68 ' HD3' ' H ' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -67.55 -47.56 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 8.2200000000000006 111.312 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' HIS . . . . . 0.55 ' HA ' HD12 ' B' ' 53' ' ' ILE . 25.0 p80 -60.41 -32.86 71.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.718 0.294 . . . . 7.1600000000000001 111.485 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -38.66 75.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 5.7199999999999998 110.312 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 54.9 mt -70.76 -26.18 63.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.46 -0.336 . . . . 3.0600000000000001 110.961 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 50' ' ' HIS . 83.2 mt -61.76 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.757 -0.46 . . . . 6.4000000000000004 109.757 174.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.22 80.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.123 0.487 . . . . 3.73 110.676 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.85 -47.6 85.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.489 -0.778 . . . . 2.46 110.168 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' B' ' 22' ' ' TRP . 26.8 tp -67.88 -35.34 78.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.005 0.431 . . . . 5.5599999999999996 110.717 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.24 -19.47 63.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.274 -0.421 . . . . 7.1900000000000004 111.256 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.01 -28.22 69.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.55 -0.295 . . . . 4.2300000000000004 111.424 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.717 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 CA-C-O 120.881 0.372 . . . . 6.46 110.897 179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.746 0 N-CA-C 112.197 -0.361 . . . . 11.48 112.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -85.67 136.51 5.36 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.881 2.387 . . . . 10.23 112.193 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 58.6 tp -97.16 -43.53 7.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.879 0.371 . . . . 10.02 110.313 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.87 -157.68 53.48 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.986 -0.626 . . . . 6.8899999999999997 112.164 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.4 m -85.47 -66.08 0.94 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.143 -0.317 . . . . 6.0199999999999996 110.143 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -176.42 -75.95 0.01 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.781 0.324 . . . . 3.5099999999999998 111.548 178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.64 -53.32 28.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 2.5 111.953 -172.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -42.01 97.17 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.074 -0.584 . . . . 2.1299999999999999 112.181 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.9 -44.78 95.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.787 0.327 . . . . 2.1899999999999999 110.713 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.648 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 49.7 tp -63.07 -47.5 82.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 1.6799999999999999 110.788 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -60.08 -47.78 84.45 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.906 -0.588 . . . . 1.71 110.155 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.5 -50.57 73.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 1.75 112.005 -177.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.8 p80 -72.78 -29.07 62.99 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.84 -0.344 . . . . 1.78 110.866 -173.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.95 -40.15 65.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 1.0900000000000001 110.528 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.65 -40.68 69.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.985 -0.552 . . . . 1.46 110.919 177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.2 t -65.24 -42.58 93.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.946 -0.57 . . . . 2.2799999999999998 111.077 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 93.3 mt -73.79 -25.09 59.96 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.05 0.452 . . . . 1.6499999999999999 110.317 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.93 44.63 6.66 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.565 -0.743 . . . . 1.28 112.587 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.636 ' O ' HD12 ' A' ' 55' ' ' LEU . 17.9 t -90.63 102.37 13.3 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 N-CA-C 109.505 -0.554 . . . . 0.98999999999999999 109.505 176.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.477 ' HE ' ' NE2' ' A' ' 58' ' ' GLN . 3.8 mpt_? -115.03 128.74 56.44 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.771 -0.455 . . . . 2.6699999999999999 109.771 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.683 ' O ' HD21 ' A' ' 56' ' ' LEU . 5.4 mp -126.11 120.7 30.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.98 -0.378 . . . . 1.45 109.98 175.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.596 ' HB3' ' CD1' ' A' ' 56' ' ' LEU . 28.8 p90 -136.22 145.77 46.04 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.011 0.434 . . . . 2.2599999999999998 110.49 -178.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.0 p -91.22 124.16 43.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.23 0.538 . . . . 2.9199999999999999 110.193 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.07 101.17 7.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.162 -0.472 . . . . 4.2000000000000002 110.076 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.29 -102.58 0.96 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.768 -0.73 . . . . 4.2000000000000002 111.67 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.635 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 4.8 pt-20 -101.27 -21.97 14.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.1500000000000004 111.274 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.49 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 10.6 tpp180 -121.33 136.51 54.95 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.174 -0.611 . . . . 5.3799999999999999 112.349 -170.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.5 tt -80.01 129.15 34.27 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.079 -0.964 . . . . 2.4399999999999999 109.453 174.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 8.0 mpt_? -99.69 136.95 38.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.255 -0.43 . . . . 4.2199999999999998 109.865 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.98 130.68 56.34 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.905 -0.589 . . . . 1.6899999999999999 109.673 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.416 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 51.8 tp60 -111.75 109.61 19.54 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.029 -0.73 . . . . 2.6800000000000002 109.029 173.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.99 113.56 4.92 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.179 -0.464 . . . . 1.6899999999999999 111.347 -176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 36' ' ' VAL . 39.8 Cg_exo -58.22 149.56 71.89 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.93 2.42 . . . . 1.8400000000000001 111.971 174.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.47 123.64 12.07 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.503 2.135 . . . . 2.3100000000000001 112.052 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.15 -34.37 5.66 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.546 -0.835 . . . . 1.76 112.945 176.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 33' ' ' PRO . 23.1 m -81.69 -21.41 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.773 0.321 . . . . 1.49 111.559 -176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.44 ' HE2' ' HA ' ' A' ' 37' ' ' MET . 8.7 tpp -82.8 22.58 0.9 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.242 0.544 . . . . 1.4099999999999999 111.402 -174.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -52.53 141.49 34.08 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 1.45 110.42 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.5 -33.19 29.5 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.14 2.56 . . . . 1.72 113.856 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 32.5 tt0 -72.21 -33.61 67.74 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.645 -0.422 . . . . 2.7599999999999998 110.708 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.409 HD13 ' O ' ' A' ' 36' ' ' VAL . 2.3 tt -65.96 -40.79 91.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-O 121.21 0.529 . . . . 1.2 109.812 177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.524 ' HA ' HD12 ' A' ' 45' ' ' LEU . 63.7 tp60 -59.65 -35.53 74.59 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 115.269 -0.878 . . . . 2.0600000000000001 110.069 177.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.4 t -69.2 -29.65 67.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.651 -0.704 . . . . 1.5700000000000001 110.107 175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.59 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.9 mmt180 -70.89 -39.83 72.56 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 109.779 -0.452 . . . . 3.3399999999999999 109.779 176.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 42' ' ' GLN . 69.4 mt -58.77 -39.44 81.03 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.064 -0.517 . . . . 1.25 109.796 174.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.0 -22.39 9.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.743 -0.662 . . . . 2.2999999999999998 112.658 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.63 33.61 81.4 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.108 -0.568 . . . . 2.5699999999999998 111.96 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB3' ' OE2' ' A' ' 51' ' ' GLU . . . -100.8 153.43 19.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.051 0.453 . . . . 2.0800000000000001 110.745 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.504 ' O ' HG13 ' A' ' 53' ' ' ILE . 9.6 ptm180 -68.8 -50.03 53.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 113.609 0.966 . . . . 5.3600000000000003 113.609 -171.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -57.37 -47.8 80.71 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.6 0.592 . . . . 2.9900000000000002 112.6 -168.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 52' ' ' LEU . 3.1 pm0 -72.59 -36.99 68.28 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.935 -0.306 . . . . 2.75 110.205 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.69 ' O ' HD22 ' A' ' 56' ' ' LEU . 43.3 mt -64.86 -38.76 92.07 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.695 -0.402 . . . . 1.8999999999999999 110.038 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 49' ' ' ARG . 82.5 mt -55.61 -41.62 65.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.186 0.517 . . . . 2.7400000000000002 109.895 173.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -26.14 65.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.85 -0.614 . . . . 1.5 111.078 176.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 19' ' ' VAL . 2.7 mm? -70.85 -31.89 68.73 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 120.946 -0.302 . . . . 1.3200000000000001 111.237 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 52' ' ' LEU . 1.0 OUTLIER -75.71 -38.27 58.75 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.127 0.489 . . . . 1.6799999999999999 110.339 171.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.6 tpp180 -51.87 -28.62 16.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.597 -1.183 . . . . 4.0700000000000003 111.202 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.477 ' NE2' ' HE ' ' A' ' 20' ' ' ARG . 3.4 pt20 -65.96 -40.48 91.33 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.369 -0.378 . . . . 1.75 110.713 175.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' CD1' ' HG2' ' A' ' 20' ' ' ARG . 19.7 mt -86.81 -13.56 44.72 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.798 1.407 . . . . 2.4700000000000002 114.798 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.476 HE21 ' HA ' ' A' ' 60' ' ' GLN . 0.0 OUTLIER -51.32 105.84 0.57 Allowed Pre-proline 0 N--CA 1.479 0.99 0 N-CA-C 113.076 0.769 . . . . 2.5800000000000001 113.076 -168.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -100.53 3.21 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.706 2.938 . . . . 2.48 112.742 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.442 ' HB2' ' HG2' ' A' ' 64' ' ' GLN . 9.7 p -61.09 -31.65 71.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.008 -0.542 . . . . 4.0599999999999996 111.954 -173.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.5 m 57.06 45.6 20.67 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 121.277 0.561 . . . . 5.8600000000000003 110.809 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' A' ' 62' ' ' SER . 31.7 mm-40 -81.19 41.63 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.804 -0.635 . . . . 8.2100000000000009 111.258 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.68 -67.32 3.75 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.691 -0.766 . . . . 10.390000000000001 112.272 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -83.12 49.01 4.15 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.27 -0.49 . . . . 11.32 112.216 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 t -104.94 112.01 24.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.463 -0.569 . . . . 13.15 109.463 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 67.91 -177.7 0.21 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.764 -0.653 . . . . 15.0 110.501 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -100.89 -47.62 4.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.115 -0.328 . . . . 16.239999999999998 110.115 -178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 56.92 73.7 0.77 Allowed Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 115.706 -0.679 . . . . 16.760000000000002 111.056 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.421 ' C ' ' H ' ' A' ' 73' ' ' ALA . 2.4 Cg_endo -82.87 -25.54 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.071 2.514 . . . . 18.719999999999999 112.168 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 68.96 -29.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.188 0.995 . . . . 19.52 112.383 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 71' ' ' PRO . . . -83.37 68.99 9.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.287 0.565 . . . . 20.52 110.099 174.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -84.94 -33.04 22.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 23.780000000000001 109.469 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -118.89 -169.93 1.82 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.065 -0.97 . . . . 22.18 109.024 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.19 -6.02 4.65 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.322 -0.942 . . . . 23.170000000000002 112.57 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -171.77 -33.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.095 0.474 . . . . 26.359999999999999 109.923 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.086 0 CA-C-O 117.909 -1.043 . . . . 26.210000000000001 109.833 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 111.806 -0.518 . . . . 14.859999999999999 111.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -65.38 121.59 9.06 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.673 2.249 . . . . 14.18 111.396 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -81.84 -59.99 2.39 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.412 -0.358 . . . . 13.74 110.476 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.77 166.03 27.16 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.886 -0.673 . . . . 11.08 111.556 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 41.2 m 72.21 -48.87 0.69 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.298 0.639 . . . . 9.7799999999999994 111.717 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -90.52 109.89 21.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.847 -0.427 . . . . 8.3800000000000008 109.847 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -113.6 84.72 2.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.027 0.441 . . . . 5.7800000000000002 111.296 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -71.98 -37.21 60.54 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 121.004 -0.617 . . . . 4.6600000000000001 112.214 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.76 -41.37 95.94 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 120.922 0.391 . . . . 5.7800000000000002 110.649 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.553 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 49.6 tp -63.52 -46.84 84.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.015 -0.538 . . . . 4.3799999999999999 110.436 178.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.61 -49.95 75.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.869 -0.605 . . . . 2.8599999999999999 110.079 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.6 -53.32 59.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.941 -0.572 . . . . 3.7400000000000002 112.125 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.553 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 3.5 p80 -69.86 -31.6 69.52 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.445 -0.502 . . . . 5.0499999999999998 111.068 -173.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.19 -40.23 74.73 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.137 0.494 . . . . 3.3300000000000001 110.343 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.63 -42.67 74.01 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.688 -0.687 . . . . 4.3700000000000001 110.761 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -62.04 -45.87 91.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.065 -0.516 . . . . 6.0999999999999996 111.282 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 95.8 mt -71.97 -24.96 61.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.729 0.3 . . . . 6.4900000000000002 111.087 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.04 39.72 6.86 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.646 -0.788 . . . . 4.7300000000000004 112.263 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.429 ' O ' HD12 ' B' ' 55' ' ' LEU . 39.6 t -90.95 110.23 22.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.708 -0.479 . . . . 3.6000000000000001 109.708 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.631 ' HE ' ' NE2' ' B' ' 58' ' ' GLN . 3.7 mpt_? -127.65 136.71 51.99 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.885 -0.326 . . . . 6.7999999999999998 110.782 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.508 ' O ' HD21 ' B' ' 56' ' ' LEU . 5.3 mp -130.02 122.4 28.34 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.247 -0.649 . . . . 3.7999999999999998 109.247 176.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . 0.578 ' HB3' HD11 ' B' ' 56' ' ' LEU . 34.5 p90 -138.35 139.29 38.97 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.139 0.495 . . . . 6.7999999999999998 110.913 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.8 p -84.34 117.38 29.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.916 -0.584 . . . . 7.7400000000000002 110.002 178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB3' HH11 ' B' ' 29' ' ' ARG . 8.9 tp10 -112.13 101.18 9.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.864 -0.607 . . . . 9.4399999999999995 109.544 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 65.8 -95.47 0.23 Allowed Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.109 -0.567 . . . . 9.6600000000000001 112.526 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 4.5 pt-20 -104.2 -25.6 12.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.999 0.428 . . . . 9.3200000000000003 111.18 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 9.7 tpp180 -122.56 130.09 52.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 7.3399999999999999 111.342 -166.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.3 tt -77.0 126.71 31.43 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.662 -0.699 . . . . 5.1799999999999997 109.57 175.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.52 HH11 ' HB3' ' B' ' 24' ' ' GLU . 7.5 mpt_? -96.76 137.82 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.174 -0.467 . . . . 8.0700000000000003 110.045 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.443 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -117.29 130.63 56.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.767 -0.651 . . . . 4.1600000000000001 109.838 -176.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -110.47 109.73 20.2 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.095 -0.705 . . . . 6.7199999999999998 109.095 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.5 112.5 5.99 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.254 -0.43 . . . . 5.75 111.255 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.522 ' O ' HG22 ' B' ' 36' ' ' VAL . 33.0 Cg_exo -59.37 146.17 95.67 Favored 'Trans proline' 0 CA--C 1.531 0.368 0 C-N-CA 122.616 2.211 . . . . 6.9800000000000004 111.673 174.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.13 123.32 12.3 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.285 1.99 . . . . 8.8499999999999996 112.129 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.09 -34.25 5.65 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.657 -0.783 . . . . 8.0899999999999999 112.831 176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.522 HG22 ' O ' ' B' ' 33' ' ' PRO . 13.9 m -83.03 -18.46 10.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.082 0.441 . . . . 7.0 111.316 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.421 ' HE2' ' HA ' ' B' ' 37' ' ' MET . 10.5 tpp -84.55 20.75 1.64 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.212 0.53 . . . . 5.7300000000000004 111.501 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.7 p -50.62 136.34 25.2 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 7.96 110.475 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.58 -38.49 21.83 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.78 2.987 . . . . 7.2999999999999998 114.499 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 31.3 tt0 -66.86 -29.45 69.37 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.643 -0.423 . . . . 9.2200000000000006 110.94 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.421 HD13 ' O ' ' B' ' 36' ' ' VAL . 7.0 tt -73.1 -35.1 66.54 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.866 -0.42 . . . . 6.1699999999999999 109.866 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -60.97 -36.33 79.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.477 0.656 . . . . 4.8399999999999999 109.348 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -67.2 -31.92 72.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.378 -0.828 . . . . 7.3499999999999996 110.313 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 38.0 mmt180 -68.54 -40.25 80.79 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.293 -0.412 . . . . 8.2799999999999994 109.936 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.489 ' HA ' HD11 ' B' ' 10' ' ' LEU . 83.2 mt -61.19 -37.73 83.99 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.739 -0.664 . . . . 4.1299999999999999 110.284 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.91 -22.53 11.5 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.628 -0.715 . . . . 5.5800000000000001 112.714 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.47 30.17 74.83 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.006 -0.616 . . . . 4.5 112.517 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.35 158.74 15.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.044 0.449 . . . . 5.4100000000000001 110.658 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.635 ' HD2' ' OE1' ' A' ' 26' ' ' GLU . 8.4 ptm180 -68.47 -50.25 53.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 113.589 0.959 . . . . 8.2200000000000006 113.589 -172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -58.33 -50.09 74.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.818 0.673 . . . . 7.1600000000000001 112.818 -167.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -68.43 -40.81 81.02 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.309 -0.256 . . . . 5.7199999999999998 110.309 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.601 ' O ' HD22 ' B' ' 56' ' ' LEU . 53.4 mt -63.72 -36.31 83.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.557 -0.292 . . . . 3.0600000000000001 111.082 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.533 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.8 mt -57.43 -42.39 80.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.13 0.49 . . . . 6.4000000000000004 110.073 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.64 -31.09 72.15 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.88 -0.6 . . . . 3.73 110.981 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.587 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.4 mm? -66.37 -28.83 68.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.17 -0.468 . . . . 2.46 111.422 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.601 HD22 ' O ' ' B' ' 52' ' ' LEU . 0.9 OUTLIER -79.65 -33.85 40.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.963 0.411 . . . . 5.5599999999999996 110.192 172.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' CG ' ' B' ' 60' ' ' GLN . 17.7 tpp180 -57.11 -32.03 65.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.311 -0.858 . . . . 7.1900000000000004 111.443 -177.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.631 ' NE2' ' HE ' ' B' ' 20' ' ' ARG . 28.6 pt20 -67.45 -26.69 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.591 -0.277 . . . . 4.2300000000000004 111.574 178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt -96.58 -15.46 21.57 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 112.382 0.512 . . . . 6.46 112.382 -175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.703 HE21 ' HA ' ' B' ' 60' ' ' GLN . 0.0 OUTLIER -51.02 105.25 0.5 Allowed Pre-proline 0 N--CA 1.467 0.386 0 O-C-N 123.698 0.624 . . . . 7.3499999999999996 112.299 -170.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -100.6 3.6 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.497 2.798 . . . . 8.1699999999999999 112.298 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.504 ' HB2' ' HG2' ' B' ' 64' ' ' GLN . 11.0 p -59.99 -30.03 68.85 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.713 -0.676 . . . . 8.8900000000000006 111.721 -174.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 13.6 m 56.57 42.13 27.62 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.133 0.492 . . . . 9.7599999999999998 110.653 176.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.504 ' HG2' ' HB2' ' B' ' 62' ' ' SER . 29.8 mm-40 -82.49 47.28 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.984 -0.553 . . . . 11.210000000000001 111.232 -177.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.79 -72.42 2.71 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.119 -0.563 . . . . 12.710000000000001 112.461 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.98 45.12 2.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.149 -0.548 . . . . 13.609999999999999 112.584 -178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 7.6 t -95.94 116.95 29.7 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.937 -0.764 . . . . 15.17 108.937 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 65.11 -171.44 0.19 Allowed 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.514 0.509 . . . . 16.82 110.758 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -106.46 -51.03 3.02 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.641 -0.503 . . . . 18.109999999999999 109.641 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . 61.59 82.48 0.22 Allowed Pre-proline 0 C--N 1.332 -0.18 0 O-C-N 124.024 0.828 . . . . 19.0 110.958 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.32 14.69 1.53 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.355 2.703 . . . . 20.289999999999999 112.217 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 p -90.4 151.84 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.804 -0.634 . . . . 21.129999999999999 110.128 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . 71.94 6.43 5.61 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.348 0.659 . . . . 22.899999999999999 111.872 177.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -149.06 131.42 15.63 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.551 -0.537 . . . . 25.059999999999999 109.551 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.463 ' HB2' HD12 ' B' ' 78' ' ' LEU . 20.3 m120 -92.17 89.88 7.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.846 0.355 . . . . 24.460000000000001 110.867 -177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.05 -115.38 7.52 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.872 -0.604 . . . . 24.609999999999999 112.771 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 21.0 mmm180 -101.71 87.3 3.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.68 0.276 . . . . 27.27 110.415 -178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . 0.463 HD12 ' HB2' ' B' ' 75' ' ' ASN . 75.1 mt . . . . . 0 C--O 1.246 0.892 0 CA-C-O 118.589 -0.719 . . . . 26.960000000000001 109.487 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 N-CA-C 111.954 -0.459 . . . . 11.48 111.954 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.64 121.54 2.56 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.619 2.213 . . . . 10.23 112.686 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -98.75 -3.26 36.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.006 -0.543 . . . . 10.02 110.11 177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.2 167.5 35.07 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.767 -0.651 . . . . 6.8899999999999997 111.925 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.2 t -105.37 124.55 49.74 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.382 -0.599 . . . . 6.0199999999999996 109.382 178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.6 p -124.32 162.68 23.26 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.033 0.383 . . . . 3.5099999999999998 112.033 -173.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 72.69 -66.33 0.31 Allowed 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.072 0.949 . . . . 2.5 112.585 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.43 -42.08 88.98 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.562 -0.351 . . . . 2.1299999999999999 112.697 -177.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.28 90.55 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.942 0.401 . . . . 2.1899999999999999 110.802 177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.99 -46.58 74.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 1.6799999999999999 110.235 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -60.06 -48.96 79.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.317 -0.856 . . . . 1.71 110.221 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.13 -45.26 79.64 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.983 0.421 . . . . 1.75 110.992 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -74.59 -28.95 61.13 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.95 -0.568 . . . . 1.78 110.956 -174.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.4 -41.08 49.07 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.693 0.282 . . . . 1.0900000000000001 110.317 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.99 82.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.156 -0.475 . . . . 1.46 111.058 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 37.0 m -66.71 -30.38 70.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.871 -0.604 . . . . 2.2799999999999998 110.661 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -85.19 -26.1 26.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.166 -0.47 . . . . 1.6499999999999999 110.841 178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.23 30.81 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.794 -0.717 . . . . 1.28 113.123 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.417 HG21 HD21 ' A' ' 41' ' ' LEU . 44.1 t -74.39 113.23 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 109.275 -0.639 . . . . 0.98999999999999999 109.275 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.66 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 98.6 mtt180 -124.56 135.91 53.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.448 -0.342 . . . . 2.6699999999999999 110.944 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -131.94 131.71 42.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.422 . . . . 1.45 110.167 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' HB3' HD13 ' A' ' 56' ' ' LEU . 30.5 p90 -151.63 152.65 33.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.717 -0.475 . . . . 2.2599999999999998 109.717 177.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.9 p -99.49 126.78 52.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.335 0.588 . . . . 2.9199999999999999 110.54 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -123.67 105.86 10.06 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.79 -0.641 . . . . 4.2000000000000002 109.77 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.16 -107.8 2.42 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.829 -0.7 . . . . 4.2000000000000002 111.397 -176.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -109.08 -8.35 15.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.811 0.339 . . . . 5.1500000000000004 110.243 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 27' ' ' ARG . 10.2 tpp180 -116.31 134.28 55.07 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 112.635 0.605 . . . . 5.3799999999999999 112.635 -170.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 8.3 tt -76.96 124.98 28.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.102 -0.954 . . . . 2.4399999999999999 108.939 171.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 11.7 mmm180 -97.94 135.32 39.84 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.592 -0.522 . . . . 4.2199999999999998 109.592 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.35 132.08 55.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.993 0.425 . . . . 1.6899999999999999 110.533 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.791 HE21 ' HA ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -123.13 114.27 20.1 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.194 -0.457 . . . . 2.6800000000000002 109.951 174.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.03 126.43 4.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.277 -0.42 . . . . 1.6899999999999999 110.736 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.627 ' HD2' HG21 ' A' ' 36' ' ' VAL . 30.2 Cg_exo -63.89 157.13 54.2 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.914 2.41 . . . . 1.8400000000000001 111.904 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.61 123.14 12.42 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.361 2.041 . . . . 2.3100000000000001 112.342 -177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 38' ' ' THR . . . 111.36 -37.32 3.76 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.671 -0.695 . . . . 1.76 113.413 176.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.627 HG21 ' HD2' ' A' ' 33' ' ' PRO . 18.6 m -77.1 -15.73 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.385 0.513 . . . . 1.49 112.385 -173.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.41 20.98 0.81 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.822 0.344 . . . . 1.4099999999999999 111.232 -173.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 35' ' ' GLY . 16.9 p -50.86 142.02 17.44 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.372 -0.376 . . . . 1.45 110.944 178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -52.06 -34.41 57.46 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.925 2.417 . . . . 1.72 112.961 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -71.29 -29.81 65.49 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.927 -0.309 . . . . 2.7599999999999998 110.372 -178.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HA ' ' HG2' ' A' ' 44' ' ' ARG . 3.0 tt -71.76 -37.13 70.56 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.748 0.785 . . . . 1.2 109.69 178.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -58.69 -36.5 74.31 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.788 -1.097 . . . . 2.0600000000000001 109.664 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.4 t -71.84 -30.09 65.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.427 -0.806 . . . . 1.5700000000000001 110.618 175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 36.2 mmt180 -63.71 -44.94 92.15 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 109.865 -0.42 . . . . 3.3399999999999999 109.865 177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.1 mt -62.09 -42.35 99.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.347 -0.842 . . . . 1.25 109.467 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.64 -22.57 8.79 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.456 -0.793 . . . . 2.2999999999999998 113.064 172.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.525 ' O ' ' HG2' ' B' ' 27' ' ' ARG . . . 71.73 20.14 78.44 Favored Glycine 0 N--CA 1.442 -0.922 0 C-N-CA 120.768 -0.729 . . . . 2.5699999999999998 112.007 -177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -81.56 147.47 29.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.854 -0.338 . . . . 2.0800000000000001 110.285 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 53' ' ' ILE . 14.3 ptm180 -70.73 -51.91 24.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.371 -0.377 . . . . 5.3600000000000003 111.863 -174.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -61.84 -32.32 72.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.506 0.669 . . . . 2.9900000000000002 110.581 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.8 tp10 -72.46 -43.34 63.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.03 -0.987 . . . . 2.75 109.974 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 81.9 mt -71.66 -24.85 61.92 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.714 -0.676 . . . . 1.8999999999999999 111.152 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 49' ' ' ARG . 73.9 mt -61.23 -49.59 83.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 109.926 -0.398 . . . . 2.7400000000000002 109.926 173.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.25 -28.63 67.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.203 0.525 . . . . 1.5 110.614 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.5 tm? -70.01 -39.43 75.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 1.3200000000000001 109.317 -177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.512 ' O ' ' HG3' ' A' ' 60' ' ' GLN . 3.8 tp -79.17 -31.27 43.86 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.763 -0.653 . . . . 1.6799999999999999 109.741 178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -64.38 -24.0 67.48 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.11 -0.495 . . . . 4.0700000000000003 110.535 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -60.18 -31.38 70.07 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.606 ' H ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -105.81 4.96 30.37 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.968 -0.693 . . . . 2.4700000000000002 111.461 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 99.1 mt-30 -87.03 144.56 36.66 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.022 -0.535 . . . . 2.5800000000000001 110.054 177.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 22.6 Cg_exo -65.21 -25.26 57.73 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.918 2.412 . . . . 2.48 112.6 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 11.7 t -90.79 105.81 18.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.061 0.458 . . . . 4.0599999999999996 109.917 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 13.2 p -136.01 -52.61 0.74 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.696 -0.684 . . . . 5.8600000000000003 110.041 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 69.44 113.41 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 O-C-N 124.049 0.843 . . . . 8.2100000000000009 111.548 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.79 19.1 18.98 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.944 -0.646 . . . . 10.390000000000001 112.281 -178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -80.0 50.04 3.85 Favored Glycine 0 C--O 1.229 -0.192 0 C-N-CA 121.185 -0.531 . . . . 11.32 112.592 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.6 m -146.22 6.78 1.0 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.375 0.607 . . . . 13.15 110.363 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.5 mp -99.48 110.28 22.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 15.0 109.668 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 63.64 -173.01 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 O-C-N 123.589 0.555 . . . . 16.239999999999998 110.394 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . 73.09 129.85 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.343 0 CA-C-O 121.594 0.711 . . . . 16.760000000000002 112.519 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 1.9 Cg_endo -83.28 60.98 7.09 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.464 2.776 . . . . 18.719999999999999 110.745 176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -72.5 106.37 2.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.5 -0.773 . . . . 19.52 111.184 -175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 58.42 -88.93 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.053 -0.976 . . . . 20.52 111.35 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -168.92 19.5 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.389 -0.597 . . . . 23.780000000000001 109.389 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 59.56 89.85 0.06 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.692 -0.686 . . . . 22.18 110.474 -171.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.87 141.99 28.06 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.785 -0.721 . . . . 23.170000000000002 111.762 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -92.23 112.19 24.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.923 0.392 . . . . 26.359999999999999 111.244 -177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.214 -0.898 . . . . 26.210000000000001 109.356 175.668 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 N-CA-C 112.171 -0.371 . . . . 14.859999999999999 112.171 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.19 -28.95 55.89 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.815 2.343 . . . . 14.18 112.009 178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 41.6 tp -159.26 -77.95 0.06 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.98 -0.554 . . . . 13.74 110.038 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 138.19 46.36 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.448 -0.661 . . . . 11.08 111.448 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.9 p -124.73 21.5 8.37 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.889 0.376 . . . . 9.7799999999999994 111.048 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 5.9 p -161.16 24.99 0.13 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.351 -0.386 . . . . 8.3800000000000008 111.476 -175.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 60.44 42.64 14.23 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.44 0.638 . . . . 5.7800000000000002 110.36 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.89 -35.41 86.72 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.29 -0.868 . . . . 4.6600000000000001 112.924 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.89 -39.79 90.62 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.82 0.343 . . . . 5.7800000000000002 110.709 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 64.5 tp -72.68 -46.06 55.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.12 -0.491 . . . . 4.3799999999999999 110.188 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.26 -51.4 70.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.719 -0.673 . . . . 2.8599999999999999 110.27 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.68 -41.17 85.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.073 0.463 . . . . 3.7400000000000002 111.156 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -66.46 -40.28 89.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.937 -0.574 . . . . 5.0499999999999998 111.004 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.84 -43.15 63.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.782 0.325 . . . . 3.3300000000000001 110.823 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.29 -46.62 87.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.91 -0.586 . . . . 4.3700000000000001 111.676 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 30.1 m -64.6 -28.35 69.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 6.0999999999999996 111.363 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.423 ' O ' ' HG2' ' B' ' 33' ' ' PRO . 70.3 mt -86.33 -25.27 25.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 6.4900000000000002 110.599 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.64 26.32 27.66 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.79 -0.719 . . . . 4.7300000000000004 112.606 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.84 111.25 12.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.552 -0.536 . . . . 3.6000000000000001 109.552 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.654 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 98.5 mtt180 -125.01 139.36 53.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.359 -0.382 . . . . 6.7999999999999998 111.055 -175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.447 HD21 ' CE2' ' B' ' 30' ' ' PHE . 5.9 mp -135.29 134.38 39.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 3.7999999999999998 109.964 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . 0.542 ' HB3' HD13 ' B' ' 56' ' ' LEU . 36.5 p90 -153.07 154.82 35.65 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.944 -0.391 . . . . 6.7999999999999998 109.944 177.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 6.9 p -99.34 123.39 52.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.216 0.531 . . . . 7.7400000000000002 110.566 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -119.39 102.85 8.97 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.5 -0.555 . . . . 9.4399999999999995 109.5 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 77.09 -109.32 2.76 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.382 -0.687 . . . . 9.6600000000000001 111.382 -175.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -108.68 -6.82 15.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.908 0.385 . . . . 9.3200000000000003 110.506 176.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.525 ' HG2' ' O ' ' A' ' 47' ' ' GLY . 9.4 tpp180 -118.22 127.46 53.76 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.206 0.526 . . . . 7.3399999999999999 111.823 -169.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 8.7 tt -73.8 126.75 31.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.416 -0.811 . . . . 5.1799999999999997 108.97 174.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.464 ' HB2' ' CE2' ' B' ' 22' ' ' TRP . 9.1 mmm180 -99.85 135.05 41.85 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.557 -0.535 . . . . 8.0700000000000003 109.557 -179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.447 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.7 OUTLIER -112.23 134.29 53.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.309 -0.405 . . . . 4.1600000000000001 110.194 -176.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.791 ' HA ' HE21 ' B' ' 31' ' ' GLN . 0.0 OUTLIER -124.2 112.63 17.29 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.145 -0.479 . . . . 6.7199999999999998 109.89 175.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -149.89 122.06 4.2 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.342 -0.39 . . . . 5.75 110.491 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.518 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.5 Cg_exo -59.94 154.09 52.91 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.882 2.388 . . . . 6.9800000000000004 112.12 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -57.8 122.97 12.66 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.534 2.156 . . . . 8.8499999999999996 112.347 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.74 -37.15 3.81 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.655 -0.783 . . . . 8.0899999999999999 113.091 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.518 HG22 ' O ' ' B' ' 33' ' ' PRO . 11.0 m -80.17 -7.38 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 117.0 0.4 . . . . 7.0 111.587 -175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.65 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.2 OUTLIER -84.18 18.82 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.81 0.338 . . . . 5.7300000000000004 111.174 -175.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.411 ' HA ' ' HD3' ' B' ' 39' ' ' PRO . 19.5 p -49.94 141.44 14.5 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.248 -0.433 . . . . 7.96 111.471 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 38' ' ' THR . 62.6 Cg_exo -52.69 -34.89 66.11 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.23 2.62 . . . . 7.2999999999999998 113.175 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 0.0 OUTLIER -72.11 -30.08 64.71 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.768 -0.373 . . . . 9.2200000000000006 110.344 -178.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.604 ' HA ' ' HG2' ' B' ' 44' ' ' ARG . 8.9 tt -74.11 -32.5 63.23 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.735 -0.469 . . . . 6.1699999999999999 109.735 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -60.39 -36.62 78.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.773 -0.649 . . . . 4.8399999999999999 109.341 172.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.0 t -72.28 -29.86 64.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.353 -0.84 . . . . 7.3499999999999996 110.497 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.604 ' HG2' ' HA ' ' B' ' 41' ' ' LEU . 35.9 mmt180 -63.32 -48.0 79.87 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.83 -0.433 . . . . 8.2799999999999994 109.83 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 48.7 mt -58.61 -43.03 89.48 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.435 -0.802 . . . . 4.1299999999999999 109.916 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.49 -24.01 6.84 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.188 -0.915 . . . . 5.5800000000000001 112.742 173.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.24 12.71 83.95 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.945 -0.645 . . . . 4.5 112.546 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -73.37 148.42 43.4 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.244 -0.28 . . . . 5.4100000000000001 110.244 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.565 ' O ' HG13 ' B' ' 53' ' ' ILE . 12.0 ptm180 -69.4 -51.09 39.92 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.34 -0.391 . . . . 8.2200000000000006 111.987 -176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -63.8 -31.18 72.28 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.935 0.398 . . . . 7.1600000000000001 111.263 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.2 OUTLIER -71.44 -40.47 70.35 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.899 0.38 . . . . 5.7199999999999998 110.302 -178.497 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 82.1 mt -76.04 -23.94 55.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.061 -0.518 . . . . 3.0600000000000001 111.211 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.565 HG13 ' O ' ' B' ' 49' ' ' ARG . 76.8 mt -61.28 -48.38 89.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.732 -0.47 . . . . 6.4000000000000004 109.732 172.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.48 -36.89 82.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 3.73 110.343 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' B' ' 52' ' ' LEU . 3.1 tm? -59.81 -45.51 92.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.55 -0.75 . . . . 2.46 110.013 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.542 HD13 ' HB3' ' B' ' 22' ' ' TRP . 43.0 tp -68.41 -35.59 77.88 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.035 0.445 . . . . 5.5599999999999996 110.575 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -65.15 -22.58 66.94 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.078 -0.51 . . . . 7.1900000000000004 111.271 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -62.55 -31.14 71.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.634 -0.257 . . . . 4.2300000000000004 111.439 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.722 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER -105.81 4.57 29.95 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.565 -0.454 . . . . 6.46 111.618 -179.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' B' ' 56' ' ' LEU . 95.7 mt-30 -86.03 145.83 41.69 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.315 -0.402 . . . . 7.3499999999999996 110.229 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 15.7 Cg_exo -68.74 -17.8 42.22 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 123.078 2.519 . . . . 8.1699999999999999 112.323 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 28.7 t -97.56 103.16 15.07 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.237 0.542 . . . . 8.8900000000000006 110.657 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 11.8 p -134.2 -47.92 0.78 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.614 -0.721 . . . . 9.7599999999999998 110.406 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 64.63 98.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.561 -0.745 . . . . 11.210000000000001 111.951 175.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.54 23.25 37.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.645 -0.788 . . . . 12.710000000000001 112.885 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.06 50.59 4.32 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.185 -0.531 . . . . 13.609999999999999 112.521 -178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -150.36 18.27 0.84 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.157 0.503 . . . . 15.17 110.345 178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 10.1 mp -110.56 113.38 25.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.705 -0.679 . . . . 16.82 109.556 178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' B' ' 69' ' ' LEU . 3.7 mm? 62.73 -166.75 0.22 Allowed 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.62 0.575 . . . . 18.109999999999999 111.091 -177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.405 ' H ' ' HB3' ' B' ' 69' ' ' LEU . . . 58.61 79.1 0.32 Allowed Pre-proline 0 N--CA 1.465 0.306 0 CA-C-O 121.175 0.512 . . . . 19.0 111.156 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -84.15 20.02 1.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 123.11 2.54 . . . . 20.289999999999999 112.689 -175.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -74.83 97.64 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.429 0.633 . . . . 21.129999999999999 111.128 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -145.64 -68.36 0.29 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.367 -0.833 . . . . 22.899999999999999 109.222 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 178.31 -33.42 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.639 -0.71 . . . . 25.059999999999999 110.571 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -83.44 71.52 10.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.642 0.734 . . . . 24.460000000000001 109.817 -178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -161.27 34.8 0.39 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 110.321 -1.112 . . . . 24.609999999999999 110.321 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 79.0 mtp180 -115.88 -38.91 3.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.074 -0.563 . . . . 27.27 109.858 -176.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.698 -0.668 . . . . 26.960000000000001 109.397 177.289 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.76 0 N-CA-C 112.053 -0.419 . . . . 11.48 112.053 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.62 -31.55 26.18 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.661 2.241 . . . . 10.23 112.083 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.57 102.89 14.76 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.126 -0.694 . . . . 10.02 109.126 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.16 -113.2 4.24 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 109.928 -1.269 . . . . 6.8899999999999997 109.928 -170.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.3 p 178.22 -46.6 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.542 0.21 . . . . 6.0199999999999996 110.479 175.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.1 m 68.57 7.92 6.36 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.704 -0.68 . . . . 3.5099999999999998 109.996 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.54 -40.07 77.1 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.494 -0.775 . . . . 2.5 110.421 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.39 -40.45 85.79 Favored Glycine 0 N--CA 1.449 -0.456 0 O-C-N 123.442 0.464 . . . . 2.1299999999999999 112.404 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.41 -48.1 76.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.976 0.417 . . . . 2.1899999999999999 111.116 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.705 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 59.2 tp -66.28 -46.55 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 1.6799999999999999 110.506 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -60.23 -48.72 80.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.678 -0.692 . . . . 1.71 110.277 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.76 84.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.454 -0.339 . . . . 1.75 111.663 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.705 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 2.1 p80 -76.5 -26.92 55.8 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.829 0.347 . . . . 1.78 110.794 -173.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.71 -35.63 51.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.122 -0.231 . . . . 1.0900000000000001 110.538 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.6 66.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.314 -0.403 . . . . 1.46 111.384 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.8 p -65.78 -41.78 91.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 2.2799999999999998 110.449 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 33' ' ' PRO . 50.0 mt -77.87 -26.38 49.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.937 -0.574 . . . . 1.6499999999999999 110.022 177.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.14 41.2 18.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.724 -0.671 . . . . 1.28 113.348 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.9 t -67.39 135.48 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 108.86 -0.793 . . . . 0.98999999999999999 108.86 172.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.676 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 71.4 mtt180 -130.81 126.63 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 119.693 -0.194 . . . . 2.6699999999999999 110.653 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.702 HD22 HD22 ' A' ' 52' ' ' LEU . 6.1 mp -133.52 117.15 16.8 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 120.417 -0.513 . . . . 1.45 111.815 173.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.528 ' HB3' HD21 ' A' ' 56' ' ' LEU . 26.7 p90 -129.75 149.08 51.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.541 -0.754 . . . . 2.2599999999999998 109.315 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.09 128.99 50.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-O 121.347 0.594 . . . . 2.9199999999999999 111.349 -175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' HB3' ' NE ' ' A' ' 29' ' ' ARG . 38.1 tt0 -120.75 116.5 25.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.747 -0.834 . . . . 4.2000000000000002 108.747 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.42 -109.46 2.9 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.092 -1.203 . . . . 4.2000000000000002 110.092 -168.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.69 -15.0 10.8 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.808 0.337 . . . . 5.1500000000000004 110.291 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 tpp180 -92.43 144.46 25.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.563 0.697 . . . . 5.3799999999999999 111.445 -172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 21' ' ' LEU . 3.4 tm? -85.96 129.28 34.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.969 -1.014 . . . . 2.4399999999999999 109.903 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.447 ' NE ' ' HB3' ' A' ' 24' ' ' GLU . 4.2 mpt_? -97.25 130.07 44.5 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.136 -0.691 . . . . 4.2199999999999998 109.136 173.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.432 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -114.26 131.32 56.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.508 -0.314 . . . . 1.6899999999999999 110.882 -171.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.676 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 6.1 tp-100 -130.15 123.87 31.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.196 -0.456 . . . . 2.6800000000000002 109.919 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.47 138.06 11.43 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.397 -0.365 . . . . 1.6899999999999999 110.816 -178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.597 ' O ' HG22 ' A' ' 36' ' ' VAL . 27.5 Cg_endo -68.03 155.31 70.09 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.6 2.2 . . . . 1.8400000000000001 111.25 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.04 122.47 10.97 Favored 'Trans proline' 0 C--N 1.329 -0.468 0 C-N-CA 122.38 2.053 . . . . 2.3100000000000001 112.464 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.5 -28.78 9.21 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.712 -0.676 . . . . 1.76 113.31 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 33' ' ' PRO . 22.9 m -83.74 -11.75 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.878 0.696 . . . . 1.49 112.878 -172.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.505 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -83.55 20.42 1.39 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.696 0.284 . . . . 1.4099999999999999 111.747 -173.517 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.3 p -53.1 147.09 18.02 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.415 -0.357 . . . . 1.45 111.444 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.7 -33.84 51.2 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 1.72 113.508 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 34.1 tt0 -70.78 -35.14 72.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.515 -0.474 . . . . 2.7599999999999998 110.499 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 36' ' ' VAL . 0.8 OUTLIER -64.36 -41.15 96.88 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-O 121.032 0.444 . . . . 1.2 109.827 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.682 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.1 OUTLIER -59.86 -37.36 79.08 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.777 -0.647 . . . . 2.0600000000000001 109.946 175.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.1 t -67.68 -28.84 68.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 1.5700000000000001 110.35 176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 35.2 mmt180 -73.18 -43.98 60.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.311 -0.404 . . . . 3.3399999999999999 110.17 176.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LEU . 53.9 mt -62.51 -42.93 99.84 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.364 0.602 . . . . 1.25 109.431 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.21 -23.06 7.44 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.607 -0.724 . . . . 2.2999999999999998 112.778 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.18 16.31 76.92 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.917 -0.659 . . . . 2.5699999999999998 111.761 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.6 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -76.63 148.77 36.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.944 0.402 . . . . 2.0800000000000001 110.357 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 53' ' ' ILE . 4.0 ptp180 -69.11 -51.04 42.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 5.3600000000000003 111.943 -173.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -61.87 -33.67 74.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.289 0.566 . . . . 2.9900000000000002 110.226 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -67.99 -46.5 71.13 Favored 'General case' 0 CA--C 1.506 -0.737 0 CA-C-N 115.253 -0.885 . . . . 2.75 110.476 -177.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.702 HD22 HD22 ' A' ' 21' ' ' LEU . 72.9 mt -66.23 -30.27 70.69 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.383 -0.826 . . . . 1.8999999999999999 111.175 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 49' ' ' ARG . 89.2 mt -60.97 -43.55 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.713 0.768 . . . . 2.7400000000000002 110.017 174.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.02 -31.86 68.47 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.166 -0.925 . . . . 1.5 110.145 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.7 tm? -64.55 -38.14 89.99 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.832 -1.173 . . . . 1.3200000000000001 107.832 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 21' ' ' LEU . 0.1 OUTLIER -69.68 -39.66 76.84 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.267 -1.333 . . . . 1.6799999999999999 112.214 174.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 57' ' ' ARG . 73.2 mtt180 -50.97 -29.7 12.99 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.157 -0.474 . . . . 4.0700000000000003 111.42 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -54.09 -47.85 71.29 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.323 0.582 . . . . 1.75 110.784 173.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 59' ' ' LEU . 7.9 tt -84.74 -32.42 23.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.209 -0.905 . . . . 2.4700000000000002 110.394 -175.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -75.35 118.18 68.8 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.636 -0.711 . . . . 2.5800000000000001 110.9 -173.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.89 140.01 44.87 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.57 2.18 . . . . 2.48 111.997 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -99.77 -13.62 19.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.461 -0.336 . . . . 4.0599999999999996 110.566 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.4 m 62.79 93.62 0.05 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.871 -0.604 . . . . 5.8600000000000003 110.487 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -102.03 -68.19 0.84 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.766 -0.652 . . . . 8.2100000000000009 110.794 -172.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.03 -162.51 21.06 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.822 -0.704 . . . . 10.390000000000001 111.538 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.75 112.12 3.68 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.651 -0.785 . . . . 11.32 112.242 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.7 t -161.54 104.06 1.23 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.144 0.497 . . . . 13.15 110.62 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.2 tp -123.16 8.61 9.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.579 0.704 . . . . 15.0 109.444 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.502 ' HA ' HD13 ' A' ' 69' ' ' LEU . 3.6 mm? -84.24 -24.02 30.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.408 -0.815 . . . . 16.239999999999998 111.472 -177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -116.88 119.88 34.75 Favored Pre-proline 0 C--N 1.319 -0.75 0 C-N-CA 120.631 -0.427 . . . . 16.760000000000002 110.492 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -81.87 39.28 0.83 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.129 2.553 . . . . 18.719999999999999 111.811 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.8 p -61.06 103.15 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.44 -0.8 . . . . 19.52 111.786 -175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 61.54 8.26 2.18 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.801 -1.09 . . . . 20.52 112.323 177.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 54.45 30.25 12.53 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.694 0.397 . . . . 23.780000000000001 111.279 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -68.63 100.3 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.897 0.38 . . . . 22.18 110.45 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.41 108.37 2.47 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.865 -0.683 . . . . 23.170000000000002 111.916 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -79.42 -18.77 51.52 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.261 0.553 . . . . 26.359999999999999 110.096 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 78' ' ' LEU . 1.1 pt? . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.421 -0.799 . . . . 26.210000000000001 109.376 174.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.664 0 N-CA-C 111.853 -0.499 . . . . 14.859999999999999 111.853 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.6 117.75 5.26 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.582 2.188 . . . . 14.18 112.762 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 93.8 mt -130.24 139.34 50.79 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 13.74 110.432 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . 0.421 ' O ' ' HG ' ' B' ' 11' ' ' LEU . . . 97.33 153.47 29.28 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.998 -0.62 . . . . 11.08 112.075 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 22.9 t -97.39 119.42 35.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.898 0.38 . . . . 9.7799999999999994 110.571 178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.617 ' HB3' HD23 ' B' ' 11' ' ' LEU . 22.9 t -155.54 41.52 0.41 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.678 -0.692 . . . . 8.3800000000000008 109.253 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . 70.2 116.78 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.418 -0.81 . . . . 5.7800000000000002 109.55 -170.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -48.25 -48.93 26.15 Favored Glycine 0 CA--C 1.518 0.251 0 CA-C-N 115.669 -0.696 . . . . 4.6600000000000001 114.296 -171.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -48.14 78.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.092 0.446 . . . . 5.7800000000000002 111.278 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.569 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 64.8 tp -63.47 -46.95 83.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 4.3799999999999999 110.688 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' B' ' 6' ' ' SER . 2.2 tm? -62.48 -47.95 81.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.977 -0.556 . . . . 2.8599999999999999 110.291 -178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.43 -47.78 84.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.461 -0.336 . . . . 3.7400000000000002 111.845 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.569 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 2.4 p80 -75.39 -27.33 59.03 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 120.342 -0.543 . . . . 5.0499999999999998 111.169 -175.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.89 -38.78 52.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.871 -0.332 . . . . 3.3300000000000001 110.848 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.64 -39.65 76.99 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.288 -0.414 . . . . 4.3700000000000001 111.311 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 23.3 p -64.22 -40.35 95.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 6.0999999999999996 110.686 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.6 mt -75.22 -25.29 58.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.966 0.413 . . . . 6.4900000000000002 110.296 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.83 37.33 19.77 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.679 -0.772 . . . . 4.7300000000000004 112.716 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.6 133.12 32.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.293 -0.632 . . . . 3.6000000000000001 109.293 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.786 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 69.4 mtt180 -130.86 128.91 41.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.678 -0.237 . . . . 6.7999999999999998 110.981 -176.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.685 HD22 HD22 ' B' ' 52' ' ' LEU . 6.2 mp -134.29 122.74 23.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.995 -0.372 . . . . 3.7999999999999998 109.995 173.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . . . . . . . . . 30.4 p90 -137.2 148.15 46.35 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.78 -0.452 . . . . 6.7999999999999998 109.78 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.12 128.17 49.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.422 0.63 . . . . 7.7400000000000002 111.345 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.486 ' HB3' ' NE ' ' B' ' 29' ' ' ARG . 37.4 tt0 -118.83 117.14 28.07 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.154 -1.054 . . . . 9.4399999999999995 108.154 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.25 -108.9 2.64 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.453 -1.059 . . . . 9.6600000000000001 110.453 -168.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.17 -15.15 10.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.232 0.539 . . . . 9.3200000000000003 110.132 173.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpp180 -94.15 142.02 27.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.407 0.623 . . . . 7.3399999999999999 111.167 -170.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.593 HD11 HD23 ' B' ' 21' ' ' LEU . 3.2 tm? -86.19 132.28 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.097 -0.956 . . . . 5.1799999999999997 110.224 -174.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.486 ' NE ' ' HB3' ' B' ' 24' ' ' GLU . 3.8 mpt_? -100.82 130.96 46.91 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.203 -0.666 . . . . 8.0700000000000003 109.203 173.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.539 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.4 OUTLIER -113.9 131.75 56.17 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.748 0.309 . . . . 4.1600000000000001 110.828 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.786 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 6.3 tp-100 -130.55 121.26 25.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.78 -0.452 . . . . 6.7199999999999998 109.78 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -152.61 134.49 8.59 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.484 -0.325 . . . . 5.75 110.939 -178.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.499 ' O ' HG22 ' B' ' 36' ' ' VAL . 29.8 Cg_endo -63.97 154.73 68.43 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.491 2.127 . . . . 6.9800000000000004 111.865 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.38 122.96 12.56 Favored 'Trans proline' 0 N--CA 1.464 -0.212 0 C-N-CA 122.424 2.083 . . . . 8.8499999999999996 112.779 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.22 -32.13 6.7 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.81 -0.709 . . . . 8.0899999999999999 113.402 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.617 ' HB ' HD13 ' B' ' 17' ' ' LEU . 10.7 m -85.29 2.99 3.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 112.183 0.438 . . . . 7.0 112.183 -172.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.662 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -93.46 19.35 8.49 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.894 0.378 . . . . 5.7300000000000004 111.03 -176.052 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -53.46 145.51 27.58 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.547 . . . . 7.96 111.966 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.86 -39.51 39.42 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.356 2.704 . . . . 7.2999999999999998 113.536 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 32.4 tt0 -65.62 -36.65 84.32 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.866 -0.334 . . . . 9.2200000000000006 110.59 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 5.6 tt -68.26 -34.12 75.62 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.059 -0.348 . . . . 6.1699999999999999 110.059 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -62.89 -37.8 88.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.996 0.427 . . . . 4.8399999999999999 109.991 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 31.7 t -68.74 -34.11 75.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.014 -0.539 . . . . 7.3499999999999996 110.183 176.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 28.2 mmt180 -63.84 -43.68 95.44 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.114 -0.494 . . . . 8.2799999999999994 109.946 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 69.8 mt -65.97 -43.71 87.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 4.1299999999999999 109.933 176.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.63 -22.16 9.57 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.572 -0.74 . . . . 5.5800000000000001 112.408 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.14 19.74 78.69 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.877 -0.678 . . . . 4.5 111.42 -174.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.639 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.85 149.41 36.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.826 0.346 . . . . 5.4100000000000001 110.7 -177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.505 ' O ' HG13 ' B' ' 53' ' ' ILE . 3.4 ptp180 -69.49 -50.32 46.45 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.206 -0.452 . . . . 8.2200000000000006 111.735 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -64.73 -30.43 71.44 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.748 0.309 . . . . 7.1600000000000001 111.456 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.3 OUTLIER -69.61 -45.35 68.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 5.7199999999999998 110.814 -179.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.685 HD22 HD22 ' B' ' 21' ' ' LEU . 61.2 mt -67.32 -28.08 67.69 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.28 -0.418 . . . . 3.0600000000000001 110.911 -178.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.505 HG13 ' O ' ' B' ' 49' ' ' ARG . 90.9 mt -63.41 -48.67 86.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.114 0.483 . . . . 6.4000000000000004 110.017 174.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' B' ' 6' ' ' SER . . . -68.4 -36.08 78.6 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 3.73 110.734 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.435 ' O ' HD13 ' B' ' 55' ' ' LEU . 2.1 tm? -55.93 -39.95 72.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.509 -0.768 . . . . 2.46 109.399 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.534 HD23 ' O ' ' B' ' 21' ' ' LEU . 0.8 OUTLIER -74.69 -27.65 60.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.57 -0.741 . . . . 5.5599999999999996 110.234 178.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.497 ' HD2' ' HA ' ' B' ' 54' ' ' ALA . 80.1 mtt180 -62.58 -26.33 68.54 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.494 -0.321 . . . . 7.1900000000000004 111.114 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -57.31 -39.71 76.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.349 0.595 . . . . 4.2300000000000004 110.872 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 9.7 tt -91.99 -31.38 15.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.48 -0.782 . . . . 6.46 110.332 -176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -74.76 117.68 64.35 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.711 -0.677 . . . . 7.3499999999999996 111.046 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.57 138.09 37.6 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.713 2.275 . . . . 8.1699999999999999 112.112 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . 0.469 ' HB3' ' OE1' ' B' ' 64' ' ' GLN . 41.7 t -98.48 -15.32 19.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.165 -0.47 . . . . 8.8900000000000006 110.34 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 23.9 m 64.07 95.0 0.05 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.38 0.609 . . . . 9.7599999999999998 110.191 -175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.469 ' OE1' ' HB3' ' B' ' 62' ' ' SER . 1.6 mp0 -100.95 -66.58 0.9 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.896 -0.593 . . . . 11.210000000000001 110.942 -173.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.44 -166.34 26.69 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.477 -0.649 . . . . 12.710000000000001 111.477 -176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.25 104.67 2.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.887 -0.673 . . . . 13.609999999999999 111.899 -179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.7 t -151.55 103.76 3.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.809 0.338 . . . . 15.17 110.309 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 33.5 tp -127.25 5.03 6.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.362 0.601 . . . . 16.82 110.232 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' B' ' 69' ' ' LEU . 4.1 mm? -82.43 -25.7 33.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.953 -0.567 . . . . 18.109999999999999 110.315 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.29 71.81 82.12 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.657 -0.701 . . . . 19.0 109.946 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -89.42 -1.04 6.04 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.889 2.393 . . . . 20.289999999999999 112.196 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 24.3 t 58.64 69.79 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.512 0.672 . . . . 21.129999999999999 109.62 -174.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.04 96.13 5.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.098 -0.955 . . . . 22.899999999999999 110.34 -178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -81.77 139.13 34.99 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.909 -0.587 . . . . 25.059999999999999 109.763 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 73.72 92.44 0.08 Allowed 'General case' 0 C--O 1.232 0.155 0 O-C-N 123.896 0.747 . . . . 24.460000000000001 109.424 -174.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -81.01 57.79 4.83 Favored Glycine 0 N--CA 1.453 -0.173 0 CA-C-N 115.531 -0.759 . . . . 24.609999999999999 113.491 -171.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 5.9 mpt_? -106.41 95.65 5.91 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.808 -0.442 . . . . 27.27 109.808 174.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.605 -0.712 . . . . 26.960000000000001 109.888 -178.243 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.646 0 CA-C-O 119.841 -0.422 . . . . 11.48 112.05 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.77 105.23 0.76 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.791 2.327 . . . . 10.23 111.913 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.414 HD13 ' N ' ' A' ' 4' ' ' GLY . 1.1 tm? -130.89 126.94 37.47 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.422 -0.585 . . . . 10.02 109.422 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.414 ' N ' HD13 ' A' ' 3' ' ' LEU . . . 165.38 54.06 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.47 -0.872 . . . . 6.8899999999999997 112.501 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.8 t -80.43 96.53 6.76 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 121.393 0.616 . . . . 6.0199999999999996 109.423 178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.4 m -139.02 38.88 2.14 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.501 -0.772 . . . . 3.5099999999999998 109.614 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.2 -51.91 67.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.026 -0.534 . . . . 2.5 110.913 -176.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.13 -39.14 95.44 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.137 -0.554 . . . . 2.1299999999999999 112.24 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.75 -42.86 85.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.06 0.457 . . . . 2.1899999999999999 110.682 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.686 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 45.9 tp -64.65 -47.13 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.813 -0.63 . . . . 1.6799999999999999 110.268 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.21 -46.5 88.29 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.628 -0.715 . . . . 1.71 110.062 178.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.82 -50.98 71.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.217 -0.447 . . . . 1.75 111.673 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.686 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 3.8 p80 -76.83 -27.96 55.35 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.657 -0.417 . . . . 1.78 110.954 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.11 66.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.068 -0.253 . . . . 1.0900000000000001 110.496 177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.3 -38.75 92.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-O 121.131 0.491 . . . . 1.46 110.764 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.2 m -65.08 -33.39 75.92 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.498 -0.774 . . . . 2.2799999999999998 110.845 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.515 HD13 ' HB ' ' A' ' 36' ' ' VAL . 83.8 mt -85.73 -26.32 25.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.108 0.48 . . . . 1.6499999999999999 109.949 176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.72 35.73 35.13 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.442 -0.799 . . . . 1.28 112.476 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.499 ' O ' HD11 ' A' ' 55' ' ' LEU . 97.4 t -69.38 108.67 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.335 -0.987 . . . . 0.98999999999999999 108.335 170.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.56 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 51.7 mtt180 -112.18 133.64 54.2 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.155 0.502 . . . . 2.6699999999999999 111.625 -170.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 52' ' ' LEU . 5.9 mp -130.41 136.69 49.3 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.892 -1.049 . . . . 1.45 109.728 172.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.591 ' HA ' HD21 ' A' ' 56' ' ' LEU . 22.9 p90 -158.2 137.92 12.06 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.49 -0.777 . . . . 2.2599999999999998 109.257 176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.8 p -85.33 121.63 37.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 109.665 -0.494 . . . . 2.9199999999999999 109.665 176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 29' ' ' ARG . 33.1 tt0 -115.77 102.38 9.66 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.777 -0.647 . . . . 4.2000000000000002 109.843 -175.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.67 -90.39 0.39 Allowed Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.485 -0.779 . . . . 4.2000000000000002 111.938 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -111.43 -28.71 8.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.546 0.212 . . . . 5.1500000000000004 111.338 -176.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -117.07 142.48 46.93 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.946 -0.701 . . . . 5.3799999999999999 112.252 -169.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.642 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -69.3 124.34 23.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 114.867 -1.061 . . . . 2.4399999999999999 108.565 172.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 15.5 mmm180 -101.45 136.36 41.42 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.601 -0.518 . . . . 4.2199999999999998 109.601 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.8 135.67 55.1 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.539 -0.541 . . . . 1.6899999999999999 109.539 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.56 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 25.2 tp60 -131.56 106.56 8.27 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.859 -0.422 . . . . 2.6800000000000002 109.859 174.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -119.43 123.67 28.56 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.748 -0.66 . . . . 1.6899999999999999 111.196 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 17' ' ' LEU . 31.5 Cg_exo -61.51 160.01 29.64 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.649 2.233 . . . . 1.8400000000000001 111.581 171.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.725 ' HB3' HG22 ' B' ' 38' ' ' THR . 28.4 Cg_endo -63.97 122.73 10.86 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.35 2.033 . . . . 2.3100000000000001 112.753 -176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.56 ' O ' HG23 ' A' ' 38' ' ' THR . . . 97.55 -37.66 3.38 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.875 -0.679 . . . . 1.76 114.06 173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HB ' HD13 ' A' ' 17' ' ' LEU . 26.7 m -68.63 -14.01 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.285 0.846 . . . . 1.49 113.285 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.8 tpp -86.01 23.51 1.48 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.892 0.377 . . . . 1.4099999999999999 111.41 -175.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.645 HG22 ' HB3' ' B' ' 34' ' ' PRO . 43.7 p -50.74 145.77 10.89 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.44 -0.346 . . . . 1.45 110.764 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.513 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 52.1 Cg_exo -53.18 -28.97 44.09 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.915 2.41 . . . . 1.72 113.435 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 38.7 tt0 -67.97 -48.33 66.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.886 -0.413 . . . . 2.7599999999999998 109.886 176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.7 tt -65.26 -37.23 86.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.428 0.633 . . . . 1.2 109.883 177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.8 tp60 -56.42 -41.15 75.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.92 -1.036 . . . . 2.0600000000000001 109.85 176.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.31 -30.08 64.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.805 -0.634 . . . . 1.5700000000000001 110.663 176.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 44' ' ' ARG . 3.4 mmp_? -67.61 -38.04 83.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.487 -0.324 . . . . 3.3399999999999999 110.432 177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.7 mt -64.6 -43.26 94.36 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.152 -0.684 . . . . 1.25 109.152 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.65 -23.78 6.31 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.415 -0.811 . . . . 2.2999999999999998 113.448 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.92 14.38 75.88 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.84 -0.695 . . . . 2.5699999999999998 111.825 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.547 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -84.0 150.15 25.81 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.991 -0.374 . . . . 2.0800000000000001 109.991 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 19.1 ptp180 -69.35 -50.56 45.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 111.773 0.286 . . . . 5.3600000000000003 111.773 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.507 ' HA ' HD12 ' A' ' 53' ' ' ILE . 8.9 p80 -56.96 -35.73 69.46 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.052 0.454 . . . . 2.9900000000000002 110.529 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -63.09 -51.12 67.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 115.368 -0.833 . . . . 2.75 109.852 178.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.727 HD22 HD22 ' A' ' 21' ' ' LEU . 80.8 mt -69.18 -25.65 64.45 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.672 -1.149 . . . . 1.8999999999999999 111.016 -176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.5 mt -59.74 -47.7 90.29 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.789 0.328 . . . . 2.7400000000000002 110.304 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.31 -31.49 71.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.342 0.591 . . . . 1.5 110.494 177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD11 ' O ' ' A' ' 19' ' ' VAL . 2.1 tm? -71.54 -41.34 69.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 122.201 1.001 . . . . 1.3200000000000001 108.461 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.596 ' HB2' ' O ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -62.93 -43.14 99.61 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 113.808 -1.542 . . . . 1.6799999999999999 110.135 178.388 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -63.38 -29.26 70.59 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 114.576 -1.193 . . . . 4.0700000000000003 111.616 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.6 pt20 -62.38 -32.81 73.68 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.659 -0.417 . . . . 1.75 110.847 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.87 21.52 17.15 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.805 0.336 . . . . 2.4700000000000002 110.552 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -73.68 122.63 88.07 Favored Pre-proline 0 C--N 1.326 -0.433 0 N-CA-C 109.485 -0.561 . . . . 2.5800000000000001 109.485 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -61.52 152.41 73.51 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.137 2.558 . . . . 2.48 113.793 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.3 p -97.43 164.76 12.32 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.343 -0.844 . . . . 4.0599999999999996 110.691 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 21.9 m -102.65 142.18 34.23 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.358 -0.383 . . . . 5.8600000000000003 110.427 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.67 -19.09 6.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.233 -0.439 . . . . 8.2100000000000009 111.227 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.28 -72.64 2.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.417 -0.897 . . . . 10.390000000000001 111.787 -177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 176.27 -52.03 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.487 -0.863 . . . . 11.32 112.865 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m 66.6 99.63 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.353 0.597 . . . . 13.15 111.835 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.1 tp -123.66 151.46 43.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.789 -0.641 . . . . 15.0 109.708 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 69' ' ' LEU . 2.6 pt? -128.19 147.33 50.56 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.911 -0.403 . . . . 16.239999999999998 109.911 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.01 113.01 57.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 116.621 -0.263 . . . . 16.760000000000002 110.573 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -86.46 44.77 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 123.102 2.535 . . . . 18.719999999999999 112.576 -179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.12 0.23 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.614 0.721 . . . . 19.52 110.041 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.04 -25.51 63.78 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.416 -0.811 . . . . 20.52 111.741 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -106.13 96.04 6.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.986 -0.376 . . . . 23.780000000000001 109.986 177.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -114.82 165.33 12.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.966 0.412 . . . . 22.18 111.357 -177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -134.53 -161.11 9.4 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.765 -0.652 . . . . 23.170000000000002 111.699 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.9 ttp180 -134.36 149.04 50.8 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.86 -0.422 . . . . 26.359999999999999 109.86 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' N ' HD12 ' A' ' 78' ' ' LEU . 5.6 mp . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.702 -0.666 . . . . 26.210000000000001 109.776 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.729 0 N-CA-C 112.038 -0.425 . . . . 14.859999999999999 112.038 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.56 149.23 18.61 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.642 2.228 . . . . 14.18 112.37 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.543 HD22 ' HB3' ' B' ' 5' ' ' SER . 0.7 OUTLIER -105.28 -46.8 4.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.315 -0.624 . . . . 13.74 109.315 177.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.82 17.23 71.13 Favored Glycine 0 C--O 1.227 -0.294 0 CA-C-N 115.833 -0.621 . . . . 11.08 113.177 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.543 ' HB3' HD22 ' B' ' 3' ' ' LEU . 15.0 p -69.11 113.93 6.92 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.474 0.176 . . . . 9.7799999999999994 111.474 -177.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 29.8 p 44.32 -90.52 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.596 1.158 . . . . 8.3800000000000008 113.426 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.3 -39.63 73.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.244 -0.434 . . . . 5.7800000000000002 111.899 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.49 -47.01 92.56 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.6 -0.809 . . . . 4.6600000000000001 112.812 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.72 -43.46 62.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.815 0.34 . . . . 5.7800000000000002 110.747 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 69.1 tp -59.05 -47.54 84.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.805 -0.634 . . . . 4.3799999999999999 110.76 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.92 -45.58 94.09 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.0 -0.545 . . . . 2.8599999999999999 110.048 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.71 -52.9 63.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.045 -0.525 . . . . 3.7400000000000002 112.323 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.516 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 8.9 p80 -76.81 -28.42 55.56 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 120.461 -0.496 . . . . 5.0499999999999998 111.299 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.53 -45.32 69.1 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.711 0.291 . . . . 3.3300000000000001 110.583 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.0 -40.25 95.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.953 -0.567 . . . . 4.3700000000000001 111.182 178.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 49.6 m -61.83 -39.33 91.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.875 -0.602 . . . . 6.0999999999999996 111.096 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.576 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -79.47 -26.63 41.65 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.796 -0.361 . . . . 6.4900000000000002 110.594 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.76 33.03 19.99 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.849 -0.691 . . . . 4.7300000000000004 112.495 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.419 ' O ' HD11 ' B' ' 55' ' ' LEU . 77.4 t -75.86 104.92 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.124 -0.695 . . . . 3.6000000000000001 109.124 175.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 50.3 mtt180 -110.81 135.05 51.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.083 0.468 . . . . 6.7999999999999998 111.9 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.657 HD22 HD22 ' B' ' 52' ' ' LEU . 6.2 mp -131.0 140.86 50.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.437 -0.801 . . . . 3.7999999999999998 108.961 171.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . 0.636 ' HA ' HD21 ' B' ' 56' ' ' LEU . 30.0 p90 -159.44 141.67 13.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.745 -0.465 . . . . 6.7999999999999998 109.745 176.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.05 115.89 28.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.328 0.585 . . . . 7.7400000000000002 109.793 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HG3' ' B' ' 29' ' ' ARG . 27.4 tt0 -112.25 103.97 12.13 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.96 -0.563 . . . . 9.4399999999999995 109.909 -175.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.1 -90.7 0.51 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.752 -0.658 . . . . 9.6600000000000001 112.342 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -115.7 -29.53 6.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.953 0.406 . . . . 9.3200000000000003 110.871 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' B' ' 27' ' ' ARG . 5.9 tpp180 -115.08 138.83 50.44 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.291 -0.563 . . . . 7.3399999999999999 111.651 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.569 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -68.48 126.34 29.32 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.405 -0.816 . . . . 5.1799999999999997 108.984 175.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.493 ' HG3' ' HB2' ' B' ' 24' ' ' GLU . 14.1 mmm180 -102.97 135.24 45.02 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.799 -0.445 . . . . 8.0700000000000003 109.799 -177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.515 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.1 t80 -119.76 132.44 55.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.912 -0.586 . . . . 4.1600000000000001 109.54 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 24.9 tp60 -128.23 102.78 6.84 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.781 -0.451 . . . . 6.7199999999999998 109.781 175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.4 ' HB2' ' HE3' ' B' ' 37' ' ' MET . . . -116.45 122.59 31.71 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.957 -0.565 . . . . 5.75 111.335 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.484 ' HG2' ' O ' ' B' ' 17' ' ' LEU . 31.4 Cg_exo -61.82 158.54 37.41 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.752 2.301 . . . . 6.9800000000000004 111.748 172.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.645 ' HB3' HG22 ' A' ' 38' ' ' THR . 33.8 Cg_endo -64.86 123.4 11.58 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.404 2.069 . . . . 8.8499999999999996 112.771 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.491 ' O ' HG23 ' B' ' 38' ' ' THR . . . 98.27 -36.92 3.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.968 -0.634 . . . . 8.0899999999999999 113.777 172.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' B' ' 17' ' ' LEU . 24.8 m -72.09 -12.74 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 N-CA-C 112.658 0.614 . . . . 7.0 112.658 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.4 ' HE3' ' HB2' ' B' ' 32' ' ' ALA . 19.3 tpp -86.2 22.58 1.74 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.923 0.392 . . . . 5.7300000000000004 111.419 -175.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.725 HG22 ' HB3' ' A' ' 34' ' ' PRO . 22.9 p -48.73 143.55 7.91 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.273 -0.421 . . . . 7.96 111.049 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.39 -27.5 39.83 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.236 2.624 . . . . 7.2999999999999998 113.443 -175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -66.82 -50.68 61.82 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.949 -0.389 . . . . 9.2200000000000006 109.949 176.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 8.2 tt -66.89 -33.45 75.62 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.817 -0.438 . . . . 6.1699999999999999 109.817 178.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -56.83 -42.68 80.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.842 -0.617 . . . . 4.8399999999999999 109.731 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -72.52 -29.65 63.79 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.499 -0.773 . . . . 7.3499999999999996 110.702 178.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.646 ' CZ ' ' HA ' ' B' ' 44' ' ' ARG . 3.1 mmp_? -67.17 -38.79 86.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 8.2799999999999994 110.482 177.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 89.4 mt -63.99 -43.33 96.04 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.25 -0.648 . . . . 4.1299999999999999 109.25 171.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.17 -23.85 6.72 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.436 -0.802 . . . . 5.5800000000000001 113.354 169.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.16 12.25 79.5 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.71 -0.757 . . . . 4.5 112.007 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.508 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -80.46 151.36 29.32 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.265 -0.272 . . . . 5.4100000000000001 110.265 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 18.0 ptp180 -68.31 -45.2 73.65 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.869 -0.332 . . . . 8.2200000000000006 111.493 -174.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -63.22 -35.61 80.89 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.227 -0.189 . . . . 7.1600000000000001 111.49 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.59 -46.47 82.52 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.071 0.462 . . . . 5.7199999999999998 110.422 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.657 HD22 HD22 ' B' ' 21' ' ' LEU . 68.8 mt -69.97 -24.56 63.35 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.814 -0.63 . . . . 3.0600000000000001 111.391 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 77.8 mt -65.07 -48.74 82.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.765 0.317 . . . . 6.4000000000000004 110.264 175.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.56 95.51 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.316 0.579 . . . . 3.73 110.022 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.419 HD11 ' O ' ' B' ' 19' ' ' VAL . 1.1 tm? -58.88 -47.06 86.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.211 -0.904 . . . . 2.46 109.751 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.636 HD21 ' HA ' ' B' ' 22' ' ' TRP . 0.1 OUTLIER -55.39 -45.29 76.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.469 0.652 . . . . 5.5599999999999996 110.604 177.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -64.72 -28.92 69.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.097 -0.956 . . . . 7.1900000000000004 112.022 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -63.69 -30.01 71.17 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.769 0.318 . . . . 4.2300000000000004 111.266 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.25 16.99 22.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.722 0.296 . . . . 6.46 110.771 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -70.37 121.16 82.48 Favored Pre-proline 0 C--O 1.236 0.392 0 N-CA-C 109.633 -0.506 . . . . 7.3499999999999996 109.633 177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.33 160.24 24.1 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.252 2.635 . . . . 8.1699999999999999 113.24 -173.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 56.5 p -104.21 169.24 8.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.368 -0.833 . . . . 8.8900000000000006 110.475 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 50.2 m -104.85 143.84 32.58 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.705 -0.479 . . . . 9.7599999999999998 109.705 176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.41 -18.8 4.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.959 0.409 . . . . 11.210000000000001 110.851 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.1 -83.23 1.36 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.904 -0.589 . . . . 12.710000000000001 111.79 -176.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -177.48 -49.42 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 121.009 -0.615 . . . . 13.609999999999999 111.609 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 18.8 m 67.79 94.06 0.07 Allowed 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.526 0.679 . . . . 15.17 111.52 176.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 48.4 tp -120.05 145.36 46.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.616 -0.72 . . . . 16.82 109.981 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.58 HD23 ' H ' ' B' ' 69' ' ' LEU . 2.7 pt? -121.2 141.92 50.39 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.868 0.366 . . . . 18.109999999999999 110.323 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' B' ' 71' ' ' PRO . . . -97.73 139.11 21.14 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 109.306 -0.627 . . . . 19.0 109.306 173.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 70' ' ' ALA . 16.8 Cg_exo -67.37 77.01 0.49 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.776 2.317 . . . . 20.289999999999999 112.848 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 5.6 p -83.17 79.51 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 122.222 1.01 . . . . 21.129999999999999 110.413 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -143.31 8.01 1.58 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.055 -0.975 . . . . 22.899999999999999 110.118 178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -103.27 152.7 21.21 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.605 -0.725 . . . . 25.059999999999999 109.817 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -71.26 124.08 23.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.118 0.485 . . . . 24.460000000000001 111.144 -178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.17 16.66 29.84 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.855 -0.611 . . . . 24.609999999999999 111.749 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 62.41 82.23 0.18 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.353 0.597 . . . . 27.27 112.092 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.406 -0.807 . . . . 26.960000000000001 108.928 174.371 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.665 -0.574 . . . . 11.48 111.665 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.89 -45.45 16.62 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.509 2.14 . . . . 10.23 111.136 175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 54.1 tp -96.62 101.13 12.69 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.772 -0.649 . . . . 10.02 109.951 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.01 104.19 0.25 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.098 -0.801 . . . . 6.8899999999999997 111.098 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.0 m -58.64 -76.6 0.04 OUTLIER 'General case' 0 C--O 1.236 0.346 0 N-CA-C 112.117 0.414 . . . . 6.0199999999999996 112.117 -174.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 t -167.8 111.81 0.66 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.9 0.381 . . . . 3.5099999999999998 110.517 -178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.483 ' O ' ' HG ' ' A' ' 11' ' ' LEU . . . -114.43 -46.29 2.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.141 -0.481 . . . . 2.5 110.121 177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.53 -44.23 96.92 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 115.698 -0.683 . . . . 2.1299999999999999 112.482 -178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.16 98.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.033 0.444 . . . . 2.1899999999999999 111.055 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.638 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 39.9 tp -64.83 -46.67 80.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.829 -0.623 . . . . 1.6799999999999999 110.755 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 7' ' ' ALA . 87.7 mt -58.73 -51.04 71.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.119 -0.491 . . . . 1.71 109.941 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.53 -50.4 73.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.451 -0.795 . . . . 1.75 112.175 -175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.638 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 5.6 p80 -71.7 -28.09 63.47 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 120.625 -0.43 . . . . 1.78 110.841 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.7 -40.85 39.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.035 0.445 . . . . 1.0900000000000001 110.504 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.7 85.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.862 -0.608 . . . . 1.46 110.927 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 t -69.21 -22.95 63.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.034 -0.53 . . . . 2.2799999999999998 110.776 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 98.9 mt -84.23 -25.52 29.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.232 0.539 . . . . 1.6499999999999999 109.776 174.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.29 16.12 25.94 Favored Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 120.831 -0.7 . . . . 1.28 112.899 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.98 115.11 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.582 -0.525 . . . . 0.98999999999999999 109.582 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.756 ' HD3' HD12 ' A' ' 59' ' ' LEU . 95.5 mtt180 -131.11 134.14 46.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.25 -0.432 . . . . 2.6699999999999999 111.544 -177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.544 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.5 mp -128.82 133.46 48.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.123 -0.489 . . . . 1.45 109.856 175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.519 ' HB3' HD13 ' A' ' 56' ' ' LEU . 22.8 p90 -151.92 149.1 28.56 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.179 -0.304 . . . . 2.2599999999999998 110.179 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.6 p -87.86 128.76 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.073 0.463 . . . . 2.9199999999999999 109.818 177.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 32.8 tt0 -132.73 110.97 10.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.116 -0.493 . . . . 4.2000000000000002 110.152 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.58 -101.46 1.0 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.766 -0.731 . . . . 4.2000000000000002 111.712 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.508 ' OE1' ' HD3' ' B' ' 49' ' ' ARG . 0.3 OUTLIER -116.78 -3.79 11.67 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.575 0.213 . . . . 5.1500000000000004 111.575 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.517 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 11.9 tpp180 -134.58 152.12 51.55 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-O 121.391 0.615 . . . . 5.3799999999999999 111.912 -174.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 10.4 tt -80.81 132.66 35.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.302 -0.863 . . . . 2.4399999999999999 109.751 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.3 mpt_? -99.71 140.57 33.72 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.027 -0.533 . . . . 4.2199999999999998 109.836 175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.402 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.8 OUTLIER -122.08 130.95 53.71 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.071 -0.715 . . . . 1.6899999999999999 109.071 -177.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 62.7 tp60 -122.77 119.66 31.3 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.624 -0.51 . . . . 2.6800000000000002 109.624 177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.11 129.13 5.24 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.798 0.332 . . . . 1.6899999999999999 110.851 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' A' ' 36' ' ' VAL . 31.5 Cg_exo -61.48 154.47 59.03 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.681 2.254 . . . . 1.8400000000000001 112.166 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -67.51 122.51 9.72 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.113 1.876 . . . . 2.3100000000000001 112.115 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.88 -33.98 5.47 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.7 -0.762 . . . . 1.76 113.101 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.573 ' O ' HD22 ' A' ' 41' ' ' LEU . 34.1 m -79.69 -12.89 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-N 117.245 0.522 . . . . 1.49 112.1 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.61 21.71 0.79 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.086 -0.506 . . . . 1.4099999999999999 111.243 -173.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.7 p -50.4 139.5 19.66 Favored Pre-proline 0 C--O 1.234 0.242 0 CA-C-N 116.329 -0.396 . . . . 1.45 110.971 -178.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.534 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 83.3 Cg_exo -47.22 -39.36 26.75 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.314 2.676 . . . . 1.72 113.282 -177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 39.3 tt0 -63.08 -40.68 98.38 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 121.207 -0.197 . . . . 2.7599999999999998 110.517 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD22 ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -62.95 -40.04 96.47 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-O 120.793 0.33 . . . . 1.2 110.362 179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.491 ' HA ' HD12 ' A' ' 45' ' ' LEU . 5.8 mt-30 -64.8 -39.48 93.66 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-O 121.249 0.547 . . . . 2.0600000000000001 110.129 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.3 t -66.79 -29.63 69.62 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 115.094 -0.957 . . . . 1.5700000000000001 109.601 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 51.0 mtt-85 -75.19 -38.61 60.72 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 115.882 -0.599 . . . . 3.3399999999999999 110.079 174.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 42' ' ' GLN . 97.4 mt -55.69 -44.32 77.23 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.189 -0.671 . . . . 1.25 109.189 175.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.28 -23.24 5.52 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.579 -0.737 . . . . 2.2999999999999998 113.134 168.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.76 24.71 74.18 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.737 -0.744 . . . . 2.5699999999999998 111.484 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -85.08 149.52 25.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.652 0.263 . . . . 2.0800000000000001 110.57 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.644 ' HD3' ' OE1' ' B' ' 26' ' ' GLU . 7.6 ptt180 -67.47 -51.65 48.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.374 -0.375 . . . . 5.3600000000000003 111.984 -175.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -57.23 -39.34 75.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.384 0.611 . . . . 2.9900000000000002 110.036 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.77 -55.83 22.98 Favored 'General case' 0 CA--C 1.507 -0.676 0 CA-C-N 114.853 -1.067 . . . . 2.75 110.351 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.573 ' HA ' ' HB3' ' A' ' 55' ' ' LEU . 93.3 mt -70.33 -26.65 63.85 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.091 -0.959 . . . . 1.8999999999999999 111.854 -172.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 49' ' ' ARG . 70.7 mt -62.02 -52.29 62.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.832 0.349 . . . . 2.7400000000000002 110.227 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.39 -31.29 70.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.401 0.62 . . . . 1.5 110.23 177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.586 ' O ' HD13 ' A' ' 55' ' ' LEU . 3.5 tm? -68.46 -29.46 68.1 Favored 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.196 -0.911 . . . . 1.3200000000000001 109.929 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 0.9 OUTLIER -82.72 -32.85 27.75 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.058 0.456 . . . . 1.6799999999999999 110.602 174.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -60.76 -21.9 63.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.284 -0.416 . . . . 4.0700000000000003 111.67 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -69.15 -22.63 63.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.916 0.389 . . . . 1.75 111.03 174.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.756 HD12 ' HD3' ' A' ' 20' ' ' ARG . 10.4 tt -73.98 -27.59 61.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.244 -0.651 . . . . 2.4700000000000002 109.244 178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -68.24 146.94 98.24 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.523 -0.762 . . . . 2.5800000000000001 110.357 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.8 84.69 0.11 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.894 2.396 . . . . 2.48 112.46 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.9 t -137.04 -66.69 0.51 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.867 -0.606 . . . . 4.0599999999999996 109.63 176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.4 t -143.26 140.31 30.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.372 -0.603 . . . . 5.8600000000000003 109.372 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -121.95 153.93 37.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.921 0.391 . . . . 8.2100000000000009 110.571 -178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.41 160.94 26.07 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.3 -0.72 . . . . 10.390000000000001 111.3 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.85 112.61 0.53 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.424 -0.893 . . . . 11.32 112.58 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.9 m -93.47 -3.32 53.22 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.628 0.252 . . . . 13.15 110.706 177.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 68.19 -81.87 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.753 -0.658 . . . . 15.0 111.078 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.89 162.45 18.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.749 0.309 . . . . 16.239999999999998 110.446 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -133.3 123.42 17.7 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.316 -0.402 . . . . 16.760000000000002 110.226 179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 2.7 Cg_exo -77.26 35.87 0.51 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 123.269 2.646 . . . . 18.719999999999999 112.721 -179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 p -75.75 87.73 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 122.159 0.981 . . . . 19.52 110.554 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.67 173.63 7.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.143 -0.935 . . . . 20.52 110.362 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -76.13 78.47 2.95 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.778 0.799 . . . . 23.780000000000001 110.768 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -87.12 -50.42 6.64 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.859 -1.064 . . . . 22.18 110.2 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.68 161.54 37.44 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.812 -0.709 . . . . 23.170000000000002 111.826 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -94.1 34.4 1.26 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.142 0.496 . . . . 26.359999999999999 110.759 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.2 tp . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.734 -0.65 . . . . 26.210000000000001 109.987 178.078 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 CA-C-O 120.005 -0.331 . . . . 14.859999999999999 112.637 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.52 127.08 24.5 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.982 2.455 . . . . 14.18 112.738 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.75 -102.9 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.186 -0.915 . . . . 13.74 111.385 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 64.47 -100.69 0.44 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.612 -0.804 . . . . 11.08 111.595 -176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 45.3 m -109.41 -50.77 2.95 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.046 -0.353 . . . . 9.7799999999999994 110.046 175.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 50.2 m 61.66 38.8 15.01 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 115.777 -0.647 . . . . 8.3800000000000008 111.138 178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' B' ' 11' ' ' LEU . . . 60.76 43.95 11.65 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.3 0.572 . . . . 5.7800000000000002 110.205 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -55.62 -40.63 79.58 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.136 -0.938 . . . . 4.6600000000000001 113.369 -175.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.22 -45.72 83.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.0 0.4 . . . . 5.7800000000000002 110.96 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.405 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 61.6 tp -61.45 -46.6 89.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.025 -0.534 . . . . 4.3799999999999999 110.354 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' B' ' 7' ' ' ALA . 87.1 mt -61.89 -49.94 74.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.001 -0.545 . . . . 2.8599999999999999 110.792 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.06 -53.04 62.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.551 . . . . 3.7400000000000002 112.337 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.543 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 5.0 p80 -70.73 -28.42 64.7 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.283 -0.567 . . . . 5.0499999999999998 110.903 -174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.58 -41.95 59.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.066 0.46 . . . . 3.3300000000000001 110.406 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.11 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.691 -0.686 . . . . 4.3700000000000001 110.85 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 7.6 t -67.69 -26.74 66.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.983 -0.553 . . . . 6.0999999999999996 110.547 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' B' ' 13' ' ' HIS . 92.5 mt -81.27 -24.88 36.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.38 -0.373 . . . . 6.4900000000000002 110.42 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.28 15.47 25.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.841 -0.695 . . . . 4.7300000000000004 112.809 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -73.95 114.92 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 109.939 -0.393 . . . . 3.6000000000000001 109.939 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.752 ' HD3' HD12 ' B' ' 59' ' ' LEU . 94.6 mtt180 -131.05 136.99 48.94 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.315 -0.402 . . . . 6.7999999999999998 111.491 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.494 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.7 mp -129.91 136.42 49.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.84 -0.618 . . . . 3.7999999999999998 109.751 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . 0.742 ' HB3' HD13 ' B' ' 56' ' ' LEU . 28.8 p90 -153.9 150.07 27.98 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.792 0.329 . . . . 6.7999999999999998 110.381 175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.2 p -88.03 130.69 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.482 -0.562 . . . . 7.7400000000000002 109.482 177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.681 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 35.0 tt0 -134.89 114.37 12.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.236 -0.438 . . . . 9.4399999999999995 110.272 -174.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 67.3 -102.86 0.85 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.984 -0.627 . . . . 9.6600000000000001 111.912 -176.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.644 ' OE1' ' HD3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -0.08 12.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.572 0.225 . . . . 9.3200000000000003 111.266 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.523 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 10.7 tpp180 -140.14 146.77 39.24 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 120.106 -0.638 . . . . 7.3399999999999999 111.395 -171.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 10.2 tt -79.13 135.71 36.91 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.068 -0.515 . . . . 5.1799999999999997 110.332 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 4.8 mpt_? -101.09 137.86 38.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.863 -0.608 . . . . 8.0700000000000003 110.134 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.494 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.6 t80 -119.01 131.49 56.0 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.355 -0.609 . . . . 4.1600000000000001 109.355 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 31.2 tp60 -126.18 114.02 17.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.833 -0.432 . . . . 6.7199999999999998 109.833 178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.39 130.49 7.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.528 -0.305 . . . . 5.75 111.265 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.498 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.1 Cg_exo -61.98 151.71 79.74 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.806 2.337 . . . . 6.9800000000000004 112.302 175.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.534 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 34.9 Cg_endo -65.86 123.26 11.08 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.158 1.905 . . . . 8.8499999999999996 112.326 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.42 -33.07 5.87 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.758 -0.734 . . . . 8.0899999999999999 112.945 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.573 ' O ' HD22 ' B' ' 41' ' ' LEU . 22.5 m -83.99 -7.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 117.181 0.49 . . . . 7.0 111.53 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.554 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.43 20.22 1.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.399 . . . . 5.7300000000000004 111.289 -175.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 14.9 p -50.67 138.91 22.11 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.347 -0.388 . . . . 7.96 111.338 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -48.01 -41.4 33.18 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.486 2.791 . . . . 7.2999999999999998 113.473 -176.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.587 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 42.5 tt0 -57.74 -40.74 80.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.506 0.194 . . . . 9.2200000000000006 111.043 178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.573 HD22 ' O ' ' B' ' 36' ' ' VAL . 2.5 tp -64.37 -42.39 96.2 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 120.86 0.362 . . . . 6.1699999999999999 110.081 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.498 ' HA ' HD12 ' B' ' 45' ' ' LEU . 22.8 mt-30 -63.66 -36.99 85.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.991 -0.55 . . . . 4.8399999999999999 109.97 -179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 17.2 t -68.02 -37.02 80.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.666 -0.697 . . . . 7.3499999999999996 109.955 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 56.5 mtt-85 -66.56 -40.36 88.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.418 -0.355 . . . . 8.2799999999999994 110.422 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' B' ' 42' ' ' GLN . 91.7 mt -56.92 -43.76 81.74 Favored 'General case' 0 CA--C 1.524 -0.042 0 CA-C-O 121.285 0.564 . . . . 4.1299999999999999 109.732 176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.19 -23.42 6.15 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.474 -0.784 . . . . 5.5800000000000001 112.95 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.99 28.14 73.28 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.994 -0.622 . . . . 4.5 111.664 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.44 150.26 24.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.528 0.204 . . . . 5.4100000000000001 110.467 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.508 ' HD3' ' OE1' ' A' ' 26' ' ' GLU . 11.0 ptt-85 -65.89 -50.21 65.31 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.338 -0.392 . . . . 8.2200000000000006 111.403 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -57.48 -42.11 82.02 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 116.752 -0.204 . . . . 7.1600000000000001 111.398 -177.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -54.22 40.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.448 -0.342 . . . . 5.7199999999999998 110.809 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.463 ' HA ' ' HB3' ' B' ' 55' ' ' LEU . 75.8 mt -67.91 -27.67 66.85 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.286 0.476 . . . . 3.0600000000000001 112.286 -173.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.459 HG13 ' O ' ' B' ' 49' ' ' ARG . 72.0 mt -64.02 -49.84 79.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.808 -0.357 . . . . 6.4000000000000004 110.09 175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.75 -36.08 77.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.413 0.625 . . . . 3.73 110.486 177.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.506 ' O ' ' HG3' ' B' ' 58' ' ' GLN . 2.9 tm? -63.39 -29.21 70.55 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 2.46 110.134 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.742 HD13 ' HB3' ' B' ' 22' ' ' TRP . 22.9 tp -79.25 -32.38 43.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.912 0.387 . . . . 5.5599999999999996 110.694 173.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.59 -20.23 65.34 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.013 0.375 . . . . 7.1900000000000004 112.013 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' B' ' 55' ' ' LEU . 1.5 pp0? -73.36 -17.93 61.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 120.768 -0.373 . . . . 4.2300000000000004 110.893 174.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.752 HD12 ' HD3' ' B' ' 20' ' ' ARG . 10.1 tt -75.3 -26.82 59.01 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.398 -0.593 . . . . 6.46 109.398 176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 22.0 mt-30 -71.64 147.9 92.41 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.657 -0.701 . . . . 7.3499999999999996 110.335 178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 26.4 Cg_exo -62.53 93.22 0.14 Allowed 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 122.749 2.3 . . . . 8.1699999999999999 112.372 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 12.6 t -147.31 -66.42 0.26 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 8.8900000000000006 109.417 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 26.4 t -142.77 137.98 30.12 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.381 -0.6 . . . . 9.7599999999999998 109.381 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -120.74 157.53 29.47 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.555 -0.293 . . . . 11.210000000000001 110.422 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -145.88 157.66 27.44 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.928 -0.653 . . . . 12.710000000000001 111.769 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.66 116.84 0.74 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.633 -0.794 . . . . 13.609999999999999 112.473 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 56.6 m -97.69 -3.89 38.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.655 0.264 . . . . 15.17 110.516 177.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' B' ' 68' ' ' LEU . 4.0 mm? 69.68 -82.9 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.529 -0.76 . . . . 16.82 110.825 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 pp -164.08 159.71 20.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.187 -0.46 . . . . 18.109999999999999 109.982 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.15 114.67 38.72 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 116.302 -0.408 . . . . 19.0 110.245 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.14 -35.94 90.57 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.911 2.408 . . . . 20.289999999999999 112.032 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 p -166.85 150.07 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.496 -0.775 . . . . 21.129999999999999 109.315 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.5 102.11 10.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.014 -0.365 . . . . 22.899999999999999 110.014 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.693 ' HD3' ' H ' ' B' ' 74' ' ' ARG . 0.0 OUTLIER -50.93 121.23 5.7 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.364 0.602 . . . . 25.059999999999999 110.663 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -91.21 122.02 33.48 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.733 -0.667 . . . . 24.460000000000001 111.007 -175.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -79.17 -83.89 0.62 Allowed Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.632 -0.987 . . . . 24.609999999999999 110.632 173.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.462 ' HA ' ' NE ' ' B' ' 77' ' ' ARG . 5.6 mmp_? -132.41 82.54 2.02 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.604 -0.517 . . . . 27.27 109.604 171.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.405 -0.807 . . . . 26.960000000000001 111.201 179.472 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.67 0 N-CA-C 111.436 -0.666 . . . . 11.48 111.436 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.37 -55.19 3.84 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.651 2.234 . . . . 10.23 112.049 177.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 36.8 tp -163.07 107.74 1.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.963 -0.562 . . . . 10.02 110.035 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 113.95 88.06 1.6 Allowed Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.49 -0.862 . . . . 6.8899999999999997 112.837 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.5 t 71.93 128.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.741 0.781 . . . . 6.0199999999999996 112.88 173.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.1 m -98.56 -16.68 19.03 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.818 -0.808 . . . . 3.5099999999999998 108.818 169.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.54 -34.12 65.05 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 114.937 -1.029 . . . . 2.5 110.379 177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.33 -38.1 92.87 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.579 -0.609 . . . . 2.1299999999999999 111.579 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.37 -40.22 85.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.0 0.429 . . . . 2.1899999999999999 110.306 176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.7 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 36.6 tp -61.76 -46.84 87.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.918 -0.583 . . . . 1.6799999999999999 110.042 175.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.4 -47.57 85.53 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.493 -0.776 . . . . 1.71 109.933 176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.23 -50.42 73.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.211 -0.449 . . . . 1.75 112.043 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.7 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 4.5 p80 -74.75 -27.76 60.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.649 -0.421 . . . . 1.78 110.625 -175.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.74 -45.36 71.69 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.203 -0.295 . . . . 1.0900000000000001 110.203 174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.62 -39.1 93.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 1.46 110.935 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.9 m -65.34 -31.98 73.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 2.2799999999999998 111.235 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.6 HD13 ' HB ' ' A' ' 36' ' ' VAL . 74.6 mt -85.35 -26.43 26.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.072 0.463 . . . . 1.6499999999999999 110.166 176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.35 33.23 26.22 Favored Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.51 -0.768 . . . . 1.28 112.804 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.668 HG21 HD21 ' A' ' 41' ' ' LEU . 54.0 t -71.71 121.06 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.81 -0.811 . . . . 0.98999999999999999 108.81 173.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.788 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 74.7 mtt180 -126.5 131.71 51.56 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.378 -0.23 . . . . 2.6699999999999999 110.378 -174.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.594 HD23 HD11 ' A' ' 28' ' ' LEU . 6.1 mp -132.33 125.52 31.11 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.729 -0.471 . . . . 1.45 109.729 175.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 19.9 p90 -143.11 134.45 26.07 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.917 0.389 . . . . 2.2599999999999998 109.984 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -92.77 125.41 45.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.052 0.453 . . . . 2.9199999999999999 109.959 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -121.25 118.16 28.88 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.907 -0.588 . . . . 4.2000000000000002 109.661 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.05 -97.04 0.56 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.688 -0.687 . . . . 4.2000000000000002 111.664 -176.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -116.63 -16.29 10.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.734 0.302 . . . . 5.1500000000000004 111.444 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -114.76 135.2 54.43 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 119.836 -0.746 . . . . 5.3799999999999999 112.643 -167.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.594 HD11 HD23 ' A' ' 21' ' ' LEU . 3.4 tm? -78.24 124.76 28.44 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.505 -1.225 . . . . 2.4399999999999999 108.84 172.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -100.96 143.97 30.46 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.001 -0.37 . . . . 4.2199999999999998 110.001 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.66 131.89 55.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.185 -0.461 . . . . 1.6899999999999999 110.702 -174.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.788 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 5.2 tp-100 -126.36 114.33 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.872 -0.603 . . . . 2.6800000000000002 109.692 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -151.83 126.85 4.72 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-O 120.864 0.364 . . . . 1.6899999999999999 111.343 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.59 ' O ' HG22 ' A' ' 36' ' ' VAL . 24.0 Cg_exo -65.38 155.83 66.61 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.904 2.402 . . . . 1.8400000000000001 112.053 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.09 123.79 13.91 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.728 2.285 . . . . 2.3100000000000001 112.563 -178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.15 -31.88 6.68 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.855 -0.688 . . . . 1.76 113.2 177.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.6 ' HB ' HD13 ' A' ' 17' ' ' LEU . 15.4 m -85.11 -19.87 8.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 117.091 0.446 . . . . 1.49 112.157 -174.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.511 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -81.39 20.29 0.89 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.019 0.438 . . . . 1.4099999999999999 111.43 -171.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.3 p -51.75 142.16 24.77 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.096 -0.502 . . . . 1.45 110.894 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.68 -38.29 28.88 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.207 2.605 . . . . 1.72 113.244 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.599 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 55.4 tt0 -61.54 -39.98 93.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.448 -0.342 . . . . 2.7599999999999998 111.056 178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.668 HD21 HG21 ' A' ' 19' ' ' VAL . 1.9 tp -60.35 -44.55 95.44 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 120.882 0.372 . . . . 1.2 110.134 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.704 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -57.36 -39.01 75.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.594 -0.73 . . . . 2.0600000000000001 110.125 178.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.4 t -68.84 -29.84 68.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.927 -0.578 . . . . 1.5700000000000001 110.504 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 27.4 mmt180 -73.1 -40.9 64.59 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.99 -0.374 . . . . 3.3399999999999999 109.99 176.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.494 HD12 HE21 ' A' ' 42' ' ' GLN . 50.8 mt -60.19 -38.46 83.34 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.544 0.688 . . . . 1.25 109.161 174.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.3 -23.23 8.57 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.183 -0.917 . . . . 2.2999999999999998 113.062 172.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.14 19.32 71.96 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.934 -0.651 . . . . 2.5699999999999998 112.064 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -82.87 149.66 26.98 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.899 -0.408 . . . . 2.0800000000000001 109.899 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' O ' HG13 ' A' ' 53' ' ' ILE . 8.4 ptp85 -69.06 -50.62 46.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.487 -0.324 . . . . 5.3600000000000003 111.521 -173.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.457 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 8.6 p80 -61.59 -32.97 73.1 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.095 0.474 . . . . 2.9900000000000002 110.836 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -66.25 -51.24 59.43 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-N 115.326 -0.852 . . . . 2.75 110.309 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.486 HD22 HD22 ' A' ' 21' ' ' LEU . 91.2 mt -69.08 -26.52 64.98 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.925 -1.034 . . . . 1.8999999999999999 111.124 -175.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 49' ' ' ARG . 79.4 mt -61.0 -48.16 90.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.035 0.445 . . . . 2.7400000000000002 109.998 174.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.37 -27.63 66.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 1.5 110.609 177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.44 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.7 tm? -69.39 -38.13 77.86 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.677 -0.692 . . . . 1.3200000000000001 109.398 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.5 tp -79.46 -26.8 41.65 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.452 0.644 . . . . 1.6799999999999999 109.633 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -65.29 -26.77 68.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.007 -0.542 . . . . 4.0700000000000003 110.437 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -66.57 -27.89 68.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 1.75 110.274 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 20' ' ' ARG . 51.0 mt -74.24 -19.19 60.59 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.581 -0.736 . . . . 2.4700000000000002 110.911 -176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 45.0 mt-30 -90.94 106.14 14.68 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.798 -0.637 . . . . 2.5800000000000001 109.875 178.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HB2' ' HA2' ' A' ' 65' ' ' GLY . 9.7 Cg_exo -69.98 85.15 0.66 Allowed 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 123.124 2.549 . . . . 2.48 112.931 -175.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 41.8 m 59.11 -108.59 0.41 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 115.448 -0.796 . . . . 4.0599999999999996 110.801 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.6 m -138.05 2.34 2.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.94 0.4 . . . . 5.8600000000000003 110.879 176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -132.69 -76.17 0.5 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.007 -0.368 . . . . 8.2100000000000009 110.007 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 61' ' ' PRO . . . -175.96 -51.36 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.531 -0.843 . . . . 10.390000000000001 112.383 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.54 101.84 0.56 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.169 -0.539 . . . . 11.32 112.741 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.6 m -99.63 92.18 5.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.991 0.424 . . . . 13.15 110.183 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.8 tp -152.64 168.01 27.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.081 -0.509 . . . . 15.0 109.778 -176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.4 mt -77.3 -63.46 1.37 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.962 -0.755 . . . . 16.239999999999998 108.962 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HB1' HG12 ' A' ' 72' ' ' VAL . . . 48.83 93.64 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 114.377 -1.283 . . . . 16.760000000000002 113.415 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -78.95 25.41 0.56 Allowed 'Trans proline' 0 C--O 1.233 0.27 0 C-N-CA 122.818 2.345 . . . . 18.719999999999999 111.949 176.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.436 HG12 ' HB1' ' A' ' 70' ' ' ALA . 4.4 p -73.27 109.87 6.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.626 0.727 . . . . 19.52 110.228 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.61 -177.88 6.47 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.428 -0.805 . . . . 20.52 110.108 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -93.09 7.94 42.11 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.809 -0.441 . . . . 23.780000000000001 109.809 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 67.59 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.211 -0.904 . . . . 22.18 110.942 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.5 69.81 1.99 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.76 -0.733 . . . . 23.170000000000002 112.656 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.523 ' HG3' ' HG ' ' A' ' 78' ' ' LEU . 5.1 ptp180 -70.21 -18.37 63.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.102 0.477 . . . . 26.359999999999999 110.041 175.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.523 ' HG ' ' HG3' ' A' ' 77' ' ' ARG . 85.6 mt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.249 -0.881 . . . . 26.210000000000001 109.818 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 112.222 -0.351 . . . . 14.859999999999999 112.222 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.458 ' HA ' ' NH1' ' B' ' 44' ' ' ARG . 92.2 Cg_endo -86.98 -12.32 5.05 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.855 2.37 . . . . 14.18 113.015 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.98 -85.59 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 122.954 0.502 . . . . 13.74 111.234 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.42 -174.73 25.64 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.713 -0.555 . . . . 11.08 111.713 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 15.6 m 60.37 20.45 10.03 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.861 0.464 . . . . 9.7799999999999994 111.556 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 20.1 m -119.43 83.13 1.98 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.266 0.555 . . . . 8.3800000000000008 111.327 -174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -135.31 -77.81 0.44 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.522 -0.763 . . . . 5.7800000000000002 109.895 175.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.44 -38.32 79.9 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.975 -0.631 . . . . 4.6600000000000001 111.693 176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.0 83.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.892 0.377 . . . . 5.7800000000000002 110.173 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.52 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 58.5 tp -61.51 -46.59 89.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.867 -0.606 . . . . 4.3799999999999999 109.89 176.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.31 -49.15 76.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.728 -0.669 . . . . 2.8599999999999999 109.66 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.78 -53.26 58.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.856 -0.611 . . . . 3.7400000000000002 112.307 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.52 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 4.0 p80 -73.52 -27.92 61.61 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.19 -0.604 . . . . 5.0499999999999998 110.952 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.17 78.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 3.3300000000000001 110.445 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.72 -40.15 94.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 4.3700000000000001 110.8 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 50.0 m -61.99 -36.7 82.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.749 -0.66 . . . . 6.0999999999999996 111.141 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.54 HD13 ' HB ' ' B' ' 36' ' ' VAL . 82.5 mt -82.03 -24.92 35.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.39 . . . . 6.4900000000000002 110.632 178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.409 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 86.52 31.65 18.28 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 121.045 -0.598 . . . . 4.7300000000000004 112.673 178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.621 HG21 HD21 ' B' ' 41' ' ' LEU . 45.8 t -75.38 123.08 30.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 N-CA-C 109.689 -0.486 . . . . 3.6000000000000001 109.689 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.889 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 77.6 mtt180 -129.33 131.11 46.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.531 -0.304 . . . . 6.7999999999999998 111.107 -173.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.669 HD23 HD11 ' B' ' 28' ' ' LEU . 5.7 mp -134.64 125.74 27.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.328 -0.396 . . . . 3.7999999999999998 110.135 175.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . 0.497 ' HB3' HD13 ' B' ' 56' ' ' LEU . 20.4 p90 -143.5 137.05 28.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.273 -0.421 . . . . 6.7999999999999998 110.21 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 5.7 p -96.48 118.37 42.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.183 0.515 . . . . 7.7400000000000002 110.172 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -113.3 114.43 26.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.85 -0.614 . . . . 9.4399999999999995 109.664 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 74.36 -98.89 1.05 Allowed Glycine 0 N--CA 1.442 -0.908 0 N-CA-C 111.327 -0.709 . . . . 9.6600000000000001 111.327 -176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -116.99 -16.53 10.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.852 0.358 . . . . 9.3200000000000003 111.598 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.427 ' HD3' ' HA ' ' B' ' 27' ' ' ARG . 7.5 tpp180 -115.53 128.44 55.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.409 0.623 . . . . 7.3399999999999999 111.962 -166.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.669 HD11 HD23 ' B' ' 21' ' ' LEU . 3.3 tm? -74.62 124.39 26.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.801 -1.09 . . . . 5.1799999999999997 109.551 175.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -100.38 145.31 28.35 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.295 -0.261 . . . . 8.0700000000000003 110.295 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.472 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.3 OUTLIER -120.14 131.67 55.12 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.113 -0.494 . . . . 4.1600000000000001 110.57 -174.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.889 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 5.6 tp-100 -125.32 114.39 18.84 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.433 -0.58 . . . . 6.7199999999999998 109.433 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -151.58 122.17 3.67 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 5.75 111.031 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.539 ' O ' HG22 ' B' ' 36' ' ' VAL . 31.4 Cg_exo -60.27 152.92 63.14 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.917 2.411 . . . . 6.9800000000000004 112.181 177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.07 124.05 15.05 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.512 2.141 . . . . 8.8499999999999996 112.409 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.75 -29.03 8.86 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.705 -0.76 . . . . 8.0899999999999999 112.926 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.557 ' O ' HD22 ' B' ' 41' ' ' LEU . 6.4 m -89.0 -14.61 9.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 122.533 -0.393 . . . . 7.0 111.293 -176.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.59 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.4 OUTLIER -82.25 18.45 1.41 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.89 0.376 . . . . 5.7300000000000004 111.239 -174.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.8 p -52.08 142.91 25.94 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.43 . . . . 7.96 111.114 176.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . 0.432 ' HG3' ' OE1' ' A' ' 31' ' ' GLN . 71.4 Cg_exo -49.33 -37.16 39.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.263 2.642 . . . . 7.2999999999999998 113.302 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 38.0 tt0 -61.43 -38.26 86.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.077 -0.249 . . . . 9.2200000000000006 111.13 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.621 HD21 HG21 ' B' ' 19' ' ' VAL . 2.9 tp -62.79 -40.36 97.09 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 120.869 0.366 . . . . 6.1699999999999999 110.115 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.763 HE21 ' HA ' ' B' ' 42' ' ' GLN . 0.0 OUTLIER -59.62 -39.64 84.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 4.8399999999999999 109.857 176.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 24.5 t -68.29 -32.35 72.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.499 -0.773 . . . . 7.3499999999999996 110.703 177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 23.7 mmt180 -71.71 -41.67 68.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.377 -0.374 . . . . 8.2799999999999994 110.093 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 78.3 mt -61.28 -39.6 91.01 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.858 -0.61 . . . . 4.1299999999999999 109.779 175.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.06 -23.16 8.26 Favored Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.532 -0.758 . . . . 5.5800000000000001 112.807 173.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.89 72.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.077 -0.582 . . . . 4.5 112.381 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.456 ' HB3' ' HB2' ' B' ' 51' ' ' GLU . . . -76.1 150.43 37.25 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.047 -0.353 . . . . 5.4100000000000001 110.047 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 53' ' ' ILE . 8.8 ptp85 -65.27 -48.99 71.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.579 -0.282 . . . . 8.2200000000000006 111.034 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -66.66 -32.07 73.15 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.806 0.299 . . . . 7.1600000000000001 111.806 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' B' ' 48' ' ' ALA . 0.4 OUTLIER -64.97 -44.27 89.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.982 0.42 . . . . 5.7199999999999998 110.534 179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 85.8 mt -75.85 -25.0 55.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.047 -0.524 . . . . 3.0600000000000001 111.506 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 49' ' ' ARG . 80.0 mt -63.54 -47.46 91.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.672 -0.492 . . . . 6.4000000000000004 109.672 173.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.04 -33.21 74.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 3.73 110.233 177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.8 tm? -62.53 -44.57 96.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.761 -0.654 . . . . 2.46 109.778 177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' B' ' 22' ' ' TRP . 28.2 tp -68.58 -30.95 69.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.3 0.571 . . . . 5.5599999999999996 110.763 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -66.55 -29.66 69.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.074 -0.512 . . . . 7.1900000000000004 110.911 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 8.2 pt20 -68.03 -24.59 65.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 4.2300000000000004 110.381 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.434 HD12 HD12 ' B' ' 56' ' ' LEU . 55.7 mt -74.98 -17.63 60.51 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.805 -0.634 . . . . 6.46 110.453 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.453 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 43.9 mt-30 -91.47 107.06 19.07 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.626 -0.715 . . . . 7.3499999999999996 109.492 177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.579 ' HB2' ' HA2' ' B' ' 65' ' ' GLY . 6.9 Cg_exo -73.04 82.89 1.49 Allowed 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.159 2.573 . . . . 8.1699999999999999 112.225 -175.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 15.7 m 56.77 -143.06 0.73 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.666 -0.697 . . . . 8.8900000000000006 109.571 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 23.5 m -100.12 -6.96 25.44 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.804 -0.358 . . . . 9.7599999999999998 111.384 178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -122.49 -78.98 0.61 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.685 0.278 . . . . 11.210000000000001 110.565 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' B' ' 61' ' ' PRO . . . -179.7 -50.64 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.988 -0.625 . . . . 12.710000000000001 111.94 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.78 100.04 0.35 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.868 -0.682 . . . . 13.609999999999999 112.381 178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.8 m -98.54 103.62 15.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.991 -0.374 . . . . 15.17 109.991 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 29.3 tp -162.29 163.52 28.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.191 -0.459 . . . . 16.82 109.811 -177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 63.0 mt -73.43 -62.15 1.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.018 -0.734 . . . . 18.109999999999999 109.018 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . 56.67 95.98 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 115.134 -0.939 . . . . 19.0 112.776 174.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.38 -18.14 62.05 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.636 2.224 . . . . 20.289999999999999 111.136 174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 57.8 t -78.87 113.64 18.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.389 -0.823 . . . . 21.129999999999999 109.924 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -96.64 176.19 6.1 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.023 -0.535 . . . . 22.899999999999999 110.803 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -65.53 -37.38 86.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.885 0.374 . . . . 25.059999999999999 111.051 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -75.37 95.16 3.17 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.173 -0.467 . . . . 24.460000000000001 110.385 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.26 -8.27 6.29 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.419 -0.896 . . . . 24.609999999999999 112.852 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -74.7 -72.74 0.27 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 117.196 0.498 . . . . 27.27 109.921 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 43.4 tp . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.687 -0.673 . . . . 26.960000000000001 110.001 175.754 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.678 0 N-CA-C 111.868 -0.493 . . . . 11.48 111.868 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 18.1 Cg_exo -66.54 -36.65 25.19 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 123.073 2.515 . . . . 10.23 112.573 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 mp -76.42 -45.79 29.97 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.485 -0.325 . . . . 10.02 110.432 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.24 155.67 26.26 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.566 -0.826 . . . . 6.8899999999999997 112.661 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.8 m -101.57 -30.22 11.51 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.179 0.514 . . . . 6.0199999999999996 110.353 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 9' ' ' ALA . 66.3 m -85.72 95.82 9.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.9 -0.591 . . . . 3.5099999999999998 110.815 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.25 -48.65 6.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.152 -0.477 . . . . 2.5 110.449 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.37 -37.58 94.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.943 -0.571 . . . . 2.1299999999999999 111.947 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.681 ' HB3' ' HB3' ' A' ' 6' ' ' SER . . . -59.35 -41.55 89.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.868 0.366 . . . . 2.1899999999999999 110.748 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.751 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 32.6 tp -64.22 -47.33 80.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.228 -0.442 . . . . 1.6799999999999999 110.152 176.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -57.81 -49.09 77.83 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.443 -0.798 . . . . 1.71 109.999 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.46 -50.48 71.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.813 -0.63 . . . . 1.75 112.238 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.751 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 4.2 p80 -73.13 -27.49 61.71 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.454 -0.498 . . . . 1.78 110.55 -174.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.91 -47.68 68.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.818 0.342 . . . . 1.0900000000000001 110.392 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -31.82 73.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 1.46 110.696 177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.2 t -64.38 -40.95 96.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.977 -0.556 . . . . 2.2799999999999998 110.762 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.603 HD13 ' HB ' ' A' ' 36' ' ' VAL . 97.6 mt -79.96 -25.89 40.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.094 0.474 . . . . 1.6499999999999999 110.257 177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.94 24.15 42.63 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.984 -0.627 . . . . 1.28 112.276 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -68.67 121.28 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 N-CA-C 109.353 -0.61 . . . . 0.98999999999999999 109.353 175.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 76.8 mtt180 -122.25 135.23 54.72 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.77 -0.456 . . . . 2.6699999999999999 109.77 -178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.806 HD22 HD22 ' A' ' 52' ' ' LEU . 6.0 mp -135.85 124.36 23.56 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.183 -0.303 . . . . 1.45 110.183 175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.485 ' HB3' HD13 ' A' ' 56' ' ' LEU . 23.8 p90 -140.84 140.6 34.66 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.894 -0.41 . . . . 2.2599999999999998 109.894 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -85.51 123.0 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 120.943 0.401 . . . . 2.9199999999999999 110.147 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.647 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -110.34 101.84 10.54 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.025 -0.731 . . . . 4.2000000000000002 109.025 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.01 -86.15 0.22 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.766 -0.652 . . . . 4.2000000000000002 112.1 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -116.63 -32.03 5.32 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.207 0.527 . . . . 5.1500000000000004 110.78 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -105.31 133.37 50.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.301 0.572 . . . . 5.3799999999999999 112.029 -167.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.616 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -69.6 126.15 28.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.882 -1.054 . . . . 2.4399999999999999 109.445 174.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.647 ' NH1' ' HB3' ' A' ' 24' ' ' GLU . 7.3 mpt_? -98.58 131.11 45.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.628 -0.508 . . . . 4.2199999999999998 109.628 176.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.417 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.2 OUTLIER -108.45 145.99 33.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.063 -0.517 . . . . 1.6899999999999999 110.201 -175.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 8.6 tp-100 -145.41 110.49 5.21 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.981 -0.378 . . . . 2.6800000000000002 109.981 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -146.03 135.68 11.63 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.565 -0.289 . . . . 1.6899999999999999 110.848 -178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' O ' HG22 ' A' ' 36' ' ' VAL . 35.3 Cg_exo -60.26 156.98 37.42 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.89 2.394 . . . . 1.8400000000000001 112.179 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' B' ' 38' ' ' THR . 20.0 Cg_endo -63.1 123.95 13.08 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.437 2.092 . . . . 2.3100000000000001 112.35 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.64 -37.23 3.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.76 113.275 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.603 ' HB ' HD13 ' A' ' 17' ' ' LEU . 33.3 m -75.06 -11.92 14.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 112.609 0.596 . . . . 1.49 112.609 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.442 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -82.16 21.51 0.9 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.187 -0.46 . . . . 1.4099999999999999 111.711 -173.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.621 HG22 ' HB3' ' B' ' 34' ' ' PRO . 35.2 p -50.64 143.91 13.58 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 116.608 -0.269 . . . . 1.45 110.954 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.413 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 50.6 Cg_exo -53.51 -32.91 65.48 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.54 2.16 . . . . 1.72 111.954 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 18.4 tp10 -57.93 -50.21 74.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.856 -0.611 . . . . 2.7599999999999998 110.2 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 36' ' ' VAL . 2.4 tp -61.79 -47.53 84.73 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.115 0.483 . . . . 1.2 110.293 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HA ' HD12 ' A' ' 45' ' ' LEU . 25.3 tp60 -57.13 -39.25 74.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.985 . . . . 2.0600000000000001 111.204 -176.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.9 t -71.44 -29.55 65.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.381 -0.372 . . . . 1.5700000000000001 110.391 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 96.3 mtt180 -77.76 -28.73 50.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.381 -0.372 . . . . 3.3399999999999999 110.94 178.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 42' ' ' GLN . 87.2 mt -64.86 -33.85 76.99 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.784 -0.821 . . . . 1.25 108.784 171.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.45 -24.03 6.79 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.078 -0.965 . . . . 2.2999999999999998 113.044 171.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.87 11.6 60.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.967 -0.635 . . . . 2.5699999999999998 112.12 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.554 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -78.42 150.47 33.07 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 110.137 -0.32 . . . . 2.0800000000000001 110.137 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.552 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -67.46 -50.15 60.45 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.298 -0.41 . . . . 5.3600000000000003 111.16 -173.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -63.62 -34.54 78.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.92 0.39 . . . . 2.9900000000000002 110.808 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -66.1 -48.67 70.14 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 115.699 -0.682 . . . . 2.75 109.844 -178.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.806 HD22 HD22 ' A' ' 21' ' ' LEU . 76.8 mt -72.07 -24.2 61.47 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.05 -0.977 . . . . 1.8999999999999999 111.238 -176.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 49' ' ' ARG . 74.7 mt -62.37 -43.92 98.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.769 -0.456 . . . . 2.7400000000000002 109.769 172.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.06 -25.76 65.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.2 -0.454 . . . . 1.5 110.319 176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.69 ' HB2' ' HA ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -71.56 -29.76 65.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.37 -0.832 . . . . 1.3200000000000001 110.202 -178.303 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 5.5 tp -84.27 -40.15 18.36 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.444 -0.798 . . . . 1.6799999999999999 110.619 172.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -56.89 -28.97 62.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.276 -0.875 . . . . 4.0700000000000003 111.156 -178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.641 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 11.8 pt20 -68.21 -20.36 64.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.357 -0.838 . . . . 1.75 111.594 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 24.8 tp -89.23 -6.44 56.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.352 -0.385 . . . . 2.4700000000000002 110.718 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 14.7 mm100 -67.83 120.58 74.78 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.235 -0.439 . . . . 2.5800000000000001 110.605 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 12.8 Cg_exo -69.94 94.62 0.55 Allowed 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.622 2.214 . . . . 2.48 112.004 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.7 p -73.24 -15.86 61.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.922 -0.581 . . . . 4.0599999999999996 111.008 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 20.0 m -65.48 149.4 50.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.115 -0.493 . . . . 5.8600000000000003 110.329 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -96.47 23.81 6.46 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.84 0.353 . . . . 8.2100000000000009 111.523 -174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.81 -68.81 2.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.661 -0.781 . . . . 10.390000000000001 112.494 176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -163.66 -167.97 24.94 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.747 -0.739 . . . . 11.32 111.722 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.5 t -137.59 63.68 1.54 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.37 0.605 . . . . 13.15 110.473 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.44 92.23 3.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.97 -0.559 . . . . 15.0 110.333 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.93 -49.15 9.93 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.377 -0.601 . . . . 16.239999999999998 109.377 176.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.74 102.04 5.92 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.305 -0.861 . . . . 16.760000000000002 110.421 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.29 48.55 2.92 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.717 2.278 . . . . 18.719999999999999 110.885 175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.75 122.34 33.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.224 -0.898 . . . . 19.52 111.299 -174.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.1 -60.76 1.77 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.605 -0.725 . . . . 20.52 111.426 -175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.0 ptt180 -108.03 75.61 1.0 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.063 -0.517 . . . . 23.780000000000001 111.774 -173.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.9 t-20 71.07 -69.9 0.17 Allowed 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.508 -0.769 . . . . 22.18 110.806 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 60.34 25.1 62.22 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 116.378 -0.374 . . . . 23.170000000000002 113.843 174.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 26.1 ttp180 59.66 78.5 0.27 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.568 0.699 . . . . 26.359999999999999 110.992 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.5 tp . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.468 -0.787 . . . . 26.210000000000001 109.812 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.23 -0.348 . . . . 14.859999999999999 112.23 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -86.9 109.12 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.137 2.558 . . . . 14.18 112.087 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 39.9 tp -110.12 -14.92 14.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.128 0.49 . . . . 13.74 110.092 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -78.72 13.03 19.71 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 121.077 -0.582 . . . . 11.08 112.758 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 19.1 m 67.28 -85.83 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.288 0.635 . . . . 9.7799999999999994 111.659 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.9 p -101.45 90.49 4.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.139 0.495 . . . . 8.3800000000000008 111.432 -175.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -108.04 -30.33 8.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.631 -0.713 . . . . 5.7800000000000002 109.314 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.18 -36.15 91.42 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.42 -0.809 . . . . 4.6600000000000001 112.096 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.39 -43.22 88.43 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.886 0.374 . . . . 5.7800000000000002 110.705 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.542 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 63.3 tp -64.22 -46.94 81.65 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.006 -0.543 . . . . 4.3799999999999999 110.141 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' B' ' 58' ' ' GLN . 3.2 tm? -59.57 -49.2 78.68 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.796 -0.638 . . . . 2.8599999999999999 110.544 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.11 -53.28 59.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 3.7400000000000002 111.979 -176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.542 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 3.3 p80 -71.79 -27.03 62.66 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.605 -0.438 . . . . 5.0499999999999998 111.068 -174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.36 -47.5 73.2 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.199 -0.297 . . . . 3.3300000000000001 110.199 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.67 -36.54 83.95 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.03 -0.532 . . . . 4.3700000000000001 110.473 176.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 35.5 t -58.64 -39.45 80.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.695 -0.684 . . . . 6.0999999999999996 110.701 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.635 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.7 mt -82.61 -25.22 33.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.769 0.319 . . . . 6.4900000000000002 110.871 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.7 30.0 27.91 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.781 -0.723 . . . . 4.7300000000000004 111.939 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' B' ' 17' ' ' LEU . 47.7 t -77.71 121.84 31.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.687 -0.486 . . . . 3.6000000000000001 109.687 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.605 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 78.1 mtt180 -122.59 133.36 54.55 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.317 -0.401 . . . . 6.7999999999999998 110.427 -175.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.723 HD22 HD22 ' B' ' 52' ' ' LEU . 5.9 mp -136.27 124.7 23.44 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 3.7999999999999998 110.219 175.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . 0.726 ' HB3' HD13 ' B' ' 56' ' ' LEU . 30.0 p90 -142.23 140.81 32.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.917 0.389 . . . . 6.7999999999999998 110.329 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.39 123.16 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.227 0.537 . . . . 7.7400000000000002 110.337 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.611 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 2.8 tm-20 -111.91 100.66 9.08 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.884 -0.784 . . . . 9.4399999999999995 108.884 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.55 -87.42 0.27 Allowed Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.801 -0.636 . . . . 9.6600000000000001 112.137 -177.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -116.25 -31.82 5.52 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.308 0.575 . . . . 9.3200000000000003 110.725 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -106.26 128.42 53.96 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.146 0.498 . . . . 7.3399999999999999 111.659 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.601 HD11 HD23 ' B' ' 21' ' ' LEU . 3.2 tm? -64.97 123.5 19.61 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.874 -1.057 . . . . 5.1799999999999997 109.648 174.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.611 ' NH1' ' HB3' ' B' ' 24' ' ' GLU . 8.1 mpt_? -95.75 130.5 42.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.749 -0.463 . . . . 8.0700000000000003 109.749 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.544 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -106.49 150.13 26.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.059 -0.519 . . . . 4.1600000000000001 110.134 -176.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.605 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 8.4 tp-100 -149.16 112.06 4.85 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.742 -0.466 . . . . 6.7199999999999998 109.742 176.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' B' ' 33' ' ' PRO . . . -148.67 135.04 10.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.628 -0.26 . . . . 5.75 110.78 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.515 ' O ' HG22 ' B' ' 36' ' ' VAL . 32.0 Cg_exo -60.54 153.62 59.82 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.752 2.301 . . . . 6.9800000000000004 112.458 176.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.621 ' HB3' HG22 ' A' ' 38' ' ' THR . 19.3 Cg_endo -60.83 123.19 12.47 Favored 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 122.557 2.172 . . . . 8.8499999999999996 112.52 -178.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.71 -35.37 4.84 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.674 -0.774 . . . . 8.0899999999999999 113.281 174.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.635 ' HB ' HD13 ' B' ' 17' ' ' LEU . 18.9 m -80.62 -7.53 10.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 117.03 0.415 . . . . 7.0 111.935 -173.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.57 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.6 OUTLIER -82.84 20.14 1.23 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.344 -0.389 . . . . 5.7300000000000004 111.692 -173.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.486 HG22 ' HB3' ' A' ' 34' ' ' PRO . 38.0 p -51.28 144.75 15.06 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.719 0.295 . . . . 7.96 111.603 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.96 -30.59 59.51 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.805 2.336 . . . . 7.2999999999999998 112.188 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 17.6 tp10 -59.56 -50.0 75.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.932 -0.576 . . . . 9.2200000000000006 109.789 175.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.569 HD22 ' O ' ' B' ' 36' ' ' VAL . 3.1 tp -63.5 -45.8 89.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.065 -0.516 . . . . 6.1699999999999999 110.14 179.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -56.97 -41.03 77.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.711 -0.677 . . . . 4.8399999999999999 111.036 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -70.0 -31.75 69.59 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.301 -0.408 . . . . 7.3499999999999996 110.622 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 99.4 mtt180 -76.9 -28.84 55.48 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.523 -0.308 . . . . 8.2799999999999994 110.883 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 94.5 mt -64.62 -33.56 76.22 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.114 -0.699 . . . . 4.1299999999999999 109.114 172.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.93 -23.09 8.17 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.127 -0.942 . . . . 5.5800000000000001 112.824 171.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.1 8.64 54.9 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.983 -0.627 . . . . 4.5 112.208 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -76.47 149.82 36.75 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 120.975 0.417 . . . . 5.4100000000000001 110.429 -177.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.555 ' O ' HG13 ' B' ' 53' ' ' ILE . 0.3 OUTLIER -62.72 -49.96 72.99 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.838 -0.619 . . . . 8.2200000000000006 111.665 -175.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -66.18 -33.48 75.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.644 0.239 . . . . 7.1600000000000001 111.644 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.95 -45.01 75.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.982 0.42 . . . . 5.7199999999999998 110.51 178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.723 HD22 HD22 ' B' ' 21' ' ' LEU . 53.2 mt -73.97 -23.74 59.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.136 -0.483 . . . . 3.0600000000000001 111.34 -177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.555 HG13 ' O ' ' B' ' 49' ' ' ARG . 71.3 mt -64.16 -41.9 93.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.615 -0.513 . . . . 6.4000000000000004 109.615 171.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.18 -31.44 70.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.211 -0.449 . . . . 3.73 110.534 175.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.681 ' HB2' ' HA ' ' B' ' 52' ' ' LEU . 1.1 mm? -63.32 -34.52 77.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.838 -0.619 . . . . 2.46 110.82 175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.726 HD13 ' HB3' ' B' ' 22' ' ' TRP . 34.5 tp -79.46 -41.8 26.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 5.5599999999999996 110.506 174.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -61.45 -20.84 63.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.482 -0.781 . . . . 7.1900000000000004 111.638 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 24.7 pt20 -77.72 -20.85 52.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.788 0.328 . . . . 4.2300000000000004 110.613 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 32.2 tp -85.46 -11.72 53.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.097 0.475 . . . . 6.46 110.362 -176.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.422 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 13.7 mm100 -64.13 117.78 39.8 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.475 -0.784 . . . . 7.3499999999999996 110.547 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 16.8 Cg_exo -67.32 108.02 1.49 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.616 2.21 . . . . 8.1699999999999999 111.651 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.3 p -88.71 -13.23 40.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.449 0.642 . . . . 8.8900000000000006 109.356 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 14.5 m -62.41 149.45 42.49 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.318 -0.855 . . . . 9.7599999999999998 110.296 175.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -97.31 27.12 4.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.754 0.311 . . . . 11.210000000000001 111.715 -174.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.53 -60.63 4.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.865 -0.683 . . . . 12.710000000000001 112.364 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 179.28 -174.33 46.25 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.102 -0.57 . . . . 13.609999999999999 111.933 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 24.2 t -131.44 79.72 1.89 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.046 0.451 . . . . 15.17 110.679 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 9.7 mp -124.19 85.85 2.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.034 -0.53 . . . . 16.82 110.289 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 57.0 tp -77.67 -44.67 27.28 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.088 0.47 . . . . 18.109999999999999 109.973 177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -139.6 89.52 11.77 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.854 -0.612 . . . . 19.0 110.673 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -73.03 177.12 8.16 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.022 2.481 . . . . 20.289999999999999 111.971 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 10.4 p -155.79 139.89 8.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 21.129999999999999 110.055 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.18 96.1 4.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.36 -0.382 . . . . 22.899999999999999 110.648 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -76.87 114.28 15.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.065 -0.516 . . . . 25.059999999999999 110.543 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -128.48 95.59 4.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.039 -0.528 . . . . 24.460000000000001 111.032 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.7 -150.43 46.42 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.945 -0.645 . . . . 24.609999999999999 112.737 176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -101.28 -38.56 8.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.076 0.465 . . . . 27.27 109.829 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 83.3 mt . . . . . 0 C--O 1.247 0.963 0 CA-C-N 115.748 -0.66 . . . . 26.960000000000001 110.209 -178.209 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.723 0 N-CA-C 111.63 -0.588 . . . . 11.48 111.63 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -71.01 -14.27 32.02 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.667 2.244 . . . . 10.23 112.827 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.85 169.21 18.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.76 0.314 . . . . 10.02 110.862 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.03 -71.02 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.521 -1.031 . . . . 6.8899999999999997 110.521 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 p -156.35 154.19 30.18 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.157 -0.683 . . . . 6.0199999999999996 109.157 173.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.9 t -79.01 76.05 5.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.315 0.579 . . . . 3.5099999999999998 109.71 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.62 -45.43 75.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.569 -0.742 . . . . 2.5 111.476 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.62 -46.93 92.6 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.127 -0.559 . . . . 2.1299999999999999 112.37 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.0 -41.31 77.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.8 0.333 . . . . 2.1899999999999999 110.995 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.671 ' HA ' ' CD2' ' A' ' 13' ' ' HIS . 28.2 tp -62.9 -47.3 83.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.432 . . . . 1.6799999999999999 110.667 178.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.14 -44.46 95.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.843 -0.617 . . . . 1.71 109.584 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.92 -48.17 80.08 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.008 -0.542 . . . . 1.75 112.148 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.671 ' CD2' ' HA ' ' A' ' 10' ' ' LEU . 7.0 p80 -71.67 -28.4 63.71 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.415 -0.514 . . . . 1.78 110.617 -176.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.22 -42.29 69.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.976 0.417 . . . . 1.0900000000000001 109.927 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.81 -34.0 75.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.46 110.762 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.1 t -65.54 -38.14 88.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.081 -0.509 . . . . 2.2799999999999998 110.224 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 13' ' ' HIS . 92.2 mt -73.99 -24.77 59.65 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.116 0.484 . . . . 1.6499999999999999 109.941 177.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.56 31.93 17.36 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.618 -0.719 . . . . 1.28 112.461 178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.41 ' O ' HD11 ' A' ' 55' ' ' LEU . 47.2 t -71.2 132.89 32.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.965 -0.754 . . . . 0.98999999999999999 108.965 174.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.741 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 44.6 mtt180 -129.99 134.15 47.24 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.914 -0.402 . . . . 2.6699999999999999 109.914 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.694 HD22 HD13 ' A' ' 52' ' ' LEU . 6.0 mp -137.14 127.36 26.26 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.563 -0.532 . . . . 1.45 109.563 174.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.533 ' HB3' HD13 ' A' ' 56' ' ' LEU . 24.2 p90 -146.61 137.01 23.81 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.013 0.435 . . . . 2.2599999999999998 110.325 178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.3 p -79.56 124.0 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.149 0.499 . . . . 2.9199999999999999 110.402 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -126.24 105.25 8.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.623 -0.717 . . . . 4.2000000000000002 109.568 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.66 -112.22 4.33 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.395 -0.907 . . . . 4.2000000000000002 111.403 -175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -104.19 -18.8 14.36 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.809 0.338 . . . . 5.1500000000000004 110.8 179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -107.05 127.05 53.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.495 0.664 . . . . 5.3799999999999999 111.35 -174.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.499 HD21 HD23 ' A' ' 21' ' ' LEU . 9.7 tt -74.68 114.42 13.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.479 -0.782 . . . . 2.4399999999999999 109.269 174.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 22' ' ' TRP . 9.1 mmm180 -80.47 139.53 36.37 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.752 -0.462 . . . . 4.2199999999999998 109.752 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.426 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -124.25 132.72 53.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.996 -0.547 . . . . 1.6899999999999999 109.73 -174.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.741 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 56.7 tp60 -127.47 114.75 17.89 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.574 -0.528 . . . . 2.6800000000000002 109.574 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -142.53 127.71 10.24 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.342 -0.39 . . . . 1.6899999999999999 110.893 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.509 ' O ' HG22 ' A' ' 36' ' ' VAL . 32.1 Cg_exo -60.42 156.49 40.97 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.934 2.422 . . . . 1.8400000000000001 111.705 174.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' B' ' 38' ' ' THR . 30.0 Cg_endo -65.76 123.36 11.25 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.268 1.979 . . . . 2.3100000000000001 112.39 -177.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 38' ' ' THR . . . 106.89 -37.13 3.98 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.777 -0.725 . . . . 1.76 113.406 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 33' ' ' PRO . 35.8 m -75.82 -15.69 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.682 0.623 . . . . 1.49 112.682 -173.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.501 ' HE2' ' HA ' ' A' ' 37' ' ' MET . 9.1 tpp -84.57 23.27 1.16 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.294 0.569 . . . . 1.4099999999999999 111.311 -175.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.679 HG22 ' HB3' ' B' ' 34' ' ' PRO . 17.8 p -50.7 143.73 14.08 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.138 -0.483 . . . . 1.45 110.39 176.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -52.79 -30.17 45.82 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.801 2.334 . . . . 1.72 112.435 -178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.626 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 8.4 tp10 -60.54 -47.4 86.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 2.7599999999999998 110.106 175.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.452 HD22 ' O ' ' A' ' 36' ' ' VAL . 4.0 tp -58.08 -49.55 76.52 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 120.793 0.33 . . . . 1.2 110.572 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' HD12 ' A' ' 45' ' ' LEU . 18.3 tp60 -60.45 -36.11 77.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.939 -0.573 . . . . 2.0600000000000001 110.754 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.5 t -64.18 -32.61 74.25 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.012 0.434 . . . . 1.5700000000000001 110.039 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.626 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 19.9 mmt180 -78.92 -40.38 32.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.905 -0.589 . . . . 3.3399999999999999 110.873 178.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.553 HD12 ' HA ' ' A' ' 42' ' ' GLN . 84.6 mt -52.82 -37.24 59.69 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 108.979 -0.748 . . . . 1.25 108.979 171.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.69 -22.84 8.32 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.231 -0.895 . . . . 2.2999999999999998 112.048 175.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.71 14.21 72.45 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.978 -0.63 . . . . 2.5699999999999998 112.229 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . . . -79.38 148.42 32.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.935 -0.394 . . . . 2.0800000000000001 109.935 -179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' A' ' 53' ' ' ILE . 1.6 ptm180 -69.76 -51.2 36.12 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.459 -0.337 . . . . 5.3600000000000003 111.745 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -56.99 -34.86 68.54 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.148 0.499 . . . . 2.9900000000000002 110.564 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -65.82 -49.96 66.37 Favored 'General case' 0 CA--C 1.507 -0.707 0 CA-C-N 115.639 -0.709 . . . . 2.75 110.316 179.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 21' ' ' LEU . 87.4 mt -75.21 -24.54 57.76 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.965 -1.016 . . . . 1.8999999999999999 111.284 -174.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.9 mt -63.68 -42.91 97.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 N-CA-C 109.852 -0.425 . . . . 2.7400000000000002 109.852 174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.44 -33.57 76.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.316 0.579 . . . . 1.5 110.133 175.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.653 ' O ' ' HG2' ' A' ' 58' ' ' GLN . 3.4 tm? -70.74 -31.67 68.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.081 -0.963 . . . . 1.3200000000000001 109.508 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.623 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.7 tp -79.2 -36.72 39.7 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.993 -0.549 . . . . 1.6799999999999999 109.737 176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 36.2 ttp180 -55.5 -29.62 59.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.401 -0.818 . . . . 4.0700000000000003 111.251 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.653 ' HG2' ' O ' ' A' ' 55' ' ' LEU . 9.3 pt20 -56.1 -34.3 65.91 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.5 -0.318 . . . . 1.75 111.183 175.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.67 HD11 ' HB3' ' A' ' 20' ' ' ARG . 79.2 mt -83.72 -5.46 59.2 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 111.887 0.328 . . . . 2.4700000000000002 111.887 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.482 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 97.1 mt-30 -90.35 127.05 54.54 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 110.337 -0.246 . . . . 2.5800000000000001 110.337 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 8.1 Cg_exo -72.52 34.19 0.3 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.363 2.709 . . . . 2.48 112.911 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -90.62 25.66 2.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.166 0.507 . . . . 4.0599999999999996 109.843 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 m -60.55 125.23 22.91 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.38 -0.827 . . . . 5.8600000000000003 111.725 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -123.44 -146.98 0.37 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.449 -0.796 . . . . 8.2100000000000009 109.237 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.54 76.16 0.98 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.526 -0.845 . . . . 10.390000000000001 111.847 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.25 -128.22 8.37 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.267 -0.733 . . . . 11.32 111.267 -177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.5 t -99.01 7.64 45.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.008 0.432 . . . . 13.15 109.973 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.99 152.38 26.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.149 -0.478 . . . . 15.0 110.056 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD23 ' H ' ' A' ' 69' ' ' LEU . 1.9 pt? -121.86 8.77 9.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.08 0.467 . . . . 16.239999999999998 110.589 -175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -81.65 135.75 49.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.792 -0.64 . . . . 16.760000000000002 111.687 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 4.4 Cg_exo -77.81 90.24 1.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.264 2.643 . . . . 18.719999999999999 109.98 173.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 p -105.92 138.12 32.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.532 -0.758 . . . . 19.52 110.92 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.38 -67.87 0.47 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.892 -0.594 . . . . 20.52 111.346 -176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -170.02 54.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.682 0.754 . . . . 23.780000000000001 109.97 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.472 HD22 ' HB2' ' A' ' 78' ' ' LEU . 7.1 p-10 -149.76 126.06 10.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.607 -0.724 . . . . 22.18 110.686 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.55 -42.36 99.75 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.377 -0.828 . . . . 23.170000000000002 113.063 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -162.99 86.8 0.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.835 0.35 . . . . 26.359999999999999 110.897 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.472 ' HB2' HD22 ' A' ' 75' ' ' ASN . 35.7 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 115.689 -0.687 . . . . 26.210000000000001 109.849 176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 112.07 -0.412 . . . . 14.859999999999999 112.07 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.33 148.13 93.78 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.912 2.408 . . . . 14.18 112.669 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 52.1 tp 66.24 -83.42 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.635 -0.711 . . . . 13.74 111.469 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.13 -82.53 0.35 Allowed Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.885 -0.674 . . . . 11.08 111.7 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t 58.66 40.22 23.65 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.876 -0.416 . . . . 9.7799999999999994 109.876 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 54.1 m 70.04 -53.96 0.62 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.266 -0.879 . . . . 8.3800000000000008 111.118 -173.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.85 113.92 5.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.683 0.278 . . . . 5.7800000000000002 110.495 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.76 98.69 Favored Glycine 0 N--CA 1.451 -0.303 0 CA-C-N 116.048 -0.524 . . . . 4.6600000000000001 112.945 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.32 -39.2 93.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.766 0.317 . . . . 5.7800000000000002 110.81 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.524 ' HA ' ' CD2' ' B' ' 13' ' ' HIS . 56.0 tp -60.85 -47.52 86.0 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.056 -0.52 . . . . 4.3799999999999999 110.47 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -64.97 -43.44 92.65 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.732 -0.667 . . . . 2.8599999999999999 109.653 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.33 -51.43 69.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.795 -0.639 . . . . 3.7400000000000002 112.315 -177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.524 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 14.2 p80 -72.52 -28.22 62.73 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.334 -0.546 . . . . 5.0499999999999998 110.934 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.85 -43.43 75.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.189 0.519 . . . . 3.3300000000000001 110.054 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.9 -33.71 76.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.477 -0.783 . . . . 4.3700000000000001 110.806 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -67.57 -34.33 76.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.053 -0.521 . . . . 6.0999999999999996 110.308 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.565 HD13 ' HB ' ' B' ' 36' ' ' VAL . 86.7 mt -75.85 -24.34 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 6.4900000000000002 110.426 177.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.86 28.43 21.2 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.785 -0.722 . . . . 4.7300000000000004 112.389 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.407 ' O ' HD11 ' B' ' 55' ' ' LEU . 46.2 t -72.11 132.74 32.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.471 -0.566 . . . . 3.6000000000000001 109.471 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.851 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 76.6 mtt180 -130.48 132.9 45.89 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.592 0.234 . . . . 6.7999999999999998 110.971 -178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.585 HD22 HD13 ' B' ' 52' ' ' LEU . 5.7 mp -137.98 127.45 24.85 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.843 -0.429 . . . . 3.7999999999999998 109.843 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . 0.665 ' HB3' HD13 ' B' ' 56' ' ' LEU . 29.3 p90 -147.78 139.97 24.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.932 0.396 . . . . 6.7999999999999998 110.361 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.3 p -78.65 130.67 35.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.155 0.502 . . . . 7.7400000000000002 110.405 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -132.16 101.0 5.22 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.88 -0.6 . . . . 9.4399999999999995 109.668 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.74 -110.3 3.27 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.691 -0.766 . . . . 9.6600000000000001 111.364 -176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -104.76 -11.69 16.7 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.701 0.286 . . . . 9.3200000000000003 111.077 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -115.12 123.31 48.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.115 0.483 . . . . 7.3399999999999999 111.054 -173.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 9.1 tt -74.64 115.07 13.78 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.329 -0.619 . . . . 5.1799999999999997 109.329 175.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -79.89 139.31 37.17 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.006 -0.368 . . . . 8.0700000000000003 110.006 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.512 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -122.14 133.2 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.457 -0.571 . . . . 4.1600000000000001 109.457 -177.164 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.851 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 55.3 tp60 -129.81 112.52 13.67 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.63 -0.508 . . . . 6.7199999999999998 109.63 176.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.05 133.1 16.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 116.421 -0.354 . . . . 5.75 111.136 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.45 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.2 Cg_exo -62.98 153.58 72.58 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.056 2.504 . . . . 6.9800000000000004 112.007 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.679 ' HB3' HG22 ' A' ' 38' ' ' THR . 30.3 Cg_endo -63.77 123.95 12.82 Favored 'Trans proline' 0 CA--C 1.53 0.287 0 C-N-CA 122.421 2.081 . . . . 8.8499999999999996 112.725 -177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.93 -36.85 4.13 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.597 -0.811 . . . . 8.0899999999999999 113.455 174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.565 ' HB ' HD13 ' B' ' 17' ' ' LEU . 23.3 m -78.96 -9.71 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.017 0.377 . . . . 7.0 112.017 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.55 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.1 OUTLIER -82.85 19.98 1.26 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.856 0.36 . . . . 5.7300000000000004 111.35 -176.009 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.46 HG22 ' HB3' ' A' ' 34' ' ' PRO . 10.6 p -51.04 144.7 13.62 Favored Pre-proline 0 C--O 1.236 0.387 0 CA-C-N 116.442 -0.344 . . . . 7.96 111.094 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -52.99 -30.71 49.96 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.819 2.346 . . . . 7.2999999999999998 112.304 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 11.7 tp10 -60.42 -43.64 96.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.937 -0.574 . . . . 9.2200000000000006 110.556 177.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.527 HD22 ' O ' ' B' ' 36' ' ' VAL . 11.1 tp -62.43 -46.19 89.7 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 110.234 -0.284 . . . . 6.1699999999999999 110.234 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.438 ' HA ' HD12 ' B' ' 45' ' ' LEU . 18.9 tp60 -61.73 -37.55 84.64 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.169 -0.469 . . . . 4.8399999999999999 110.378 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 23.0 t -63.06 -35.17 79.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.38 -0.373 . . . . 7.3499999999999996 110.343 176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 16.7 mmt180 -77.54 -39.95 44.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.223 -0.444 . . . . 8.2799999999999994 110.868 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' B' ' 42' ' ' GLN . 86.3 mt -56.81 -36.01 69.43 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.468 0.651 . . . . 4.1299999999999999 109.625 173.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.67 -22.95 8.09 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.162 -0.926 . . . . 5.5800000000000001 112.219 175.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.12 17.44 75.73 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.083 -0.58 . . . . 4.5 111.863 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.69 149.93 29.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.217 -0.29 . . . . 5.4100000000000001 110.217 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.514 ' O ' HG13 ' B' ' 53' ' ' ILE . 2.0 ptm180 -68.67 -48.86 62.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.661 -0.245 . . . . 8.2200000000000006 111.182 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -60.07 -36.52 77.55 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.846 0.313 . . . . 7.1600000000000001 111.846 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -47.11 80.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.114 0.483 . . . . 5.7199999999999998 110.718 177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.585 HD13 HD22 ' B' ' 21' ' ' LEU . 86.0 mt -75.33 -24.77 57.42 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.879 -0.6 . . . . 3.0600000000000001 111.616 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 49' ' ' ARG . 83.1 mt -66.67 -39.57 84.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.946 -0.39 . . . . 6.4000000000000004 109.946 174.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.92 -38.89 83.46 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.201 0.524 . . . . 3.73 110.207 175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.71 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 3.1 tm? -63.38 -34.93 78.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.247 -0.888 . . . . 2.46 110.02 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' B' ' 22' ' ' TRP . 17.8 tp -73.24 -38.67 65.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.202 -0.454 . . . . 5.5599999999999996 110.473 174.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -57.18 -28.63 62.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.859 -0.61 . . . . 7.1900000000000004 111.985 -177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 17.5 pt20 -60.92 -26.37 67.43 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 120.887 -0.325 . . . . 4.2300000000000004 110.905 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -88.63 -7.28 56.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.331 -0.395 . . . . 6.46 111.052 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.479 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 96.8 mt-30 -90.78 131.64 37.02 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.412 -0.358 . . . . 7.3499999999999996 110.414 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 7.0 Cg_exo -75.22 30.8 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.77 2.98 . . . . 8.1699999999999999 112.82 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 23.2 t -88.3 22.42 2.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.36 0.6 . . . . 8.8900000000000006 109.569 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 5.9 m -59.55 117.71 5.21 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.45 -0.796 . . . . 9.7599999999999998 111.211 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -113.75 -146.94 0.41 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.302 -0.629 . . . . 11.210000000000001 109.302 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -73.13 80.73 0.71 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.916 -0.659 . . . . 12.710000000000001 111.574 175.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.98 -125.12 7.68 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.122 -0.791 . . . . 13.609999999999999 111.122 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 22.9 t -105.29 11.27 33.09 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.174 0.512 . . . . 15.17 110.062 177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -87.13 139.24 30.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.854 -0.612 . . . . 16.82 109.762 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.72 HD23 ' H ' ' B' ' 69' ' ' LEU . 2.3 pt? -102.75 7.21 39.69 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.407 -0.36 . . . . 18.109999999999999 110.934 -176.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' B' ' 71' ' ' PRO . . . -69.53 128.55 92.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 19.0 109.888 175.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 70' ' ' ALA . 34.4 Cg_exo -57.4 103.38 0.13 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.83 2.353 . . . . 20.289999999999999 112.615 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 3.9 m -86.14 96.41 5.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.634 0.73 . . . . 21.129999999999999 110.394 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.29 51.72 0.77 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.421 -0.808 . . . . 22.899999999999999 110.658 -175.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 ttt85 69.17 19.91 7.76 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.784 0.802 . . . . 25.059999999999999 110.072 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.55 81.94 5.88 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.531 -0.758 . . . . 24.460000000000001 110.048 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.57 169.19 17.53 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.366 -0.834 . . . . 24.609999999999999 111.855 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -88.29 80.05 7.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.337 0.589 . . . . 27.27 109.502 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.293 -0.867 . . . . 26.960000000000001 110.199 -176.811 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.037 -0.425 . . . . 11.48 112.037 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.427 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 21.0 Cg_exo -65.73 119.28 6.29 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.685 2.257 . . . . 10.23 111.608 178.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.45 -38.98 25.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.094 -0.503 . . . . 10.02 110.574 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.14 95.39 0.42 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.003 -0.618 . . . . 6.8899999999999997 112.214 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.0 t -78.73 84.04 4.84 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 122.28 0.232 . . . . 6.0199999999999996 110.964 -177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.8 m 55.36 74.77 0.35 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.667 -0.697 . . . . 3.5099999999999998 112.127 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.28 -37.96 81.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 2.5 110.849 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.78 -37.38 92.36 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 116.049 -0.523 . . . . 2.1299999999999999 111.909 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.06 -41.7 90.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.962 0.411 . . . . 2.1899999999999999 110.728 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.692 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 51.0 tp -62.12 -46.4 89.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.041 -0.527 . . . . 1.6799999999999999 110.317 176.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.16 -47.36 86.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.391 -0.822 . . . . 1.71 110.115 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.33 70.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 1.75 112.116 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.692 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.9 p80 -69.94 -27.07 64.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.884 0.373 . . . . 1.78 110.216 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.12 -36.88 66.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.415 -0.357 . . . . 1.0900000000000001 110.284 175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.74 -38.52 83.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.948 -0.569 . . . . 1.46 111.146 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 p -67.0 -21.93 65.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.94 0.4 . . . . 2.2799999999999998 111.515 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 73.9 mt -97.15 -25.07 15.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.189 0.518 . . . . 1.6499999999999999 110.447 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 20' ' ' ARG . . . 82.76 37.38 13.64 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 1.28 112.636 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.2 t -76.25 120.15 25.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.992 -0.744 . . . . 0.98999999999999999 108.992 174.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.552 ' HB3' HD22 ' A' ' 59' ' ' LEU . 20.7 mtt180 -120.07 128.89 53.91 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.57 -0.286 . . . . 2.6699999999999999 110.69 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.585 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.3 mp -133.03 124.11 27.05 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.484 -0.562 . . . . 1.45 109.484 173.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.425 ' HB3' HD13 ' A' ' 56' ' ' LEU . 27.3 p90 -141.48 143.15 33.68 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.937 -0.394 . . . . 2.2599999999999998 109.937 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.27 129.81 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.689 -0.486 . . . . 2.9199999999999999 109.689 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 29' ' ' ARG . 14.2 tp10 -136.91 120.2 16.82 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.375 -0.602 . . . . 4.2000000000000002 109.375 -177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.9 -105.04 1.36 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.824 -0.703 . . . . 4.2000000000000002 111.82 -177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.446 ' OE1' ' HB3' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.86 -3.06 11.69 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 111.69 0.255 . . . . 5.1500000000000004 111.69 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.468 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 9.4 tpp180 -129.19 152.18 49.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 5.3799999999999999 112.116 -171.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.461 HD11 HD23 ' A' ' 21' ' ' LEU . 3.2 tm? -75.7 122.34 23.86 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.046 -0.979 . . . . 2.4399999999999999 108.618 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.468 ' NH1' ' HB3' ' A' ' 27' ' ' ARG . 4.2 mpt_? -99.03 131.08 45.34 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.366 -0.605 . . . . 4.2199999999999998 109.366 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.454 ' CE2' HD21 ' A' ' 21' ' ' LEU . 0.7 OUTLIER -108.21 154.07 22.29 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 1.6899999999999999 110.245 -172.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.532 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 23.9 tp60 -153.25 110.43 3.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.805 -0.442 . . . . 2.6800000000000002 109.805 172.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . . . -131.74 134.98 26.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 116.122 -0.49 . . . . 1.6899999999999999 110.66 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.575 ' HD2' HG21 ' A' ' 36' ' ' VAL . 37.0 Cg_exo -61.91 156.09 51.05 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.612 2.208 . . . . 1.8400000000000001 111.555 172.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.519 ' HB3' HG22 ' B' ' 38' ' ' THR . 22.9 Cg_endo -63.79 123.3 11.75 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.267 1.978 . . . . 2.3100000000000001 112.305 -178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 38' ' ' THR . . . 106.88 -37.68 3.7 Favored Glycine 0 C--O 1.227 -0.337 0 C-N-CA 120.936 -0.649 . . . . 1.76 113.448 173.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.575 HG21 ' HD2' ' A' ' 33' ' ' PRO . 33.8 m -70.65 -20.3 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 112.518 0.562 . . . . 1.49 112.518 -173.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 15.4 tpp -82.61 24.14 0.74 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.022 0.439 . . . . 1.4099999999999999 111.446 -173.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.491 HG22 ' HB3' ' B' ' 34' ' ' PRO . 8.3 p -49.69 143.08 11.48 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 1.45 110.872 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.648 ' HD3' ' HD3' ' B' ' 34' ' ' PRO . 82.6 Cg_exo -45.76 -40.76 19.51 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.299 2.666 . . . . 1.72 113.773 -174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.655 ' O ' ' HG3' ' A' ' 44' ' ' ARG . 8.9 pt-20 -61.89 -44.61 96.45 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 120.736 0.303 . . . . 2.7599999999999998 110.525 178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.417 ' N ' ' HG3' ' A' ' 40' ' ' GLU . 3.0 tt -67.69 -44.82 76.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.334 0.588 . . . . 1.2 109.908 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.7 tp60 -56.17 -41.7 75.89 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.578 -1.192 . . . . 2.0600000000000001 110.548 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.2 t -72.8 -29.24 63.11 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.927 -0.579 . . . . 1.5700000000000001 111.042 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.655 ' HG3' ' O ' ' A' ' 40' ' ' GLU . 76.8 mtp180 -75.84 -28.08 58.11 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.956 -0.298 . . . . 3.3399999999999999 111.017 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 79.3 mt -61.69 -43.77 98.22 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.536 -0.542 . . . . 1.25 109.536 172.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.9 -23.61 5.77 Favored Glycine 0 C--N 1.329 0.158 0 CA-C-N 115.644 -0.707 . . . . 2.2999999999999998 112.97 171.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.41 18.11 69.28 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.907 -0.663 . . . . 2.5699999999999998 112.47 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.619 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -72.72 147.8 45.28 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.121 -0.325 . . . . 2.0800000000000001 110.121 -177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.576 ' O ' HG13 ' A' ' 53' ' ' ILE . 22.9 ptt180 -68.34 -50.67 51.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.334 -0.393 . . . . 5.3600000000000003 111.644 -172.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.433 ' N ' ' HG3' ' A' ' 49' ' ' ARG . 11.9 p80 -60.23 -36.06 76.86 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.739 0.781 . . . . 2.9900000000000002 110.048 -178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -70.63 -42.75 70.46 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.608 -1.178 . . . . 2.75 110.214 -177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 63.3 mt -70.4 -25.41 63.22 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.598 -0.728 . . . . 1.8999999999999999 110.822 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 49' ' ' ARG . 80.1 mt -60.5 -50.03 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.792 -0.447 . . . . 2.7400000000000002 109.792 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.86 -31.15 70.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.199 0.523 . . . . 1.5 110.758 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.425 ' O ' HD13 ' A' ' 55' ' ' LEU . 2.6 tm? -71.09 -40.6 71.45 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.801 . . . . 1.3200000000000001 109.959 -176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 21' ' ' LEU . 1.2 tp -77.23 -31.31 55.04 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.952 -0.567 . . . . 1.6799999999999999 109.756 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -61.81 -31.22 71.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.855 -0.612 . . . . 4.0700000000000003 110.506 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -61.61 -29.62 70.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.053 -0.522 . . . . 1.75 110.613 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.552 HD22 ' HB3' ' A' ' 20' ' ' ARG . 29.7 tp -90.02 -2.87 58.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.903 -0.589 . . . . 2.4700000000000002 110.553 -176.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.427 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 27.9 mt-30 -114.07 130.54 23.81 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.108 -0.496 . . . . 2.5800000000000001 110.617 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 8.1 Cg_exo -74.18 -9.9 22.24 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.606 2.204 . . . . 2.48 112.095 175.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.5 t -95.96 151.8 19.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.027 -0.533 . . . . 4.0599999999999996 109.873 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.7 m 66.34 82.85 0.18 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.726 0.641 . . . . 5.8600000000000003 111.929 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.684 ' N ' HE21 ' A' ' 64' ' ' GLN . 0.0 OUTLIER -97.82 -22.7 16.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.926 -0.579 . . . . 8.2100000000000009 110.381 175.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 129.83 -90.84 0.31 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.825 -0.703 . . . . 10.390000000000001 111.795 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.67 119.52 1.88 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.931 -0.652 . . . . 11.32 112.498 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.9 p -114.6 107.56 15.65 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.124 0.488 . . . . 13.15 110.616 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.67 91.38 3.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.936 -0.575 . . . . 15.0 109.872 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -143.77 4.99 1.34 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.449 -0.796 . . . . 16.239999999999998 110.757 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . . . -75.65 133.3 73.77 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.083 -0.508 . . . . 16.760000000000002 110.647 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 70' ' ' ALA . 6.3 Cg_exo -73.48 107.05 2.3 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 122.76 2.307 . . . . 18.719999999999999 110.466 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.35 104.35 6.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-O 121.786 0.803 . . . . 19.52 110.787 -175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.83 -52.77 15.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.111 -0.95 . . . . 20.52 110.999 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 74' ' ' ARG . 1.3 ptm180 -176.11 -32.67 0.01 OUTLIER 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.157 -0.474 . . . . 23.780000000000001 111.152 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.4 m120 66.96 -175.69 0.19 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.358 0.599 . . . . 22.18 111.411 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.44 -123.26 6.38 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 109.732 -1.347 . . . . 23.170000000000002 109.732 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -157.22 -46.54 0.07 Allowed 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.384 -0.969 . . . . 26.359999999999999 108.384 172.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.5 tp . . . . . 0 C--O 1.247 0.943 0 CA-C-N 115.06 -0.973 . . . . 26.210000000000001 109.85 172.778 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.797 0 N-CA-C 111.756 -0.538 . . . . 14.859999999999999 111.756 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -85.62 153.63 10.32 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 123.033 2.489 . . . . 14.18 112.578 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 86.6 mt -75.31 -48.13 24.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.844 -0.798 . . . . 13.74 108.844 175.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.45 -133.81 12.15 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.305 -0.861 . . . . 11.08 113.038 173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 7.3 m -116.43 103.99 11.0 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.603 -0.299 . . . . 9.7799999999999994 111.779 -170.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 29.9 m -81.73 106.63 13.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.991 -1.115 . . . . 8.3800000000000008 107.991 167.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' B' ' 10' ' ' LEU . . . -64.83 106.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.159 -0.473 . . . . 5.7800000000000002 112.233 -168.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.2 -42.57 99.35 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.626 -0.715 . . . . 4.6600000000000001 112.012 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.38 92.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.055 0.455 . . . . 5.7800000000000002 110.906 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' B' ' 7' ' ' ALA . 57.1 tp -64.29 -45.91 85.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.954 -0.567 . . . . 4.3799999999999999 109.844 177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.78 -47.08 87.92 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.528 -0.76 . . . . 2.8599999999999999 110.114 177.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.08 -52.85 63.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.135 -0.484 . . . . 3.7400000000000002 112.291 -176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.476 ' CD2' ' HA ' ' B' ' 10' ' ' LEU . 5.0 p80 -72.45 -26.34 61.79 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.566 -0.453 . . . . 5.0499999999999998 110.963 -176.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.62 -36.33 70.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.941 0.4 . . . . 3.3300000000000001 110.093 175.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.67 -37.39 82.29 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.79 -0.641 . . . . 4.3700000000000001 111.292 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 12.3 p -71.47 -23.88 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.696 0.284 . . . . 6.0999999999999996 111.282 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.565 HD13 ' HB ' ' B' ' 36' ' ' VAL . 93.4 mt -91.7 -25.17 19.23 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 6.4900000000000002 110.548 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' B' ' 20' ' ' ARG . . . 84.7 35.65 13.11 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.843 -0.694 . . . . 4.7300000000000004 112.51 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.4 t -75.4 124.62 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.396 -0.594 . . . . 3.6000000000000001 109.396 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 30.4 mtt180 -124.01 127.85 48.51 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.776 0.322 . . . . 6.7999999999999998 111.194 -171.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.506 HD21 ' CE2' ' B' ' 30' ' ' PHE . 6.1 mp -135.15 124.74 25.08 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.476 -0.564 . . . . 3.7999999999999998 109.476 174.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . 0.567 ' HB3' HD13 ' B' ' 56' ' ' LEU . 26.5 p90 -143.63 143.6 31.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.881 0.372 . . . . 6.7999999999999998 110.712 179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.15 124.73 39.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.123 0.487 . . . . 7.7400000000000002 110.076 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.597 ' HB3' ' HD3' ' B' ' 29' ' ' ARG . 10.8 tp10 -130.98 118.28 20.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.614 -0.513 . . . . 9.4399999999999995 109.614 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.98 -104.26 1.3 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.76 -0.733 . . . . 9.6600000000000001 111.803 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . 0.562 ' OE1' ' HB3' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -116.84 -4.86 11.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.79 0.329 . . . . 9.3200000000000003 111.763 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.463 ' HB3' ' NH1' ' B' ' 29' ' ' ARG . 8.5 tpp180 -130.33 148.69 52.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.343 0.592 . . . . 7.3399999999999999 111.872 -170.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.501 HD11 HD23 ' B' ' 21' ' ' LEU . 3.0 tm? -73.48 115.96 13.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.154 -0.93 . . . . 5.1799999999999997 108.735 173.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . 0.597 ' HD3' ' HB3' ' B' ' 24' ' ' GLU . 6.2 mpt_? -90.81 132.59 35.78 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.895 -0.409 . . . . 8.0700000000000003 109.895 177.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.506 ' CE2' HD21 ' B' ' 21' ' ' LEU . 1.0 OUTLIER -109.78 152.23 25.95 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.922 -0.581 . . . . 4.1600000000000001 110.263 -173.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.634 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 25.4 tp60 -152.65 110.02 3.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.836 -0.431 . . . . 6.7199999999999998 109.836 172.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.09 137.04 29.23 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 116.288 -0.415 . . . . 5.75 111.115 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.436 ' O ' HG22 ' B' ' 36' ' ' VAL . 38.6 Cg_exo -62.75 154.6 64.7 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.675 2.25 . . . . 6.9800000000000004 111.796 173.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.648 ' HD3' ' HD3' ' A' ' 39' ' ' PRO . 27.9 Cg_endo -63.22 123.52 12.31 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.306 2.004 . . . . 8.8499999999999996 112.629 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.471 ' O ' HG23 ' B' ' 38' ' ' THR . . . 105.5 -37.46 3.8 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.661 -0.78 . . . . 8.0899999999999999 113.499 173.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.565 ' HB ' HD13 ' B' ' 17' ' ' LEU . 19.8 m -73.28 -12.19 15.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 117.108 0.454 . . . . 7.0 111.948 -173.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . . . . . . . . . 18.5 tpp -89.11 22.43 2.79 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.958 0.409 . . . . 5.7300000000000004 111.505 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.519 HG22 ' HB3' ' A' ' 34' ' ' PRO . 18.7 p -49.06 142.93 9.32 Favored Pre-proline 0 C--O 1.234 0.251 0 CA-C-N 116.433 -0.349 . . . . 7.96 111.149 177.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -43.76 -42.33 11.75 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.964 3.109 . . . . 7.2999999999999998 114.187 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.661 ' O ' ' HG3' ' B' ' 44' ' ' ARG . 8.5 pt-20 -59.91 -45.65 91.86 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 121.133 -0.227 . . . . 9.2200000000000006 110.921 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.506 ' N ' ' HG3' ' B' ' 40' ' ' GLU . 9.2 tt -70.34 -39.7 74.53 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.908 -0.404 . . . . 6.1699999999999999 109.908 -177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . 0.408 ' OE1' ' HB3' ' A' ' 30' ' ' PHE . 21.9 tp60 -56.76 -43.51 80.87 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.668 -0.697 . . . . 4.8399999999999999 110.515 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 33.3 t -72.14 -31.25 65.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.911 -0.586 . . . . 7.3499999999999996 110.842 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' B' ' 40' ' ' GLU . 65.3 mtp180 -71.51 -28.87 64.2 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 121.225 -0.19 . . . . 8.2799999999999994 111.292 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.34 -44.74 86.8 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.529 0.68 . . . . 4.1299999999999999 109.328 173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.68 -23.75 5.51 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.278 -0.873 . . . . 5.5800000000000001 112.982 172.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.7 18.74 74.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.266 -0.492 . . . . 4.5 112.39 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . 0.626 ' O ' ' HG ' ' B' ' 52' ' ' LEU . . . -71.55 148.75 46.38 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.835 0.317 . . . . 5.4100000000000001 110.425 -178.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.579 ' O ' HG13 ' B' ' 53' ' ' ILE . 17.6 ptt180 -68.15 -46.93 69.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.331 -0.395 . . . . 8.2200000000000006 111.448 -172.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -63.62 -35.64 81.19 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.702 0.287 . . . . 7.1600000000000001 111.238 -178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.9 -38.96 69.85 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.658 -0.417 . . . . 5.7199999999999998 110.302 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' B' ' 48' ' ' ALA . 46.4 mt -70.57 -26.02 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.579 -0.282 . . . . 3.0600000000000001 110.97 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.579 HG13 ' O ' ' B' ' 49' ' ' ARG . 82.6 mt -62.33 -49.44 83.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.753 -0.462 . . . . 6.4000000000000004 109.753 173.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.43 -38.11 86.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 3.73 110.433 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' B' ' 58' ' ' GLN . 1.5 tm? -62.21 -47.06 86.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.557 -0.747 . . . . 2.46 110.259 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.567 HD13 ' HB3' ' B' ' 22' ' ' TRP . 21.1 tp -66.27 -36.58 83.35 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.354 -0.385 . . . . 5.5599999999999996 110.769 177.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 48.0 ttp180 -63.04 -29.27 70.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.415 -0.357 . . . . 7.1900000000000004 111.361 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' B' ' 55' ' ' LEU . 6.9 pt20 -67.28 -27.67 67.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.177 0.513 . . . . 4.2300000000000004 110.261 178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.408 HD22 ' HB3' ' B' ' 20' ' ' ARG . 37.7 tp -88.93 -6.34 57.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.845 -0.616 . . . . 6.46 110.495 -176.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.414 ' HA ' ' HD3' ' B' ' 61' ' ' PRO . 27.1 mt-30 -112.31 133.93 21.64 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.916 -0.584 . . . . 7.3499999999999996 110.618 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' B' ' 60' ' ' GLN . 7.4 Cg_exo -73.81 -13.06 24.33 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.797 2.331 . . . . 8.1699999999999999 111.506 175.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 43.4 t -91.58 146.76 23.52 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.889 -0.596 . . . . 8.8900000000000006 110.568 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 67.5 m 69.25 89.92 0.1 Allowed 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.896 0.747 . . . . 9.7599999999999998 111.706 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . 0.665 ' N ' HE21 ' B' ' 64' ' ' GLN . 0.0 OUTLIER -107.03 -7.48 16.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.484 -0.78 . . . . 11.210000000000001 110.029 174.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.95 -105.1 1.74 Allowed Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.662 -0.699 . . . . 12.710000000000001 111.452 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.12 113.98 3.87 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.761 -0.733 . . . . 13.609999999999999 112.162 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.9 p -105.28 107.42 18.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.155 0.502 . . . . 15.17 111.141 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 39.3 tp -115.64 96.61 5.7 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.191 -0.458 . . . . 16.82 109.863 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.404 HD23 ' N ' ' B' ' 69' ' ' LEU . 2.3 pt? -145.17 -2.74 0.78 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.047 -0.524 . . . . 18.109999999999999 110.773 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.813 ' HB3' ' HD3' ' B' ' 71' ' ' PRO . . . -93.38 -59.71 0.21 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.409 -0.36 . . . . 19.0 111.644 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' B' ' 70' ' ' ALA . 2.9 Cg_exo -76.33 122.48 6.59 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.275 1.983 . . . . 20.289999999999999 111.969 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p 38.35 73.93 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.246 1.018 . . . . 21.129999999999999 112.671 -178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.86 83.26 4.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.363 -0.835 . . . . 22.899999999999999 110.704 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' B' ' 77' ' ' ARG . 30.1 mmm180 -127.18 159.03 35.52 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.916 -0.583 . . . . 25.059999999999999 109.429 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -63.47 -47.7 80.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.804 0.335 . . . . 24.460000000000001 110.998 -176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -96.75 -9.55 56.23 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.659 -0.781 . . . . 24.609999999999999 111.641 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.472 ' HA ' ' HB2' ' B' ' 74' ' ' ARG . 63.4 mtm180 71.28 -57.59 0.6 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.007 0.923 . . . . 27.27 111.093 -178.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.092 -0.956 . . . . 26.960000000000001 111.087 -179.807 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.781 0 N-CA-C 111.821 -0.512 . . . . 11.48 111.821 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.81 -178.4 4.57 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.064 2.509 . . . . 10.23 111.638 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.3 mt -79.03 -10.75 59.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.979 0.418 . . . . 10.02 110.385 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.88 152.85 17.91 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.894 -0.594 . . . . 6.8899999999999997 111.638 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 m -67.34 95.51 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.032 0.444 . . . . 6.0199999999999996 110.851 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 p -171.12 163.36 7.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.686 -0.688 . . . . 3.5099999999999998 109.901 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 73.8 -55.39 0.67 Allowed 'General case' 0 N--CA 1.469 0.486 0 O-C-N 123.937 0.773 . . . . 2.5 111.597 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.48 -44.85 96.37 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.494 -0.384 . . . . 2.1299999999999999 112.346 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.11 -40.63 90.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.06 0.457 . . . . 2.1899999999999999 111.088 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.662 ' HA ' ' HD2' ' A' ' 13' ' ' HIS . 57.8 tp -67.91 -46.83 70.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.989 -0.55 . . . . 1.6799999999999999 110.492 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.98 -44.59 97.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.672 -0.694 . . . . 1.71 110.052 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.71 -50.42 73.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.014 -0.539 . . . . 1.75 111.972 -178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.662 ' HD2' ' HA ' ' A' ' 10' ' ' LEU . 3.2 p80 -72.02 -27.79 62.95 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 120.519 -0.472 . . . . 1.78 110.231 -175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -46.15 65.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.51 -0.314 . . . . 1.0900000000000001 110.319 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.21 85.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.973 -0.558 . . . . 1.46 110.813 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.1 t -59.82 -43.94 94.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.976 -0.556 . . . . 2.2799999999999998 110.764 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.543 HD13 ' HB ' ' A' ' 36' ' ' VAL . 84.2 mt -80.97 -25.63 37.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.786 0.327 . . . . 1.6499999999999999 110.781 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.42 31.09 9.88 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.606 -0.806 . . . . 1.28 112.98 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.406 HG13 ' HE1' ' A' ' 30' ' ' PHE . 57.8 t -75.17 112.9 13.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 109.525 -0.546 . . . . 0.98999999999999999 109.525 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.743 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 68.1 mtp180 -123.39 133.49 54.08 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 2.6699999999999999 110.54 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.2 mp -132.73 127.39 34.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.467 -0.333 . . . . 1.45 110.674 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HB3' HD13 ' A' ' 56' ' ' LEU . 18.0 p90 -150.85 145.34 25.61 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.209 -0.663 . . . . 2.2599999999999998 109.209 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 28' ' ' LEU . 7.2 p -93.22 128.92 44.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.208 0.528 . . . . 2.9199999999999999 111.036 -176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -123.35 106.8 10.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.639 -0.71 . . . . 4.2000000000000002 109.206 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.5 -107.3 2.13 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.118 -0.793 . . . . 4.2000000000000002 111.118 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' OE1' ' HD2' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -116.1 -6.78 11.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.206 0.527 . . . . 5.1500000000000004 110.093 177.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -102.36 118.17 36.31 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 5.3799999999999999 110.758 -177.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 7.8 tt -70.38 118.59 13.39 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.331 -0.988 . . . . 2.4399999999999999 108.331 170.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -85.74 129.24 34.88 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.601 -0.518 . . . . 4.2199999999999998 109.601 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.406 ' HE1' HG13 ' A' ' 19' ' ' VAL . 0.2 OUTLIER -114.75 130.74 56.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.114 -0.494 . . . . 1.6899999999999999 109.867 -177.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.743 ' HB3' ' HB2' ' A' ' 20' ' ' ARG . 0.0 OUTLIER -123.35 110.24 14.92 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.458 -0.571 . . . . 2.6800000000000002 109.458 177.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.56 130.37 6.69 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.376 -0.374 . . . . 1.6899999999999999 110.601 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' HG22 ' A' ' 36' ' ' VAL . 34.1 Cg_endo -69.24 157.91 59.64 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.646 2.231 . . . . 1.8400000000000001 111.502 177.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.31 122.92 11.03 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.556 2.17 . . . . 2.3100000000000001 112.328 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -15.36 27.59 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.956 -0.64 . . . . 1.76 113.167 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 33' ' ' PRO . 19.1 m -100.3 -8.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 117.399 0.599 . . . . 1.49 112.162 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.529 ' CE ' ' HA ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -86.58 20.8 2.35 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.181 -0.463 . . . . 1.4099999999999999 111.46 -174.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.1 p -56.3 145.63 56.4 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.141 -0.482 . . . . 1.45 111.147 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.35 -38.45 62.65 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.952 2.434 . . . . 1.72 113.043 -178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 44' ' ' ARG . 40.6 tt0 -59.61 -47.94 83.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 2.7599999999999998 110.398 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 tt -63.67 -42.81 98.0 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 121.14 0.495 . . . . 1.2 110.665 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.409 ' HA ' HD12 ' A' ' 45' ' ' LEU . 9.3 tp-100 -56.89 -40.35 76.08 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.492 -0.776 . . . . 2.0600000000000001 110.071 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -72.66 -29.51 63.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.736 -0.666 . . . . 1.5700000000000001 110.36 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 15.1 mmm180 -65.88 -38.13 87.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 120.984 0.421 . . . . 3.3399999999999999 110.604 177.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 42' ' ' GLN . 60.6 mt -57.29 -25.52 59.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.309 -0.86 . . . . 1.25 110.043 174.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.13 -22.88 8.83 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.546 -0.752 . . . . 2.2999999999999998 112.981 171.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.18 25.82 73.45 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.711 -0.756 . . . . 2.5699999999999998 111.923 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -98.38 149.18 22.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 120.981 0.42 . . . . 2.0800000000000001 110.706 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.532 ' O ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -68.44 -46.75 69.01 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.442 -0.799 . . . . 5.3600000000000003 111.211 -179.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.514 ' HA ' HD12 ' A' ' 53' ' ' ILE . 19.5 p80 -66.16 -33.28 75.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.391 0.615 . . . . 2.9900000000000002 109.99 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 1.7 tp10 -66.73 -42.71 85.86 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.243 -0.889 . . . . 2.75 109.478 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 48' ' ' ALA . 67.6 mt -67.89 -29.04 68.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.29 -0.868 . . . . 1.8999999999999999 111.103 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 49' ' ' ARG . 84.1 mt -58.55 -51.55 70.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.096 0.474 . . . . 2.7400000000000002 109.855 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.24 68.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.743 -0.662 . . . . 1.5 110.827 177.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 52' ' ' LEU . 3.2 tm? -69.43 -40.78 77.02 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.722 -0.672 . . . . 1.3200000000000001 109.678 -176.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 22' ' ' TRP . 1.2 tp -79.17 -30.48 43.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 109.66 -0.496 . . . . 1.6799999999999999 109.66 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -67.15 -21.38 65.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.265 -0.425 . . . . 4.0700000000000003 110.372 177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -61.76 -28.94 69.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.301 -0.408 . . . . 1.75 110.847 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.583 ' H ' HD13 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -106.82 12.67 28.73 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 119.847 -0.741 . . . . 2.4700000000000002 111.646 178.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 56' ' ' LEU . 51.1 mt-30 -97.11 127.29 39.16 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 2.5800000000000001 110.345 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 60' ' ' GLN . 12.5 Cg_exo -70.43 8.31 0.95 Allowed 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.93 2.42 . . . . 2.48 113.086 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.7 m -77.31 -26.17 51.96 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.895 0.378 . . . . 4.0599999999999996 110.966 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.1 m -117.93 120.35 37.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.11 -0.495 . . . . 5.8600000000000003 111.131 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -101.63 153.98 19.28 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.804 -0.635 . . . . 8.2100000000000009 109.601 174.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -88.34 -39.3 6.85 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.684 -0.77 . . . . 10.390000000000001 112.091 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.86 60.29 0.54 Allowed Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.674 -0.774 . . . . 11.32 112.224 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.9 p -109.61 -18.22 13.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.86 0.362 . . . . 13.15 111.519 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.8 tp -109.74 118.53 36.77 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.926 0.393 . . . . 15.0 111.059 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 69' ' ' LEU . 4.3 pp -141.75 133.74 27.49 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.931 -0.577 . . . . 16.239999999999998 109.505 175.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -145.3 94.27 5.27 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.323 -0.399 . . . . 16.760000000000002 111.396 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.574 ' HB2' ' HB3' ' A' ' 75' ' ' ASN . 2.3 Cg_endo -82.44 72.64 5.96 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.978 2.452 . . . . 18.719999999999999 109.858 172.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 p -78.37 -16.17 13.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.263 -0.88 . . . . 19.52 110.524 -173.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.08 -50.54 39.93 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.33 -0.619 . . . . 20.52 109.33 173.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -169.42 122.87 0.77 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.921 -0.581 . . . . 23.780000000000001 111.121 172.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 71' ' ' PRO . 8.2 p30 -126.23 171.47 10.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.73 -0.668 . . . . 22.18 109.306 173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -112.2 101.39 1.24 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.476 -0.869 . . . . 23.170000000000002 113.472 -173.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -100.28 -9.04 22.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.993 -0.743 . . . . 26.359999999999999 108.993 173.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 C--O 1.249 1.05 0 CA-C-N 114.534 -1.212 . . . . 26.210000000000001 110.465 -179.636 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.653 0 N-CA-C 111.845 -0.502 . . . . 14.859999999999999 111.845 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -62.9 115.3 2.85 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.621 2.214 . . . . 14.18 111.342 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 53.1 tp -121.37 -37.25 2.95 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.047 -0.524 . . . . 13.74 110.084 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.88 -36.79 51.85 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.94 -0.864 . . . . 11.08 110.94 177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 33.0 t 71.43 135.84 0.04 OUTLIER 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.562 0.696 . . . . 9.7799999999999994 112.698 171.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 24.5 m -92.25 134.42 34.9 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.827 -0.805 . . . . 8.3800000000000008 108.827 171.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.83 94.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.492 0.186 . . . . 5.7800000000000002 111.423 -175.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.62 -50.53 66.68 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.93 -0.652 . . . . 4.6600000000000001 112.378 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.62 -39.34 87.85 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.02 0.438 . . . . 5.7800000000000002 111.263 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.586 ' HA ' ' HD2' ' B' ' 13' ' ' HIS . 68.0 tp -64.72 -46.79 80.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 4.3799999999999999 110.498 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -64.08 -46.38 84.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.895 -0.593 . . . . 2.8599999999999999 109.843 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.51 75.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 3.7400000000000002 111.838 -177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' HIS . . . . . 0.586 ' HD2' ' HA ' ' B' ' 10' ' ' LEU . 1.5 p80 -73.58 -27.57 61.39 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.634 -0.426 . . . . 5.0499999999999998 110.674 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.04 61.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.681 0.277 . . . . 3.3300000000000001 110.367 177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.07 82.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 4.3700000000000001 110.8 177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 19.8 t -61.41 -42.98 99.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.778 -0.646 . . . . 6.0999999999999996 110.833 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.505 HD13 ' HB ' ' B' ' 36' ' ' VAL . 90.2 mt -81.2 -24.37 37.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.837 0.351 . . . . 6.4900000000000002 110.937 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.11 36.7 7.02 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.748 -0.739 . . . . 4.7300000000000004 112.344 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . . . . . . . . . 61.6 t -83.22 113.44 22.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.531 -0.544 . . . . 3.6000000000000001 109.531 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ARG . . . . . 0.72 ' HB2' ' HB3' ' B' ' 31' ' ' GLN . 63.1 mtp180 -124.8 134.81 52.62 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.358 -0.383 . . . . 6.7999999999999998 110.858 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.483 HD23 HD21 ' B' ' 28' ' ' LEU . 6.2 mp -134.22 128.64 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.388 -0.369 . . . . 3.7999999999999998 110.767 177.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' TRP . . . . . 0.72 ' HB3' HD13 ' B' ' 56' ' ' LEU . 26.6 p90 -151.62 143.78 23.97 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.658 -0.497 . . . . 6.7999999999999998 109.658 176.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' B' ' 28' ' ' LEU . 7.1 p -88.92 126.87 41.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.17 0.51 . . . . 7.7400000000000002 111.205 -177.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -118.86 106.23 12.29 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.922 -0.77 . . . . 9.4399999999999995 108.922 177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.14 -106.45 1.84 Allowed Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.775 -0.726 . . . . 9.6600000000000001 111.394 -174.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.03 -3.69 12.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 9.3200000000000003 110.313 177.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.405 ' NE ' HD11 ' A' ' 52' ' ' LEU . 6.8 tpt85 -107.76 114.24 28.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 7.3399999999999999 110.854 -176.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' B' ' 23' ' ' VAL . 7.5 tt -68.12 118.9 11.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.5 -0.926 . . . . 5.1799999999999997 108.5 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -87.34 126.8 35.08 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.679 -0.489 . . . . 8.0700000000000003 109.679 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' PHE . . . . . 0.469 ' CE2' HD21 ' B' ' 21' ' ' LEU . 0.5 OUTLIER -111.57 131.25 55.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.931 -0.577 . . . . 4.1600000000000001 109.745 -177.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.72 ' HB3' ' HB2' ' B' ' 20' ' ' ARG . 7.6 tp-100 -124.89 107.92 11.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.235 -0.439 . . . . 6.7199999999999998 110.079 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.98 129.85 6.64 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.329 -0.396 . . . . 5.75 110.52 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.499 ' O ' HG22 ' B' ' 36' ' ' VAL . 37.6 Cg_endo -67.1 157.45 61.66 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.544 2.163 . . . . 6.9800000000000004 111.768 177.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -59.29 123.75 14.09 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.453 2.102 . . . . 8.8499999999999996 112.529 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.67 -24.68 14.71 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 115.694 -0.684 . . . . 8.0899999999999999 113.401 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' B' ' 17' ' ' LEU . 10.4 m -95.25 4.59 8.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.003 0.402 . . . . 7.0 111.36 -176.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' MET . . . . . 0.672 ' HA ' ' CE ' ' B' ' 37' ' ' MET . 0.0 OUTLIER -95.91 18.96 12.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.185 0.517 . . . . 5.7300000000000004 110.809 -176.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.5 p -57.27 145.88 64.81 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.682 -0.69 . . . . 7.96 111.48 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.36 -41.02 52.62 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.312 2.674 . . . . 7.2999999999999998 113.167 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' B' ' 44' ' ' ARG . 35.1 tt0 -57.98 -48.67 79.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.654 -0.248 . . . . 9.2200000000000006 110.473 178.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' B' ' 45' ' ' LEU . 9.0 tt -66.1 -38.21 87.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.466 -0.334 . . . . 6.1699999999999999 110.63 -177.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -60.09 -40.45 89.61 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.735 -0.468 . . . . 4.8399999999999999 109.735 176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -72.57 -29.75 63.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.758 -0.656 . . . . 7.3499999999999996 110.556 177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' B' ' 40' ' ' GLU . 14.4 mmm180 -66.67 -32.66 74.12 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.502 -0.317 . . . . 8.2799999999999994 110.657 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' B' ' 41' ' ' LEU . 86.3 mt -62.61 -25.36 68.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.88 -0.6 . . . . 4.1299999999999999 110.032 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.95 -23.67 7.6 Favored Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.642 -0.708 . . . . 5.5800000000000001 112.699 173.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.42 24.2 73.65 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.856 -0.688 . . . . 4.5 112.155 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.47 149.78 21.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.627 0.251 . . . . 5.4100000000000001 111.068 -177.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.68 ' HD3' ' H ' ' B' ' 49' ' ' ARG . 0.0 OUTLIER -67.55 -47.56 69.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 8.2200000000000006 111.312 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' HIS . . . . . 0.55 ' HA ' HD12 ' B' ' 53' ' ' ILE . 25.0 p80 -60.41 -32.86 71.74 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.718 0.294 . . . . 7.1600000000000001 111.485 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -38.66 75.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.43 -0.35 . . . . 5.7199999999999998 110.312 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 54.9 mt -70.76 -26.18 63.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.46 -0.336 . . . . 3.0600000000000001 110.961 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 50' ' ' HIS . 83.2 mt -61.76 -51.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.757 -0.46 . . . . 6.4000000000000004 109.757 174.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 -37.22 80.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.123 0.487 . . . . 3.73 110.676 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -59.85 -47.6 85.08 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.489 -0.778 . . . . 2.46 110.168 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.72 HD13 ' HB3' ' B' ' 22' ' ' TRP . 26.8 tp -67.88 -35.34 78.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.005 0.431 . . . . 5.5599999999999996 110.717 177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -69.24 -19.47 63.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.274 -0.421 . . . . 7.1900000000000004 111.256 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.01 -28.22 69.65 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.55 -0.295 . . . . 4.2300000000000004 111.424 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.717 HD13 ' H ' ' B' ' 59' ' ' LEU . 0.0 OUTLIER -107.16 9.55 30.25 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.881 0.372 . . . . 6.46 110.897 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' B' ' 56' ' ' LEU . 52.3 mt-30 -93.66 128.32 42.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.377 -0.374 . . . . 7.3499999999999996 110.107 176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.62 9.45 1.26 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 123.225 2.617 . . . . 8.1699999999999999 112.643 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' SER . . . . . . . . . . . . . 7.1 m -75.91 -32.06 59.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.123 0.487 . . . . 8.8900000000000006 110.601 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' SER . . . . . . . . . . . . . 15.5 m -114.31 121.66 44.34 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.18 -0.464 . . . . 9.7599999999999998 111.18 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -102.35 148.57 25.31 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.492 -0.559 . . . . 11.210000000000001 109.492 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.3 -48.56 9.29 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.73 -0.748 . . . . 12.710000000000001 112.646 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.13 62.24 0.43 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.998 -0.62 . . . . 13.609999999999999 112.073 -178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.6 p -105.85 -21.17 13.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.999 0.428 . . . . 15.17 111.048 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 63.5 tp -106.35 122.56 46.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.224 -0.444 . . . . 16.82 110.521 -176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 pp -143.51 141.19 30.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.255 -0.43 . . . . 18.109999999999999 110.172 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -151.54 94.08 3.46 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.181 -0.463 . . . . 19.0 110.305 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.87 99.35 1.23 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 123.108 2.538 . . . . 20.289999999999999 112.097 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.97 -31.92 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.027 -0.533 . . . . 21.129999999999999 110.916 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' B' ' 75' ' ' ASN . . . -73.03 113.4 10.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.556 -0.293 . . . . 22.899999999999999 110.353 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 70.18 -15.64 0.33 Allowed 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.896 0.878 . . . . 25.059999999999999 112.043 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' B' ' 73' ' ' ALA . 28.6 t-20 67.28 -76.3 0.05 Allowed 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.657 0.783 . . . . 24.460000000000001 111.48 178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' GLY . . . . . . . . . . . . . . . -167.6 28.87 0.17 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.68 -0.568 . . . . 24.609999999999999 111.68 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -107.27 98.09 7.77 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.007 0.432 . . . . 27.27 110.624 -178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' LEU . . . . . . . . . . . . . 57.8 tp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.379 -0.819 . . . . 26.960000000000001 109.133 175.914 . . . . . . . . 0 0 . 1 stop_ save_